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This thesis develops the implementation of the capability approach within health economic 
evaluations. Until now, the focus of applying the capability approach within health economics 
has centred on its theoretical merits, as well as the development of capability questionnaires. 
 
The aim of this research is to establish methods for applying the capability approach in an 
evaluation framework. Specifically, this is done by (i.) investigating how a measure of 
capability well-being, the ICECAP-O, can be incorporated into a health economic model and 
(ii.) establishing the objective of capability evaluations to aid the decision-making process in 
allocating scarce resources for health. 
 
The relationship between capability and condition-specific health status for osteoarthritis 
patients is studied through statistical mapping. Methods from the capability literature are 
drawn upon to construct a methodology for generating capability outcomes that can be used to 
aid decision-making. This methodology is then tested on an existing economic model, the 
Birmingham Rheumatoid Arthritis Model (BRAM). 
 
Key findings from this thesis are that (i.) it is feasible to predict capability from a condition-
specific health instrument and (ii.) establishing “sufficient capability” as the objective for 
capability evaluations. Further research is required to see what difference a capability based 
evaluation would make in practice. 
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CHAPTER 1. INTRODUCTION 
The study of the economics of health and healthcare has grown significantly in the past fifty 
years, ever since Nobel Laureate in Economics Kenneth Arrow wrote his seminal paper on the 
welfare economics of medical care in 1963 (Arrow, 1963). Economic evaluations are an 
analytical approach to assessing the benefits of  competing resources in relation to their cost 
(Morris et al., 2007). Health economics, as a standalone social science discipline, has 
developed a number of unique methods for measuring the benefits of health interventions, 
which are for the most part, focused on the quantification of health benefits from 
interventions. This is in contrast with the majority of UK public policy economic assessments, 
which continue to focus on the monetary valuation of benefits (HM Treasury, 2003). 
 
The role of health economic evaluations in aiding decision-making has grown significantly 
within the UK since the foundation of the advisory body for health guidance, the National 
Institute for Health and Care Excellence (NICE) in 1999. Since then, NICE has stipulated the 
requirement for economic evaluations for new interventions to be conducted before these 
interventions can be recommended for use within the National Health Service (NHS) (NICE, 
2004; NICE, 2009a; NICE, 2013). 
 
The Quality Adjusted Life Year (QALY) is the primary outcome measure of benefit in the 
majority of economic evaluations for NICE (NICE, 2013). The QALY combines health 
related quality of life (HRQoL) with length of time in that health state and changes over time 
to generate a single outcome of health status over time (Weinstein et al., 2009). The QALY 
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has faced a number of criticisms since it has been developed, from both the theoretical 
assumptions underpinning the outcome measure (Carr-Hill, 1989; Loomes & McKenzie, 
1989), as well as the considerations that are overlooked within the measure (Nord, 1999). 
 
The objective of the QALY within NICE is to provide a generic measure of health over time, 
so that all interventions across the health service are treated in an equivalent manner in terms 
of the potential benefit accrued from a given intervention (NICE, 2013). To implement such 
an outcome in practice, a “reference case” HRQoL measure is required. The EQ-5D 
questionnaire (Brooks, 1996) is the currently recommended measure by NICE (NICE, 2013). 
However, notable difficulties of using a generic health questionnaire to capture all changes in 
health status for a number of conditions have been found, so alternative HRQoL measures 
(Brazier et al., 2002; Furlong et al., 2001), bolt-on dimensions to the EQ-5D (Lin et al., 2013) 
and condition-specific instruments (Brazier & Tsuchiya, 2010) to generate QALYs have been 
proposed instead. The development of alternative HRQoL instruments has led to the difficulty 
in comparing QALY outcomes produced via the original EQ-5D compared to alternative 
HRQoL measures (Mortimer & Segal, 2008). This is because alternative HRQoL measures, 
bolt-on dimensions or condition-specific instruments are likely to capture different 
dimensions than the reference case advocated by guidance bodies like NICE. 
 
Additionally, there are a number of theoretical arguments against the use of the QALY 
outcome for measuring the benefits from health interventions. One such argument is the focus 
on changes in individual health status only, rather than a more holistic measure of individual 
welfare which would capture the broader benefits to individual wellness from healthcare 
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(Dolan et al., 2005b). This has led to some health economists for an outcome of benefit more 
in line with traditional economic theory to focus on utility from health interventions, such as 
willingness to pay (WTP) questionnaires (McIntosh et al., 2010; Donaldson et al., 2012).  
 
An alternative proposal to the welfarist (through WTP) and extra-welfarist (through HRQoL 
and QALYs) approaches to measure benefits is the capability approach. The capability 
approach, developed originally by Amartya Sen (Sen, 1985; Sen, 1992; Sen, 1993; Sen, 
2009), is a prominent critique of standard welfare economic theory. Sen argues that standard 
welfare economic theory is used to evaluate societal well-being through a narrow focus on a 
person’s utility levels (Sen, 1980). The capability approach has been used to justify the use of 
the QALY (Culyer, 1989; Cookson, 2005b; Bleichrodt & Quiggin, 2013). Nonetheless, a 
number of health economists believe that a broader outcome measure based on individual 
capabilities rather than HRQoL would be a more appropriate implementation of the capability 
approach within a health economics framework (Verkerk et al., 2001; Grewal et al., 2006; 
Coast et al., 2008c; Lorgelly et al., 2010a; Kinghorn, 2010; Smith et al., 2012; Payne et al., 
2013). 
 
The use of the capability approach directly in the health economics field has so far focused on 
the development of capability questionnaires (Coast et al., 2008a; Lorgelly et al., 2008; Anand 
et al., 2009; Al-Janabi et al., 2012a). Less progress has been made on how such 
questionnaires, once fully developed and validated, can be used within an economic 
evaluation framework to aid priority setting in healthcare for advisory bodies like NICE. This 
thesis aims to further develop the implementation of the capability approach within health 
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economics by addressing how capability questionnaires can be incorporated within an 
evaluation framework to aid decision making by allocating resources from a capability 
perspective. 
 
The thesis is structured as follows; 
 
In Chapter 2, the theory and use of economic evaluations in aiding decision-making in 
healthcare are examined. The chapter begins by examining the theory which underpins the 
current standard evaluation framework in health economics, known as “extra-welfarism” 
(Culyer, 1989). The evaluation frameworks that have emerged from extra-welfarism are 
compared with welfare economic methods to analysing healthcare. The QALY outcome is 
explained in detail as well as alternative outcomes that have been proposed. The difficulties of 
capturing benefits from healthcare are discussed in terms of the types of economic models 
that have been developed to model costs and outcomes from the dynamic nature of individual 
welfare over time. Such decision models are crucial in aiding decision-making for new 
treatments of complex health interventions. The chapter closes with a critique of the QALY in 
terms of the narrow evaluation space inferred from its focus on health alone. 
 
Chapter 3 discusses an alternative theoretical base to the current approaches used within 
health economics. The theory behind the capability approach is detailed and compared with 
the alternative frameworks discussed in Chapter 2. Two possible means by which the 
capability approach could be applied to health are elaborated and critiqued from a health 
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economics perspective. The focus then shifts from theoretical arguments to practical 
application of the capability approach. Two attempts have been made to combine capability 
theory with the QALY instrument. Alternative approaches through developing capability 
questionnaires for assessing interventions are then explored. 
 
Chapter 3 raises a number of potential methods and different interpretations as to how 
questionnaires are aligned to capability theory. In Chapter 4 a literature review is conducted to 
explore how the capability approach has been applied across disciplines to assess capability 
and inform decision-making. A summary of previous reviews of empirical capability 
applications are first detailed. The original literature review in Chapter 4 attempts to highlight 
how recent measures of capability have been developed and the objective of such instruments 
once aggregated. 
 
Chapter 5 begins the process of implementing capability questionnaires within a health 
economic evaluation, by identifying an appropriate case study for this thesis. A difficulty with 
the lack of routine collection of new capability questionnaires meant that the availability of 
longitudinal data on capability questionnaires were scarce at the beginning of this research 
project. While routine collection of capability questionnaires in clinical trials is improving 
(Henderson et al., 2013), it will take time to build a portfolio of studies across the many 
different types of conditions that currently exist. Therefore, alternative methods for 
incorporating capability questionnaires within an economic evaluation are explored through a 
process known as mapping, which allow for the generation of economic outcomes. Mapping 
between two instruments allows for the prediction of one instrument from another instrument. 
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This approach is already used in health economics when measures used to generate QALYs 
have not been collected. The guidance for researchers new to mapping is limited, although 
two recent notable publications are discussed (Brazier et al., 2010; Longworth & Rowen, 
2011). 
 
Chapter 6 explores the possibility of mapping to predict capability from condition-specific 
health instruments. The collection of capability data longitudinally at the time of this research 
was scarce, so mapping offered a way of incorporating capability questionnaires into decision 
models. Before implementing a capability instrument in an economic evaluation, a predictive 
relationship between a generic measure of capability and a health status instrument was first 
required, so that a prediction of capability from health was feasible. A dataset of osteoarthritis 
patients requiring knee or hip replacement was identified containing a measure of capability, 
the ICEPOP Capability questionnaire for older people – the ICECAP-O (Coast et al., 2008a), 
and a condition-specific instrument, the WOMAC Osteoarthritis index (Bellamy et al., 1988). 
The objective of this chapter is to assess the feasibility of mapping between these two 
instruments and to produce a method of mapping to a decision model, which is applied later 
in the thesis. 
 
In Chapter 7, the findings from the review of capability questionnaire applications in Chapter 
4 are drawn upon to develop an appropriate objective for capability outcomes in health 
economics. “Sufficient capability” is used to assess the improvements of capability below a 
threshold level deemed as sufficient. A number of potential capability outcomes are explored 
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with a sample of patients completing the ICECAP-O at three time points to illustrate the 
calculations of these outcomes over time. 
 
Building on the previous two chapters of implementing the use of a capability instrument 
within a mapping study (Chapter 6) and the sufficient capability objective (Chapter 7), in 
Chapter 8, a case study is used to illustrate the capability outcomes in a decision model. In 
Chapter 5, the Birmingham Rheumatoid Arthritis Model (BRAM) was identified as the most 
relevant case study given the data availability at the time (Malottki et al., 2011). The BRAM 
relied on a mapping between the Health Assessment Questionnaire Disability Index (HAQ-
DI) to predict HRQoL for QALY calculations to assess different drug treatment strategies for 
Rheumatoid Arthritis patients within the UK. This case study allows the direct application of 
a capability instrument through a similar mapping process used in Chapter 6 and to test the 
alternative capability outcomes developed in Chapter 7 within an economic model used 
previously to aid decision-making. 
 
Chapter 9 presents the results of the case study. Previous BRAM results are compared with 
the capability outcomes generated in the mapping study detailed in the preceding Chapter 
(Chapter 8). The cost per unit change of capability gained varied considerably depending on 
the outcome implemented within the model. 
 
In Chapter 10 an overall discussion and conclusion to the thesis is presented. The principal 
findings of the thesis are highlighted. Strengths and weaknesses of the thesis are also 
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discussed. For decision-makers interested in using a capability instrument, a number of policy 
implications from this research are outlined. Finally, future research directions on the further 
implementation of the capability approach within health economics are suggested. 
 
Figure 1 presents the inter-relationships between the thesis and how they relate to one another 
in developing the capability approach within model-based economic evaluations. 
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While there are many interpretations about what economic analysis involves, Backhouse and 
Medema (2009) explored some of the common definitions of economic analysis in textbooks. 
The following quotation gives a flavour of some of the areas which are covered within the 
economic discipline (Backhouse & Medema, 2009): 
“Thus, economics is apparently the study of the economy, the study of the 
coordination process, the study of the effects of scarcity, the science of choice, and the 
study of human behaviour” (Backhouse & Medema, 2009, p. 222) 
 
Economics has evolved dramatically since the work of classical economists in the eighteenth 
century, like Adam Smith, who was primarily concerned with factors which influenced the 
wealth of nations and societal welfare from economic progress more generally (Smith, 1776). 
Increasingly, economics has been applied in areas which have less of a direct link to the 
traditional role of economic attempts to understand society. The primary concern of economic 
analysis in healthcare is to do with understanding the role of allocating scarce healthcare 
resources across a national service (Morris et al., 2007). This chapter aims to explore the 
leading theories within health economics today, with a particular focus on the justifications 
provided for economic evaluations used to aid the decision-making process in healthcare 




In Section 2.2, the role of economic theory in developing a framework by which healthcare 
ought to be examined is summarised. Particular attention is given to the shift in health 
economics from standard welfare economic theory to something which has become known as 
extra-welfarism. The reasoning behind the need for an alternative theoretical framework 
within health is detailed within this section. In Section 2.3, focus turns to the types of 
outcomes applied within health economic evaluations to measure individual improvements in 
well-being, how these outcomes are formulated as well as the differences between the 
outcomes. In Section 2.4, the types of economic evaluations which have been applied within 
the health economics literature are described. Primary attention is given to the dominant 
evaluation framework within the UK, cost-utility analysis (CUA). The reasons CUA has 
developed a dominant role within health care evaluation is further elaborated in this section. 
In Section 2.5, the role of modelling within health economics is detailed. Due to the complex 
nature of how individual health can change over time, a number of different ways of 
accounting for such changes within an evaluation based on economic models have been 
developed. Such modelling approaches, as well as how outcomes are incorporated within 
these evaluations are dealt with in section 2.5. In Section 2.6, the types of decision rules used 
to compare competing interventions are discussed. A review of critiques of the primary health 
economic outcome, the Quality-Adjusted Life Year (QALY), is presented in Section 2.7. 
Attention is focused on the evaluative space, the underlying assumptions and decision rules 
used in applying the outcome in economic assessments. The conclusion to the chapter 





2.2 HEALTH ECONOMIC THEORY: WELFARISM AND EXTRA-WELFARISM 
Any normative formulation of what society ought to be needs a form of ethical theory 
(Broome, 2009). This section focuses on the two prevailing theoretical bases for conducting 
economic evaluation in healthcare analysis. The first theory considered is the use of standard 
welfare economic theory as the basis for evaluation, generally referred to as welfarism 
(Brouwer et al., 2008). The second approach looks at tackling some of the problems 
associated with the application of standard welfare economic theory to healthcare, but still 
maintaining principles related to the ideals from welfare economics. This theoretical basis is 
generally referred to as extra-welfarism (Brouwer et al., 2008). 
 
2.2.1 Welfarism 
Alongside the numerous definitions used to define economics, welfarism is a term that has 
many interpretations, as it has been applied in a variety of ways. When referring to welfarism, 
welfarist or welfare economics in this thesis, it is within the interpretation as noted by Sen as 
a focus on individual utilities only, in terms of desire and satisfaction based on people’s 
preferences, as the function of welfare (Sen, 1992). Welfare economics is the standard 
theoretical framework for assessing market based solutions in areas such as environmental 
economics (Hanley & Barbier, 2009) and transport economics (Button, 2003), and is the 
theoretical basis for the majority of economic evaluations applied in public policy by the UK 
government (HM Treasury, 2003). Welfare economics is primarily concerned with economic 
efficiency, meaning: 
“to order social states on the basis of some minimal value judgements” (Boadway & 




There are four key principles upon which welfarism attempts to achieve economic efficiency 
(Hurley, 1998; Hurley, 2000):  
The first principle is known as utilitarianism. Utilitarianism means that each individual in 
society is a rational agent. Under utilitarianism, each agent acts to maximise their utility or 
preferences to their optimum or highest possible level (Hurley, 1998). 
 
The second principle of welfarism is individualism. This is where individuals themselves are 
thought to be the best judges of how to maximise their utility, with a laissez-faire approach 
from the state which permits utility maximisation by individuals (Hurley, 2000).  
 
Principle number three is consequentialism. Consequentialism is where the outcome of 
choices made by individuals is the only consideration for assessing their goodness. The means 
to how the ends or outcomes are reached are deemed irrelevant (Hurley, 1998). 
 
The final principle is welfarism itself. Welfarism can be defined in many different ways, but 
the principle tenet is concerned with the judgement that is made for allocating resources to 
improve human welfare. Within welfarism this judgement is based only on individual utility 
(Hurley, 1998). 
 
The evaluation of individual utility within the welfare economic framework is mainly 




economist Vilfredo Pareto (1848-1923). The theory behind Pareto optimality in welfare 
economics is that there is a socially optimum point at which efficiency is reached, which 
represents societal welfare whereby no change in individual utility level can be improved 
without making someone else’s utility worse (Boadway & Bruce, 1984). Any change in utility 
which moves society closer to the point of Pareto optimality is referred to as a Pareto 
improvement (Morris et al., 2007). This objective is closely associated to the writings of 
utilitarian economist Léon Walras (1834-1910) and his theory on general economic 
equilibrium (Hunt, 2002). 
 
While the Pareto principle allows for a judgement on welfare levels to be made where no one 
loses utility and there are only utility gainers, it does not help to make a judgement under a 
fixed healthcare budget as there will be both gains and losses, in terms of individual utility, 
from the impact of a particular policy. In reality, most policy interventions will have winners 
and losers, which the Pareto improvement rule does not take into consideration (Coast et al., 
2008d). To counteract this problem welfare economists have proposed a compensation 
principle (Hicks, 1939; Kaldor, 1939), whereby a potential Pareto improvement is achieved if 
those who gain utility are able to hypothetically compensate the individuals who lose utility 
and still be better off themselves (Morris et al., 2007). In this case, the policy intervention 
should be implemented.  
 
2.2.2 Extra-Welfarism 
The application of the normative theoretical framework of welfarism to a healthcare setting is 




nature of healthcare. The principle underlying welfarism that has been most strongly 
challenged within health economics is the principle of utilitarianism, i.e. relying solely on 
utility information to judge individual wellbeing. While early applications of the extra-
welfarist approach evolved out of the importance of valuing health from healthcare (Coast, 
2004), more recently the theoretical critique of welfarism for use in healthcare has been drawn 
primarily from the critique of utility as a basis for assessing societal welfare by Amartya Sen 
(Sen, 1977). In his critique of welfare economics, Sen referred to capturing additional 
information beyond individual utility as extra-welfarist. From this critique, the term 
extra-welfarist has become associated with the health economics alternative to welfarism. 
 
Brouwer and colleagues (2008) identified four ways in which extra-welfarism can be 
distinguished from welfare economic theory, as presented in Section 2.2.1 (Brouwer et al., 
2008). 
 
First, extra-welfarism permits the use of non-utility outcomes. Given that the focus on the 
healthcare sector is on improving health, Brouwer and colleagues (2008) argue that a sole 
focus on utility is too narrow for health analysis. The primary normative framework for extra-
welfarism in health economics is mainly based on incorporating additional information 






Second, extra-welfarism allows for the valuation of outcomes from those not directly affected 
by the outcome of interest. Within extra-welfarism, a number of different population groups 
could be considered relevant for valuing outcomes using this theory, not only the values (in 
terms of utility) of those directly affected within the welfarist tradition (Brouwer et al., 2008). 
Alternative values from the individual(s) under consideration can be appropriate within state 
provision of healthcare, for example, where the general population is funding the treatment of 
those who receive treatment, so it could be argued that they are stakeholders in the benefit 
obtained from such interventions and should be involved in the valuation of outcomes (Gold 
et al., 1996). 
  
Thirdly, Brouwer et al. (2008) consider extra-welfarism to be different from welfarism 
because it allows the weight of outcomes to vary from individual preferences. For example 
different weights could be applied based upon a socio-demographic characteristic of the 
individuals receiving the intervention (Brouwer et al., 2008), or additional weight could be 
added if priority was advocated for a particular patient group (e.g. children). 
 
Finally, extra-welfarism is different from welfarism because it permits interpersonal 
comparison in a number of dimensions of well-being (Brouwer et al., 2008). The primary 
difference in outcomes used within the extra-welfarism umbrella is that comparisons of 
wellness in terms of health are possible within this framework and comparisons between the 






While it has been argued that there are a number of differences between the extra-welfarist 
and welfarist frameworks, a number of similarities between the applications of the two 
theories remain. The objective within the extra-welfarist framework remains consequential in 
evaluation (i.e. maximisation), mirroring the same form of consequentialism as applied in 
welfarism. The only difference is what is maximised, with the maximisation of utility in 
welfarism replaced with the maximisation of health in extra-welfarism (Hurley, 1998). While 
the extra-welfarism framework argues for the multidimensionality of outcomes to be 
accounted within evaluation, the practical application of extra-welfarism focuses on a single 
dimension (Hurley, 1998). This is particularly true within the extra-welfarism theoretical 
framework applied within health economics presently, with the objective of the maximisation 
of health using health related outcomes as the primary objective of interest (Culyer, 1989). 
 
2.3 MEASURING BENEFITS FOR ALLOCATING RESOURCES IN HEALTH 
ECONOMICS 
The first section on outcome measurement in economic evaluation focuses on the Quality 
Adjusted Life Year (QALY). In particular, this section addresses what the QALY is, how it is 
calculated and the history of its use in health economic evaluations. The second part of this 
section focuses on outcomes that have been proposed as an alternative to the QALY in 
economic evaluations. 
 
2.3.1 Quality Adjusted Life Years 
The QALY is the recommended measure of health benefit by the UK health guidance body 




outcome for the UK healthcare system was originally recommended in the first guidance to 
manufacturers of new technologies by NICE (NICE, 2001). This recommendation by NICE 
remains for new healthcare technologies (NICE, 2004) and also for public health interventions 
(NICE, 2011). These recommendations have led to a significant increase in the use of the 
QALY within the UK, with their use increasing globally too (Neumann et al., 2009).  
 
The QALY is a single outcome comprising a combination of two key components: health 
related quality of life (HRQoL) and length of life. Originally the idea of incorporating quality 
of life into economic outcomes was mooted 45 years ago (Klarman et al., 1968). In more 
recent times where QALYs have been identified as ‘reference cases’ by advisory bodies in the 
UK (NICE, 2004), the concept of incorporating quality as well as quantity of life into resource 
allocation decisions has been the primary outcome of economic evaluations.  
 
The QALY as it was defined first in 1977 (Weinstein & Stason, 1977) has changed relatively 
little over time (Johnson, 2009). The QALY takes account of both quality of life in terms of 
health (quality or Q) and length of life (i.e. life years LY). The quality part of the QALY is 
measured on a scale with the common anchoring of full health anchored to one and health 
states equivalent to being dead anchored to zero (Drummond et al., 2005). The quality part of 
the QALY is collected over time and combined with time spent in health states to measure 
QALYs, where 1 QALY is equivalent to one year in full health. When applied to patient 
populations, the QALY seeks to find the additional health benefit of receiving a new 
treatment in comparison to an alternative by measuring the change in quality and quantity of 




Three steps are required to value the quality part of the QALY: 1. what attributes of quality 
need to be valued; 2. how are these attributes to be valued; 3. who is to value them (Dolan et 
al., 2009). Each of these three issues are addressed below: 
 
2.3.1.1 What attributes to value 
To calculate what is to be valued in the QALY, a generic measure of health status is usually 
collected from patients. The recommended method by NICE for measuring quality for 
QALYs is the EuroQol (EQ-5D)  (Brooks, 1996). The EQ-5D is a five item questionnaire of 
health status which assesses mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression (Brooks, 1996). The dimensions on the EQ-5D were originally developed 
on three levels (i.e. no problems, some problems and a lot of problems on a given dimension). 
The EQ-5D has recently been expanded to a five level version, the EQ-5D-5L (Herdman et 
al., 2011) and is now recommended instead of the three level (EQ-5D-3L) version (NICE, 
2013). 
 
Other generic health status instruments to calculate the quality part of the QALY formula 
include the Short Form 6 dimension (SF-6D), the health utilities index Mark II (HUI2) or 
Mark III (HUI3) and the Assessment of Quality of Life (AQoL). The SF-6D is derived from 
the SF-36 or SF-12 generic health questionnaire. Dimensions on the SF-6D are physical 
functioning, role limitations, social functioning, pain, mental health and vitality, with four to 
six levels for each dimension (Brazier et al., 2002). The HUI3 consist of eight attributes 
which are vision, hearing, speech, ambulation, dexterity, emotion, cognition and 




impaired/disabled (Feeny et al., 1995). The HUI2 and HUI3 are mainly applied in North 
America (Furlong et al., 2001). Four versions of the AQoL exist, ranging from the AQoL-4D 
with four dimensions (independent living, mental health, relationships and stress) assessed 
across twelve questions, to the AQoL-8D with eight dimensions (four dimensions of AQoL-
4D plus happiness, coping, self worth and pain) assessed across thirty five questions 
(Richardson et al., 2011). The AQoL questionnaires are predominantly used in Australia 
(Hawthorne et al., 1999). 
 
2.3.1.2 How are the attributes valued 
Second, generic health status instruments need to be valued. NICE stipulates that the method 
for valuing between different health states must be choice based (NICE, 2013). This is the 
reason why rating scales of health such as the EuroQol Visual Analogue Scale (EQ-VAS), a 
scale of 0 (worst health state imaginable) to 100 (best health state imaginable) cannot be used 
to value health states, as respondents are not presented with a choice in the task.  Preferences 
for health states are used to compare different interventions to represent a societal value of 
changes in health status (Gold et al., 1996).  
 
For the EQ-5D-3L, the values associated with each of the 245 possible health states (3
5
 or 243 
health states and two additional health states for ‘unconscious’ and ‘dead’) were generated in 
the UK by Dolan from a representative sample of the general UK adult population (Dolan, 
1997). These preferences were elicited using the time-trade off (TTO) technique developed by 
Torrance and colleagues to generate health preferences between quality and quantity of life 




willing to trade off in a worse state of full health (i.e. less than 1) to improve their quality of 
life to its optimum level of full health (Torrance et al., 1972).  
 
Values for the SF-6D (Brazier et al., 2004a) and child-orienteted HUI2 (McCabe et al., 
2005b) questionnaires are calculated by adopting the standard gamble (SG) approach, which 
is based on von Neumann and Morgenstern utility theory (Drummond et al., 2005). Cardinal 
preferences are measured by choosing between two options for a specific health state: one 
option is the current option or the ‘do nothing’ approach; the second option is a new treatment 
with probabilities attached to the likelihood of outcomes if this new treatment replaces current 
practice (Gafni, 1994). Other alternative valuation methods include discrete choice 
experiments, whereby respondents are asked to choose between alternative states, and thus 
deriving a latent (unobservable) utility function of their preferences (de Bekker-Grob et al., 
2012). 
 
Once a health status questionnaire has been completed to give a profile of an individual for a 
given condition, values are then assigned to the patient profile to generate an index score for 
that state of being (Morris et al., 2012). Index scores of individual health states can then be 
combined with the length of period a given individual spends within this health state to 
calculate the QALY. For example, an individual who scores an EQ-5D score of 0.5 and is in 





2.3.1.3 Who to value the attributes 
Finally, there is the question of who should value health. As was already mentioned, the 
EQ-5D values were derived from the general population, which is the recommended approach 
by NICE (NICE, 2013). There is a debate between who should value health, with some 
arguing for the preferences of the general population in health outcomes (“decision utility”), 
while others believe that patients experiences (“experienced utility”) should be used instead 
(Dolan & Kahneman, 2008).  
 
Theoretical justification of the valuation by the general population is contributed mostly by a 
US panel of experts who suggested population valuations as the preferred approach due to the 
“veil of ignorance” of the general population. The general population would therefore 
maximise the aggregation of “utility” across the population lives within a given society 
(Garber et al., 1996). Additionally, there is the argument that the public should have a role 
within deciding what values are implemented within a publicly funded healthcare system, 
such as the NHS (Hadorn, 1991b).  
 
There are a number of arguments against using general population values. The main 
alternative proposed is that patients with experience of the condition should be valuing health 
states rather than the hypothetical values the population perceive for the same conditions 
(Dolan & Kahneman, 2008). There are also questions over the theoretical grounding of the 
population value approach within welfare economics (Gandjour, 2010). However, there are a 
number of issues with using patients’ values too. There are arguments that patients’ values are 




shift” down from what the best health state imaginable was before the condition (Sprangers & 
Schwartz, 1999). These concerns are reflected in research which shows that patients record 
higher values (i.e. in a better health state) than the general population do for the same 
condition (Ubel et al., 2003; Mann et al., 2009). 
 
2.3.2 Alternatives to the QALY 
A number of alternatives to the QALY outcome measure have been proposed within the 
health economics literature. Welfarists argue that the QALY is not consistent with standard 
welfare economic theory and development of outcomes which have theoretical grounding in 
welfarism are more appropriate for assessing allocative efficiency (see Section 2.3.2.1). 
Alternatively, other critiques of the QALY outcome have come from within extra-welfarism, 
arguing that aspects of the QALY calculation can be improved with the focus remaining on 
health status. Each additional proposal will be briefly discussed in Section 2.3.2.2. However, 
since the primary interest of this chapter is to demonstrate and critique the standard format of 
the health economic evaluation methods used most often in practice, critiques of the 
alternative measures are discussed only briefly. 
 
2.3.2.1 Willingness to Pay 
A major reason for the original deviation of health economics evaluation frameworks and 
outcomes from welfare economics was a difficulty of measuring individual benefits in 
monetary terms. Within a health setting, putting a direct monetary valuation on life is difficult 
on a number of levels, namely the ethical issues involved with valuing life monetarily as well 




However, this has not deterred attempts within health economics to develop methodologies 
more in line with standard welfare economic theory. 
 
Given that there is no market price for healthcare in the UK, due to the public funding of the 
NHS, alternative methods are required to ascertain monetary values of healthcare within the 
welfarist approach. The main method of valuing individuals’ utility (benefit) in this format is 
eliciting willingness to pay (WTP) values from individuals who would benefit from a given 
intervention. WTP methodology has normative grounding in the application of welfare 
economics of John Hicks (Hicks, 1939). Unlike the revealed preference approach to valuing 
benefits monetarily, where values are inferred from choices that individuals make in real 
world scenarios, WTP methodology is based on the stated preference approach, derived from 
survey or experimental responses (Morris et al., 2012). WTP for healthcare is usually 
captured in contingent valuation surveys, which vary from open-ended questions on an 
individual’s willingness to pay for an intervention, to iterative bidding games, payment scales 
and closed ended questions (Frew, 2010). The aim of all of these approaches, however, is to 
measure the maximum amount that an individual is willing to pay for the introduction of a 
new programme. Research within WTP studies has tended to focus on developing a greater 
understanding of which methodology is most appropriate for capturing individual’s WTP, 
with no overall consensus amongst welfare economists concerned, at present, as to the 





2.3.2.2 Extra-welfarist QALY alternatives 
A number of alternatives to the QALY have been suggested within the health economics 
literature. The most well-known of these is the Disability Adjusted Life Year (DALY), which 
has been the measure of choice for assessing the global burden of disease by the World Health 
Organisation (WHO) since the early 1990s (Murray & Lopez, 1996). The calculation of 
QALYs and DALYs are somewhat similar. However, the objective of maximising health 
within the QALY approach is substituted in the DALY approach with minimising disease 
burden by reducing DALYs lost (Murray & Lopez, 1996).  
 
DALYs consist of four components (Fox-Rushby, 2002):  
 
1. Life expectancy measured through years of life lost from what would be an expected 
average of life expectancy  
2.  Age values – greater weight is given to individuals with diseases between 20 and 40 
years old as they are the most likely to have caring responsibility for others. Less 
weight is given to those under five and over ninety 
3. Value of future time – DALYs are discounted at a rate of 3% per annum (this type of 
discounting is also included in QALYs) 
4. Value of avoiding disability, which is the inverse of the QALY calculation measuring 





The DALY has been developed to assess population health within developing countries, 
which is easier to measure where information on HRQoL may not be easily accessible 
(Murray & Lopez, 1996). The DALY provides more information than focusing on mortality 
data alone (Morris et al., 2012). 
 
Originally, the values associated with given health conditions measured by DALYs were 
derived from a person trade off (PTO) method from healthcare practitioners, as opposed to 
valuations from the general population through TTO or standard gamble for health status 
instruments used for QALYs. The PTO asks individuals how much of a particular outcome 
for disease X is worth compared to particular outcomes for disease Y (Nord, 1995). However, 
new values for DALYs have been generated from a general population sample across five 
countries (Salomon et al., 2012). 
 
Originally, the PTO was developed for another alternative outcome measure to QALYs, the 
Saved Young Life Equivalent (SAVEs) (Nord, 1992). SAVEs equal to 1 is the value 
associated with saving the life of a young person which, in Nord’s opinion, all other 
interventions should be compared against using PTO (Nord, 1995). While SAVEs allow for 
cost utility comparisons similar to QALYs, Nord (1992) argues that SAVEs are markedly 
different than QALYs by comparing all interventions against an intervention which is seen as 
the maximum benefit from healthcare (i.e. saving the life of a young person). However, 
SAVEs are not necessarily a replacement for the QALY, as decision-makers may still be 





Finally, the healthy-years equivalent (HYE) is an outcome instrument considered by some as 
a theoretically superior measure to the QALY (Mehrez & Gafni, 1989). While HYEs also 
combines health and length of life within one measure, HYEs differ in two respects to the 
QALY (Drummond et al., 2005) : 
1. HYEs measure preferences over all of the varying states a person would find 
themselves in during treatments rather than measuring preferences of each state on its 
own  
 
2.  HYEs use a two-stage standard gamble process taking account of utility for each 
health path and the healthy year gained, whilst QALYs are compiled of a one stage 
process of standard gamble or time trade-off  
 
However, due to the extensive and more complex calculation of the HYEs (Hauber, 2009), 
like SAVEs, DALYs, and WTP measures, the HYE has failed to catch the decision-makers 
attention in the same way as the simpler QALY outcome, within the UK at least. 
 
The majority of these non-QALY extra-welfarist outcomes have been proposed because of 
some of the underlying assumptions with the QALY. The shortcomings of the QALY will be 





2.4 EVALUATION FRAMEWORKS FOR HEALTH 
In this section, an account of the main economic evaluation types that have been employed to 
aid decision-making for healthcare provision are examined. While most attention is given to 
the recommended evaluation framework by NICE, the section starts with an introduction to 
the standard economic evaluation framework, cost-benefit analysis (Section 2.4.1). Other 
types of evaluation frameworks which have been implemented are also discussed in this 
section. 
 
2.4.1 Cost-Benefit Analysis (CBA) 
The main type of economic evaluation arising from the theoretical basis of welfare economics 
is cost-benefit analysis (CBA). The main aim of CBAs are to value the costs and benefits of 
different interventions/treatments against each other, usually in monetary terms (Drummond 
et al., 2005). This is the most clearly Paretian form of economic analysis in practice, where 
benefits are sought which deliver a societal increase in utility. It is the primary evaluation 
framework used by the UK in appraising and evaluating public policy projects outside of 
healthcare (HM Treasury, 2003). 
 
The origins of CBA can be traced back to the first half of the nineteenth century when French 
economist and engineer, Jules Dupuit, enquired about how the use of toll roads would benefit 
the public at large (Boardman, 2006). Cost-benefit analysis plays a major role in aiding 
decision-making in areas concerning transport and other areas across the public sector, such 




healthcare, however, it remains somewhat on the periphery in comparison to its use in other 
areas of the public sector. 
 
Cost-benefit analysis can be defined as: 
“a policy assessment method that quantifies in monetary terms the value of all 
consequences of a policy to all members of society” (Boardman, 2006, p.2)  
 
The aim of this type of analysis is to estimate monetary values for benefits, compare them 
with the monetary costs of providing a given project, for example the building of a new road. 
If the benefits outweigh the costs, then the project should go ahead. This is usually 
represented in terms of Net Monetary Benefit (NMB). If the monetary gains outweigh the cost 
of a proposal, then the project under review should be implemented on economic grounds 
(Morris et al., 2012). The CBA approach to evaluation relies on the assumptions of changes in 
individual utility as the key to aggregating social welfare and that individuals are the best 
judges of their own welfare (Drummond et al., 2005). 
 
CBA focuses on allocative efficiency, that is, the overall impact of a project across the sector 
where resources are being allocated. This means that when CBA is applied within the health 
service, all health and non-health related cost and benefits are, in theory, accounted for within 
monetary outcomes. Allocative efficiency allows for comparison of welfare across multiple 
interventions for different population groups (Palmer & Torgerson, 1999). Practical examples 




comparing helicopter ambulance services, heart operations and hip replacements (Olsen & 
Donaldson, 1998), and mental healthcare compared to cancer and elderly care (O'Shea et al., 
2008). However, only one CBA in healthcare is known to have been completed in practice 
(Haefeli et al., 2008). 
 
A major issue with the application of CBA within a healthcare setting is the monetary 
valuation on the benefits of health improvements to human life, thereby indirectly leading to a 
monetary value on a human life (Robinson, 1986). However, many economists believe it is 
the best way of evaluating outcomes because it is grounded within welfare economic theory. 
New methods of valuing improvements in health in monetary terms continue to be made to 
further develop this type of evaluation for healthcare (McIntosh et al., 2010). 
 
2.4.2 Cost-Utility Analysis (CUA) 
Since the establishment of the National Institute for Clinical Excellence (as it was originally 
known) within the UK in 1999, the use of economic evaluations, particularly alongside 
assessment of new technologies, has grown significantly. This is due partly to the 
recommendations for the conduct of economic evaluation for new pharmaceuticals within the 
earliest guidance by NICE (NICE, 2001). The role of NICE has expanded since it was 
founded, to advise on public health interventions by local government (NICE, 2011), social 
care and other areas of evidence in the NHS such as a Quality Outcomes Framework, an 
incentive scheme for GPs and an international branch of NICE, NICE International, too 
(NICE, 2013). Cost-utility analysis (CUA) is the preferred evaluation framework of NICE for 




CUA is a type of economic evaluation which focuses attention particularly on health related 
outcomes for healthcare treatments (Drummond et al., 2005). While CUA is also referred to 
as cost-effectiveness analysis (CEA) in the United States (Gold et al., 1996), CUA is 
differentiated from CEA in a number of ways (see Section 2.4.3 for more on CEA). CUA 
attempts to develop a framework which allows for a generic measure of health related utility 
(often referred to as preference based measures) from health related quality of life (HRQoL) 
instruments, which can be implemented and compared for priority setting decisions between 
interventions across a health service (Drummond et al., 2005).  
 
CUA is the main evaluation framework of the extra-welfarism theory for healthcare as 
developed by Culyer (Culyer, 1989). Culyer believed that the objective of the extra-welfarism 
theory should be the output of health as the maximand (Culyer, 1989). While utility is 
referred to within the title of CUA, it is not utility as is commonly interpreted within welfare 
economics. Utilities within the CUA framework refer to the von Neumann-Morgenstern 
‘utility theory’ as measures of cardinal utility which are interpersonally comparable (von 
Neumann & Morgenstern, 1953). Measures of HRQoL rely on preferences of individuals to 
value a generic health state in comparison to the anchors of full health and a state equivalent 
to being dead (Dolan et al., 1995). The index scores generated from HRQoL questionnaires 
are then combined with length of time, to form a QALY (or other outcome, see Section 2.3), 
which is used as the outcome of  benefit from economic evaluation and provides the reference 





The CUA evaluation framework requires a consistent outcome measure to be applied across 
all interventions evaluated, so that decisions can be made that not only address technical 
efficiency between treatment options for the same health condition, but also allocative 
efficiency, so that funding can be justified in comparison with any other treatment across the 
health service (Palmer & Torgerson, 1999). This is of particular importance in the UK 
healthcare system which is mainly funded by the UK taxpayer and as decisions on the 
allocation of scarce resources need to ensure resources are appropriately allocated to different 
areas of the health service, so that taxpayers are getting value for money (Gerard, 1993). 
 
2.4.3 Alternative Evaluation Frameworks 
A number of alternative frameworks have also been used to evaluate health from an 
economics perspective when it has been felt that the appropriateness of CUA or CBA for a 
certain intervention has been challenged. The majority of these frameworks would be 
classified within the extra-welfarism framework primarily because their outcomes usually 
move away from utility as interpreted in the Paretian welfare economic sense of the word. 
  
One framework which has already been mentioned in passing is cost-effectiveness analysis 
(CEA). What distinguishes CEA from CUA, is that outcomes within CEA are focused on a 
particular condition, rather than a generic measure applicable across many conditions 
(Drummond et al., 2005). The measurement of outcomes usually takes place in what are 
referred to “natural units” such as life years gained (Weinstein, 1990), or major outcomes 
averted (Roberts et al., 2007). While CEA can be a useful tool for a decision-maker with a 




natural units (e.g. comparing a rehabilitation service for drug addicts with hip replacements 
would be difficult as there is no common outcome to both interventions). CEA is therefore 
only useful in situations of technical efficiency within a health service, which is concerned 
with measuring the efficiency of interventions for a specific population group (Palmer & 
Torgerson, 1999). This is a more constrained measure of efficiency than allocative efficiency 




Cost Minimisation Analysis (CMA) is sometimes used when CEA results produce similar 
natural unit outcomes and the focus switches to the cost side of the analysis (Drummond et 
al., 2005). However, such an analysis, which targets the reduction of costs only, has been 
widely discredited within the health economics literature due to the uncertainty of costs and 
effects for outcomes of different interventions (Briggs & O'Brien, 2001). Nonetheless, CMAs 
continue to be conducted and published, albeit on a small scale, even though the evaluation 
format continues to be questioned within the health economics literature (Dakin & 
Wordsworth, 2013).  
 
A final evaluation framework used within health economics is known as cost-consequence 
analysis (CCA). CCA, like CEA, is concerned with technical efficiency. However, CCA is a 
disaggregated evaluation of all costs, resource use and outcomes in natural or generic units of 
the interventions under consideration. It is then left up to the decision-maker to weigh up for 
themselves how to value which intervention is best (Mauskopf et al., 1998). CCA has the 
                                                 
1
 While there is a debate as to whether CUAs are an extension from CEAs or a limited form of CBA (see Morris 
et al. 2007, p. 250), in terms of resource allocation within a health service, both evaluation practices can be 




advantage of all the necessary information given to the decision-maker, but again this 
framework would be difficult to use for allocating resources across a health service without a 
common metric (Coast, 2004).  
 
An evaluation approach which is an extension of CCA called Multi Criteria Decision 
Analysis (MCDA), has also been suggested as a method for aiding decision-making within a 
health service (Devlin & Sussex, 2011; Thokala & Duenas, 2012). What makes MCDA 
different from CCA is that numerical values are attached to the multiple outcomes, with 
different outcomes (e.g. cost-effectiveness, severity, disease of the poor, age etc.) given 
weights of importance and aggregated to find the optimal intervention (Baltussen & Niessen, 
2006). While the MCDA framework is in its infancy within health economics, it may offer a 
mechanism for allocating resources across a health service, which is beyond the reach of cost-
consequence analysis. 
 
2.5 MODELLING APPROACHES IN HEALTH ECONOMIC EVALUATIONS 
To combine data on the costs and benefits of different interventions from multiple sources, 
decision models are frequently used to generate the required outcomes to aid decision-
making. A model-based evaluation has been defined as: 
“a formal quantified comparison of health technologies synthesising sources of 
evidence on costs and benefits, in order to identify the best option for decision makers 





Economic modelling plays an important role in capturing changes in patient quality of life 
over time. Decision models are used as a method to simplify the complexities of reality across 
a multitude of academic disciplines, not least health economics. Two important aspects within 
evaluating health require the incorporation of economic models to capture changes in 
individual wellbeing (Buxton et al., 1997): 
1. Where data which can be used to generate economic outcomes (i.e. QALYs) have not 
been collected prospectively within a clinical trial, models are used to combine the 
best available data to estimate such outcomes. 
 
2. Where economic outcomes have been collected, due to resource constraints they may 
only be collected for patients over a short time period. Interventions which will have 
impacts over the individual’s life cycle also need to be evaluated, so models allow for 
the extrapolation of data over time. 
 
Moreover, decision models are also useful even when a clinical trial has been conducted as 
the trial in question may not compare all the relevant interventions (Sculpher et al., 2006). 
Additionally, relying on one clinical trial does not allow the incorporation of data from 
previously conducted related research from trials, meta-analysis and observational studies 
(Petrou & Gray, 2011).  
 
Another key component as to why economic models are used is that they allow for a 
comprehensive assessment of uncertainty around the model parameters (Briggs et al., 2006). 




The main focus of decision analysis is to address parameter uncertainty, i.e. the accuracy of 
the individual data inputs (e.g. HRQoL of individual at a certain time point), and decision 
uncertainty, the likelihood that the decision made from the data within the model is the correct 
one (Briggs et al., 2006). Each of these types of uncertainty can be addressed through what is 
known as sensitivity analysis, which are statistical techniques which assess the sensitivity of 
results due to uncertainty around the parameter inputs (Briggs et al., 1994). The uncertainty 
around the final decision from the model outputs can be ascertained by changing model 
parameters simultaneously through the use of  probabilistic sensitivity analysis (PSA) 
(Claxton et al., 2005). 
 
The underlying need for model-based economic evaluations is driven by the requirements of 
considerations necessary within economic appraisals for decision-making bodies like NICE in 
the UK, the Pharmaceutical Benefits Advisory Committee in Australia and the Canadian Drug 
Expert Advisory Committee (Fischer, 2012). For example, within the UK, the most recent 
edition of the methods for technology appraisal by NICE advises that models should be used 
when all relevant data (i.e. comparators of interventions, healthcare costs and benefits over 
technology lifetime etc.) are not contained within a single trial, where patients in trials are not 
representative of real-world patients, where HRQoL and survival data are not collected within 
trials and also where treatment switching of patients occurs in trials (NICE, 2013, p. 44-45).  
 
There are a number of different types of models which have been employed within health 
economics that carry different assumptions when calculating outcomes. The simplest of these 




the population are calculated at the cohort, rather than individual level (Briggs et al., 2006). 
The simplest type of decision analysis cohort model is a decision tree, consisting of decision 
strategies from which outcome nodes (e.g. costs, QALYs) are calculated for each decision 
strategy. A decision node is then used to compare the outcome nodes from each decision 
strategy from a pre-defined decision rule by the decision-maker (Stahl, 2008). However, the 
simplicity of the tree does not allow recursion, which can make decision trees unwieldy 
(Barton et al., 2004b; Brennan et al., 2006). Therefore, Markov models are a simpler method 
to capture cyclical events within a decision strategy as an alternative cohort model to decision 
trees. In Markov models, each individual within a decision strategy is assigned to a finite 
number of states (e.g. well, sick, dead) over a fixed time period, with transition probabilities 
assigned between states, representing the likelihood of patients moving to different states or 
staying in the same state (Barton et al., 2004b). 
 
While Markov models readily allow calculations of recurring states, Markov models have no 
memory of the states individuals were in previously. Therefore, this Markov assumption of 
homogeneity of individuals within the same state can be overcome through more detailed 
individual sampling models using Monte Carlo simulation (Barton et al., 2004b). Within these 
models, individuals are processed one at a time, rather than in cohorts like decision trees or 
Markov models, allowing for the patient pathways to be reflected within the decision strategy 
(Briggs et al., 2006). Also, different models for infectious diseases have been implemented to 
reflect the dynamic nature of the progression of these types of diseases (Brennan et al., 2006; 





While there are benefits to the more complex individual sampling models and dynamic 
models, such models are more demanding on the amount of data required, the computational 
burden and the assessment of uncertainty for such models is much more demanding as a result 
(Briggs et al., 2006). Therefore, the choice of model for a given economic evaluation needs to 
be representative of the complexity of the condition, which should aid in deciding how simple 
or complex the representation of decision strategies are required to make that decision (Barton 
et al., 2004a).  
 
Outcomes within economic models are employed to capture the changes in health benefits 
throughout the period at which an intervention will benefit the patient population. While 
outcomes are preferably based on primary data, it is often the case that the quality part for 
calculating QALYs is not collected directly for a particular intervention. Therefore, measures 
which are not preference based are sometimes used to predict values within health related 
utility instruments such as the EQ-5D (Lin et al., 2013). This process of prediction is referred 
to as mapping or cross-walking within the literature (Brazier et al., 2010). With the growing 
recognition of the need for economic evaluation, this practice of mapping between 
instruments appears to be on a decreasing trend, as new health technology assessments are 
increasingly collecting HRQoL directly (Tosh et al., 2011). However, such procedures are 






2.6 DECISION RULES IN HEALTH ECONOMIC EVALUATIONS 
There are a number of decision rules which, in theory, could be used to aid healthcare 
decision-making. Decision rules are generally based on aiding decision-making as to whether 
new interventions are worth the additional cost burden to the body in question (e.g. hospital, 
regional or national provision). For NICE, QALY scores are aggregated for the population 
under consideration with the costs and benefits combined by calculating a cost effectiveness 
ratio or cost per QALY. To compare differences between costs and effects for competing 
interventions, the incremental cost-effectiveness ratio (ICER) is applied to measure the cost 
per additional QALY gained for the more expensive and/or effective treatments (Drummond 
et al., 2005). The ICER for a given treatment is then compared with a shadow price of the 
budget of interest. This is known as the threshold ICER rule (Birch & Gafni, 2006). For new 
interventions to be recommended by NICE, the willingness to pay for an additional QALY 
must fall within or below the threshold range of £20,000-£30,000 (NICE, 2013). However, in 
exceptional circumstances, the willingness to pay for QALY gains is sometimes raised above 
the £30,000 threshold (NICE, 2013). A recent study has suggested that over four fifths (81%) 
of NICE decisions can be predicted by the prevailing threshold ICER rule of less than 
£30,000 per QALY gain (Dakin et al., 2013a). 
 
Another rule with the ICER is the league table rule, where interventions with the lowest 
ICERs are recommended until no more resources are available (Birch & Gafni, 2006). This 
type of analysis is better known as cost-effectiveness league tables, which compare outcomes 
for different patient groups in terms of costs per QALYs and have been applied within the UK 
previously (Williams, 1985; Maynard, 1991). However, the league tables approach came 




ICER threshold rule as the dominant method for comparing interventions in health economics 
currently. Members of the DALY team have also attempted to implement the league table 
decision rule through what they refer to as generalised cost-effectiveness analysis (Tan-Torres 
Edejer et al., 2003).  
 
One alternative advocated is an incremental approach whereby only improvements over prior 
treatments could be recommended for treatment (Sendi et al., 2002). This incremental 
approach has recently been expanded so that the probability of ‘bad outcomes’ can be 
quantified through a loss function to aid resource allocation, by incorporating opportunity 
costs into the function so that the size of these outcomes (good or bad) are accounted for in a 
transparent manner (Gafni et al., 2013).  
 
2.7 CRITIQUING CURRENT HEALTH ECONOMICS PRACTICE 
While Section 2.5 showed the uncertainty in calculating accurate outcomes when modelling in 
economic evaluation, another concern relates to the three requirements for valuing outcomes 
(see Section 2.3.1) (Dolan et al., 2009). As was alluded to throughout the chapter, the QALY 
outcome, based on the extra-welfarism framework, is the primary economic outcome measure 
of health interventions. Both the theoretical grounding of the extra-welfarism framework and 
the evaluative space of the HRQoL within QALYs have been challenged from a number of 
different angles. In this section, the aim is to identify some of the main critiques of the QALY 
extra-welfarist perspective within health economics, with a particular focus on how 
alternative frameworks and outcomes have been used to address the issues identified. The 




position of primary economic outcome for measuring changes in health, despite these 
critiques. 
 
2.7.1 Critiquing the QALY: Evaluation Space 
The conventional QALY application in CUA is justified from the extra-welfarist framework 
developed by Culyer (Culyer, 1989). Culyer’s interpretation of extra-welfarism draws from a 
number of sources, including the capability theory of Amartya Sen and the need for healthcare 
provision to improve health (Culyer, 1989). This is the main rationale for justifying more than 
utility. However, in practice the conventional QALY is concerned with HRQoL alone. 
Preferences for different health states are obtained through the valuation exercises of TTO or 
SG for generic health instruments. By presenting the population with health states, the general 
population is presented limited health scenarios with generic HRQoL valuation exercises. 
This could lead to the so-called “focusing illusion” and may not fully capture the impact of 
the condition (Ubel et al., 2003). 
 
An additional issue with the focus on health only is the generalisability of QALYs beyond the 
health service to compare the benefits to society with other public interventions such as 
education, justice and transport. While there has been some interest in adopting the QALY 
measure within environmental economics (Hammitt, 2002; Chokshi & Farley, 2012) and 
crime (Dolan et al., 2005a), a health QALY across the whole public service is not feasible, 
nor sensible given the limited direct health benefits some important public interventions may 




a measure of health and not well-being more generally (Drummond et al., 2009), therefore 
limiting the role of the conventional QALY to healthcare only. 
 
A primary concern within the evaluative space of QALYs is the understanding of what health 
means. Traditionally the instruments which are used to calculate the quality part of the QALY 
are anchored on a scale of being dead (0) to full health (1) (Drummond et al., 2005). Much of 
the ethical debate focuses on the lower end of the scale, whether in fact there are health states 
worse than dead (Rawles, 1989). Another concern is the determination of full health, as the 
full health for an athlete who is able to complete a marathon is likely to be greater than the 
“full health” envisaged by the majority of the population when completing valuation tasks 
used to calculate full health for QALYs, such as the EQ-5D (Sullivan, 2011).  
 
An argument could be made that the welfarist approach is more generalisable across the 
whole public provision of services than the extra-welfarist QALY approach, as resource 
allocation decisions are not limited to the health benefits in WTP studies (Hammitt, 2002). 
However, for this to be unequivocally true, then the QALY would be the sole interpretation of 
an extra-welfarism framework. As Brouwer and colleagues (2008) show, the conventional 
QALY approach is just one interpretation of an extra-welfarist methodology. The capability 
approach, for example, does not exclude utility or life satisfaction from its calculation of a 
capability set (Sen, 1985), but does have a focus on more than one dimension of space to 
evaluate societal welfare. The focus on a uni-dimensional space is a critique that can be 
levelled equally with the QALY extra-welfarist framework as well as that of the WTP 




While in some respects, the focus on maximising health through the health service makes 
intuitive sense, it is equally arguable that such a focus is not extra-welfarist per se, in the 
sense that the objective is not welfarist plus something additional. This has led to some health 
economists referring to the approach as non-welfarist (Birch & Donaldson, 2003; Morris et 
al., 2007). 
 
2.7.2 Critiquing the QALY: Underlying Assumptions 
Another key criticism of the QALY as the basis for aiding decision-making focuses on what 
the overall objective of healthcare provision should be. The objective of maximising health is 
embedded within the QALY extra-welfarist approach (Culyer, 1989; Garber et al., 1996). The 
criterion that a QALY is a QALY is a QALY, irrespective of who are the QALY gainers has 
caused much of the criticism with the current health economics approach. Challenges have 
been made as to whether QALY maximisation reflects societal preferences for health 
maximisation as QALYs infer (Dolan et al., 2005b). There have been many claims on the 
basis of differing arguments based on ethics, equity and equality which have challenged the 
QALY assumption that all QALYs are equal and the objective of healthcare is to maximise 
QALYs. 
 
Equity is an issue because QALY gains are considered equivalent irrespective of age, prior 
health state or severity of illness (Nord, 1999). Three notable challenges to this basis have 
been made within the health economics literature, all of which focus on prioritising those in 




attempting to incorporate priority of saving the life of a young person as the optimal objective 
as to which every other health service intervention should be compared (Nord, 1992).  
 
Issues of incorporating age is highlighted by the fair innings approach, in which those who 
have lived a relatively long lifetime (e.g. 70 years) are given lower priority for health 
interventions compared with those who had failed to reach their fair innings (Williams, 1997). 
Some argue that the QALYs indirectly account for this type of argument given that older 
people are likely to gain fewer QALYs than younger people, as their potential for more 
QALYs is less (Harris, 1987) makes the role of incorporating this kind of equity argument 
less compelling.  
 
Incorporating age weights is an issue captured within the DALY outcome, where more weight 
is given to individuals who are likely to have a caring responsibility for younger and older 
adults, between the ages of twenty and forty (Fox-Rushby, 2002).  
 
Severity of illness is also seen as a primary concern when measuring the benefits from an 
intervention. Erik Nord and colleagues have been prominent advocates of this approach. They 
argue that a fairer way to set resource allocation decisions is by valuing the avoidance of 
severe conditions, rather than the benefit of treatment from such conditions (Nord et al., 1999; 
Nord, 1999; Nord et al., 2010). In certain aspects, there are some similarities between the 
arguments by Nord and colleagues and the rule of rescue, which states that those whose lives 




rule of rescue was primarily driven by QALY calculations which appeared to favour minor 
treatments over life saving action (Hadorn, 1991a). 
 
There are many other aspects where the QALY maximisation principle has been the target of 
criticism. For instance, special treatment has been proposed for orphan drugs and rare 
conditions and these are currently more likely to be funded than other treatments within the 
UK (McCabe et al., 2005a). However, this would appear to be in conflict with those that 
propose the societal distribution of health which aims to reach as many people as possible 
(Dolan et al., 2005b). The role of the individual in their own health state also appears to show 
varying instances of how people would prioritise against those who are responsible for their 
health state (Dolan & Tsuchiya, 2009). End of life care (Round, 2012), social care (Al-Janabi 
et al., 2011) and process of care (Brennan & Dixon, 2013) are other areas where the QALY 
health maximisation objective has been questioned because healthcare provision may not be 
primarily focused on the maximisation of health over time. 
 
2.7.3 Critiquing the QALY: Decision Rule 
Both ICER decision rules discussed in Section 2.6 (i.e. threshold rule and league table rule), 
which are used to show efficient allocations of QALYs, have come under scrutiny in the 
health economics literature. The ICER threshold rule relies on divisibility and constant return 
to scale, which in practice would require an infinite supply of resources and a constant 
marginal opportunity cost (Sendi et al., 2002). This does not reflect the reality for decision-
makers faced with scarce resources for competing interventions (Birch & Gafni, 2003). The 




efficiently, which is rarely available within a national healthcare system for all interventions 
(Hutubessy et al., 2003) and there are difficulties of accounting for uncertainty within this 
framework (Evans et al., 2006). Similarly, mathematical integer programming has been 
suggested as another alternative (Birch & Donaldson, 1987; Stinnett & Paltiel, 1996), but this 
approach also requires perfect information on the costs and benefits of all interventions for 
efficient resource allocation. While the incremental approach has been suggested as an 
alternative (Sendi et al., 2002), this has rarely been applied in practice and has been criticised 
because of its inability to account for all potential efficiency gains (Lord et al., 2004). More 
recent research may make the incremental approach more practical for decision-makers 
(Gafni et al., 2013).  
 
2.7.4 The Durability of QALYs  
Notwithstanding the alternative outcomes and opposition to the QALY, the QALY remains 
the primary health economic outcome measure within the UK, through NICE, and also in the 
Canadian (CADTH, 2006) and Australian (Pharmaceutical Benefits Advisory Committee, 
2008) health systems for assessing new technologies as well.  
 
There are a number of examples of countries which have rejected the use of QALYs for use in 
decision-making in health. This includes Germany which has explicitly rejected the use of 
QALYs in favour of an efficiency frontier approach for assessing new pharmaceuticals (Caro 
et al., 2010) and France which also does not use QALYs (Holmes, 2013). The role of the 
QALY in cost-effectiveness league tables, which ranked health treatments against one another 




in the United States (Drummond et al., 1993). However, there are signs of a relaxation of 
opposition to the QALY in the United States to some extent (Neumann & Greenberg, 2009). 
 
Even within some countries where a sole reliance on QALYs has been rejected, they have 
continued to play a role in the evidence base for making decisions. There are two European 
examples of this. In the Netherlands, QALYs are used in an approach known as proportional 
shortfall, which combines the maximisation of QALYs with the equity argument by Williams 
for a fair innings (Stolk et al., 2004; van de Wetering et al., 2013). In Norway, alongside cost-
per-QALY calculations are supplemented by a scale of severity of the condition in the final 
decision (Nord, 2012). So, even when the QALY decision rule is objected to, there appears to 
be a willingness to continue to use the outcome. 
 
2.8 CONCLUDING COMMENTS 
This chapter has highlighted the main methods of measuring outcomes for assessing health 
benefits which are applied by health economists in economic evaluations. The extra-welfarist 
framework using the QALY is elaborated in detail. While there are challenges to the 
evaluative space and decision rules from which the conventional QALY is applied, the QALY 
as a measure of health has withstood many of the challenges and remains the primary method 
for measuring the benefit associated with health interventions in economic evaluations. The 
QALY as currently formulated, however, is a measure of health and not a broader measure of 
well-being (Drummond et al., 2009). Excluding the application of WTP in health economics 
(Frew, 2010), no other outcome measures discussed here have attempted to measure anything 




being may address some of the challenges to the QALY methodology in its current form (as 
outlined in Section 2.7), and it is to that area, with a focus on capability measures, that the 




CHAPTER 3. CAPABILITY, ECONOMICS AND HEALTH 
3.1 INTRODUCTION 
In the previous chapter, the current theory, evaluation frameworks and outcomes of health 
economic evaluations were explained in detail. It was shown that there are many challenges in 
determining the appropriate outcome measure to use and how it should be implemented to aid 
decision-making across a health service. In this chapter, a possible alternative theoretical base 
for conducting evaluations for aiding decision making in health is explored. 
 
In Section 3.2 the capability approach proposed by Amartya Sen, Nobel Laureate in 
Economics for his contribution to welfare economics in 1998, is introduced. Through his 
many normative works (Sen, 1985; Sen, 1992; Sen, 1993; Sen, 2009) on the problems of 
using welfare economics as the theoretical basis for economic evaluation, Sen provides an 
alternative in the capability approach. This is explored in detail in that section. Also 
considered in Section 3.2 is a comparison of the capability approach and the extra-welfarist 
basis for health economic evaluations. As extra-welfarism differs notably from standard 
welfare economic theory (Brouwer et al., 2008) and since Sen’s critique is primarily of 
welfare economic theory, a comparison between the capability approach and extra-welfarism 
is required to review whether Sen’s criticisms of welfarism are also applicable to extra-
welfarism as currently practiced within health economics. 
 
In Section 3.3 the focus moves on to those within the capability approach who have 




Venkatapuram (2011) are discussed in detail here, and critiques of their conceptions of the 
capability approach to health for practical application within an evaluation format are 
provided. 
 
An analysis of previous attempts to incorporate the capability approach within health 
economics is presented in Section 3.4. The focus is directed towards two notable attempts to 
re-interpret the QALY as an outcome measure that is compatible with the capability approach. 
These attempts, as well as other suggestions within the health economics literature, are 
explored here. 
 
In Section 3.5 the focus is on the instruments that have been developed which have attempted 
to capture capability for use in aiding decision-making and healthcare resource allocation 
decisions. The three most developed questionnaires for health and social care that have links 
with the capability approach are of central importance here. One method relies on a capability 
list to design the appropriate questionnaire. Another interpretation has drawn on the 
capabilities that are of most relevance to the patient population at hand. The final method 
involves developing capability questionnaires for social care. Questionnaires related to each 
approach are explained in detail.  
 
Finally, in Section 3.6, the chapter closes with a summary of the previous sections and areas 
which require further research so that a capability perspective can be adopted within an 




3.2 WHAT IS THE CAPABILITY APPROACH? 
In this section, the objective is to highlight some of the key arguments typically used against 
the current approaches to health economic evaluation (i.e. welfarism & extra welfarism) based 
on the beliefs of an alternative theory as a normative basis for evaluation, which is referred to 
as the capability approach. The basic concepts and ideals upon which the capability approach 
is founded are explored in detail in Section 3.2.1. Section 3.2.2 presents an investigation of 
the differences between the capability approach to evaluation and the current health economic 
evaluation techniques which are standard practice at present.  
 
3.2.1 Theoretical Argument against Welfare Economics: Amartya Sen and the 
Capability Approach 
Amartya Sen is the philosophical and theoretical inspiration for the capability approach. 
Throughout his career in economics, he has been a fierce critic of the utilitarianism agenda 
that has dominated economic policy since the end of World War II (Sen, 1979). From his 
early mathematical formulations on social choice theory (Sen, 1970) to his most recent 
writings focusing on social justice (Sen, 2009) a dominating theme of his work has been to 
expose the limitations of the Pareto/welfare economic approach to evaluation. Since 1979, 
when he first asked the question “Equality of What?” (Sen, 1980), the capability approach has 
been constructed and formulated into a normative philosophical basis (Sen, 1985; Sen, 1992; 
Sen, 1993). Today it provides an alternative way of analysing important issues related to 






The capability approach has been defined as follows: 
“The capability approach is a broad normative framework for the evaluation and 
assessment of individual well-being and social arrangements, the design of policies, 
and proposals about social change in society.” (Robeyns, 2005b, p. 94) 
 
3.2.1.1 A Primer in Capability Terminology 
There are three key concepts which dominate the capability literature that need to be defined 
before exploring the approach any further. Whilst these three definitions are related, in the 
sense that they all focus on individual well-being, they are important concepts independently.  
The three central definitions within the capability approach are: 
 Functionings: 
“represent parts of the state of a person – in particular the various things that he or 
she manages to do or be in leading a life” (Sen 1993, p. 31) 
 Capability:  
“the various combinations of functionings (beings and doings) that the person can 
achieve. Capability is, thus, a set of vectors of functionings, reflecting the person’s 
freedom to lead one type of life or another…to choose from possible livings”  
(Sen 1992, p.40) 
 Agency: 
“the goals that a person has reason to adopt, which can inter alia include goals other 




The distinction between functionings and capabilities is crucial to understanding how 
individual welfare through the capability approach is assessed. Examples of functionings 
range from basic achievements in life such as being well-nourished or avoiding premature 
mortality, to achievements which vary across different cultures, such as having self-respect 
(Sen, 1992).  
 
The capability an individual has, relates to his or her ability to achieve valuable functionings 
in his or her life. Functionings for individuals can also include income or utility (in terms of 
desire fulfilment), but Sen, and others, believe that focusing on one of these issues alone is 
inadequate for assessing individual or societal welfare (Sen 1985). Instead, Sen states the 
focus should be on the capability to achieve various valuable functionings. This has been 
termed as the “capability criterion” when evaluations are made using Sen’s theoretical basis 
(Gasper, 2007). The focus of analysis should not be on well-being as such, but rather on the 
opportunity to achieve such well-being (Sen, 1985).  
 
To understand the capability approach by the definitions of functionings and capabilities 
alone, however, does not give a complete picture of the theoretical basis of the approach. 
What is key and unique within this theory is the role of “agency”
2
. Agency represents the 
opportunity to achieve well-being, but because an individual, as an agent of their values, can 
                                                 
2
 The numerous meanings of words like “agency” and “capability” are of considerable angst to Sen in his 
writings. Indeed, Sen (1993, p. 30) wishes to have phrased terms, in particular capability differently, which may 
have led to less confusion of his theory. “Agency” as defined by Sen is not the same as agency usually defined 
in health economics, which refers to the agency relationship, for example, when a doctor makes decisions on 




have reasons to value goals which may harm their own well-being, agency can increase while 
the functionings or capabilities of the individual may decrease.  
Sen (1992) states:  
“A person as an agent need not be guided only by her own well-being.” (Sen 1992, p. 
56)  
The pursuit of agency expansion, which can damage individual well-being, does not refer to 
irresponsible acts of social behaviour which an individual may have reason to value (e.g. 
being drunk and disorderly, consuming illegal drugs etc.). Alternatively, agency in Sen’s 
approach references issues where capabilities, not necessarily one’s own, may be limited and 
where one feels so strongly that action must be taken, be it protesting against political 
oppression or sacrificing one’s career in an advanced economy to help others in the 
developing part of the world (Sen, 1992). 
 
3.2.1.2 Evaluation Base of the Capability Approach 
Now that the three underlying concepts (capabilities, functioning and agency) have been 
introduced, it is possible to look more closely at the detail behind the key facets of the 
capability approach. Sen’s capability approach focuses on how the three main foci of 
functionings, capability and agency, affect an individual’s well-being, not just in terms of 
specific functionings, e.g. income, but in a multi-dimensional fashion that influences all 
relevant spaces for assessing welfare. A capability evaluation, thus, focuses on an individual’s 
capability set, i.e.: 
“capability is a set of such points (representing the alternative functioning n-tuples 




There are two key distinctions within a capability set: (1) “the promotion of the person’s well-
being” versus “the pursuit of the person’s overall agency goals” and (2) “achievement” versus 
“freedom to achieve” (Sen, 1993). The first distinction concerns where the pursuit of a 
person’s agency goals may conflict with the promotion of one’s well-being because the 
person feels strongly enough to risk their well-being in pursuit of their agency goals. The 
second distinction is in relation to what is at the heart of the evaluation process: what a person 
has achieved versus what a person has the freedom or capability to achieve. “Achievement” in 
this sense refers to the functionings which affect well-being that have been realised by the 
individual, whilst the freedom to achieve is related to the choices available (and possible 
limits to choice) which have an impact on an individual’s functioning achievement. 
 
Following on from these two distinctions within the capability set, Sen (1992) pin-points four 
options for evaluation:  
 well-being achievement;  
 agency achievement;  
 well-being freedom;  
 agency freedom. 
 
The relationships between well-being and agency, and achievement and freedom to achieve, 
are the key dynamic interactions that influence how the capability set is measured, which can 
be done under the four different headings concerning individual “advantage” outlined above. 




not just the achievements themselves, which overcomes one of the main critiques of current 
approaches within welfare economics.  
 
Even though Sen refers to his theory as “capability”, what he is really trying to measure is the 
“freedom” or “advantage” an individual has in life. When Sen refers to freedom, it is not a 
generic statement that can be applied differently in varying scenarios but relates specifically 
to what he defines as “effective freedom”: 
“If the levers of control were used by those in charge of them to, say, promote 
epidemics, rather than to eliminate them, our ‘freedom to control’ would not be 
changed (i.e. would continue to be absent) but our ‘effective freedom’ (in particular, 
the freedom to live the types of lives we would choose to lead) would be severely 
compromised” (Sen, 1992, p.66) 
 
Figure 2 summarises the capability approach in relation to the ways that “effective freedom” 
can be assessed. The capability approach, in theory, allows for factors generally not 
considered when measuring individual well-being, such as the agency of a person, and the 
freedom to choose. However, assessments rarely consider all four forms of welfare 
assessment simultaneously. For example, capability researchers have argued that in many 
situations a focus on functioning or well-being achievement is of primary importance for 














3.2.1.3 Early Applications of the Capability Approach 
Since the capability approach allows for a broader intake of information which has an impact 
on individual well-being, it is not surprising that the approach has been applied within a wide 
variety of disciplines. One of the first, and most recognisable applications of the approach was 
developed by Sen and a Pakistani economist, Mahbub ul Haq, who established the Human 
Development Reports (HDR) for the United Nations Development Programme (UNDP) in 
1990 (ul Haq, 1990). The Human Development Index (HDI), now described annually within 
these reports, compiles measures relating to health (life expectancy at birth), income (Gross 
Domestic Product or GDP per capita) and education (combination of adult literacy rate and 
school enrolment), rather than focusing on a single dimension for measuring a country’s 
progress (e.g. GDP) to better understand “the real wealth of nations” (ul Haq, 1990). At the 
time of the first reporting of the HDI, this represented a significant departure in the way a 
country’s progress could be assessed year on year. 
 
Process of welfare: Welfare Assessment: 
Agent (where Individual A 
chooses their own functionings) 
Capability set for Functioning Fx: 
Cs(Fx) (Sen, 1999) 
f1  = functioning achieved 








The HDI has shown that a uni-dimensional measure for development may not capture the 
whole picture of development in terms of societal progress. One example of the frailty in 
analysing national income data alone is provided by Saudi Arabia, which scores very well in 
terms of GDP, but when the other issues of measurement in the Human Development Reports 
are included (including adult literacy rates, child mortality rates), the society is not so well-off 
as it might appear if the focus was purely on economic progress (Alkire & Deneulin, 2009). 
 
3.2.1.4 Critiques of Applying the Capability Approach Quantitatively 
Sen’s philosophical theory is complex and is underspecified for practical policy evaluation, so 
there are a number of potential conceptual difficulties that arise for researchers in practice. 
These difficulties are highlighted in detail by Robeyns (Robeyns, 2005b). 
  
3.2.1.4.1 Functionings or capabilities? 
Firstly, there is a choice about whether the analysis should focus on individual functionings or 
capabilities. Most of the empirical research within the capability approach, particularly in the 
early applications, has focused exclusively on functioning achievement (Kuklys & Robeyns, 
2005). This has been largely due to the difficulty with measuring capability (Krishnakumar & 
Ballon, 2008) and agency (Alkire, 2009) using data routinely collected for other purposes. 
More theoretical arguments against measuring capabilities come in the form of a welfare 
economics perspective with regard to the expansion of the capability set. The expansion of the 
capability set alone may not subsequently enhance the person’s functioning well-being, and 
can in fact decrease functioning well-being with the number of choices a person may now 




(Cohen, 1993). However, Sen was well aware that this misinterpretation could surface, and he 
tried to counteract this problem by excluding the word choice from most of the literature 
around the capability approach. Instead he relied on the use of the word freedom more often 
than not and hoped that this would clear up any misconceptions with regards to choice: 
“Actually the capability approach recognizes that the goal is not to expand the 
number of choices – it is to expand the quality of human life” (Alkire & Deneulin, 
2009, p. 34) 
 
3.2.1.4.2 Which capabilities/functionings to measure? 
The second issue concerns the choice about which capabilities or functionings to focus on 
within an evaluation. The breadth of the capability approach is a strength in that it allows a 
vast array of information to be captured, but it is also regarded as one of the main weaknesses 
of the framework (Sugden, 1993). The lack of identified specific capabilities that are inherent 
when applying the approach and that different capabilities may be of more priority in different 
scenarios was a distinctive criticism of Sen’s theory in practice (Robeyns, 2005b). Table 1 
gives three examples of capability lists developed within the capability approach, including a 
list of “instrumental freedoms” from work by Sen (Sen, 1999). 
 
Martha Nussbaum (Nussbaum, 2000; Nussbaum, 2011), a leading scholar and philosopher 
within the capability approach, has been one of the most notable critics of this problem with 
the approach and consequently she has compiled a list of ten ‘central human capabilities’ 




including all capabilities that matter for human life. However, others have argued that a more 
deliberate and procedural process to reflect important capabilities in different contexts 
(Alkire, 2002; Robeyns, 2005b). An example of one of these context specific lists was 
developed by Robeyns to assess gender inequality in developed societies (Robeyns, 2003) 
(see Table 1).  
 
Whilst aiming to be comprehensive, Nussbaum’s list of ten central human capabilities is not 
appropriate for application in all areas of evaluation, particularly in context specific 
evaluations (e.g. “care for other species” would not generally be seen as an appropriate 
criterion by which to evaluate healthcare interventions). Indeed, Sen argues against the use of 
a pre-determined list as too constraining (Sen, 2004). Robeyns’ (2005b) advice is to be as 
explicit as possible about the choice included in each given scenario, as well as providing a 
clear rationale for that choice.  
 
Table 1 Examples of Capability Lists 
Developer Sen (1999) Nussbaum (2000) Robeyns (2003) 
Description Instrumental freedoms “central human capabilities” 
for a good life 
Assessing gender inequality in 
developed nations 










 Bodily health 
 Bodily integrity 
 Senses, imagination 
and thought 
 Emotions 
 Practical reason 
 Affiliation 
 Other species 
 Play 
 Control over one’s 
environment 
 Life and physical health 
 Mental well-being 
 Bodily integrity and 
safety 
 Social relations 
 Political empowerment 
 Education and 
knowledge 
 Domestic work and non 
market care 
 Paid work and other 
projects 
 Shelter and environment 
 Mobility 
 Leisure activities 



















3.2.1.4.3 The individual as the focus of analysis 
The third issue of concern relates to the interpretation of individualism in the capability 
approach and the effect on the aggregation of capabilities across a population. A distinction is 
made as to what type of individualism is important in the capability approach by Alkire & 
Deneulin (2009): 
“The capability approach thus does not defend methodological or ontological 
individualism. But even if we are highly interested in groups, the capability approach, 
as initially framed by Sen, takes the normative position of ‘ethical individualism’ – the 
view that what ultimately matters is what happens to every single individual in a 
society.” (Alkire & Deneulin, 2009, p.35) 
 
While this specific kind of ethical individualism takes into account societal structures and 
constraints by theoretically distinguishing functionings from capabilities (Robeyns, 2005b, 
p.108), some believe that ethical individualism is not a sufficient requirement in measuring 
capabilities and that any measurement of individualism should also include ontological 
individualism, a measurement of: 
“nothing more than the sum of individuals and their properties” (Alkire & Deneulin, 
2009, p.35) 
 
However, most scholars within the capability literature “embrace ethical individualism” 
(Robeyns, 2005b, p.109) and the belief remains that the capability approach addresses the 




assessing societal welfare across populations who want to embrace the capability approach, 
but require a summary measure of some kind to compare between populations. However, as 
the example of the HDI and the focus on functioning variables within the literature, the 
theoretical richness of the capability approach has been interpreted for practical empirical 
applications to add a role for the theory to influence decision-making and public policy within 
a summary index. 
 
3.2.1.4.4 Critiquing the link between the HDI and the capability approach 
There are criticisms against the summation of the capability approach within a single index 
(Fukuda-Parr, 2003). It has also been argued that including a measure of income within an 
index, such as the HDI, is counter-intuitive in providing an alternative evaluative base to a 
uni-dimensional focus on human progress from welfare economic measures such as Gross 
Domestic Product (GDP) (Gasper, 2007). However, as much as the QALY has put health 
economics on the policy map, the HDI has helped to show that the capability approach can be 
applied as an alternative theoretical basis to welfare economics. 
 
3.2.2 How is the capability approach different from health economic theory? 
While the capability approach is primarily a critique of the use of welfare economic 
evaluation methods in assessing human well-being, it is important to note that the foundations 
of extra-welfarism, in health economics, derive in part from the capability approach (Culyer, 





The underlying theory of welfarism was explained in detail in Chapter 2. The practical 
examples of this application within the health economics field have focused on the economic 
evaluative practice of cost-benefit analysis (Mishan, 1988) where the most common outcome 
measurement has been with the use of the willingness-to-pay method (McIntosh et al., 2010). 
There have been notable limitations with this method beyond Sen’s critique of the welfare 
economics, including the use of stated preference of individuals for treatment in areas where 
they may not be able to weigh up alternative options realistically because of a lack of 
knowledge within the field (Cookson, 2003) and also that such data gathering is likely to 
favour individuals with the largest income, as they are likely to put a higher value on health 
treatments than those on modest or low incomes (Hammitt, 2002). 
 
Extra-welfarism, as it is commonly known in health economics, has tried to move away from 
some of the problems associated with the normative foundations of welfarism to be more 
useful to healthcare decision-makers (Sugden & Williams, 1978) and to align itself more 
closely with the capability approach (Culyer, 1989). Under extra-welfarism, health economics 
has tried to avoid some of the problems associated with cost-benefit analysis in healthcare. 
The main priority of “extra-welfarism” focuses on the incorporation of information other than 
utility for consideration in evaluation (Culyer, 1989). While this would be referred to as the 
“extra” part of the extra-welfarism approach, it is also known as non-welfarism in welfare 
economics, as it moves away from utility as the sole measurement of individual well-being 





Although Culyer’s (1989) extra-welfarism draws on the capability approach, a number of 
health economists have highlighted that the full implementation of Sen’s concepts has not 
taken place with extra-welfarism theory as currently practiced (Cookson, 2005b; Coast et al., 
2008d) . Many of the key aspects of welfarism theory are still intact, which contradicts Sen’s 
capability theory. While the focus of welfarism is on utility maximisation, extra-welfarism, 
and in particular cost-utility analysis (using the QALY as the outcome measure) focuses 
primarily on health maximisation (Coast et al., 2008d). Even though this may be considered 
by some, or even many, as a superior basis for evaluation within health economics (Williams, 
1985; Gold et al., 1996; Lipscomb et al., 2009; Edlin et al., 2013), it does not incorporate 
some of the main theory which the capability approach is based on, such as the ability to 
incorporate more than one dimension of individual well-being (Coast et al., 2008c).  
 
Therefore, the “extra-welfarism” approach could favour treatments that are supposedly more 
beneficial in CUA, but could forgo information of importance to well-being freedom, such as 
the loss of capability which is not captured when looking at health only. As Sen points out in 
much of his analysis, utility, in terms of desire fulfilment, is an important functioning for 
individual well-being but it is not the only factor and as such not sufficient as the sole basis of 
analysis (Sen, 1992). Similarly, it is argued here that while achieving the best health state may 
be important to an individual, it is not the only factor which affects well-being freedom for 
that person.  
 
Another aspect of the capability approach which extra-welfarism does not adopt in its 




this limitation has not been restricted to health economics alone, where much capability 
analysis relies on measuring functioning rather than capability (Robeyns, 2006). The focus of 
the extra-welfarism approach remains largely on functionings, specifically health functioning. 
This can be seen quite clearly in the common outcome measurement used under extra-
welfarism theory, the QALY, which measures quality of life by the impact a treatment has on 
improving health function and not broader well-being (Drummond et al., 2009).  
 
A final feature which is not addressed in extra-welfarism is the issue of agency, which was 
raised in Sen’s approach. While there have been attempts to conceptualise how this could be 
taken into account in relation to health policy (see Section 3.3), there has been difficulty in 
operationalising such considerations for evaluation. Again, this is not limited to health 
economics, but is a broader obstacle for researchers wanting to operationalise the capability 
approach (Alkire 2009).  
 
3.3 CONCEPTUALISING THE CAPABILITY APPROACH FOR ASSESSING 
HEALTH 
While the capability approach can be applied across a wide range of topics and disciplines, 
the main focus of this section is to analyse the literature which has conceptualised the 
capability approach within health. The two primary conceptualisations of the approach to date 
are presented within Sections 3.3.1 and 3.3.2. In Section 3.3.3 a critique of the two 
conceptualisations is presented from the standpoint of applying the conceptualisations within 





3.3.1 Ruger: Health and Social Justice 
Arguably the most comprehensive attempt to develop the capability approach within the fields 
of health ethics, policy and law, has been made through numerous studies over a decade by 
Jennifer Prah Ruger (Ruger, 1998; Ruger, 2004; Ruger, 2006; Ruger, 2010a; Ruger, 2010b; 
Ruger, 2011; Ruger, 2012). Recently, Ruger has compiled her attempts within a book (Ruger 
2010a) to provide a single conceptualisation of the theoretical justification for what she calls 
the “health capability paradigm” (Ruger 2010a & 2010b).  
 
While Ruger’s argument for Health Justice appears on first viewing to be a very complex 
collection of ideas, theory and applications across a wide variety of disciplines that are not 
easily digestible (Reinhardt, 2011), the health capability paradigm can be broken down into 
four distinct parts. The health capability paradigm consists of a number of (1) objectives; (2) 
rules for decision making (3) application requirements and (4) examples of how applications 
ought to be developed (see Figure 3). 
 
3.3.1.1 Objectives of the Health Capability Paradigm 
There are a number of objectives within the health capability paradigm. The primary objective 
is the promotion of human flourishing, an Aristotelian understanding of the good life, 
combined with health capabilities, which includes Sen’s notions of capability, functioning and 
agency, specifically applied to health. The prioritisation of ‘central’ health capabilities is said 
to take precedence in this paradigm over ‘secondary’ capabilities. Ruger defines the two 
central human capabilities as: 
“the capability to avoid premature mortality and the capability to avoid escapable 
























1. Promote human flourishing (in Aristotelian terms) and health 
capability (including health achievement and health agency) 
2. Prioritization of ‘central’ health capabilities (i.e. avoiding premature 
death and escapable morbidity) 
3. Equality in health measured by “shortfall equality” of health capability 
 
DECISION MAKING 
1. Collective Agreement and Social Decision Making 
through Incompletely Theorized Agreements (ITA) 
2. Shared Health Governance  




1. Public Moral Norms – buy in from general population of 
“public norms” essential. (e.g. Universal Health 
Insurance in the U.S. would require the rich and healthy 
to be willing to pay more for this type of health system.) 




1. Equal access to “high-quality care” (as opposed to a ‘decent minimum’, 
‘adequate care’ or ‘tiered health care’) 
2. Responsibility and Health – enhancing individual responsibility through 
increased health agency 
3. Universal Health Insurance – “essential for human flourishing” 
4. Opportunity costs and efficiency – CMA and CEA acting as “complement” 




However, this is not a very helpful objective for allocating resources as the majority if not all 
interventions are likely to have an impact on one or both of the above “central” health 
capabilities. The most intriguing objective of Ruger’s framework is her objective for equality 
in health, which is called “shortfall equality” in health capabilities, i.e.: 
“the shortfalls of actual achievements from their respective maximal achievements” 
(Sen, 1992, p. 90).  
 
This is proposed as an alternative to “attainment equality”, the levels of achievements actually 
attained (Sen, 1992). Ruger argues where the former may be more beneficial than the latter 
when evaluating health capabilities: 
“This (shortfall equality) might be particularly relevant for assessing health 
capabilities  of people with disabilities because it accounts for differences in the 
maximal potential for health functioning without ‘levelling down’ achievement goals 
for the entire group” (Ruger 2010a, p.90)  
 
Such an approach in practice would be interesting when assessing health capabilities. 
Unfortunately, there is no clear example within Ruger’s (2010a) work as to how it would be 





3.3.1.2 Decision Making Rules in the Health Capability Paradigm 
How Ruger plans to see through these objectives requires a number of decision making rules 
to be operated simultaneously. First, there is a need for a joint social decision-making 
framework within a society in what Ruger refers to as “shared health governance” (Ruger 
2010a; 2011). This system of collective social governance across society requires:  
“individuals, providers, and institutions work together to empower individuals and 
create an environment for all to be healthy” (Ruger, 2010a, p.173) 
  
The shared health governance process is founded upon a joint scientific (or consequential) and 
deliberative (or procedural) approach to cooperating on the appropriate allocation of resources 
for a given society (Ruger, 2010a). Shared health governance, as Ruger (2011) describes, 
combines the rationality of economic game/cooperation theory with the field of ethics, so that 
responsibility of resource allocation is a part of national to individual governance, to achieve: 
 “the alignment between the common good and self-interest” (Ruger, 2011, p. 32) 
 
As a method for solving conflicting conceptions on resource allocations, consensus within 
shared health governance is made through a social choice theory solution known as 
“incompletely theorized agreements” (Ruger, 2006; Ruger, 2010a). Incompletely theorized 
agreements (ITA) is a concept primarily used within aiding decision-making in law (Sunstein, 





The first type of ITA are “incompletely specified agreements”, which occur when there is 
agreement on a general high level principle, but disagreement on mid-level associated 
principles. For example, people may support good health, but disagree on how good health 
could be achieved (Ruger, 2010a, p. 71).  
 
The second type of ITA, called “incompletely specified and generalized agreements”, 
involves an agreement on a mid-level principle, but where there is disagreement on how this 
principle can be achieved. An example is that people may agree on Universal Health 
Insurance, but not on a theory of equality or public policy about how it should be 
implemented (Ruger, 2010a, p. 72).  
 
Finally, “incompletely theorized agreements on particular outcomes” is used to aid decision-
making when agreement is reached on low-level principles, but which are perhaps not 
justifiable by a single higher principle. This happens when people might agree on a particular 
judgement, but for varying reasons (Ruger, 2010a, p. 72.).  
 
Ruger (2010a) believes that the ITA approach could have a place in setting public policy, and 
particularly for setting policy within the health capability paradigm. This is because the likely 
interpretation of health capability will be different among individuals within a particular 
population. The ITA approach also adds flexibility when making decisions where: 




3.3.1.3 Application requirements in the Health Capability Paradigm 
For the health capability paradigm objectives and decision making practices to be met in 
practice, the theoretical argument of the approach needs to be simultaneously equipped with a 
certain level of general population consensus that such an approach is correct. Ruger’s 
objective of health capability (including health agency and health functioning) for public 
policy could not be implemented in practice without a general consensus that health capability 
was generally agreed upon within society as something worth pursuing. Ruger (2010a) refers 
to this societal consensus as “public moral norms”. For example, there would need to be an 
ethical commitment at a national level to finance a Universal Health Insurance scheme in the 
United States, a commitment to collective action for public involvement (Ruger, 2010a, p.14).  
 
Additionally, in helping to achieve the objectives of the health capability paradigm, the social 
determinants of health need to be assessed on an individual basis (Ruger, 2010a). Ruger 
appears to reject the pursuit of reducing socio-economic inequalities (i.e. health and income) 
in improving societal welfare, as advanced by others (Daniels et al., 2000). However, it is not 
entirely clear why this is objected to in the health capability paradigm. 
 
3.3.1.4 Applying the Health Capability Paradigm in practice 
 No matter how theoretically appealing some may find the health capability paradigm, the 
ability to apply the theory into practice is essential. Four examples of “applications” as 





While the health capability paradigm is supposedly set within a global context, there is a clear 
focus on the United States public policy towards health within this work. Ruger (2010a) 
argues that Universal Health Insurance is “essential for human flourishing”, although she 
points out that Universal Health Insurance could be justified under many normative theories, 
including a utilitarian or welfare economic theory of justice (Ruger, 2010a, p.220). Within her 
analysis of the attempt to introduce Universal Health Insurance within the United States in the 
early 1990s, Ruger states the proposal at that time represented the second type of 
incompletely theorized agreement (incompletely specified and generalized agreement). Ruger 
(2010a) argues this type of ITA is unstable to carry out in practice due to a lack of one overall 
high-level principle or one lower-level principle within Universal Health Insurance (a mid-
level principle) that could have brought the change within US healthcare, which the majority 
of Americans supported at one point in time (Ruger 2010a, p.225). Ruger (2010a) illustrates 
what she calls a “wedge theory”, an attack from opponents of the mid-level principle with 
numerous high-level and low-level principles upon which there is no general consensus. 
Ruger (2010a) suggests such attacks can lead to problems in reaching a general consensus 
through with the second form of ITA.  
 
The second “application” by Ruger (2010a) states that the equity argument of the health 
capability paradigm must ensure: 
“equal access to high-quality care, not a ‘decent minimum’, ‘adequate care’, or 






Once more, this application of the capability paradigm appears aimed at economically 
developed nations like the United States, where a decent minimum at least is expected from 
public policy for health. Ruger has expanded on this equity argument more recently, where in 
the United States a state-by-state approach to setting healthcare objectives has been proposed 
by the health and human services (HHS) agency (Ruger 2012). Ruger labels such an approach 
“inadequate” as it would give: 
“potential for discrimination against patients with rare, severe and costly health 
conditions” and that “A better approach would be to establish uniform standards so 
that all Americans would have access to the same high-quality goods and services” 
(Ruger 2012, p. 682) 
 
Third, by focusing on health capability, which includes health agency, the paradigm shifts 
responsibility of health towards the individual with increased agency for their health choices. 
Whilst an intriguing proposition, that with added health capability in terms of agency 
necessitates additional responsibility to make healthy choices, Ruger believes that it is not 
feasible to assess in practice, given the varying degrees of responsibility people contribute to 
their own health, combined with their genetic make-up (Ruger, 2010a, pp. 9-10). 
 
The final application presented in Ruger’s (2010a) book is the incorporation of opportunity 
costs within the paradigm, recognising that for resource allocation: 





However, Ruger (2010a) dismisses the idea of using valued health status outcomes like 
QALYs or societal value outcomes like Saved Young Life Equivalents (SAVEs) (Nord, 
1992). Such an approach, Ruger argues is:  
“monistic - evaluating health programmes or policies by one measure” (Ruger, 
2010a, pp. 23-24)  
 
Ruger (2010a) suggests using cost-minimisation analysis (CMA) as the primary method of 
assessing between different interventions, although recognising that cost-effectiveness 
analysis (CEA) can also be useful at times. The role of health economics in aiding decision-
making is of small importance within Ruger’s paradigm, and should play a secondary role to 
clinical effectiveness:  
“Under the health capability paradigm, economic solutions should follow and 
complement clinical progress, not vice versa” (Ruger 2010a, p. 195) 
 
3.3.2 Venkatapuram: Health Justice 
In “Health Justice: An Argument for the Capabilities Approach” Venkatapuram (2011) makes 
an argument for “the capability to be healthy” to be the primary basis for a theory of health 
justice. Venkatapuram rejects standard definitions of health as the absence of disease or 
illness (Boorse, 1975; Boorse, 1977). Instead, Venkatapuram argues for an alternative theory 
of health based upon the capability approach, the capability to be healthy. His conception is a 
combination of two philosophers work. Firstly, he justifies an alternative theory of health 
based on the work of Lennart Nordenfelt, who reasoned that health could be conceptualised in 




(Nordenfelt, 1995; Nordenfelt, 2007). However, Venkatapuram argued that aspects of 
Nordenfelt’s theory were not compatible with the capability approach, arguing against the 
emphasis on “subjective preferences” and “cultural relativism” (Venkatapuram, 2011). 
Instead, Venkatapuram favours the use of the list of ten central human capabilities, developed 
by the eminent capability philosopher Martha Nussbaum (Nussbaum, 2000; Nussbaum, 2011) 
(see Table 1), as the set of vital goals to be accounted for in Nordenfelt’s conception of health.  
Venkatapuram argues that Nussbaum’s list of “pre-political moral entitlements” can be 
applied across countries as:  
“a minimum conception of vital goals that is applicable across the human species” 
(Venkatapuram 2011, p. 31) 
 
In order to measure Venkatapuram’s vital goals, he next turns to the epidemiology literature 
to examine how his methods could be used in practice. Once more Venkatapuram draws from 
work linked to the capability field in terms of research on famines and the development of an 
entitlement theory to understand such phenomenon (Drèze & Sen, 1989). The entitlement 
theory is used by Venkatapuram to emphasise the need for moving beyond an explanatory 
model approach within epidemiology. Instead, he argues, epidemiology should focus on four 
causal factors: individual biology, physical exposures, social conditions and individual agency 
(Venkatapuram, 2011). He links this approach to measuring causation within the social 
epidemiology literature, where researchers are keen to emphasise the role the environment 
plays within both individual and population health over their life course (Kelly et al., 2010). 




entitlement analysis, used principally to measure the capability to be adequately nourished 
previously, to measure his set of vital goals more broadly (Venkatapuram, 2011). 
 
The second part of Venkatapuram’s focuses on justifying his conception of health justice 
within the theory of the capability approach. From his capability literature review, he focuses 
primarily on the distinction between the writings of Sen and Nussbaum. He uses this review 
to justify the role of the capability approach in health as the ethical justification for the 
assessment of the “capability to be healthy” in terms of the vital goals of Nussbaum’s list. He 
argues that his approach is again a combination of two alternative conceptions of the 
capability approach, by applying Sen’s analytical methods with Nussbaum’s list to develop a: 
 “Sen-Nussbaum ‘hybrid’ argument” (Venkatapuram 2011, p. 34) 
 
In the final part of his work, Venkatapuram contrasts his proposal for the capability to be 
healthy with five alternative ways in which claims on health have been made. The health 
equity argument, primarily the work of Margaret Whitehead (Whitehead, 1990), the linkage 
of health and human rights (Mann et al., 1994), a resource theory based on equality of 
opportunity (Daniels, 2008) and luck egalitarianism (Segall, 2010). However, of greatest 
interest for this thesis is his comparison with welfarist claims on health. 
 
While Venkatapuram considers in great detail the links between the resource based equality of 
opportunity in health and the capability to be healthy, he finds little in common with the 
welfarist approach. He states: 
“a welfarist approach to health would probably focus on just maximising a single 




He then draws from work by Sen (Sen, 1999) to formulate the welfarist  approach as a 
consequentialist focus on preference satisfaction and sum-ranking across populations 
(although he is really referring to extra-welfarism as presented in Chapter 2). All three 
components of the welfare theory are objected to by Venkatapuram. He rejects the singular 
focus on outcomes in health economics as “myopic” or short sighted (Venkatapuram 2011, p. 
185). The role of aggregating across populations for average welfare improvements is also 
rejected as the “individuals on the tail of the population” need to be accounted for, especially 
if their disadvantage includes more than health alone (Venkatapuram, p. 188). His primary 
objection to the welfarist approach is the role of subjective preferences, however, especially 
when relying on assessment of physical and mental functioning, stating: 
“The ‘happy sick’ or ‘worried well’ both point to the possible perverse results of 
relying wholly on subjective well-being” (Venkatapuram 2011, p. 186) 
 
The second section in part 3 of his work asks how the capability to be healthy proposition 
handles groups rather than individuals. There is an inherent focus on individualism within the 
capability approach, known as ethical individualism, where individuals are the ultimate units 
of moral concern (Robeyns, 2005b). As already mentioned in his critique, even with a shift 
towards capabilities, the maximisation of overall capability should not be traded off at the 
expense of the minority. He states: 
“Improving the capabilities of the many does not make up for others not having their 
minimal or threshold level of capabilities commensurate with human dignity” 





Any focus on group capability to be healthy must also account for the individual entitlement 
of the capability to be healthy across Nussbaum’s list, in the argument presented by 
Venkatapuram. Part 3 closes with an argument of the capability to be healthy as an argument 
for a global conception of health, which can be applied across national borders and monetarily 
rich and poor nationalities. 
 
3.3.3 Comparing, contrasting and critiquing conceptualisations of the 
capability approach for health 
Unlike Ruger (2010a) who, to a certain degree, ignores the social determinants of health in 
her health capability paradigm (Saith, 2011), Venkatapuram (2011) places the social 
determinants of health at the heart of the capability to be healthy. He describes the capability 
to be healthy as a: 
“meta-capability; an overarching capability to achieve a cluster of basic capabilities 
to do and be things that make up a minimally good human life in the contemporary 
world” (Venkatapuram, 2011, p. 20) 
 
While the capability to be healthy can be placed within Nussbaum’s conceptualisation of 
basic capabilities, there are many similarities between Ruger’s and Venkatapuram’s 
proposals. Venkatapuram also places the role of personal responsibility within his conception 
of the capability to be healthy, albeit with a caveat: 
“From the capabilities approach perspective, individuals become morally responsible 
for their choices in light of their capabilities, not irrespective of their capabilities” 




The pluralist nature of capabilities is emphasised in Venkatapuram’s focus on the social 
determinants of health, with human health and longevity as a primary focus in his conception 
of the capability to be healthy, as in Ruger’s “core” health capabilities. It may be then 
somewhat surprising that both theories reject the role of summary measures like the QALY 
and DALY out of hand given they would appear to complement the primary objectives of the 
theories, albeit with a notable difference on the focus on capabilities rather than health status. 
However, it is primarily related to their stances on inequality and equity that such outcomes 
appear to be rejected. Unlike Ruger (2010a) who proposed equal access to high-quality 
healthcare as the equity criterion for health capability, Venkatapuram draws on work rejected 
by Ruger, and focuses on a more minimalist objective in reducing health inequalities: 
“The idea of sufficient and equitable capabilities commensurate with equal human 
dignity in the modern world aims to capture such multidimensional concern” 
(Venkatapuram, 2011, p. 21). 
 
Both Ruger and Venkatapuram argue that their objectives are not compatible with “monist” 
measures used within health economics currently. Unlike Ruger (2010a), Venkatapuram 
(2011) does not indicate how the capability to be healthy should be measured beyond 
improving health and longevity. It may be over-critical of this conception of “health justice” 
given his theory is notably incomplete, but to criticise health economic outcomes related to 
welfarist economics and utilitarian ideals, an alternative must be proposed instead. Proposing 






Whilst both Ruger (2010a) and Venkatapuram (2011) offer an illuminating dissection of the 
multidimensional nature of the role in health in improving societal well-being through the 
capability perspective, neither proposes a practical method for evaluating choices with 
healthcare.  
 
Ruger’s (2010a) example of incompletely theorized agreements (ITA) in the United States in 
the early 1990s helps to show the health capability paradigm in practice and explain where the 
problems arose in the past that could have been handled differently. However, it does not give 
a clear rationale as to how the introduction of health capability could be achieved, without 
health capability as a public moral norm high end principle in the ITA framework. Since there 
is no guarantee that this is the general consensus of the public, it is hard to see how the health 
capability paradigm can be implemented fully in practice without such an agreement. How 
realistic her equity argument of “equal access for high-quality care” is, is an additional 
problem with her proposition. 
 
Whilst Ruger (2010a) offers a critique of current health economic practices, primarily the 
QALY, there is no alternative suggested as to how resources should be allocated if choices 
need to be made between two or more interventions. Her primary choice of evaluation, CMA, 
appears to be a major oversight within her paradigm. It has been noted within the health 
economics literature that the role of CMA should be diminished because of issues around 
uncertainty (rather than anything related to outcome measurement) (Briggs & O'Brien, 2001) 
and more recently it has been argued that the role of CMA within economic evaluation: 




This has led to questions of Ruger’s knowledge of the scope of work within health economics 
and how it relates to her paradigm (Lorgelly et al., 2010b; Saith, 2011). 
 
Venkatapuram (2011) has similar qualms about the use of health economic outcome 
measures, stating that the focus of the capability approach should be on the individual. 
However, his objection with such outcomes is questionable. He states: 
“Fundamentally, the difference lies in relying on individual’s subjective preferences 
about states of physical and mental functioning...Yet, despite the external visibility of 
pain and suffering, people’s valuation of their own physiological functioning is not a 
good indicator of their claims for social support.” (Venkatapuram, 2011, p. 186).  
 
The basis of this critique is drawn from research by Sen on self-reported morbidity in India, 
where regions with higher life expectancy reported the highest amount of morbidity problems, 
compared to poorer regions with less life expectancy (Sen, 2002). Where Venkatapuram’s 
analysis falls down is that Sen (2002) also recognises that internal morbidity related to health 
cannot be reported externally as it can be difficult for an observer to quantify mental illness or 
chronic pain (Sen 2002). There is no clear rationale as to why a so called “objective” view on 
health would supposedly be a more accurate description of an individual’s health status in this 
scenario. 
 
Venkatapuram is strident in his opposition to outcome measures such as QALYs and DALYs. 




required within health (Venkatapuram 2011, p. 189). He seems unaware that such outcomes 
used within health would consider themselves “extra-welfarist” too. It would appear that, like 
Ruger, Venkatapuram offers a critique of economics in health without a complete 
understanding of what the different approaches within health economics are.  
 
Somewhat more puzzling is Venkatapuram’s (2011) distinct bewilderment with economic 
concepts. While there are many questionable things within the health economics literature, 
some concepts are taken as a given and are unavoidable. However, this does not appear to 
hold for Venkatapuram: 
“They maintain that resources are always finite, all individuals cannot be helped, and 
therefore, weighting lives is unavoidable and must be tackled head on” 
(Venkatapuram 2011, p. 186) 
 
Indeed any comparison between individuals seems a non-starter within Venkatapuram’s 
conception of health justice. He seems taken aback by the idea that QALYs could even be 
extended beyond their current form to all aspects of public policy as suggested by one notable 
economic philosopher (Broome, 2006). 
 
At the start of his critique of welfarism, Venkatapuram (2011) made a very important point: 
that all states of distributive justice have a metric (object of justice) and a rule (how to 
distribute the object) (Anderson, 2010). Throughout both lengthy conceptions of the 




distributive justice offers an alternative combination of a metric and decision rule that could 
be used instead of current outcome measures like QALYs and DALYs. While a substantial 
effort is made to conceptualise the capability to be healthy as a measure of social justice 
(Venkatapuram, 2011), the reliance of his vital goals on Nussbaum’s list makes a rule based 
around his metric unoperationalisable within its current form. A similar critique can be 
levelled at Ruger, whose detailed approach to conceptualisation leaves little in the way of 
advising on the conduct of prospective evaluation. 
 
3.4 ALIGNING THE CAPABILITY APPROACH WITH TRADITIONAL OUTCOMES 
A number of attempts have been made to incorporate the capability approach beyond Culyer’s 
(1989) attempts in extra-welfarism. Section 3.4.1 looks at further attempts to align the 
capability approach with current health economic outcome measures. The second section 
presents a critique of such an approach. 
 
3.4.1 Capability and the QALY outcome 
The first attempt ‘post-Culyer’ to incorporate the capability approach within a health 
economic evaluation format was by Cookson (2005b) (although it had been previously 
suggested as an alternative to HRQoL measures (Verkerk et al., 2001)). Cookson (2005b) 
attempts to bring the current QALY outcome in line with the capability approach:  
“to re-interpret the QALY as a cardinal and interpersonally comparable index of the 





In his analysis, Cookson (2005b) suggests rejecting a welfare economic interpretation of a 
“utility QALY” and moving beyond the general consensus of a “health QALY”. Cookson 
(2005b) instead recommends the continuing use of the QALY, but suggests a reshaping of the 
current QALY as a capability set, representing a “capability QALY”. 
 
Cookson (2005b) argues that, in his view, the QALY outcome is a feasible option for 
assessing health interventions through the capability approach. He believes that the direct 
estimation and valuation of capability sets is not feasible and he also rejects alternative 
preference based measures used in public policy evaluation such as WTP as being 
“inadequate” for capturing capability as intended by Sen and others. Cookson refers to the use 
of his capability QALY as a measure of: 
“capability efficiency alone (i.e. maximising the aggregate value of individual 
capability sets, ignoring equity considerations)” (Cookson, 2005b, p. 824).  
 
Cookson advocates that the capability QALY be used as an alternative to the health QALY 
for a number of reasons. Firstly, the capability QALY captures health and non-health within 
the same measure (i.e. “non-separability”). Secondly, the “process of care” can be captured 
with a shift to a focus on non-health functionings within capability sets. Finally, his approach 
can also account for the value different people could attach to achieving the same level of 





In a similar theme, Bleichrodt and Quiggin (Bleichrodt & Quiggin, 2013) offer a formulation 
of the QALY which they argue can be interpreted as: 
“a local approximation to a ranking over capabilities” (Bleichrodt & Quiggin, 2013, 
p.129) 
 
Cookson (2005b) recognises the need for incorporating broader non-health functionings 
within the QALY, but he feels that the EQ-5D dimension “usual activities” fulfils this role 
currently (Cookson, 2005a). However, Bleichrodt and Quiggin (2013) argue that such an 
interpretation is not required. Bleichrodt and Quiggin (2013) model “capabilities as menus” 
(i.e. a person chooses a capability set from a menu of capabilities, from which they then 
choose their functioning attainment). They draw upon previous methodology on incorporating 
a two step choice process into an axiomatic framework (Kreps, 1979) to test their assumptions 
that the QALY is a compatible measure of their formulation of “capabilities as menus”. They 
prove, under a number of assumptions, which include freedom of choice and preferences for 
capability sets, that:  
“any rankings of capabilities gives rise to a ‘shadow price’ for QALYs” (Bleichordt & 
Quiggin, 2013, p.129)  
 
3.4.2 Critiquing the formulation of QALYs with the capability approach 
Whilst the above suggestions are impressive for their efforts in their meticulous 
conceptualisation, there are a number of problems which neither Cookson (2005b) or 




“capability efficiency” as the maximisation of capability, regardless of equity concerns is at 
odds with both Ruger’s (2010a) and Venkatapuram’s (2011) conceptualisations of the 
capability approach for health. Additionally, the objective of maximising health has been a 
critique of those who support a move towards the capability approach (Coast, 2009; Smith et 
al., 2012; Payne et al., 2013). Therefore, a uniform interpretation of the purpose of evaluation 
within health under a capability approach being to maximise absolute levels of capability is 
not necessarily a good reflection of how the capability approach, as understood more 
generally, should be employed in practice. 
 
Secondly, whilst the model presented by Bleichrodt and Quiggin (2013) is mathematically 
precise, it appears distinctly at odds with the capability approach in assuming a capability set 
with the highest attainable functioning will automatically be chosen. Notably, their model 
does not take into account the role of agency within a capability set. Therefore, their 
formulation would appear more appropriate for a justification of a functionings only approach 
or even the current extra-welfarist health economics framework rather than a capability 
framework. 
 
Additionally, advocates of the capability approach within health economics believe that 
adopting such an approach should provide a more encompassing basis for evaluation than that 
involved within the QALY measure. For example, Coast and colleagues (Coast et al., 2008c) 
suggest that a broader evaluative space based on capabilities would encapsulate non-health 
benefits for interventions like public health. This view of “more than health” appears a strong 




Dolan, 2005). Specific areas such as chronic pain (Kinghorn, 2010), public health (Lorgelly et 
al., 2010a), social care (Grewal et al., 2006; Netten et al., 2012), mental health (Simon et al., 
2013) and complex interventions (Payne et al., 2013) have been identified as areas that would 
benefit from the capability concept of a broader set of benefits than is measured by HRQoL 
instruments currently. 
 
A final critique of the re-interpretation of the QALY as a capability measure is that it makes 
no attempt to measure capabilities, focusing instead on the assessment of functionings used to 
calculate QALYs. This appears a dilution of what the capability approach tries to encompass. 
 
3.5 MEASURING CAPABILITY  
Section 3.4 outlined an argument against capturing capabilities directly as unfeasible 
(Cookson, 2005b). However, a number of researchers have attempted to develop 
questionnaires representing the capability approach more closely for use in decision-making 
in healthcare resource allocation. In this section, three attempts to incorporate measures of 
capability for use in such decision-making are outlined. The three attempts discussed are 
those that are most advanced and related to the UK health system. However, it is worth noting 






3.5.1 Capability Indicators: The OxCAP family of instruments 
The first attempt to measure capabilities directly by using existing data from household and 
panel surveys was developed initially by Anand and colleagues (Anand et al., 2009). Instead 
of trying to develop measures of capability directly, Anand et al. (2009) proposed that 
“capability indicators” could be constructed from Nussbaum’s list of 10 central human 
capabilities, similarly to Venkatapuram’s theory for the capability to be healthy (see Section 
3.3.2). Here, capability is largely inferred through questions of individual achieved 
functioning. The use of secondary data to infer capabilities from achieved functionings has 
been a popular method for the application of the capability approach in practice, primarily due 
to the ease of using data that has already been collected (Kuklys & Robeyns, 2005; 
Chiappero-Martinetti & Roche, 2009). Subsequent questionnaires developed using 
Nussbaum’s list as compiled by Anand are referred to as questionnaires within the OxCAP 
(Oxford Capability) family of instruments (even though OCAP is used as abbreviation for 
some of the questionnaires too). 
 
Originally developed in 2005 (Anand et al., 2005), the OCAP survey contains 64 indicators of 
capability, drawn from the British Household Panel Survey. The primary goal of Anand et al. 
(2009) was to test two hypotheses from their capability indicators – firstly, if their indicators 
are related through a measure of subjective well-being in terms of satisfaction with life and 
secondly, whether people place different values on capability indicators. These tests are 
carried out by comparing results from their cross-sectional dataset (n=1000) with a measure 
of life satisfaction to give a measure of subjective well-being (SWB) or happiness. The 64 




The advantage of incorporating existing questionnaires from a pre-existing panel survey was 
that similar questions are likely to be collected across a number of countries, which could 
allow for cross-country comparison of capability indicators (Anand et al. 2009). However, it 
does have the problem of being limited to data which are already collected and may not 
capture capability as accurately as developing a questionnaire with this exact purpose. This is 
particularly a problem for the broad and, in some cases, vague interpretations that can be 
drawn from Nussbaum’s list. Refined lists may be more appropriate for policy specific 
instruments, such as Robeyns (2003) set of capabilities for assessing gender inequality (see 
Table 1). 
 
One of the problems of relying on secondary data was shown by Anand and colleagues (2009) 
as they used their capability indicators to predict life satisfaction, a 7-part Likert scale of 
subjective well-being (where 1 is completely dissatisfied and 7 is completely satisfied with 
life). By predicting life satisfaction through their indicators using ordinary least squares 
(OLS) regression, only 17 of the 64 indicators were found to be statistically significant (see 
Table 2, column 2). Of greatest concern is that from the ten capability categories, only six 
have statistically significant indicators of life satisfaction within OCAP. This raises another 








Table 2 The OxCap family of questionnaires 
Nussbaum’s 
capability list (2000) 
OCAP 
(Anand et al. 2009) 
OCAP-18 
(Lorgelly et al. 2008) 
OxCap-MH 
(Simon et al. 2013) 
1.Life Life Expectancy Life Expectancy Life expectancy 




Ability to move home 
Health limits activities 
Adequate shelter 
Adequate shelter 
3.Bodily integrity Safe during day 
Safe during night 
Previous violent assault 
Future violent assault 
Past sexual assault 
Future sexual assault 
Past domestic violence* 
Future domestic violence 
Sexual satisfaction* 
Reproduction choice 
Safe walking alone near 
your home 
Future assault (any) 
Safe walking alone near 
home 








Political and religious 
expression 
Uses imagination 
Political and religious 
expression 
Uses imagination 
Access to interesting 
activities (or employment) 





Enjoy love and friendship of 
family and friends 
Lost sleep 
Enjoy love and friendship of 
family and friends 
Lost sleep 
6.Practical reason Concept of good life 
Plan of Life 
Evaluates Life* 
Useful role* 
Free to decide how to live 
life 
Free to decide how to live 
life 
7.Affiliation Respects others* 
Takes holidays* 
Meets friends 
Thinks of others 
Feels worthless* 
Past Discrimination 
(question each for 
race,gender,sexual 
orientation, religious and 
age discrimination) 
Future Discrimination 
(five questions – same as 
past discrimination) 
Respect others 
Able to meet people socially 
Likelihood of discrimination 
outside of work 
Respect others 
Able to meet people socially 
Likelihood of discrimination 
8.Other species Appreciates plants, animals, 
nature 
Able to appreciate plants 
animals, nature 
Able to appreciate plants 
animals, nature 
9.Play Enjoy recreation Ability to enjoy recreation Ability to enjoy recreation 
10.Control over one’s 
life 
Participate in politics 
Owns home 
Discrimination (work) 
Past* and Future* (10 
questions, same categories 
as capability 7, affiliation, 
discrimination questions) 
Expect stop and search* 
Skills used at work* 
Useful role at work 
Relate to colleagues 
Respected by colleagues 
Participate in local decisions 
Owns home 
Current or future 
discrimination within work 
Participate in local decisions 
Owns home 
 




To address the issues raised above and to adjust the OCAP for evaluating health interventions, 
Lorgelly et al. (2008) developed a refinement of the OCAP questionnaire. Lorgelly and 
colleagues (2008) aims were not only to further develop and refine the OCAP survey, but to 
validate the survey so that it could be used to evaluate public health interventions. After a 
number of phases of focus groups, factor analysis, pilot questionnaires and interviews, 18 
questions across Nussbaum’s 10 central human capabilities were found to be of most 
relevance. Additionally, some questions were re-worded so that the capability of an individual 
and not their functioning levels was captured (Lorgelly et al., 2008).  
 
To develop the measure for economic evaluations, Lorgelly and colleagues (2008) provide an 
index of capability for their refinement of OCAP (OCAP-18, see Table 2, column 3). All 
capability indicators (18) are valued equally, with 1 assigned to the highest level for each 
question, resulting in a scale of 0-18 (binary questions given a 0 or 1 value, while questions 
with 5 options were given values of 0, 0.25, 0.5, 0.75 and 1). This resulted in an OCAP-18 
mean score for a general population of Glasgow (n=166) of 12.44 (ranging from 3-17.75). 
This capability score correlates strongly with the EQ-5D score (mean 0.757) for the same 
population (pairwise correlation of 0.576; p-value:<0.001) (Lorgelly et al., 2008).  
 
However, Lorgelly and colleagues (2008) rightly note that their method of valuation means 
that some of Nussbaum’s list will have extra weight if they have more indicators per 
capability. Additionally, there is no weighting attached when people value the 10 capabilities 




“life” and “other species” (see capability 1 and 6 in Table 2), which may not be seen as a 
sensible basis by decision-makers for use in prioritising health interventions in practice. 
 
While Lorgelly and colleagues’ (2008) refinement of the OCAP survey was designed for 
public health, it has more recently been adjusted again for the purpose of evaluating 
capabilities for mental health interventions (Simon et al., 2013). The work by Simon and 
colleagues focused on altering the original OCAP of Anand et al. (2009), but offers a very 
similar questionnaire to the OCAP-18 of Lorgelly et al. (2008). The primary difference 
between the OCAP-18 and the OxCap-MH (Oxford Capability Measure for Mental Health) is 
that only one capability question on discrimination appears in OxCap-MH as opposed to two 
(work and outside work) indicators of discrimination for OCAP-18. Some of the questions on 
OxCap-MH were re-worded but intend to capture the same capability principle as on the 
OCAP-18. The OxCap-MH also includes 18 questions in total, with an additional question 
related to access to activity (or employment), for senses, imagination and thought (capability 
four, see Table 2, column 4).  
 
Simon and colleagues (2013) tested their capability instrument within the Oxford Community 
Treatment Evaluation Trial (OCTET) and developed a capability index (CAPINDEX16). 
They also adopt a similar valuation approach to Lorgelly et al. (2008) for the OxCap-MH, 
treating each question equally but placing all questions on a 1 to 5 scale instead of the 0 to 1 
scale used for the OCAP-18 questions. 172 patients recorded a response for sixteen questions 
(CAPINDEX16, which excluded questions on property ownership and life expectancy), 




EQ-5D (0.514; p-value: 0.01) and Visual Analogue Scale (0.415; p-value: 0.01) (Simon et al., 
2013). 
  
 3.5.2 ASCOT measure of Social Care 
Another questionnaire which has been developed with an aim to capture capability to be used 
in economic evaluations is the adult social care outcome toolkit (ASCOT). The ASCOT 
questionnaire aims to measure social care related quality of life (SCRQoL), which can then be 
used to measure a social care QALY (SC-QALY) and make comparisons between health 
related QALY interventions. The developers of ASCOT argue that social care is a particular 
case where there is no start and end point of treatment, so to measure the gain from social care 
interventions questions are posed on their current SCRQoL status as well as their expected 
SCRQoL state if the intervention was not available (Netten et al., 2012). 
 
The ASCOT questionnaire has evolved through four versions to the present version, which 
attempts to account for Sen’s capability theory within the latest version of the questionnaire’s 
development (Netten et al., 2012). Originally the ASCOT instrument was called the Older 
People’s Utility Scale (OPUS), based on five attributes (food and drink; personal care; safety; 
social participation and involvement; control over daily living) of social care for older people 
across four levels (no problem, all needs met, low unmet needs , high unmet needs) (Netten et 
al., 2002). This was further developed to capture social care outcomes for adults less than 65, 
with the new instrument including three new dimensions (which are employment and 





Version three of the ASCOT was the first attempt to incorporate the theory of Sen’s capability 
approach within the instrument. The rationale for drawing on the capability approach in social 
care was outlined in a Measuring Outcomes for Public Service Users (MOPSU) study which 
showed that the OPUS instruments developed focused more on functionings and not on 
capability (Forder et al., 2008). The ASCOT questionnaire was thus developed further to 
measure whether social care was at or below what patients wanted and liked, rather than if the 
social care was good or bad, to account for the measurement of capabilities achievable and 
constraints on capability within the questionnaire phraseology (Caiels et al., 2010). As well as 
the rewording of the questionnaire, two more attributes were added between the second and 
the third version of ASCOT, one category on anxiety and worry and another category for 
dignity.  
 
Through an extensive qualitative investigation of the attributes to reflect social care outcomes 
of importance to service users, the most recent (“final ASCOT”) questionnaire was developed 
which included the five categories from the first questionnaire, as well as accommodation, 
cleanliness and comfort, occupation and dignity (Netten et al., 2012). Unlike the first two 
versions which focused on needs of the service users, each attribute on the final ASCOT has 
an emphasis on the highest level of each attribute on the wants and likes of patients to reflect 
a broader aspect of the questionnaire on capability, with the other three levels reflecting levels 
of basic functioning (Netten et al., 2012). 
 
The final ASCOT version aims to reflect the SCRQOL of social service users which can be 




a preference weighting of states, such that “1” represents the ideal state of SCRQOL and “0” 
represents a state equivalent to being dead. Valuation exercises were conducted through a 
combination of TTO and best-worst scaling (BWS), which is a type of discrete choice model 
(Flynn et al., 2007). Values for social care states were calculated for the general population 
and service users, with little difference between the values of both groups. The final value set 
implemented allowed for the calculation of an SC-QALY which could range from -0.19 to 1. 
The authors state that this study could allow for comparisons between health QALYs and SC-
QALYs once a relationship between a health status instrument like the EQ-5D and  the final 
ASCOT version is established (Netten et al., 2012). 
 
3.5.3 ICECAP Capability Questionnaires  
The ICEpop CAPability (ICECAP) measures were developed as an alternative way of 
capturing individual well-being compared to current measures of preference-based health 
status indices that are used to generate QALYs. Grewal and colleagues (2006) aimed initially 
to develop a measure of quality of life for older people that could cross health and social care. 
They found through qualitative analysis that it was the capability to achieve important 
functionings that was of most relevance for older people within the UK. Additionally, it 
wasn’t good health as an end in itself that was the objective for this population group, but it 
was how that good health allowed them to live a good life: 
“it was not poor health in itself which was perceived to reduce quality of life, but the 
influence of that poor health upon each informant’s ability to achieve the attributes of 





Grewal and colleagues (2006) found many factors that influenced quality of life such as 
activities, home, family and relationships, health, standard of living and faith. However, it 
was the role of these factors across a number of key attributes of quality of life that were 
found to be of primary importance in their analysis. Five key attributes were found by Grewal 
et al. (2006) in total. They are: 
 Attachment – “feelings of love, friendship, affection and companionship” 
 Role – “having a purpose that is valued” 
 Enjoyment – “notions of pleasure and joy, and a sense of satisfaction” 
 Security – “ideas of feeling safe and secure...which include having sufficient finances, 
sufficient practical and emotional support and sufficient health” 
 Control – “being independent and able to make one’s own decisions” 
(all from Grewal et al. 2006, p.1897) 
 
These attributes of quality of life for older people led to further research which involved the 
development of an index of capability for older people, the ICEPOP (Investigating Choice 
Experiments for Preferences of Older People) CAPability measure for Older people or 
ICECAP-O (Coast et al. 2008). The attributes identified by Grewal and colleagues (2006) 
were used as the basis for developing a short self-report questionnaire, that could be used to 
aid decision making in health and social care (Coast et al., 2008a). An iterative process was 
used to test the understanding of questions and make sure that questions were interpreted as 
meant within the research by Grewal and colleagues (2006). This resulted in five attributes of 
capability across four levels of well-being, ranging from no capability to full capability for 




Values for the ICECAP-O capability index were generated for a sample of the over 65 UK 
population through the BWS method of valuation. BWS presents scenarios to participants 
whereby, for the ICECAP-O, they are asked to state their most and least favoured attribute 
from the five options presented to them (i.e. one from each attribute). Coast and colleagues 
(2008a) argue that this method is appropriate for the capability approach as it represents the 
values of the individuals, and not necessarily their choices or preferences, as there is no trade-
off between capabilities with BWS. 
 
The validity of the ICECAP-O has been tested in various countries for different populations. 
The construct validity of the ICECAP-O was established within the UK older population 
twice. Firstly, Coast et al. (2008) reported a relationship between the ICECAP-O categories 
for 315 elderly individuals with age and general well-being (i.e. a single question “are you 
basically satisfied with your life?”) (Coast et al. 2008b, p. 969).  The attributes of role, 
enjoyment and control were related to physical measures of health, whilst the attachment and 
enjoyment attributes were more closely associated with mental health measures (Coast et al., 
2008b). A larger sample size of older people (n=809) was later examined, with similar 
associations found between ICECAP-O and poor physical and mental health (Flynn et al., 
2011). Additionally, living alone, low social contact, feeling unsafe after dark and being 
without a faith can result in lower capability scores (Flynn et al. 2011).  
 
Validity studies for ICECAP-O have also been conducted in the Netherlands for elderly 
psycho-geriatric patients (Makai et al., 2012), in Canada for older people who attended a falls 




older hospital patients in Australia (Couzner et al., 2012). The ICECAP-O was also tested 
within a general adult population sample in Australia, with lower income and employment 
being closely associated with poor capability, whilst marriage and cohabitation was a positive 
sign of capability for those under 65 years old (Couzner et al., 2013a). 
 
With a growing interest in using capability instruments internationally and across a broader 
range of population groups than the over 65 population, it is not surprising then that this has 
led the ICECAP research team to develop a capability measure for the general adult 
population. The ICECAP instrument for adults (ICECAP-A) has recently been developed to 
provide a measure that would be able to capture the capability of all adults over 18 in a 
similar way to the ICECAP-O. A similar qualitative process to that used by Grewal et al. 
(2006) was carried out to capture attributes of capability wellbeing for the general UK 
population (Al-Janabi et al., 2012a). This resulted in five attributes: “stability”, “attachment”, 
“achievement”, “autonomy” and “enjoyment” (Al-Janabi et al., 2012a). The questions were 
then developed to capture capability across four levels for the five attributes. 
 
Similarly to the ICECAP-O construct validity studies (Coast et al. 2008b; Flynn et al. 2011), 
the first ICECAP-A validation study found capability differences between health and 
socioeconomic groups (Al-Janabi et al., 2012b). While there was no significant difference 
found for those classed as deprived and non-deprived, this may be as a result of the small 
sample size (n=418) within this study, which might make distinctions between deprivation 





While there are noticeable similarities between some of the attributes in the ICECAP-O and 
ICECAP-A, the ICECAP-A captures a wider demographic of valuable capabilities. Indeed, 
further qualitative investigation found that the older population struggle with the 
“achievement” attribute, given that it has been closely associated with purely work 
achievement by some individuals (Al-Janabi et al., 2013).  
 
Finally, the ICECAP team has most recently developed an instrument to account for the 
attributes of capability that are important at the end of life, which is known as the ICECAP 
supportive care measure (ICECAP-SCM) (Sutton & Coast, 2013). Unlike the ICECAP-O and 
ICECAP-A which both have five capability attributes, the ICECAP-SCM consists of seven 
capabilities “autonomy”, “love”, “physical suffering”, “emotional suffering”, “dignity”, 
“support”, and “preparation”. Given that the current focus within health economics is on 
health maximisation over time, the role of end of life and palliative care are areas which have 
not been tackled extensively within health economics. Therefore, the ICECAP-SCM offers a 
departure from current health economic questionnaires for aiding decision-making to assess 
care at this stage of life. 
 
3.5.4 Choosing a questionnaire for resource allocation 
The three approaches to capability questionnaire development are notable advances in the 
application of the capability approach. With three diverse approaches to questionnaire 
development, there are a number of similarities between the methods, but also different 





Overall, the OxCAP related research is a welcome addition to the capabilities research field 
and particularly the refinements for assessing health interventions, indicating that there are 
many important capability indicators which affect human well-being and are important to 
consider in decision-making. The diversity of each of the three questionnaire types have a 
number of different strengths and weaknesses in their design. However, of particular concern 
would be a lack of a consistent approach to evaluating interventions across a health service. 
The OxCAP family of instruments do not provide a consistent approach to valuing 
capabilities or questions to include, which would be a major concern for making resource 
allocation decisions across different population groups as in the current approach of, for 
example, NICE. 
 
While the ASCOT claims that the questionnaire is geared towards the capability approach, it 
is difficult to grasp the influence of the capability approach in practice. The most recent 
version of the ASCOT was developed using a similar mechanism to that of the ICECAP-O 
but the actual attributes of the ASCOT questionnaire have not changed much since the first 
questionnaire was developed, which as the authors rightly suggest is focused on functionings 
only (Netten et al., 2012). Therefore, the implementation of the capability approach appears 
an afterthought for justifying the development of the questionnaire, rather than a specific 
interest in applying the capability approach itself. This argument is based on the fact that the 
third version developed for the low-level interventions has no reference to any capability 






Additionally, the development of the final ASCOT version to generate a SC-QALY outcome 
has the aim of being a comparable instrument with the QALY outcome. However, a health 
QALY and an SC-QALY are measuring two different aspects of well-being. The ASCOT 
does not claim to be a broader measure than health related quality of life, so the comparison 
of the questionnaire could be further hampered by the attempt to measure capabilities rather 
than functionings as instruments such as the EQ-5D does. In reality, the comparison of the 
different health instruments that produce health QALYs is already questionable given the 
different areas of health captured by different health utility instruments  (Brazier et al., 2004a; 
Grieve et al., 2009; Whitehurst & Bryan, 2011). Therefore, to be able to say that a SC-QALY 
is directly comparable with a health QALY, an investigation needs to be carried out in much 
greater detail. 
 
Nonetheless, there are a number of important innovations within the ASCOT instrument. The 
recognition that it is unsatisfactory to focus on functionings only, within a social care setting, 
to capture changes in SCRQoL supports the argument that a capability approach to assessing 
both health and social care is appropriate. However, whether a measure of SCRQoL such as 
the final ASCOT could be used to allocate resources across a health and social services 
together appears unlikely. The role of ASCOT as a technically efficient measure is possible 
between interventions for the same intervention group or for allocating resources within the 
social care service only. The mechanism of measuring expected SCRQoL scores in the 
absence of social care interventions is also a novel method for accounting for absence of an 




The ICECAP questionnaires have been qualitatively developed to capture key capabilities 
within the UK population and these are methods of procedure that are highly recommended in 
the capability approach (Alkire, 2002; Comim et al., 2008). Values within the ICECAP 
instruments are also an important aspect of public valuation and participation in what 
capabilities are important to them. While the ICECAP questionnaires attempt to capture a 
small number of capabilities (5 each for ICECAP-A and ICECAP-O; 7 for ICECAP-SCM), 
there is a possibility that these questionnaires could be challenged to be less comprehensive 
compared with the capability indicators on OxCap instruments and less context specific 
compared to the ASCOT social care instrument. 
 
While there are a number of benefits with all three questionnaire types, the remainder of this 
thesis will focus on the implementation of the ICECAP questionnaires. The ICECAP 
questionnaires are the only questionnaires out of the three that have both a generic method of 
capturing individual capability, which could be applied across the health service, as well as 
values from the general public attached to the respective ICECAP questionnaires. 
 
3.6 SUMMARY OF CAPABILITY, ECONOMICS AND HEALTH 
In this chapter, the key terms and concepts of the capability approach have been explained. 
What makes the capability approach distinct from both welfarist and extra-welfarist 
economics (as currently practiced) was an important theme. Conceptualisations of the 
capability approach for health were outlined and critiqued with a key concern being the lack 





In Sections 3.4 and 3.5, attention turned to how health economists have tried to incorporate 
the capability approach within outcome measures. Some have formulated the QALY as the 
most suitable estimation of capability but this was argued to be limiting. Others within health 
economics have challenged the use of the outcome measure from a capability perspective. 
The most advanced examples of direct attempts to incorporate capability within 
questionnaires were presented in Section 3.5. Each of the measures has strengths and 
weaknesses for taking this research forward. The ICECAP measures have the advantage of 
conducting a valuation exercise with their measure, while the OCAP survey has the benefit of 
capturing capabilities that may routinely be collected within most country’s household 
surveys. The refinements by Lorgelly et al. (2008) and Simon et al. (2013) are, however, less 
likely to benefit from this advantage. The ASCOT questionnaire has been developed to 
capture social care related quality of life to develop an outcome which could be comparable to 
QALYs. How such an instrument could be used to compare capabilities from interventions 
outside of social care would face similar difficulties to those of any condition-specific health 
instrument collected presently. The ICECAP instruments would appear, currently, to be the 
most appropriate choice for a generic instrument capability which can be applied across health 
and social care interventions equally. 
 
A number of questions remain if the capability measures are to be used in health evaluations. 
Firstly, there is a question of whether capability questionnaires can be used in a similar way to 
HRQoL questionnaires which are currently used to aid decision-making within economic 
evaluations. Secondly, there is little guidance as to the objective and decision rule that should 
be used with such measures (i.e. should the capability questionnaires be used to maximise 




CHAPTER 4. A REVIEW OF EMPIRICAL APPLICATIONS OF THE 
CAPABILITY APPROACH ACROSS DISCIPLINES 
 
4.1 INTRODUCTION 
In Chapter 3, the theoretical basis of the capability approach was described as an alternative to 
the extra-welfarist paradigm. Chapter 3 also presented a discussion of the evolution of the 
capability approach within health economics and debated the merits of the approach (Verkerk 
et al., 2001; Anand & Dolan, 2005; Coast et al., 2008c). The recent focus of the capability 
approach in health economics has turned increasingly to the development of measures or 
indicators of capability as alternatives to HRQoL instruments (Grewal et al., 2006; Anand et 
al., 2009; Al-Janabi et al., 2012a). However, other authors have suggested that the capability 
approach could be aligned with the QALY outcome used predominantly in health economic 
evaluations (Cookson, 2005b; Bleichrodt & Quiggin, 2013). Therefore, no clear consensus 
exists as to how capability instruments, once developed, should be applied within an 
evaluation framework. This chapter aims to illustrate the attributes that are captured within 
capability measures across disciplines, how different attributes are aggregated within 
capability questionnaires and what is the objective and decision rules applied to capability 
measures once aggregated. 
 
The chapter is structured as follows: in Section 4.2, previous empirical reviews of the 
capability literature are assessed. Both the reasoning behind each review and the papers 




introduction of the methodology for undertaking the literature review in this chapter is 
presented. This literature review implements a search strategy known as “comprehensive 
pearl growing” (Schlosser et al., 2006). The rationale for choosing this review type, how it 
works in practice and a review of the inclusion and exclusion criteria for studies is also 
documented in this section. In Section 4.4, the results of the review in terms of the summary 
statistics of the papers included/excluded are presented. Each study is categorised and 
described. In Section 4.5, an analytical review of the studies is presented, addressing in 
particular the aims of the chapter. In Section 4.6, the chapter concludes with a discussion on 
the findings from this chapter and what health economics can learn for future studies that 
adopt a capability perspective. 
 
4.2 PREVIOUS REVIEWS OF EMPIRICAL CAPABILITY APPLICATIONS 
Before undertaking an empirical review of the capability approach, a preliminary search of 
previous quantitative capability reviews was carried out to establish what is already known 
within the literature. Three reviews were identified, including one paper and two book 
chapters which were found in a manual search of the relevant literature. These reviews 
represent summaries of previous attempts to analyse how the quantification of the capability 
approach has evolved since the development of the capability theory since the 1980s and early 
1990s (Sen, 1980; Sen, 1985; Sen, 1992; Sen, 1993). A summary of the three literature 





4.2.1 Literature Review (1): Kuklys & Robeyns (2005)  
The first review of the capability literature was undertaken in a book chapter by Kuklys and 
Robeyns (2005), which looked to collect information on the early quantitative empirical 
applications of the capability approach. The focus of the review by these authors was to 
explore the empirical applications of the capability approach up until 2002. Following the 
findings from the review, Kuklys furthered the research in the area by developing a monetary-
based functioning approach for assessing disability well-being through “equivalence scales” 
(Kuklys, 2005). 
 
The early empirical applications of the capability approach captured by the review of Kuklys 
and Robeyns (2005) found that instruments developed were based on functioning 
achievement rather than the broader conception of capability. Their review identified 
seventeen studies which attempted to measure individual well-being from a capability 
perspective. Five of the 17 studies focused on national and regional comparisons of 
functioning based welfare, while the remaining twelve studies either consisted of micro 
analysis of functionings within a particular population group (e.g. unemployed, poor, 
children) or an assessment across a population group without a comparison with another 
region. Their review aimed to show differences in studies which chose to elicit functionings in 
comparison to measures based on income when assessing welfare. This change of focus is one 
of the primary rationales for adopting a capability based approach, so it was important to 






Four main methodological themes were used in their review to compare the selected studies:  
1. selecting which functionings were of relevance for welfare assessment; 
2. the measurement of the chosen functionings at the individual level;  
3. the aggregation of functionings at the individual level;  
4. the aggregation of individual functionings across a population. 
 
The main finding from their review was that there were considerable distinctions between 
those who are classed as “functioning-poor” and those who are classified as “income-poor” in 
many of the studies reviewed. They also acknowledged the challenge of measuring 
capabilities directly, with all applications in their review focusing on functionings achieved as 
a proxy for capability measurement (Kuklys & Robeyns, 2005). 
 
4.2.2 Literature Review (2): Robeyns (2006) 
The second literature review is the sole peer-reviewed paper identified. Robeyns (2006) 
presented a scoping exercise, showing the breadth of the practical applications of the 
capability approach across a wide variety of disciplines. Robeyns (2006) asked what 
specifications are required for a study to be considered within the remit of the theoretical 
justification of the capability approach. She concluded that these were (Robeyns, 2006): 
1. the choice between focusing on capabilities or functionings;  
2. the selection of relevant capabilities to answer a specific question and;  
3. the weighting of the capabilities chosen to give an overall assessment or aggregation 




Her review suggests that a number of different approaches to the above three specifications 
have been made in different studies (Robeyns, 2006), with no “reference case”, comparable to 
NICE guidance for cost-effectiveness, being established for capability applications. Robeyns’ 
(2006) review suggested that the first two issues have generally been dealt with in relation to 
the data available, and weights have usually been set arbitrarily as equal across the chosen 
dimensions. It should be clarified that this practice is not her recommendation, but rather 
reflects the state of practice as observed in her review (Robeyns, 2006). 
 
In terms of empirical capability applications, the most interesting part of the study by 
Robeyns (2006), for health economics, is to show exactly where the capability approach has 
been applied in practice. Table 3 presents a summary of the thematic groups identified in 
Robeyns’ (2006) review where the capability approach has been applied in terms of areas of 
analysis, examples of the objectives within each groups and the studies which were found in 
each group. In total, Robeyns (2006) identified nine areas where the capability approach had 
been applied at the time of the review, ranging from cross-country comparisons of well-being 
to small scale development projects to help alleviate poverty in deprived populations 
(Robeyns, 2006). Many of the areas identified by Robeyns (2006) focus on particular 
populations who may be unfairly treated when traditional measurement techniques are used. 
Such research is primarily aimed towards the poor, the disabled and studies on gender 
inequality. Some studies identified here aimed to address a particular policy concern, while 
other studies were more exploratory, looking to understand the extent that household 
questionnaires are able to capture indicators of capability from existing capability lists. For 
example Anand and van Hees (2006)  examined the British Household Panel Survey (BHPS) 




Table 3 Robeyns’ (2006) Overview of where the capability approach has been 
applied 
Application Type Examples or Explanations Studies 
General Assessments of the 
Human Development of 
Countries 
Human Development Index 
(HDI) 
(Sen, 1985) 





Poverty reduction projects (Alkire, 2002) 
Identifying the Poor in 
Developing Countries 
Functionings-poor versus 
income poverty measures 
(Ruggeri Laderchi, 1997) 
(Ruggeri Laderchi, 1999) 
(Ruggeri Laderchi et al., 2003) 
(Klasen, 2000) 
(Qizilbash, 2002) 
(Asali et al., 2005) 
Poverty and Well-Being 
Assessment in Advanced 
Economies 
Profiles of the poor; well-being 
trends in household surveys 
(Balestrino, 1996) 
(Phipps, 2002) 
(Brandolini & D'Alessio, 1998) 
(Chiappero-Martinetti, 2000) 
(Anand & van Hees, 2006) 
Deprivation of Disabled People Achievement of functionings 
compared to non-disabled 
(Zaidi & Burchardt, 2005) 
(Kuklys, 2005) 
Assessing Gender Inequalities Differences between males and 





Debating Policies Discuss and assess government 
policies (e.g. education, welfare 
state reform) 
(Schokkaert & Van Ootegem, 
1990) 
(Lewis & Giullari, 2005) 
(Dean et al., 2005) 
Critiquing and Assessing Social 
Norms, Practices and 
Discourses 




(Robeyns, 2005a)  
Functionings and Capabilities 




(Arends-Kuenning & Amin, 
2001) 
(Anand et al., 2005) 
 
Robeyns’ (2006) review of applied research raises a number of challenges to those advocating 
the application of the capability approach. One of the most important of these is around the 
value added of including indicators of capability, compared to the indicators of sociological 
research and multidimensional well-being, which are already widely developed and used in a 
number of countries. A second important issue is the reliance on data that are not specifically 




Given that researchers have previously specified different ways to identify which capabilities 
are important for specific purposes, Robeyns (2006) argues that the justification for the 
selection of capabilities needs to be explicit in the analysis, to ensure that the method used is 
transparent. In summary, Robeyns (2006) recognises the challenges associated with applying 
the capability approach in practice and emphasises the need for a clear explanation and 
justification around the three specifications (i.e. 1. the choice between focusing on capabilities 
or functionings; 2. the selection of relevant capabilities to answer a specific question; 3. the 
weighting of capabilities chosen to give an overall assessment or aggregation of welfare). 
 
4.2.3 Literature Survey (3): Chiappero-Martinetti & Roche (2009) 
In the final review of empirical literature, the book chapter by Chiappero-Martinetti and 
Roche (2009) summarises the empirical challenges in applying the capability approach and 
discusses the studies they consider to be notable empirical advances within the capability 
field. They aim not to give a complete overview of all empirical applications within the field 
but: 
“to discuss some basic principles and to review how the most consolidated applied 
literature dealt with these kinds of issues.” (Chiappero-Martinetti & Roche, p 160) 
 
The review by these authors takes a more analytic approach to evaluating the literature than 
the previous two capability reviews. Drawing from the specification of capabilities as set out 
by Robeyns (see Section 4.2.2), Chiappero-Martinetti and Roche (2009) analyse different 




capability. They look at the strengths and weaknesses of four statistical strategies for 
compiling and/or analysing outcomes of capability. They are: 
1. Scaling and ranking solutions  
Scaling and ranking solutions is the primary method of aggregation of indicators within the 
studies they reviewed. These indicators are not necessarily on the same scale as each other. 
The Human Development Index (HDI) was identified as the most commonly used example of 
this methodology within the capability literature. The HDI is the main measure of a country’s 
progress used by the United Nations (UN) in their annual Human Development Reports 
(HDR). The HDI comprises three dimensions (health, education and income), measured 
across four indicators (life expectancy at birth, mean years of schooling, expected years of 
schooling, gross national income per capita at purchasing power parity). The HDI is averaged 
evenly across the three index dimensions and results in a HDI between 0-1 (lowest to highest 
human development) (Human Development Report, 2013). 
 
2. Fuzzy set theory 
Chiappero-Martinetti and Roche identified fuzzy set theory, a mathematical framework that 
allows for the study of non-binary, vague indicators (e.g. age described as “young”, “middle 
aged” and “old”), as a method for combining categorical and continuous variables to measure 
the “degree of membership” of different indicators for an unobservable outcome (Chiappero-
Martinetti & Roche, 2009). This, they argued, allowed for complex and vague indicators to be 
incorporated within an outcome to indicate capability when it may not be clear whether the 
level of attainment is a positive or negative result. However, it was also recognised that 




problem. This fuzzy set approach is a popular methodology in poverty where defining 
someone as poor or non-poor may not be obvious by some levels (Chiappero-Martinetti & 
Roche, 2009). 
 
3.  Multivariate data reduction techniques  
Multivariate data reduction techniques such as factor analysis and principal component 
analysis are used to identify key indicators of capability from a large amount of potential 
variables which could be included (Chiappero-Martinetti & Roche, 2009). This is conveyed in 
their review as a popular method due to the belief that capability itself is difficult to measure, 
so by treating capability or functioning as a latent variable, multivariate data reduction 
techniques allow for the measurement of unobservable variables from real data (e.g. 
Krishnakumar & Ballon, 2008). 
 
4. Regression modelling 
Regression modelling was shown to be implemented to predict a multidimensional outcome 
related to the capability approach. The outcome was predicted from variables thought to be 
most closely related to the capability concept of well-being. Chiappero-Martinetti and Roche 
identified a number of different types of regression models that have been implemented in 
capability literature, such as ordinary least squares (OLS), probit, logit and structural equation 
models (Chiappero-Martinetti & Roche, 2009). The choice of such model depends on the 
relationship between the dependent and independent variables. The difference between 




required for regression models, whilst fuzzy set theory assumes the dependent variable is 
unobservable (Chiappero-Martinetti & Roche, 2009). 
 
The review chapter by Chiappero-Martinetti and Roche closes with a description of the 
empirical contributions to the capability approach which have used these statistical 
techniques. The description used the specification of a capability analysis as set out by 
Robeyns (2006) in Section 4.2.2 to compare and contrast the studies in their survey. Ranging 
from the earliest applications of empirical examples by Sen (Sen, 1985) to more recent 
econometric models of capabilities as latent variables (Krishnakumar & Ballon, 2008), they 
show the growth in sophistication of the statistical techniques used to analyse capabilities 
within the literature. Thirty two studies, over thirty years, are presented to show the numerous 
methodologies that can be explored within the capability theoretical framework. This review 
also documented an increasing number of empirical capability studies in the more recent past, 
suggesting a continued and growing interest in the application of the capability approach. 
 
4.2.4 Summary of literature surveys on empirical capability research 
The three reviews of the capability literature presented in this section indicate that a wide 
range of disciplines and methods for estimating capability across studies interested in 
operationalising the capability approach quantitatively. However, there are a number of 
questions left unanswered by this research, which suggests that a further, more systematic, 





Firstly, of the three reviews, none offer a clear rationale as to how studies were included and 
excluded from each review. This could lead to concerns about the inclusion of the papers 
within each review, which may not have been subjected to any type of assessment. Given that 
the aim of two of the reviews was to improve the reporting methods for eliciting and 
measuring capabilities (Robeyns, 2006; Chiappero-Martinetti & Roche, 2009), it is surprising 
that they themselves did not transparently report their own review methodology. 
 
Secondly, there appears to be an increase in the quantity of papers included in each review as 
time has progressed. This would suggest either a high growth of research within the capability 
approach since the turn of the century, or alternatively a greater knowledge of the most recent 
advances within the literature by the authors conducting their literature reviews. If it is 
assumed that the former is true, it is likely that new methods have emerged since the last 
review conducted by Chiappero-Martinetti and Roche (2009), which included literature up 
until the start of 2008. It would seem worthwhile in a new review to focus on the most recent 
applications within the capability approach since the last empirical review was conducted, 
albeit with a different objective, given the apparent growth in applications in the twenty-first 
century in the three literature reviews presented in this section.  
 
Additionally, none of the three literature reviews contained detailed evidence relevant to the 
objectives and decision rules for which such outcomes are then used to inform decision-
making, which is a key aim for this chapter. This will help understand how the capability 
approach has been interpreted as a measure for aiding decision-making and potentially offer 





In this section, the methods used to conduct the review of capability outcomes and decision 
rules from a capability perspective are presented. First, the search strategy employed to 
identify relevant papers, known as a “comprehensive pearl growing” literature search strategy, 
is outlined. Inclusion and exclusion criteria are then presented. Second, the method of 
identifying studies through key pearls is then explained. Finally, a data extraction sheet is 
presented to show how data were extracted for the review requirements. 
 
4.3.1 Search Strategy 
The search strategy employed in this review is known as a “comprehensive pearl growing” 
literature search, which is a particularly useful search strategy for interdisciplinary topics 
(Schlosser et al., 2006). The process of pearl growing commences with the identification of 
key pearls (i.e., key studies), which can be identified from within the literature as being 
compatible with the aim of the review (Hartley et al., 1990). Once the key pearls have been 
identified, the first wave of pearls are produced, which are papers that have cited the key 
pearls within their reference list. Therefore, this type of literature review uses forward 
citations from the key pearls, unlike a more expansive forward-backward reference search 
strategy.  
 
The comprehensive pearl growing literature search is of particular use when a keyword search 
strategy would return an unmanageable number of papers: for example, searching for terms 
related to economic evaluation such as “costs” or “benefits”. Entering only these key terms 




an unmanageable number of papers to review. This is of particular concern for words which 
can have a number of different meanings within disciplines, or terms that have more everyday 
uses, such as ‘capability’.  
 
There is precedent for using this methodology in the existing health economics literature. 
Examples within health economics include Dolan et al.’s (2005) review of people’s 
preference for QALY maximisation (Dolan et al., 2005b); Tsuchiya and Dolan (2005) review 
of people’s preferences for health states and health profiles over time (Tsuchiya & Dolan, 
2005); and more recently, Stafinski and colleagues (2010 & 2011) use of the pearl growing 
method to qualitatively assess the different decision making processes for funding health 
technology across countries (Stafinski et al., 2010; Stafinski et al., 2011). A review of 
empirical applications of the capability approach seems equally well suited to this method. 
 
The literature search was undertaken through the Institute of Scientific Information (ISI) Web 
of Knowledge citation search online facility. The ISI Web of Knowledge covers a number of 
databases including Web of Science (which covers the sciences, social sciences, arts and 
humanities) and MEDLINE (topics regarding biomedicine and health sciences), which made 
it an appropriate database for searching capability literature across a wide variety of 
disciplines. 
 
Only papers published between January 1
st
 2006 and December 1
st
 2012 were included. The 




the operationalisation of the capability approach, given that earlier studies were already 
captured through the reviews discussed in Section 4.2. 
 
4.3.2 Inclusion criteria and Paper Categorisation 
To be included in this review, studies identified needed to address at least one of these two 
main objectives of this review: 
1. the aggregation of capability at an individual level and/or across populations, and/or  
2. an objective or decision-rule as to how such outcomes could be then used to aid 
decision-making (e.g. cost per QALY threshold rule in health economics) 
 
Based on the above criteria, titles and abstracts for the studies were sorted through keyword 
searching:  
Keyword searching through title and abstract was structured as follows:  
Capability OR Capabilities OR Functioning(s) OR Agency 
AND 
Measure OR Outcome OR Empirical OR Index OR Operationalisation  
 
This review followed a two stage process of study categorisation. This follows from previous 
reviews which have used this categorisation process to identify the studies of most relevance 




4.3.2.1 Stage I – Initial Categorisation of studies 
The studies identified using the previously outlined search strategy were then sorted into three 
categories based on the title and abstract.  
 
Category A, studies mentioned at least one from the two key search word lines (i.e. capability 
and operationalisation is Category A, capability only is not Category A).  
 
Category B, studies that could be potentially relevant to the review, but require more 
information than the title and abstract alone. If the study contained the keywords capability or 
functioning or agency, but none of the other keywords, the study was examined for a 
quantitative results section, which could potentially indicate an attempt to measure capability 
outcomes. If any of the other key words were found in the title and abstract but did not 
include capability or functioning or agency, the reference list of the study was searched for 
citations of the key capability writings by either Amartya Sen or Martha Nussbaum, as a 
means of eliciting whether the study was based upon capability theory.  
 
Category C, studies were excluded from the review. The studies either did not include any of 
the keywords for inclusion, or did not meet the criteria for Category B. Category C also 
included non-English publications. Conference abstracts and presentations were also excluded 
from this review, as it was not feasible to carry out a consistent quality assessment for this 





The studies identified in the first wave from the initial pearls (see Section 4.3.3) are then 
classified, according to Stage I categorisation. Therefore, the search terms are not used to 
initially to identify studies to review, but to classify studies once identified through the pearl 
growing method. Studies identified from the first wave which are classified as Category A or 
B are then employed to carry out a further wave search. Studies which have cited these new 
pearls are then categorised in the same manner as the first wave. This process of wave 
searching continues until a time where no new relevant studies are found. An illustration of 
the pearl growing method is presented in Figure 4. 
 













  Key pearl for WAVE1 
  New pearl for next WAVE 
  New pearl excluded 




4.3.2.2 Stage II – Further Categorisation of studies 
Following the completion of the pearl search, studies categorised as either A or B were further 
classified after being read in full. Four categories helped to identify the final papers for 
inclusion. 
1. Study uses capability related outcome and discussed decision rule 
2. Study uses capability related outcome but does not discuss decision rule 
3. Study discusses decision rule but does not use capability related outcome 
4. Study does not use capability related outcome nor discuss decision rule 
 
Papers which are classified within the first three categories are included in stage II 
classification in the final analysis of this review to help answer the three primary aims of the 
review. Papers classified as category 4 in stage II classification are excluded from further 
analysis. 
 
4.3.3 Selection of Key Pearls 
As a starting point for the identification of key pearls, from which the first wave of studies are 
identified within this review, the research already identified in the three previous reviews, 
presented in Section 4.2, was considered. The broadest disciplinary focus of the three 
previous reviews was the study by Robeyns (2006).  
 
In Table 3, the nine areas (identified by Robeyns (2006)) where the capability approach has 




for the initial key pearl list to commence the literature review. One group (non-normative 
research, i.e. qualitative research) was excluded from the selection for the pearl list, as the 
studies were not relevant for this review focus of quantitative empirical applications. From the 
remaining eight groups in Table 3, nine studies from this review were included as the key 
pearls. The review by Robeyns (2006) was also included as a key pearl. Overall ten key pearls 
were included as detailed in Table 4. 
 
Robeyns (2006) application groups (see Table 3) are used as a starting point for grouping and 
analysing all the studies included following the pearl search; where studies fell outside these 
groups, additional groups for new themes were generated where necessary.  
 
Table 4 Key Pearl References for identifying studies in WAVE 1 
Author Study Title Journal/Book Year 
Fukuda-Parr The Human Development Paradigm Feminist Economics 2003 
Alkire Valuing Freedoms Book 2002 
Ruggeri Laderchi et al.  
Does it matter that we do not agree on the 




A multidimensional assessment of well-
being based on Sen's functioning theory 
Rivesta 
Internazionale di 
Scienze Sociale 2000 
Anand & Van Hees 




Zaidi & Burchardt 
Comparing incomes when needs differ: 
equivilization for the extra costs of 
disability in the UK 
Review of Income 
and Wealth 2005 
Kuklys 
Amartya Sen's capability approach: 
Theoretical insights and empirical 
applications Book 2005 
Robeyns 
Sen's capability approach and gender 
inequality: selecting relevant capabilities Feminist Economics 2003 
Lewis & Giullari 
The adult worker model family, gender 
equality and care: the search for new 
policy principles and the possibilities and 
problems of a capabilities approach 
Economy and 
Society 2005 
Robeyns The capability approach in practice 
The Journal of 




4.3.4 Data extraction 
Data were extracted from all included studies using a standardised data extraction form. The 
information used to inform data extraction is presented in Appendix 2. This follows protocol 
for data extraction from systematic reviews in health (CRD, 2009). 
 
4.4 RESULTS 
The summary statistics of the comprehensive pearl growing strategy, as well as the second 
stage review categorisation process are presented in this section. 
 
4.4.1 Summary of Pearl Search 
Overall, four waves of searching resulted in the identification of 494 unique studies. The 
findings are summarised in Figure 5. From Wave 1, 309 studies were flagged to have cited the 
key pearls. Forty-six (14.89%) of these papers were classified within Category A. From the 
remaining citations which addressed one of the two keyword searches, 25 of the 83 studies 
were classified as Category B on closer inspection. The other 58 studies were classified as 
Category C studies and excluded from the review. One hundred and eighty (58.25%) research 
studies were classified within Category C based on the title and abstract alone and were 
excluded from the review, with a total of 238 of 309 (77%) studies excluded in Wave 1.  
 
From the 71 studies classified in Category A (46) or Category B (25) in the first wave, these 
studies pinpointed a further 182 unique references in wave 2. Twelve (6.60%) of these papers 
were classified in Category A based on abstract and title only, with 128 studies excluded as 




title and abstract only, 8 studies were classified as Category B on closer inspection and 
included in the review. 

















Key pearls: 10  
(see Table 4) 
309 unique studies found 
71 new pearls (Cat A/B) 
 
WAVE 1 
182 unique studies found 
20 new pearls (Cat A/B) 
WAVE 2 
3 unique studies found 
1 new pearl (Cat A/B) 
WAVE 3 
No new pearls found 
494 studies identified in total 






From the 20 studies of relevance found in WAVE 2 which were used as pearls for a third 
wave of searching, three new studies were identified (WAVE 3), with no paper meeting 
Category A or C on title and abstract only. One of the three studies was classified in Category 
B on closer analysis with two being included in Category C. This sole Category B study was 
used to run the fourth wave of literature searches, but no further studies were identified which 
fell within the timeframe of this search. Therefore, this signalled the conclusion of the search. 
 
4.4.2 Final classification of studies 
Upon Stage II classification of the remaining studies, almost half of the studies (45/92) were 
found to address the two key aims of this review (Category 1). 26 addressed one of the aims 
only (Category 2 or 3). Twenty studies did not measure capabilities directly or discuss a 
decision rule or objective for such a measurement, so these studies were excluded from 
further analysis (Category 4). Appendix 3 presents the 72 papers included in this review. 
Appendix 4 lists the papers excluded at the stage II classification. 
 
4.5 ANALYSIS OF REVIEW 
This section begins with summary data on the studies included for full review. This is 
followed by a description of the primary focus of studies within the review and whether this 
reflects findings from the previous review which are presented in Section 4.2. Section 4.5.3 
then looks at the type of attributes included in the studies which developed or employed 
capability related measures. Section 4.5.4 explores whether there are any themes within the 
review for aggregating such measures to form an index. Finally, the objectives and decision 




capability studies more broadly in Section 4.5.5. Section 4.5.6 addresses a number of 
outstanding issues related to capability application. 
 
4.5.1 Summary Data on studies included in review 
Figure 6 shows summary information about the locations of where the studies were based on. 
The highest proportion of studies took place within the UK and the rest of Europe (26 studies 
out of 72 or 36%).  
Figure 6 Population where the capability studies identified were applied 
  
 
Figure 7 shows the spread of studies across seven capability thematic groups identified by 
Robeyns’ (2006) (i.e. group i.-group vii.) and three new themes which emerged from this 
review (i.e. group viii.-group x.). Group iv. (assessing poverty and well-being assessment in 
advanced economies) has the highest proportion of studies identified out of the 10 groups 












health (group x.) account for 26 of the 72 studies identified, showing a growing interest in 
capability applications in these three groups in particular. 
 
Figure 7 Number of studies per capability thematic group 
 
Thematic groups: i. General assessment of human development; ii. Assessing small scale development projects; iii. 
Identifying the poor in developing countries; iv. Poverty and well-being assessment in advanced economics; v. Deprivation 
of disabled people; vi. assessing gender inequalities; vii. Debating policies; viii. Education; ix. Technology; x. Health 
 
4.5.2 Focus of study: Capability, Functioning or Agency? 
In Figure 8, the focus of the studies included in the review, in terms of their main interest in 
measuring capabilities, functionings or agency (as defined in Chapter 3), is outlined. Where 
studies had more than one focus (e.g. capability and agency), the predominant focus of the 










































Out of the 72 studies included in the final review, 38 studies had an applied focus on 
functionings, 29 studies on capability and 5 papers on agency. While the results of this review 
would confirm the findings of previous reviews of capability applications which are mainly 
concentrated on functionings (Kuklys & Robeyns, 2005; Robeyns, 2006; Chiappero-
Martinetti & Roche, 2009), from Figure 8 there appears to be an increasing interest in the 
applied focus on capability measures in more recent times. 
 
Figure 8 Study focus of Capability Application review (2006-2012) 
 
 
4.5.3 Attributes included in capability related measures 
From the 72 studies included in the review at this stage, 61 (85%) of them developed or 
applied an instrument of some description related to the capability approach. Each thematic 
group is discussed in terms of capability attribute inclusion. The attributes for each study are 
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4.5.3.1 Thematic Group i. General assessment of human development 
Eight studies implemented attributes assessing human development (group i.). Distaso 
developed a multidimensional sustainability well-being index across 10 dimensions and 
applied the measure within Italy (Distaso, 2007). Gardoni and Murphy (2010) developed a 
Disasters Impact Index (DII) to measure the consequences of natural disasters upon people’s 
capabilities (Gardoni & Murphy, 2010). A welfare index was developed to measure 
capabilities within Argentina across 10 dimensions (Anand et al., 2011), although this index 
was not generated from Nussbaum’s list of 10 central human capabilities like previous work 
from Anand and colleagues (2009) with the OCAP, as described in Chapter 3. Notten & 
Roelen (2012) collected thirteen indicators of deprivation for four dimensions (housing, 
neighbourhood, basic services, financial resources) to assess the most appropriate method of 
measuring childhood deprivation across the European Union (Notten & Roelen, 2012). 
Nussbaumer (2012) developed five dimensions (across six indicators) to assess energy 
poverty in Africa (cooking, lighting, services provided by household appliances, 
entertainment/education, communication). Alkire & Foster (2011a) assessed 
multidimensional poverty across four attributes in the United States (health status, health 
insurance, education and income) and across three dimensions in Indonesia (expenditure, 
health in terms of body mass index and years of schooling). Krishnakumar & Ballon (2008) 
predicted two basic capabilities (knowledge and living conditions) from six indicators of 
capability in Bolivia. Nguefack-Tsague et al. (2011) considered the methods for valuing the 
three attributes on the HDI. This is discussed at greater length in the section on aggregating 
attributes (Section 4.5.4). All but one study (Anand et al., 2011) in this thematic group 
developed attributes with a functionings assessment of well-being. Anand and colleagues 




4.5.3.2 Thematic Group ii. Assessing small scale development projects 
Only one study was identified for assessing small scale developments (group 2). Peris and 
colleagues (2012) examined the role of El-Almanario, a small grants development programme 
(SGP) tool aimed at enhancing community empowerment in a rural town in Guatemala (Peris 
et al., 2012). Community residents are asked to fill out a questionnaire, where they were asked 
to identify the problems within the communities and then decide which of these problems 
should take priority in being addressed by the community (Peris et al., 2012). 
 
4.5.3.3 Thematic Group iii. Identifying the poor in developing countries 
Seven studies were found for the group concerned with identifying the poor in developing 
countries (group iii.). The majority of these studies included attributes based on context 
specific poverty to the country of origin, such as a child poverty measure developed 
specifically for Vietnam (Roelen et al., 2010), well-being in Thai provinces (Parks, 2012), 
poverty in a Brazilian shantytown (Kerstenetzky & Santos, 2009), core poverty in South 
Africa (Clark & Qizilbash, 2008), or protecting capability in Chile (Barrientos, 2010). Other 
studies have focused more on the methodology for identifying the poor, in relation to 
measuring child poverty (Arndt et al., 2012), and defining poverty based on adequate shelter, 
which is broadly defined as somewhere that an individual can address their basic needs 
(hygiene and rest) and are able to store their personal belongings securely (Norcia et al., 
2012). All seven of these studies were based on capturing functioning, with health and 





4.5.3.4 Thematic Group iv. Poverty and well-being assessment in advanced 
economies 
Assessing well-being and poverty in advanced economies (group iv.) had the highest number 
of studies out of the ten thematic groups (13 studies altogether). Wagle produced two studies 
which looked at indicators of poverty in the United States, focusing on education, income and 
type of employment (Wagle, 2008; Wagle, 2009). Capability indicators are a dominant theme 
within this category. Jordan and colleagues (2010) explored Cape York Institute for Policy 
and Leadership ‘capability indicators’ which included eleven dimensions to assess differences 
between indigenous and non-indigenous Australians (Jordan et al., 2010). Anand’s OCAP 
survey of capability indicators, developed in the UK, was also identified but was already 
discussed in detail in the previous chapter (Anand et al., 2009). Another UK study focused on 
“basic functionings” to achieve what Binder and Broekel refer to as “conversion efficiency” 
(Binder & Broekel, 2011). Two studies looked at whether government measures of human 
rights (Burchardt & Vizard, 2011) and poverty captured in German wealth reports (Arndt & 
Volkert, 2011) are compatible indicators with the capability approach. Van Ootegem and 
Verhofstadt developed a questionnaire of capabilities, which was tested on University 
students in Belgium across seven domains that were thought to be important for University 
students (Van Ootegem & Verhofstadt, 2012). Researchers in Australia developed a freedom 
poverty measure across three dimensions (income, health and education) and have suggested 
that it can be used as an alternative measure of poverty in Australia (Callander et al., 2012b), 
to assess regional differences in poverty in Australia (Callander et al., 2012a) and as a broader 
assessment of child well-being and their ability to work once finished schooling (Callander et 
al., 2012c). The same three dimensions of education, health and income were used to assess 




(education/leisure, health, social participation, income poverty) across eight indicators were 
used to assess childhood deprivation in Germany (Wust & Volkert, 2012). The study by Van 
Ootegem and Verhofstadt (2012) was the only study to develop capability attributes, with the 
other 12 studies based on functionings achieved as indicators of capability. 
 
4.5.3.5 Thematic Group v. Deprivation of disabled people 
The deprivation of disabled people (group 5) consisted of one study. Rosano and colleagues 
(2009) applied Kuklys’ (2005) equivalence scales for disabled people within Italy and found 
that disabled Italians require twice as much income to achieve the same functioning as the 
fully able (Rosano et al., 2009). In Kuklys original study, the disabled in the UK required 
50% more income on average to reach equivalent functioning levels (Kuklys, 2005). 
 
4.5.3.6 Thematic Group vi. Assessing gender inequalities 
Five unique measures were developed for assessing gender inequality (Group vi.). Anand and 
Santos (2007) used the OCAP survey to explore three capabilities related to violent crime and 
the propensity of females to fare worse in terms of their fear of, and actual experiences of 
sexual assault, domestic violence and violent assaults (Anand & Santos, 2007). Addabbo and 
colleagues (2010) developed a gender budgeting approach as a method to audit the impact 
across genders from new government policies (Addabbo et al., 2010). Bérenger and Verdier-
Chouchane developed a Relative Womens Disadvantage index to compare women’s 
disadvantage in terms of health, education and labour participation internationally (Bérenger 
& VerdierChouchane, 2011). To assess the quality of life of home based workers in 




assess the time-use dimensions of wellbeing (Floro & Pichetpongsa, 2010). Finally, Di 
Tommaso and colleagues (2009) focused on two of Nussbaum’s two central human 
capabilities (bodily health and bodily integrity) to explore the well-being of women trafficked 
for sexual exploitation in the Balkans and Eastern Europe (Di Tommaso et al., 2009). All 
studies in this category focused on functionings. 
 
4.5.3.7 Thematic Group vii. Debating policies 
The debating policies group (group vii.) had four studies. Two of the papers are in contrast 
with the gender inequality group (group vi.) by focusing primarily on the male gender 
disadvantage when it comes to achieving work-life balance. Within these studies, Hobson and 
colleagues assess differences across Europe by drawing from European data on parents’ work 
life balance and whether parents felt they had control in achieving a good WLB (Hobson & 
Fahlén, 2009; Hobson et al., 2011). Renouard argues why “relational capability” within 
organisations is important for achieving corporate social responsibility by identifying four key 
components (network integration, individual commitment to work within groups, having 
attachment with others, valuing others objectives simultaneously) (Renouard, 2011). Reitinger 
and colleagues (2011) debate the merits of conceptualising Area of Protection over 
consumption and production processes within a given society for analysing environmental life 
cycle assessment through a capability lens. They identify eight key dimensions (Reitinger et 
al., 2011). Two of these studies focuses on capability (Renouard, 2011; Reitinger et al., 2011), 





4.5.3.8 Thematic Group viii. Education 
The group focusing on education (group viii.) had seven studies which developed alternative 
measures. The majority of these studies focused on expanding capabilities within Africa 
ranging from basic capabilities in the quality of education (Smith & Barrett, 2011; Tikly & 
Barrett, 2011), and a more general education capabilities list (Walker, 2006), to a Public-
Good Professional education index, which aimed to promote the higher education of those 
individuals who would expand societal capabilities (McLean & Walker, 2012). A list of 
functional capabilities was also developed for higher education (Walker, 2008), while in the 
US, the capabilities gained from teaching arts in schools was captured by the Arts Education 
Pathway Model (Maguire et al., 2012). A list of five basic capabilities from learning was also 
developed (Young, 2009). The majority (five) of these studies focused on capability 
attributes, with only two (McLean & Walker, 2012; Smith & Barrett, 2011) based on 
functioning attributes.  
 
4.5.3.9 Thematic Group ix. Technology 
Six studies were identified on the topic of technology (group ix.). Three of these studies show 
the development of the Choice Framework, primarily by Kleine (Kleine, 2010; Kleine, 2011; 
Kleine et al., 2012). The Choice Framework was used to assess issues such as the role of 
telecentres (i.e. free public access to computers and the internet) in Chile and Fair Tracing of 
products in the UK (i.e. allowing customers and producers to digitally follow the supply chain 
of goods), which helped to show the improved benefits gained from individual capability 
through technological advances. The role of information and communications technology for 
development (ICT4D) was also explored in the other three studies in this category, with the 




improvement of instrumental freedoms in Uganda (Kivunike et al., 2011), and in Cambodia 
through a Capability, Empowerment and sustainability virtuous spiral model (Grunfeld et al., 
2011). Three studies included capability attributes (Kleine, 2010; Kleine, 2011; Grunfeld et 
al., 2011), two studies on functioning attributes (Kivunike et al., 2011; Hatakka & Lagsten, 
2011) and one study on agency (Kleine et al., 2012). 
 
4.5.3.10 Thematic Group x. Health 
The health group (group x.) had nine studies which included capability attributes. Four of 
these studies relate to two of the three types of capability questionnaires already discussed in 
detail in Chapter 3 (Grewal et al., 2006; Coast et al., 2008a; Al-Janabi et al., 2012a; Netten et 
al., 2012). Three of the studies are focused within the United States, with attention paid to 
chronic conditions (Ferrer & Carrasco, 2010), as well as the ability of the built urban 
environment to give more capability for people to participate in healthy activities and reduce 
obesity levels (Lewis, 2012a; Lewis, 2012b). The remaining two studies were from Africa, 
with both studies interested in the control and empowerment of women’s decision making in 
accessing healthcare in Burkina Faso (Nikiema et al., 2012) and reducing shortfalls in health 
functioning in Ethiopia (Mabsout, 2011). While the role of health is an important indicator of 
capability within most of the other thematic groups in this review, an indicator of health was 
included in the minority of studies within this section, indicating that focusing on health alone 





4.5.4 Aggregating capability related attributes within an index 
The majority of studies discussed in the previous section could not be easily grouped within a 
pre-existing index, with the majority of such studies developing new outcomes to address 
particular problems with capability within a specific context or country. However, some of the 
studies identified did show trends in the development of an index once the attributes of the 
instrument had been decided. In this section, the two major methodologies that are developed 
for compiling capability indicators into an index are detailed. 
 
4.5.4.1 Alkire and Foster Multidimensional Poverty Methods 
The primary methodological contribution to index development found in this review appears 
to be the work of Alkire and Foster on multidimensional poverty (Alkire & Foster, 2011a). 
The Alkire Foster (AF) measures propose a methodology for measuring the multi-faceted 
nature of the social determinants of poverty. Alkire and Foster (2011a) do not focus on a 
single indicator of poverty such as income poverty. They show in their seminal paper on 
multidimensional poverty measurement how such a focus can be misleading in describing the 
true levels of poverty within a given society. Instead, the AF measures allow other factors to 
be considered in determining whether or not poverty is present.  
 
Alkire and Foster (2011a) follow the axiomatic approach to measuring multidimensional 
poverty as detailed by Sen (Sen, 1976). The AF measures focus on two key issues of poverty 
measurement. Firstly the “identification method”, which considers how an individual is 




from the identification step of determining who is poor, by defining the appropriate measure 
of the deprivation suffered by the poor (Alkire & Foster, 2011a). 
 
Within a unidimensional poverty measure, there is a relatively simple process involved in 
defining whether a person is in poverty. It is a case of determining the threshold on that one 
dimension below which a person is considered to be in poverty. For an example, the World 
Bank defines “extreme poverty” as individuals living on less than $1.25 a day, adjusted for 
purchasing power parity (PPP), with a higher level of $2 for middle income economies (The 
World Bank, 2010).  
 
The “identification method” becomes more complex in multidimensional poverty 
measurement. Here, the classification of an individual as poor additionally requires a decision 
about the number of dimensions in which a person has to fall below the threshold to be 
classified in this way. Atkinson (2003) outlines two common identification approaches in 
poverty assessment. Firstly, the “union approach”, whereby a person is classified as poor if 
they fall below the threshold on any dimension. Secondly, the “intersection approach”, 
whereby a person is poor only if they fall below the threshold of all included dimensions 
(Atkinson, 2003). 
 
Alkire and Foster (2011a) found flaws with both identification methods and developed an 
alternative “in between” method for AF measures, referred to as the “dual cutoff” method. 




a person is classed as deprived in that dimension, and second determining the number of 
dimensions in which an individual must be deprived to be classified as poor. These cutoffs 
can vary with context, enabling flexibility for specific purposes, whether it be a cross-national 
comparison of multidimensional poverty or a more refined policy question (Alkire & Foster, 
2011b). 
 
The “aggregation method” relies on a “censoring” step, whereby those who do not meet the 
criteria for poverty (i.e. individuals not deprived in the required number of dimensions) are 
censored from the poverty measurement exercise. The aggregation process then relies on a 
number of different methods, depending on the complexity of the poverty measurement 
required. These methods are captured in four different AF measures of multidimensional 
poverty, which consider not only whether or not a person is poor, but also on how many 
dimensions they are poor in (accounting for the breadth of poverty over dimensions 
considered), how far away an individual is from the threshold on each dimension in which 
they are deprived (accounting for poverty depth within a dimension) and whether different 
weights across dimensions are attached to the same levels below the poverty thresholds on 
dimensions (accounting for the severity of poverty across dimensions) (Alkire & Foster, 
2011a). 
The four AF measures are outlined below: 
1. Headcount ratio (H): p/P  
(where p = population who are poor; P = total population under consideration) 
This measure is essentially a counting exercise whereby the proportion of poor 





2. Adjusted headcount ratio (M0) = Headcount ratio*(dp/D) 
(where dp = dimensions which individual is poor, D = number of dimensions for poor 
population, p, any individual can be poor in) 
This measure shows on how many dimensions a person is classified as poor, with a 
proportionally higher deprivation experienced by people deprived in more dimensions. 
 
3. Adjusted poverty gap (M1) = M0*(lp/L) 
(where lp = levels below poverty threshold where poor population, p responded, L = 
total levels below threshold across dimensions for poor population, p) 
This measure takes into consideration the breadth of deprivation amongst the poor, as 
well as the depth of poverty suffered, which accounts for higher poverty levels the 
further an individual is from the cutoff threshold. 
 
4. Adjusted Foster-Greer-Thorbecke(FGT) (Foster et al., 1984) measure (M2) = 
M0*(vp/V) 
(where vp = values attached to levels below threshold where poor population, p 
responded, V = total value between lowest levels on all dimensions and threshold for 
poor population, p)  
The most sophisticated AF measure, allowing values to be attached to different 
response levels on dimensions. It allows for the measurement of the frequency, 
breadth, depth and severity of deprivation suffered by the poor. 
 
Alkire and Foster (2011a) illustrated these AF measures in the United States, by measuring 
multidimensional poverty between three ethnic groups (African-American, Hispanic and 
White) across four dimensions (income, health status, health insurance, education level), with 
a cutoff of deprivation in two dimensions for a person to be considered poor. They found that 
whilst the African-American population in their sample was the most impoverished when 
analysing income only (i.e. using the Headcount ratio H), using their dual cutoff approach for 




health insurance and education attainment indicators were considerably worse for Hispanics 
(Alkire & Foster, 2011a). This methodology has been adopted by the United Nations and 
since 2010, it reports a Multidimensional Poverty Index (MPI) annually in its Human 
Development Reports (HDR) (Klugman, 2010). 
 
Eight studies in this literature review, including the methodology paper by Alkire and Foster 
(2011a), are connected by the use of this multidimensional approach to measuring capability. 
Three of the studies are related to developing a Freedom Poverty Measure in Australia, which 
looked at accounting for three dimensions of poverty (income, education and health) 
(Callander et al., 2012b), including measuring freedom between Australian regions (Callander 
et al., 2012a) and for assessing childhood development (Callander et al., 2012c). Two further 
studies also focused on measuring childhood deprivation: one study in Germany (Wust & 
Volkert, 2012) and another study in Vietnam (Roelen et al., 2010) using the AF methodology. 
One other study focused on measuring childhood deprivation but this time by comparing 
deprivation across four European countries (Notten & Roelen, 2012). Finally, Nussbaumer 
and colleagues (2012) developed a multidimensional energy poverty index (MEPI) and 
applied it across the African continent (Nussbaumer et al., 2012). 
 
4.5.4.2 Human Development Index and related measures  
The Human Development Index (HDI) is the traditional outcome measure that is associated 
with the United Nations Development Programme (UNDP) and the capability approach. Since 




included for cross-country comparison of the “real wealth of nations” (ul Haq, 1990). The 
construction of the HDI index was explained previously in Section 4.2.3. 
 
Only four studies within this literature review used aggregation based on the HDI 
methodology. Nguefack-Tsague and colleagues (2011) provide a statistical justification for 
the equal weighting of the three dimensions captured within the HDI (Nguefack-Tsague et al., 
2011). Perrons (2012) used the three dimensions of HDI to develop a regional development 
index (RDI) to assess the development of regions within the UK. Comparing RDI with GDP 
showed that London was not as developed as other UK regions when the additional 
dimensions were accounted for in the RDI (Perrons, 2012). Two other measures were 
developed outside of the UK. One study developed an individual well-being index (WBI) 
across three dimensions (personal income index, work intensity index, education attainment 
index) to measure the well-being of home-based workers in Thailand (Floro & Pichetpongsa, 
2010). The other study developed capability indices (CI) to assess two basic capabilities 
(knowledge and living conditions) across a number of indicators to compare different regions 
in Bolivia (Krishnakumar & Ballon, 2008). 
 
4.5.5 Exploring the objectives and decision rules within the capability approach 
In this section, the third aim of this review is explored in detail. Firstly, the objectives and 
decision rules within health specifically that were found in this review are examined. Within 
the second sub-section (Section 4.5.5.2), objectives and decision rules outside of health are 
analysed to see whether compatible or alternative decision rules are being used and justified 




which are included within this review the form of a narrative review was considered the most 
suitable to explore this aim. 
 
4.5.5.1 Is the QALY objective (health maximisation over time) compatible with 
the capability approach? 
Ten out of the 72 studies identified had a specific focus on health (group x.). There are 
different interpretations of how the capability approach can be used within an evaluation 
framework for health based on these studies. The work based upon the ICECAP indices, 
which were discussed in detail in Chapter 3, suggests that one possibility for the capability 
approach is to measure a concept broader than health maximisation: 
“One option would be to use such an index essentially as a QALY replacement – as a 
means of retaining a single measure of outcome for such evaluations, but with that 
measure covering more than just health.” (Coast et al., 2008a, p. 882)  
 
Others have argued that while the QALY objective can be useful in certain circumstances, it 
is not a useful tool for assessing interventions where health is not a relevant outcome: 
“It is possible to view healthcare interventions as being on a spectrum between those 
that purely maximise health (e.g. use of insulin to control diabetes) and those that 
purely maximise empowerment (e.g. counselling interventions to improve ability to 
make informed health decisions in people living with diabetes). However, it is possible 
to conceive that the latter, if done well, could contribute significantly to the former, 
and indeed this is the basis of most self-management interventions” (McAllister et al., 




Accounting for empowerment within an evaluation framework applies as much in developed 
countries as it does in developing countries, as emphasised by another study which looked at 
how women could overcome hurdles in accessing healthcare in Burkina Faso (Nikiema et al., 
2012). 
 
However, there is no overall consensus on the separation of the QALY objective from the 
capability approach. Netten and colleagues (Netten et al., 2012) argue that the measure of 
social care ASCOT, which they link to Sen’s notion of capabilities, can be framed within the 
QALY framework in what they refer to as a social care related quality of life (SCRQOL) 
measure: 
“The revised ASCOT measure developed through the study shows considerable 
potential, providing a first estimate of a social care equivalent to the QALY, and can 
be used in a range of circumstances, including cost-effectiveness, cost-utility and 
policy evaluation.” (Netten et al., 2012, p. 95) 
 
An alternative to separating QALYs and capabilities would be to measure health alongside a 
number of indicators of well-being. Such an approach has been developed in Australia, where 
a “freedom poverty” measure has been conceptualised with indicators of health, education and 
income to assess whether a person is deprived (Callander et al., 2012b). However, Callander 
and colleagues (2012b) have yet to define what would be considered good or bad health and 
what measure should be used to calculate good or bad health. Therefore, further research is 





Barring the example of Netten and colleagues (2012), who used the time-trade off technique 
to generate a social care QALY (see Chapter 3 for more), there has been little emphasis on 
incorporating time alongside capability or empowerment measures, which has, to date, been 
an important part of health economic evaluations. The ICECAP indices provide the most 
developed attempt to capture capability directly. However, there is no guidance as to how 
such indices could be used to aid decision-making. The next section assesses information 
from studies outside of health in the literature review to see if there is any other guidance 
available on the overall objective of an evaluation based upon capability theory. 
 
4.5.5.2 Capability Objectives and Decision Rules beyond health 
While the capability approach was developed as an alternative to the traditional utilitarian 
approach in welfare economic assessment, there are some who claim that capabilities can fall 
within a similar maximisation framework. One example of this is Renouard (2011), whose 
study suggests that corporate social responsibility within private enterprise should account for 
what they term as “relational capability”, drawing upon research within anthropology and Sen 
and Nussbaum’s research, to look beyond utility maximisation of company stakeholders but 
rather achieve the: 
“maximisation of the relational capability of people impacted by the activities of 
companies” (Renouard 2011, p. 85) 
 
This concept of maximising an absolute level of capabilities is not limited to the above 




choice” is a more appropriate assessment of welfare than the standard rational choice theory 
of economics within education of low income countries: 
 
“Here the assumption is that individuals act on the basis of the maximisation of their 
own utility and that efficiency within the public welfare system is best served through 
maximising ‘choice’” (Tikly & Barrett, 2011, p. 8)  
 
However, the objective of maximising capabilities in some form or another as an absolute aim 
is not a reflection of the majority of work related to the papers found in this review. As an 
example of this, Anand et al. (2009) states: 
 
“they (people) do not wish to maximize total social welfare for a variety of reasons, 
not least of which is that they are concerned about distributional issues too” (Anand 
et al. 2009, p. 127) 
 
Many papers focus on the maximisation of something less than optimum levels as a priority, 
such as the maximisation of basic capabilities (Krishnakumar & Ballon, 2008) or by 
measuring poverty as: 





Other conceptualisations of the capability approach have developed within more advanced 
economies. Binder and Brockel (2011) develop their concept of “conversion efficiency” as an 
alternative to traditional well-being assessment: 
 
“The idea of relative efficiency means we are evaluating individuals’ efficiency not 
with a theoretically derived maximum, but to the maximum of functioning achievement 
observed in the data given a certain level of resources” (Binder & Brockel 2011, p. 
261) 
 
Binder and Brockel demonstrated their measure within Great Britain and showed that 
conversion efficiency is improved within this sample, by age, self-employment, marriage, no 
health problems and living in London and the surrounding boroughs (Binder & Broekel, 
2011). Murphy and Gardoni (2010) developed a two-stage process for assessing individual 
capability within a risk analysis, such that: 
 
“for defined groups, the goal should be to maximise variability of non-basic 
capabilities and minimise variability within sub-vectors of basic capabilities and 
among defined groups of those with similar boundary conditions” (Murphy & 
Gardoni 2010, p. 145) 
 
Another alternative to average welfare maximisation in a narrow space comes from the field 




youths is not an adequate pre-requisite to future labour force participation (Callander et al., 
2012c). Instead they develop a measure drawn from the multidimensional poverty literature 
(Alkire & Foster, 2011a) to assess health alongside education, which they argue is also likely 
to have an impact of the probability of labour force participation in the future: 
“efforts to increase children’s future labour participation rates as a means of 
improving their living standards should also focus on improving childhood health, as 
well as education.” (Callander et al. 2012c, p.179) 
 
4.5.6 Outstanding issues 
The quantitative studies analysed in this review most commonly apply the capability approach 
to compare capabilities across populations. The majority of population comparisons deal with 
cross-sectional data only, with little attention paid to how capability is affected over time 
within population groups. The reference case of current health economic evaluations for 
groups like NICE recommends accounting for changes in quality over time within outcomes 
(NICE, 2013), so this is an important consideration for using the capability approach in health 
evaluations. 
 
One notable attempt identified in this review to measure well-being over time was carried out 
by Clark and Hulme (2010). The aim of their study was to bring together two separate parts of 
poverty measurement, by measuring core poverty (at a point in time) and chronic poverty 
(over time) simultaneously (Clark & Hulme, 2010). In this study they extend the vagueness 
poverty framework (Qizilbash, 2003), which designates people within three categories based 




(Clark & Qizilbash, 2008). When combined with the research within measuring prolonged or 
“chronic poverty” research (Hulme & McKay, 2008), even more definitions are introduced 
when measuring poverty over time. Such definitions include transitory vulnerable people (at 
risk of poverty in future or just coming out of a definite poverty state of being), transitory core 
poor (people who go in and out of poverty over time) and chronically core poor (i.e. 
persistently poor over time) (Clark & Hulme, 2010).  
 
While this research is a welcome improvement in addressing capability longitudinally, it 
remains less clear of the value of different states of poverty within Clark and Hulme’s (2010) 
approach (e.g. should all resources be channelled at those in core poverty before other levels 
of poverty should be addressed?). An alternative study states that their “fuzzy” approach to 
defining different poverty levels could be used longitudinally (Betti & Verma, 2008). 
However, the question of which poverty states (or capability states) are prioritised over 
another remains to be addressed before this work can be applied within an evaluation 
framework.  
 
From this review, there does not appear to be a method for combining a measure of capability 
with the cost of an intervention, even though studies have developed outcomes as alternatives 
to measuring benefits monetarily in a cost-benefit analysis (Beyazit, 2010; Gardoni & 
Murphy, 2010). It is unlikely, then, that health economics can learn much about developing a 






The analysis of the comprehensive pearl review has shown that research in a wide variety of 
disciplines has attempted to measure and apply the capability approach quantitatively. This 
chapter reports the most recent advances within the applied capability literature. It specifically 
explores the application of the capability in health, and whether applications in other 
disciplines are appropriate when evaluating health interventions too. The areas of “Health”, 
“Education” and “Technology” are among the highest growing disciplines where the 
capability approach is being most frequently applied. This resulted in three themes being 
added to Robeyns’ (2006) initial thematic groups developed in 2006. Additionally, previous 
reviews have shown an overwhelming majority of studies have focused on functioning based 
attributes. While functioning attributes remain the most prevalent method in this review too, 
Figure 8 suggests that this review has identified an increasing trend of using capability based 
attributes. 
 
The primary results show that there is no overall consensus as to how the capability approach 
should be applied either in health or elsewhere to aid decision-making. The majority of 
studies in this review suggest that an objective other than the maximisation of health when 
applying the capability approach is likely to be more appropriate for an application which 
corresponds with the underlying theory. Rather, it seems that a more consistent theme through 
the majority of the studies reviewed is the idea of achieving “basic capabilities”(Young, 2009) 
or “minimum level of capabilities attainment” (Murphy & Gardoni, 2008). This threshold 
approach has also been referred to within regions as a “sufficiency economy” (Parks, 2012) or 
within adult literacy as a “sufficient” level of learning (Maddox & Esposito, 2011). Within the 




for applying the capability approach. This is reflected in the main way attributes were 
aggregated within an index through the Alkire and Foster methods of multidimensional 
poverty, with the purpose of allowing multiple determinants of “unfreedom” to be calculated 
simultaneously (Alkire & Foster, 2011a). 
 
Outcomes within the capability approach explored in this review offer little as to how 
resource allocation could be informed by such indices. The primary objective of studies was 
an attempt to highlight areas where inequalities or poor performance in specific contexts can 
be improved, with little guidance as to how such improvement should be made. This is not 
useful within a health economic evaluation context, where choices between alternative 
interventions are required. Additionally, capability over time is a sparsely explored topic, so a 
method for the combination of a measure of capability with time cannot be drawn from 
studies found within this review.  
 
The quality of the studies included within the final review was not assessed given the wide 
variety of areas of application and the desire to explore possible methods. Papers were chosen 
in a defined period of time based on a defined number of relevant original pearl cites; 
although the entirety of the literature is not reported, earlier capability applications were 






The strengths of this literature review in comparison to previous capability literature reviews 
are that the search strategy methodology was established and made explicit, whilst previous 
reviews of applied capability work have been less transparent. Given the growth of areas 
where the capability approach is applied, a less systematic approach is likely to be subject to 
bias arising from researcher disciplinary knowledge and is likely to miss new research 
developments in different contexts.  
 
There are a number of limitations associated with this review. The selection of key pearls 
from a previous review of themes in the capability approach was an attempt to include a wide 
variety of studies from different disciplines. However, the selection of those key pearls may 
not have been cited by all the most recent applications of the quantitative application of the 
capability approach. Therefore, not all relevant papers may have been included in this review. 
This is the trade-off associated with using the comprehensive pearl growing literature search 
strategy to identify a manageable amount of studies to review. 
 
This review suggests that those wishing to apply the capability approach should take into 
account objectives other than maximisation of an ideal state, for example health 
maximisation. The prioritisation of basic capabilities or a threshold of sufficient capability to 
have a good life would appear to be a constant theme throughout the majority of research 






The comprehensive pearl review collected papers from a range of disciplines to answer 
specific questions related to health. Studies identified within this review will be of interest to 
researchers in other disciplines in the application of the capability approach, in terms of types 
of capability attributes, methods of aggregation of attributes and decision rules applied in such 
studies. 
 
It remains to be seen how the capability approach can be combined with duration to assess 
between alternatives for health interventions. Some attempts have been made to connect 
different poverty literature to account for this (Clark & Hulme, 2010), but more research is 
required to understand the relationship in greater detail. This could be an area where the 
capability approach learns from the health economics outcomes (as detailed in Chapter 2), 








In the first three chapters of this thesis, the impact of health economics on decision-making 
over the past half century has been detailed (Chapter 2), as well as introducing the capability 
approach to evaluating societal welfare (Chapter 3). The capability approach has been 
interpreted by a number of health economists as providing an alternative to the present 
theoretical basis and objectives of health economic evaluations (Verkerk et al., 2001; Anand 
& Dolan, 2005; Coast et al., 2008c; Ruger, 2010a; Smith et al., 2012). The development of 
measures of capability well-being designed to be used in assessing health and social care 
interventions was also explained in Chapter 3. The ICECAP questionnaires were identified 
for further use in Chapter 3 as the most developed approach for generating economic 
outcomes.  
 
The first task in this chapter is to identify a relevant case study for this analysis. A study 
selection process is outlined and reasoning for the choice of the final case study chosen is 
justified. The reasons for exclusion of other potential case studies are also discussed. 
 
From the case study selection process, it became clear that the lack of directly collected 




with primary data. This chapter outlines an alternative approach to incorporating measures 
within economic models which is pursued in this thesis. This is known as mapping.  
 
Individual well-being in health economics is frequently assessed through health related 
quality of life (HRQoL) questionnaires. When such questionnaires are combined with 
population preferences, they are often referred to as health utility instruments or preference 
based measures (Brazier et al., 2007). However, not all clinical studies collect HRQoL data on 
a frequent basis, with many trials focusing instead on condition-specific health status 
questionnaires, which aim to capture specific changes in quality of life and are favoured by 
clinicians as more likely to show changes associated with a given disease/illness. However, to 
comply with guidance from the National Institute for Health and Care Excellence (NICE) for 
economic evaluations within the UK, health utilities are required to be estimated so that 
Quality Adjusted Life Years (QALYs) can be calculated (NICE, 2013). QALYs, as discussed 
in Chapter 2, allow for comparisons across different interventions and patient groups across a 
health service. 
 
Mapping from condition-specific and generic non-preference based questionnaires onto 
HRQoL to generate health utilities has become a popular method to generate QALYs when 
insufficient data on health utilities are available for the population under consideration. 
Mapping consists of generating a relationship between two instruments, allowing for the 
generation of QALYs when studies have not directly collected preference based measures 





In this chapter, the first aim is to identify where an ICECAP questionnaire could be 
implemented in a case study to show how relevant capability outcomes can be generated from 
existing data in a modelling exercise. The second aim of this chapter is to explore current 
advice available to researchers on the methodology of applying mapping to generate health 
economic outcomes. This chapter lays the foundations as to what recommendations are 
currently available when undertaking a mapping study, and provides guidance for subsequent 
mapping research which is developed in later chapters of this thesis. 
 
The chapter is structured as follows. Section 5.2 presents the case study selection process for 
exploring a capability measure in an economic model. Section 5.3 introduces the terminology 
associated with the mapping literature and the method of incorporating capability 
questionnaires within economic models, which is referred to frequently in the remainder of 
the thesis. Section 5.4 reviews the primary characteristics of a mapping study by appraising 
two recent sources of mapping research, to clarify what should be specified when formulating 
a mapping algorithm. Section 5.5 provides a summary of the case study selection process and 
the guidance that is currently available for mapping studies. 
 
5.2 CASE STUDY SELECTION 
In this section the case study selection process is chronicled step by step. 
 
The data needed to generate capability outcomes required the collection of capability 




interventions. The two capability instruments considered for generating capability outcomes 
were the ICECAP-A for the general adult population (Al-Janabi et al., 2012a) and the 
ICECAP-O for the over 65 UK population (Grewal et al., 2006; Coast et al., 2008a). The 
ICECAP-A and ICECAP-O instruments were discussed in detail in Chapter 3.  
 
It has been identified in previous research that capability outcomes are likely to be 
advantageous in areas where benefits usually are broader than health alone, for example in 
public health (Lorgelly et al., 2010a) and complex interventions (Payne et al., 2013). 
Furthermore, it has already been recognised by NICE that the benefits from public health go 
beyond health alone and therefore evaluations should take non-health benefits into 
consideration where possible (NICE, 2009b). Therefore, case studies which are from a public 
health perspective or another background that are likely to have broader benefits than health 
alone are likely to be particularly relevant for this research.  
 
Health economists and modellers at the University of Birmingham were approached in person 
or by e-mail in October 2010, and were provided with a brief synopsis of this research project. 
They were asked to provide a list of potential models which they had worked with in the past 
decade or work-in-progress at that time point for consideration as a potential case study. 
Additionally, trials that had collected ICECAP questionnaires or were known to be in the 
process of collecting ICECAP data were also explored. This was done so that all possible 
options could be examined as to how best to compile capability outcomes in economic 
evaluations with the data currently available. Resource constraints of the doctoral funding 




of assessing models from other developers outside of the University. Therefore, neither of 
these two options were considered any further in this research. 
 
Table 5 presents the 18 topics that were considered for case study selection. The primary 
reasons that 12 topics (67%) were discarded in the case study selection process was the lack 
of readily available ICECAP data or the inability to collect the data in a reasonable time 
period for this study (Connock et al., 2007b; Barton & Andronis, 2009; Barton et al., 2011; 
Andronis et al., 2009; Chen et al., 2009; Auguste et al., 2011; Roberts et al., 2011; Roberts et 
al., 2007; Lovibond et al., 2011; Fletcher et al., 2010). This initial criterion was required as 
capability outcomes could not be generated without such data. The smoking prevention topic 
(Jit et al., 2009) was discarded as the model population were primary school children. The 
ICECAP questionnaires have so far not been developed to capture children’s capabilities.  
 
Three topics (topic 16 (Dowswell et al., 2012), topic 17 (Rouse et al., 2011) and topic 18 
(Foster et al., 2010) in Table 5) which had ICECAP-A data available were subsequently ruled 
out due not having developed a model for the studies and not capturing health utility measures 
to be able to draw comparisons with the capability instrument. The final topic that was 
excluded was maintenance therapy for opioid dependents (Connock et al., 2007a; Holland et 
al., 2012). Even though ICECAP-O data could have been obtained from this topic, given the 
age group of the majority of opioid dependents is between 15-64 in the UK (Connock et al., 
2007a), the ICECAP-O capability instrument, which is designed for the older over 65 UK 
population, was deemed inappropriate for the population under consideration and ICECAP-A 




The chosen case study was therefore rheumatoid arthritis patients in the Birmingham 
Rheumatoid Arthritis Model (BRAM) (Jobanputra et al., 2002; Clark et al., 2004; Chen et al., 
2006; Malottki et al., 2011). Even though the ICECAP-O was not collected for previous 
BRAM studies, a dataset of arthritis patients was obtained and could be applied to previous 
BRAM models as condition-specific questions were collected alongside the ICECAP-O 
(Pollard et al., 2009). Whilst not a public health topic per se, there is recognition that relevant 
benefits and costs are often unaccounted for within economic evaluations given the NHS and 
personal and social services perspective in the majority of UK based evaluations, as a health 
service perspective is required, according to current guidance by NICE (NICE, 2013). The 
treatment for patients in BRAM involves complex drug treatment strategies, which is another 
area where capability measures of benefit are likely to be fruitful because complex lengthy 
treatments could be at a disadvantage if wider benefits over a longer period are unaccounted 
for in an evaluation (Payne et al., 2013). Furthermore, the use of ICECAP-O as the capability 
measure with the BRAM population is more appropriate than for the opioid dependence 
option, given that the majority of the population are aged 55 and older (Malottki et al., 2011). 
A particular advantage of this model was the possibility for drawing on the advice from the 
principal model developer, Dr. Pelham Barton. Given this additional benefit, as well as the 
BRAM model meeting the main criteria for this case study, it was decided that BRAM was 
the most appropriate option for this case study. The methods and results of the BRAM case 

























1 Rheumatoid Arthritis - Birmingham Rheumatoid Arthritis Model (Jobanputra et al., 2002; 




2 Oral Anticoagulation (Connock et al., 2007b) S Jowett Y QALYs 
   
i. 
3 Cardiovascular Disease Prevention (Barton & Andronis, 2009; Barton et al., 2011) P Barton Y QALYs 
 
√ √ i. 
4 Skin Cancer (Andronis et al., 2009) P Barton Y QALYs 
 
√ √ i. 
5 Pulmonary arterial hypertension (Chen et al., 2009) S Jowett Y QALYs 
  
√ i. 
6 Smoking cessation (Jit et al., 2009) P Barton Y QALYs 
 
√ √ ii. 
7 Breast Cancer (Auguste et al., 2011) T Roberts Y QALYs 
  
√ i. 
8 Menorrhagia (Roberts et al., 2011) T Roberts Y QALYs 
  
√ i. 
9 Chlamydia (Roberts et al., 2007) T Roberts Y MOA 
 
√ √ i. 
10 Opioid dependency (Connock et al., 2007a; Holland et al., 2012) S Jowett Y QALYs √ √ 
 
iii. 
11 High Blood Pressure Diagnosis (Lovibond et al., 2011) S Jowett N n/a* 
   
i. 
12 Past Blood Pressure & TIA (Fletcher et al., 2010) S Jowett N n/a* 
   
i. 
13 CLAHRC Stroke -  Decision Tree Model - WIP S Jowett N n/a* 
   
i. 
14 CLAHRC Transient Ischemic Attack - Discrete Event Simulation - WIP S Jowett N n/a* 
   
i. 
15 Polypill for Cardiovascular Disease Prevention - Markov Modelling - WIP S Jowett N n/a* 
   
i. 
16 Diet and Physical Activity to Prevent Recurrence of High Risk Adenomas: A Feasibility 
Study (Dowswell et al., 2012) T Keeley N n/a √ 
  
iv. 
17 Motivation to exercise for at risk Cardiovascular Disease population (Rouse et al., 2011) T Keeley N n/a √ 
  
iv. 
18 Benefits of Effective Exercise of Knee Pain (BEEP trial) (Foster et al., 2010) T Keeley N n/a √ 
  
iv. 
QALYs, Quality Adjusted Life Years; MOA, Major Outcomes Averted; n/a, Not Available; WIP, Work-In-Progress 
      
* Not available when selecting model. Could be available now. 
        
i. No ICECAP data available 
        ii. ICECAP questionnaires not applicable for population under consideration 
iii. Inappropriate capability measure for study population 
iv. Time constraints in developing new model from beginning 
 




To incorporate the ICECAP-O questionnaire into the BRAM model, a statistical association 
with a questionnaire collected within BRAM is required to produce capability outcomes. This 
requires what is referred to as mapping between instruments. The terminology and guidance 
for mapping studies is the focus of the remainder of this chapter.  
 
5.3 MAPPING TERMINOLOGY  
‘Mapping’, sometimes also referred to as ‘cross-walking’, is defined by Longworth and 
Rowen (2011) as: 
“the development and use of an algorithm (or algorithms) to predict health-state 
utility values using data on other indicators or measures of health” (Longworth & 
Rowen 2011, p. 9) 
 
Mapping has grown in prevalence and statistical complexity over the past twenty years. In the 
UK in particular, this growth has coincided with the establishment of NICE in 1999, which 
stipulated the need for QALY outcomes to be generated for economic evaluations of new 
health technologies (NICE, 2004; NICE, 2013). Mapping allows for the generation of such 
data, even when they have not been collected within the primary study. 
 
There are distinct phrases associated with the mapping literature. The terminology is primarily 
attributed to the work of Brazier and colleagues (2010). There are at least two 





According to Brazier et al. (2010) these are: 
 Starting measure: the primary measure of change in patients’ health status (either 
condition-specific or generic) which was collected within the study sample. 
 
 Target measure: the measure which is needed to generate required outcomes (i.e. 
QALYs from EQ-5D). The target measure is not collected within the study sample. In 
this case, the target measure is the ICECAP-O. 
 
There are two stages to mapping which require two datasets to be available. According to 
Brazier et al. (2010) these are: 
 Estimation dataset: In this dataset, starting and target measures must be completed by 
the sample population. The estimation dataset is where the predictive relationship 
between the starting measure and target measure is estimated to generate the mapping 
algorithm. 
 
 Study dataset: In this dataset, only the starting measure is required to be collected 
within the dataset as the mapping algorithm into the target measure has already been 
generated from the estimation dataset. The study dataset is where the target measure is 
predicted from the starting measure. 
 
The mapping algorithms generated from the estimation dataset are assessed using predictive 
error statistics to determine the most appropriate representation of the relationship between 
the starting and target measure. Lower prediction errors suggest that a mapping algorithm 




Two predictive error statistics are most frequently used in mapping studies: 
 Mean absolute error (MAE): this statistic represents the average absolute distance 
from the observed to predicted values, which is non-negative regardless of the sign of 
the individual errors. 
 
 Root mean squared error (RMSE): this statistic is calculated from the squares of 
individual errors through the mean squared error (MSE) before finding the square root 
of this overall statistic. Higher individual errors from observed to predicted will make 
RMSE larger. 
 
Predictive error statistics (MAE and RMSE) are generated by validating the mapping 
algorithms from the estimation dataset. Once again, two options are possible for choosing a 
validation dataset (Brazier et al., 2010): 
 
 External validation: Mapping algorithms are tested on an external dataset which 
should have similar population characteristics to the estimation and study dataset. 
 
 Internal validation: Also referred to as a “within-sampling” approach. The estimation 
dataset is split in two, with one split used to generate the mapping predictions, whilst 





5.4 GUIDANCE FOR MAPPING RESEARCH 
To establish the most up to date theory and techniques applied for mappings in health 
economic evaluations, this section focuses on a recent review of mapping studies, as well as 
the current guidance offered by NICE on mapping methodology within health economics. 
These studies were identified through a manual search of the mapping literature. 
 
5.4.1 Academic Guidance: Brazier et al. (2010)  
In 2010, Brazier and colleagues undertook a review of the methods for generating QALYs 
through mapping or cross-walking from non-preference based measures of health in clinical 
studies onto generic preference-based measures. In their search, they found thirty studies 
mapping from non-preference to preference based measures of health, which between them 
developed 119 different mapping algorithms (Brazier et al., 2010).  
 
Brazier and others (2010) present a table, which was adapted from an earlier discussion paper, 
that compiles the type of mapping functions that can be assembled (Tsuchiya et al., 2002). Six 
mapping functions were identified in total. The first four models predict the overall target 
measure score from: the starting measure overall score (1); dimension scores (2), item levels 
as continuous variables (3) or item levels as discrete variables (4). For the final two models, 
dimension levels for the target measure as continuous variable (5); or more appropriately as 
discrete variables (6), can be predicted by any of the previously method employed for the first 
four models from the starting measure. Additionally, other information such as demographic 
and clinical measurements as well as squared terms can be implemented as controls alongside 




The systematic review conducted by Brazier and colleagues (2010) extracted data on issues 
including the starting and target measures used, how the prediction models were specified, the 
type of regression analysis implemented and goodness-of-fit of the mapping models alongside 
predictive accuracy statistics. These data were then used to establish the validity of mapping 
models developed for economic evaluations and to generate guidance from these studies for 
future mapping research. 
 
Brazier and colleagues (2010) found that from the thirty papers identified half of the studies 
mapped onto the EQ-5D (Brooks, 1996) and eight studies mapped onto the Health Utilities 
Index (HUI) (Feeny et al., 1995). The SF-6D (Brazier et al., 2002) was the third most 
prevalent target measure with five studies, whilst the remaining four mapped on to less 
commonly used preference measures. Two studies included mappings to more than one 
measure (Brazier et al., 2010). 
 
The two most frequently applied starting measures were the SF-36 (Ware, Jr. & Sherbourne, 
1992) and the refined version of the SF-36, the SF-12 (Ware et al., 1995), with the remaining 
studies primarily focusing on condition-specific questionnaires. The number of respondents 
for the mapping papers varied from very small numbers with the lowest sample of n=68 
(Bosch & Hunink, 1996) to very large samples from national panel survey datasets, with the 





Across the paper 119 different mapping models were tested, ranging from simple linear 
prediction from summary score to summary score for both measures, to more complex 
models, including interaction terms, dimension and item scores (Brazier et al., 2010). In the 
majority of cases, added complexity produced diminishing improvements in terms of model 
goodness-of-fit. Only one published study analysed in their review mapped onto individuals 
EQ-5D dimensions (Gray et al., 2006), with prediction of preference based total scores being 
the usual approach. Ordinary Least Squares (OLS) was the most popular regression 
estimation method, although other methods such as censored least absolute derivations 
(Kaambwa et al., 2013), generalized linear models (GLM) (Kaambwa et al., 2006) and Tobit 
models (Sullivan & Ghushchyan, 2006) were also attempted. 
 
Model performance from generic health non-utility based to generic health utility instruments 
recorded average R², a routine measure of goodness-of-fit, of 0.5. Higher variation of 
goodness-of-fit was associated with condition-specific to generic measures, with R² ranging 
from 0.17 (Roberts et al., 2005) to 0.51 (Brazier et al., 2004b). In assessing the predictive 
ability of the model, however, the R² statistic is less important than prediction error statistics 
such as MAE and RMSE, with lower scores for these statistics representing better model 
predictions. MAE for all thirty studies ranged from 0.0011 to 0.19 and for RMSE, which 
gives more weight to less predictive accuracy (i.e. higher lower bound), going from 0.084 to 
0.2 (Brazier et al., 2010). Within-sample testing (i.e., internal validation), was most 
commonly applied, although a number of studies attempted out-of-sample tests (i.e., external 





In summary, Brazier and colleagues (2010) suggest that the validity of the model depends on 
a number of details. A degree of overlap between the starting measure and target measure is 
essential, as the existence of dimensions in one measure that are not captured by the other 
measure is likely to weaken such model predictions. If minimal important differences between 
measures are a guide to whether a mapping model can be used, high RMSE is likely to 
undermine such a model to be used in economic evaluations. Nonetheless, the most important 
message from Brazier and colleagues’ (2010) review is that mapping models should 
accurately account for the population as to where the algorithms will be mapped onto (i.e. the 
study dataset). Model specification is also important, as additional complexity can be added 
with little extra computational burden (Brazier et al., 2010). 
 
5.4.2 NICE Guidance: Longworth and Rowen (2011)  
Following on from Brazier et al.’s review of the mapping literature (Brazier et al., 2010), 
Longworth and Rowen (2011) produced a technical support document showing how mapping 
methods should be used to produce health state utilities for NICE. This technical support 
document was subsequently published in an academic journal (Longworth & Rowen, 2013).  
 
As discussed in detail in Chapter 2, QALYs are the recommended outcome by NICE for 
economic evaluations in health. For a study to produce QALYs, health state utilities are 
required to be estimated for the population under consideration. The NICE methods guide 
states that when health utilities are unavailable, mapping or cross-walking between two 
instruments can be applied if a suitable mapping function can be established and validated 




or “reprocessing” measures to produce QALYs (Gudex & Kind, 1988; Coast, 1992), 
mappings for NICE since 2008 require the implementation of a statistical mapping approach 
to estimating relationships between questionnaires, necessitating the use of empirical data 
(NICE, 2008). 
 
Longworth and Rowen (2011) addressed a review specifically related to how utility values 
have been produced for health technology assessments (HTAs) in the UK (Tosh et al., 2011). 
Whilst mapping has been used in economic evaluations since the origins of NICE in 1999, the 
production of mappings became widespread following the first methods guide for technology 
appraisal in 2004 (Longworth & Rowen, 2011). The review by Tosh and colleagues (2011) of 
HTAs between the production of the first (NICE, 2004) and second (NICE, 2008) NICE 
methods guidance, found that out of the 71 HTA submissions in the UK using the first guide, 
more than 1 in 4 (n=19) produced mapping algorithms, with 16 of these mappings relying on 
empirical data, and the other three using expert opinion or reprocessing. However, since the 
second methods guide recognised explicitly that mapping was an inferior method to directly 
collected health utility values (NICE, 2008), the number of mapping studies for technology 
assessments has decreased since the period between the first and second guidance compared 
to the time up to the end of the review by Tosh et al. (2011). 
 
The primary aim of the technical support document by Longworth and Rowen (2011) was to 
improve standards in the reporting of statistical performance of the mapping functions, which 
had been inconsistent and, in some cases, poorly handled within HTA submissions to NICE. 




be carried out through statistical association, where both the estimation and validation stages 
of the mapping process are clearly stated. They recognise that the estimation sample needs to 
be a fair reflection of the study dataset population characteristics. Statistical techniques should 
be implemented prior to model selection (e.g. correlation analysis) and post model selection 
(i.e. prediction error statistics), so that the appropriateness and performance of the mapping 
models can be assessed in full (Longworth & Rowen, 2011). 
 
Longworth and Rowen (2011) also recommend that prediction errors for EQ-5D sub-groups, 
in terms of different ranges of EQ-5D health states, should be reported, as lower EQ-5D 
scores have been associated with higher prediction error scores (Gray et al., 2006). Longworth 
and Rowen (2011) also recommend that mapping models should preferably be validated by an 
external dataset from the model estimation sample, although a split within-sample is sufficient 
when an external dataset is unavailable. Finally, it was noted that the application of mapping 
models will not solve the issue of appropriateness of health utility measures for certain 
populations when such measures are not sensitive to capture all condition-specific changes for 
particular interventions (Longworth & Rowen, 2011) 
 
5.4.3 Summary of Guidance available at present 
The above two examples have attempted to improve the reporting of mapping studies for 
predicting outcomes in health economic evaluations. This will be further helped with the 
recent publication of the NICE guidance within an academic journal (Longworth & Rowen, 
2013). However, there remains a gap within the health economics literature to guide 




Indeed, one of the primary complaints within the mapping review was the inconsistency of 
reporting of the key steps involved within the mapping process (Brazier et al., 2010). The 
consistency of the methods used within mapping studies could be improved with clearer 
guidance as what steps are required to conduct a valid mapping between two instruments. 
 
5.5 CONCLUDING COMMENTS 
In this chapter, the process of case study selection for exploring the generation of capability 
outcomes from economic models was explained. Only one case study, the Birmingham 
Rheumatoid Arthritis Model (BRAM), was found to be eligible for this thesis investigation. 
This chapter has also explained the role of mapping within health economics. The guidance 





CHAPTER 6. EXPLORING THE RELATIONSHIP BETWEEN HEALTH 
STATUS AND CAPABILITY: MAPPING FROM THE WOMAC 
OSTEOARTHRITIS INDEX TO THE ICECAP-O CAPABILITY INDEX 
 
6.1 INTRODUCTION 
In the previous chapter, the process of the development of an algorithm between two 
measures, generally referred to as mapping, was documented in terms of how it is commonly 
applied to generate health utility data in studies that have not collected such data directly. 
Available academic and advisory guidance was reviewed to incorporate the ICECAP-O into 
the Birmingham Rheumatoid Arthritis Model (BRAM). However, before the case study can 
be dealt with in greater detail, a number of issues need to be addressed. First, it must be 
determined whether a capability instrument, such as ICECAP-O, has a relationship with 
health status questionnaires in order to be able to establish whether capability can be predicted 
when the capability questionnaires have not been collected directly. Second, the objective of a 
capability measure like ICECAP-O in an economic evaluation must be established. In this 
chapter, the first of these two research questions is addressed. 
 
The aim of this chapter is to assess whether the mapping process used to predict health 
utilities can also be utilised to predict capability well-being for patient populations. 
Osteoarthritis (OA) patients requiring hip and knee replacement who have completed both the 
ICECAP-O capability index and the Western Ontario and McMasters Osteoarthritis Index 




questionnaire of capability well-being to be predicted from a condition-specific health status 
measure. This is the first attempt to map between health and capability and is investigated in 
terms of the feasibility and reliability of using the mapping process for predicting a capability 
instrument from a measure of health. 
 
Section 6.2 presents the dataset applied to carry out this research. The questionnaires used in 
this case study, the WOMAC Osteoarthritis Index and ICECAP-O capability index, are then 
described. Section 6.3 presents literature which has mapped from WOMAC onto a preference 
based HRQoL questionnaire previously, so that QALYs can be obtained. These mapping 
studies provide a comparison for the mapping between WOMAC and ICECAP-O that will be 
carried out here. Section 6.4 tests the feasibility of mapping from health status to capability. 
This section describes the methods employed to estimate the prediction mapping models 
between WOMAC and the ICECAP-O capability questionnaire. The mode of validating the 
mapping models is also presented in this section, before reporting the results of the case 
study. Additionally, as a secondary analysis, a closer examination of the relationship between 
health and capability through the preferred mapping model coefficients is also presented in 
this section. Section 6.5 concludes this chapter with a discussion of the implications of the 
findings shown in the case study presented in Section 6.4. 
 
Contents of this chapter have been previously published as: Mitchell, PM. et al. (2013) 
Predicting the ICECAP-O Capability Index from the WOMAC Osteoarthritis Index: Is 
Mapping onto Capability from Condition-Specific Health Status Questionnaires Feasible? 




6.2 CASE STUDY SELECTION 
To predict statistical association between two measures and develop an algorithm for 
mapping, the target measure (ICECAP-O) and starting measure (WOMAC) must be collected 
in the same dataset (Brazier et al., 2010). The dataset used was a subset of the Tayside Joint 
Replacement cohort, where ICECAP-O was collected alongside more established health status 
instruments such as WOMAC (Pollard et al., 2009). The Tayside cohort was the only dataset 
available to this author that contained follow-up data on both ICECAP-O and a condition-
specific instrument of health. This allowed the mapping models between the two instruments 
to be internally validated. The two questionnaires used to undertake the objectives in this 
chapter are explained next. 
 
6.2.1 Western Ontario and McMaster (WOMAC) Osteoarthritis Index 
The WOMAC index is a condition-specific health status questionnaire, which aims to 
measure problems for OA patients in relation to the pain, stiffness and physical function of 
their affected joints (Bellamy et al., 1988). The WOMAC questionnaire consists of twenty 
four questions and three categories (see Appendix 5). The first five questions are about pain, 
followed by two questions on stiffness, with the remaining seventeen questions concerned 
with the limits of physical function from the affected joint(s). Each question is asked on a five 
part Likert scale, ranging from no problems to extreme problems. Individual responses to each 
question produce a score between 0-4 (no problems – extreme problems). Each response is 
then summed within category and the three categories are combined to form a WOMAC score 
ranging from 0-96 (Bellamy et al., 1988). When items are missing, standard mean imputation 




which relies on probability based imputation, has recently been suggested as an alternative 
(Ghomrawi et al., 2011). 
 
6.2.2 ICECAP-O capability questionnaire 
The ICECAP-O capability index, already reported in Chapter 3, is the target measure in this 
study. The ICECAP-O consists of five attributes of capability well-being. These are 
attachment, security, role, enjoyment and control and are measured across four levels (see 
Appendix 1 for full questionnaire). Capability well-being is anchored to a 1-0 scale, where 1 
is equivalent to full capability on all attributes (44444) and 0 to having no capability on any of 
the five attributes (11111). Values for each of the five capability wellbeing attributes were 
obtained in a separate valuation study (Coast et al., 2008a). 
 
6.3 MAPPING FROM WOMAC TO HEALTH UTILITY 
Before assessing the ability to predict capability from health, it is important to assess how 
well health utility instruments have been captured from similar starting measure 
questionnaires. A recent paper identified three mapping papers where health utility has been 
predicted from WOMAC up until May 2011 (Lin et al., 2013). Similar search strategies were 
adapted by this author to update the review by Lin et al. (2013) until October 2012 and no 
new mapping papers were discovered. One paper predicted the Health Utilities Index Mark III 
(HUI3) (Grootendorst et al., 2007) and two papers predicted the EQ-5D (Barton et al., 2008; 





6.3.1 Mapping from the WOMAC to the Health Utility Index Mark III (HUI3) 
The Health Utilities Index Mark III (HUI3) is a HRQoL preference based measure, used 
predominantly in North America and can be used to generate QALYs (Furlong et al., 2001). 
The HUI3 consists of eight dimensions (vision, hearing, speech, ambulation, dexterity, 
emotion, cognition and pain) with five to six levels for each dimension ranging from severe 
limitations to normal (Feeny et al., 1995). The HUI3 is anchored on a 0-1 being dead to full 
health scale, but HUI3 scores range from -0.36 to 1 in actual practice (Feeny et al., 2002). 
Therefore, scores which can be considered worse than death can be implicitly inferred from 
patient responses. 
 
6.3.1.1 Grootendorst et al. (2007)  
The first paper to map the WOMAC onto a health utility measure mapped WOMAC onto the 
HUI3 (Grootendorst et al., 2007). The sample consists of 255 patients suffering from mild to 
moderate knee OA in a Canadian province. The mapping models in this study were validated 
from a within sample split in the estimation dataset for model prediction (two thirds of the 
population) and validation (one third of the population).  
 
The prediction of overall HUI3 score by WOMAC was tested in five different mapping 
models. In the first model, WOMAC item responses were entered as dummy variables, 
resulting in 96 explanatory variables for the HUI3 score, with no problems as the base 
category for each WOMAC item. In model two, mild and moderate were combined as one 
category, as were severe and extreme responses, which reduced the potential explanatory 




WOMAC category scores of pain, stiffness and physical function. Interaction terms between 
the category scores as well as the squared category responses to account for a potential non-
linear relationship between the two measures were added to model three to make up model 
four. Finally, model five tested overall WOMAC score and the squared WOMAC category 
score. All five models were tested with and without the demographic variables age and sex, 
and without the clinical characteristics which were years since onset of OA and Kellgran 
radiographic scale. All models were tested using OLS and random effects regressions. The 
best model was assessed through the predictive error statistic MAE, with RMSE also 
reported. 
 
The OLS regression outperformed the random effects regression for all model specifications. 
Model four which included age, gender and years since onset of OA produced the lowest 
MAE score and was therefore considered the best prediction model. When the Kellgran 
radiographic scale is included, goodness-of-fit of model four improved from explaining 39% 
to 40% of the HUI3 scores. Without the Kellgran scale, which is not collected as commonly 
for OA as the other measures included in model 4, MAE (0.1628) and RMSE (0.2065) scores 
are recorded.  
 
HUI3 score differences of 0.03 are regarded as clinically important (Horsman et al., 2003), 
but only 10% of the best model predictions fell within this range of individual error 
predictions. Group mean errors were assessed by bootstrapping the estimation sample with 
replacement for varying sample sizes. Lower HUI3 prediction errors were reported with 




crossover between particular dimensions on HUI3, such as vision, emotion and hearing, with 
WOMAC categories is the likely source for the higher prediction error at the individual level, 
as well as the moderate goodness-of-fit results (Grootendorst et al., 2007). 
 
Grootendorst et al.’s (2007) recommended model for predicting HUI3 from WOMAC is as 
follows: 
Predicted HUI3 score = 0.5274776 + [0.0079676 × Pain] + [0.006511 × Stiffness]  
-[0.0059571 × Function] + [0.0019928 × Pain*Stiffness]  
+[0.0010734 × Pain*Function] + [0.0001018 × Stiffness*Function]  
-[0.0030813 × Pain*Pain] - [0.0016583 × Stiffness*Stiffness]  
-[0.000243 × Function*Function] + [0.0113565 × Age in Years]  
-[0.0000961 × Age in Years*Age in Years] - [0.0172294 × Female]  
-[0.0057865 × Years since onset of knee OA]  
+[0.0001609 × Years since onset of knee OA*Years since onset of knee OA]  
 
6.3.2 Mapping from the WOMAC to the EQ-5D 
The EuroQol 5 Dimension (EQ-5D) has already been discussed in Chapter 2. The EQ-5D 
consists of five HRQoL dimensions (mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression) (Brooks, 1996). Preferences for health states are valued on a 0-1 death-
full health scale, with UK values for health states ranging from -0.59 to 1 (Dolan, 1997). The 
mappings undertaken previously with the EQ-5D and WOMAC were with the three level 
(EQ-5D-3L) version (Brooks, 1996) and not the more recently developed five level (EQ-5D-





6.3.2.1 Barton et al. (2008)  
Barton and colleagues (2008) explored whether EQ-5D scores estimated from WOMAC 
differed substantially from directly observed EQ-5D scores to generate QALYs for economic 
evaluations. Three hundred and eighty nine individuals participated in a Lifestyle Intervention 
for Knee Pain (LIKP) study, with EQ-5D and WOMAC collected at four time points over a 
two year period. The LIKP study explored four advisory interventions on reducing knee pain. 
Similar to the study by Grootendorst and colleagues (2007), the estimation dataset was split in 
two for estimation and validation purposes. However, whilst it was unclear in the previous 
mapping study how the dataset was divided, Barton et al. (2008) split the dataset such that 
baseline responses were used to estimate the mapping models (n=348), with questionnaires 
completed at the three follow-up time points (n=259×3) used to validate the mapping models. 
 
Five mapping models examining the predictive relationship between WOMAC and EQ-5D 
were explored. The dependent variable in all five models was overall EQ-5D score. In model 
A, only the total WOMAC score was used to predict EQ-5D. Model B predicted EQ-5D by 
the three WOMAC category scores. Model C added WOMAC squared to Model A, with the 
interactions and squares of WOMAC category scores added to Model B to Model D. Model E 
added age and sex variables to the best performing models of the four previous models 
described. MAE, RMSE and adjusted R² were estimated for all models (Barton et al., 2008).  
 
Out of the first four models, Model C, which predicted EQ-5D from the WOMAC score and 
WOMAC score squared (WOMAC*WOMAC), produced the lowest prediction error 




models at 0.129, RMSE was 0.180 and an adjusted R² of 0.313, meaning that a little less than 
one third of the overall EQ-5D score was explained by the explanatory variables included in 
Model E. 
 
Cost per QALY gains for the preferred intervention almost doubled when using actual data 
from the 259 individuals who completed all time points versus the mapping prediction 
estimates from the preferred Model C (£13,154 versus £6,086). While these results would not 
alter a decision in the UK, where current willingness-to-pay for additional QALYs is 
estimated at less than £20,000 to £30,000 per QALY gain (NICE, 2013), it nonetheless 
suggests that care should be taken when inferring results from QALYs generated from 
mapping algorithms. If at all possible, Barton and colleagues (2008) recommend that primary 
data should be used to generate QALYs, which concurs with advice produced by NICE in the 
same year (NICE, 2008). 
 
The recommended model (Model E) for predicting EQ-5D from WOMAC by Barton et al. 
(2008) is presented below: 
 
Predicted EQ-5D score = -0.3474012785 + [-0.0005977709 × total WOMAC]  
+[-0.0001081560 × total WOMAC*total WOMAC]  
+[0.0326027536 × age]  
+[-0.0002352456 × age*age]  




6.3.2.2 Xie et al. (2010)  
The most recent of the studies mapping from WOMAC to health utility is a paper by Xie and 
colleagues (2010), which looked at mapping for WOMAC to EQ-5D for knee OA patients 
(Xie et al., 2010). They identified overlap between the two measures given that both 
questionnaires addressed issues of pain and physical function/mobility explicitly. Two 
hundred and fifty eight individuals from Singapore completed the questionnaires and were 
randomly split in two for the estimation and validation of the proposed models. EQ-5D values 
were generated from a Japanese population as no existing valuation dataset was available for 
the Singapore population at the time of this research. 
 
Models were estimated using OLS and censored least absolute derivations. Four models 
examined the relationship for both regression methods. Overall EQ-5D score was predicted by 
WOMAC score (Model i.) and WOMAC category scores (Model ii.). Model iii. represented 
the same input variables as Model ii. plus interaction and category scores squared, while 
Model iv. accounted for WOMAC item scores that were identified to be significant after a 
stepwise regression procedure for OLS to eliminate non-significant explanatory variables. 
Demographics such as age and sex were not included in the mapping models (Xie et al., 
2010). 
 
Model ii. (EQ-5D predicted from WOMAC category scores) using OLS produced the lowest 
predictive errors in terms of MAE (0.0736) and RMSE (0.0947). However, these results are 
not directly comparable with individual reported errors in the two previous mapping studies, 




in individuals’ observed versus predicted scores. When the preferred model was re-estimated 
with the full sample, an adjusted R² of 0.449 was recorded, which is considerably higher than 
the two previous studies. Additional problems with comparing this research with the other 
two studies also arise due to the different valuation sets used for EQ-5D as well as the 
sensitivity of knee pain for the different mapping populations. 
 
The preferred mapping model of Xie and colleagues (2010) is presented below: 
Predicted EQ-5D score = 0.83414 - [0.00166 × WOMAC pain score]  
-[0.00092 × WOMAC stiffness score]  
-[0.00330 × WOMAC function score] 
 
6.3.3 Summary of Mappings from WOMAC to health utility 
Of the three previous studies that mapped from WOMAC to health utility, it was the preferred 
model by Xie et al. (2010) that produced the lowest MAE by a considerable distance (0.074 
compared to 0.142 to 0.163). However, different methods, patient groups, utility instruments, 
interventions and follow-up data were applied in each study so comparisons between studies 
should be treated with caution. Notwithstanding this, it is worth noting that higher R
2
 in the 
preferred models did not necessarily lead to more accurate predictions of utility, as Barton et 
al. (2008) have lower R
2
 (0.30 versus 0.39) but also lower MAE than Grootendorst and 






6.4 MAPPING FROM WOMAC TO ICECAP-O: A CASE STUDY 
In this section, the chosen case study of mapping from the WOMAC Osteoarthritis Index to 




The dataset used for this study was the Tayside Joint Replacement cohort, where ICECAP-O 
and WOMAC were collected simultaneously (Pollard et al., 2009). This dataset consisted of 
107 arthritis patients who were about to undergo primary joint replacement surgery at 
Ninewells Hospital, Dundee, UK, between September 2006 and June 2007. Prior to treatment, 
patients completed both the ICECAP-O and WOMAC. Pre-operative data were used to 
establish statistical relationships between the questionnaires through mapping models in the 
prediction dataset. Replicating the method used by Barton et al. (Barton et al., 2008), follow-
up data at 1 and 3 years post-operation were used to validate the prediction models. 
 
6.4.1.2 Measures 
The WOMAC index has been described previously in this chapter (Section 6.2.1) and is the 
starting measure in this study. WOMAC has been previously mapped onto two health utility 
instruments since 2007 (Section 6.3). The ICECAP-O capability index has also been 
described earlier in this chapter (Section 6.2.2) and is the target measure in this study. This is 





6.4.2 Statistical Analysis 
The first step in the statistical analysis involved the generation of descriptive statistics for all 
possible dependent and independent variables. Three explanatory variables (overall WOMAC 
score, age, sex) were explored for predictive significance. Overall ICECAP-O score 
(continuous variable) and ICECAP-O dimensions (categorical variables) were the dependent 
variables considered. Scatter-graphs were used initially to explore the association between 
ICECAP-O scores and each of the potential explanatory variables. Box-plots for the five 
attributes of capability well-being on ICECAP-O were employed to ascertain the relationship 
between each attribute level and overall WOMAC scores. 
 
Since this study is the first mapping attempt from a condition-specific health measure to a 
measure of capability well-being, there was no a priori position on what was the most 
appropriate model, so a process of model specification was required, following methods from 
a previous mapping study (Kaambwa et al., 2013). 
 
6.4.2.1 WOMAC Imputation 
Where all questions on the WOMAC were not completed in full, WOMAC categories and 
overall scores were completed using standard mean imputation, the most commonly used 
technique to complete WOMAC scores with missing data (Ghomrawi et al., 2011). Patient 
responses were excluded if no questions on the pain and stiffness category were answered, or 
if less than four physical function questions were completed. When not all questions were 




rounded to the nearest whole number and assigned to the missing response. This follows the 
recommended guidance for imputing WOMAC category scores (Bellamy, 2004). 
 
6.4.2.2 Regression Specification 
Two model specifications were considered for further analysis. 
6.4.2.2.1 Ordinary Least Squares (OLS) and ICECAP-O score 
ICECAP-O as continuous dependent variable. OLS regression was the first regression chosen 
due to the prevalent use of this approach in mapping studies (Brazier et al., 2010), particularly 
for arthritis mapping studies (Marra et al., 2011). There have been notable limitations when 
using OLS to predict EQ-5D scores in previous studies, particularly due to ceiling effects, 
when a high proportion of scores are observed at one end of the scale (Gray et al., 2006). 
However, there are no ceiling effects with the ICECAP-O in our current dataset, as only one 
person recorded the highest capability score achievable in the prediction dataset. Therefore, 
models that have used alternative specifications to deal with ceiling effects such as censored 
least absolute derivations (Kaambwa et al., 2013), Tobit (Sullivan & Ghushchyan, 2006), 
generalized linear models (Dakin et al., 2013b) and two part models (Dakin et al., 2013b) 
were not tested here. The three explanatory variables considered for the first mapping model 
consisted of two continuous variables (WOMAC score, age) and one discrete variable (sex). 
Stepwise regression, a process of finding the best model fit for a regression when no a priori 
knowledge of the appropriate inclusion of explanatory variables is available, was used to test 
the significance of the three explanatory variables. A number of stepwise regression 
techniques are used to specify models such as forward selection and backward elimination. 




removes the least significant variable for each model run, with the process finalised when 
only significant explanatory variables remain (Draper & Smith, 1998). Backward elimination 
is the stepwise regression process employed here. 
 
6.4.2.2.2 Multinomial Logistic (ML) Regression and ICECAP-O dimensions 
ICECAP-O attributes (5) as categorical dependent variables. There were two model options 
available for use with categorical dependent variables: ordinal logistic (OL) or multinomial 
logistic (ML) regression. While each of the five attributes of ICECAP-O are ordered, tests 
were required on the assumption of proportional odds, which is required when using the OL 
regression approach. These assumptions have been violated when applied in a previous 
mapping study (Gray et al., 2006). Alternatively, if the proportional odds assumption is 
violated, ML regression can be used. ML regression does not recognise the order of categories 
in the same way as OL, but assigns a probability to the likelihood of a person having a 
particular response level on an attribute given the explanatory variable results for an 
individual (Draper & Smith, 1998).  
 
Three ML methods considered for this study are:  
 Expected-Utility Method: The average probability across levels for each category to 
predict the overall dependent variable score (i.e. ICECAP-O score) (Le & Doctor, 
2011)  
 Most-Likely Probability: The highest probability level for each category used to 




 Monte Carlo Simulation: Using repeated simulations to generate random numbers on a 
uniform distribution. ICECAP-O responses for each ICECAP-O attribute are predicted 
by the probability of a response level, which are then combined with the other 
ICECAP-O categories to predict the overall dependent variable score (Gray et al., 
2006). Given the small sample size here, 1000 simulations were carried out in the 
analysis for each observed individual 
 
In total 10 mapping models predicting ICECAP-O scores or ICECAP-O dimensions were 
tested; the primary characteristics of each model are displayed in Table 6. Seven models 
(Models 1-7) predicted overall ICECAP-O scores as a continuous variable through Ordinary 
Least Squares (OLS) regression. Model 1 considered WOMAC score, age and sex as 
explanatory variables of overall ICECAP-O scores. The reduced equation of WOMAC as the 
sole predictor of ICECAP-O is illustrated in Model 2. In Model 3, overall ICECAP-O scores 
are predicted by the WOMAC score squared. Model 4 tested the three category scores for 
WOMAC (pain, stiffness, physical function) on ICECAP-O; while Model 5 is the reduced 
version of Model 4 where only significant predictors of capability are included. The same 
process is used for Model 7, which includes the significant items of WOMAC from all 24 
WOMAC items, which were tested in Model 6. Models 8-10 explored ICECAP-O dimensions 
as dependent variables. Three models (Expected Utility Method – Model 8, Most-Likely 
Probability – Model 9, Monte Carlo Simulation – Model 10) were analysed for their ability to 






Table 6 Mapping models for ICECAP-O prediction from WOMAC 
Model number Dependent variable(s) Independent Variable(s) 
 1 ICECAP-O score WOMAC score; age; sex 
2 ICECAP-O score WOMAC score 
3 ICECAP-O score WOMAC score squared 
4 ICECAP-O score WOMAC category scores 
5 ICECAP-O score WOMAC physical function category 
6 ICECAP-O score WOMAC items (24) 
7 ICECAP-O score Significant WOMAC items from  model 6* 
8 ICECAP-O attributes WOMAC score - Expected Utility method 
9 ICECAP-O attributes WOMAC score - Most-Likely probability 
10 ICECAP-O attributes WOMAC score – Monte Carlo simulation 
 Ordinary Least Squares (OLS) regression carried out on models 1-7; Multinomial Logistic (ML) 
regression for 8-10. 
*3 items on WOMAC were significantly related to ICECAP-O score. They were item 9 (difficulty going 
up stairs, item 15 (difficulty when shopping)  and item 22 (difficulty getting on/off toilet) 
 
6.4.2.3 Prediction Accuracy 
While common measures of goodness-of-fit of regression models such as R² play an 
important role in showing the explanatory power of a model for the dependent variable, the 
primary interest here is in the ability to accurately predict the dependent variable from the 
explanatory variables in the model. Two common measures have been prominently used in 
mapping studies: mean absolute error (MAE) and root mean squared error (RMSE). RMSE 
gives a higher error score for larger errors from the observed score to the predicted score than 
MAE and both are generally reported in mapping studies (Brazier et al., 2010). All models are 
tested for these two measures of prediction error, with lower prediction error scores indicating 
a better model for prediction. R² of all models are reported to test the goodness-of-fit between 
capability and condition-specific health status. The relationship between the preferred model 
attributes are examined in a secondary analysis to help understand the relationship between 
health and capability in greater detail. All models were also tested for normality and 






6.4.3.1 Demographics of Dataset 
Table 7 shows the demographic information for the sample population. Two patients did not 
complete either the ICECAP-O (n=1) or WOMAC (n=1) to a level where overall scores for 
both instruments could be calculated, so they were excluded from further analysis. The mean 
ICECAP-O score for the remaining 105 patients was 0.772, which is lower than the average 
UK over 65s population score of 0.832 (Flynn et al., 2011). Respondents had a mean age of 
approximately seventy years. The mean WOMAC score was 50.628. Figure 9 shows the 
distribution of the ICECAP-O scores for the prediction dataset at baseline. It shows that 
ICECAP-O scores are negatively skewed, with the majority of scores closest to the higher end 
of the scale. 
 
 







Table 7 Descriptive statistics for prediction and validation dataset 
  N n Mean 
Standard 
Deviation Min Max 
Sample size  107 
     Missing data 107 2 
    Males  105 54 
    Employed 105 13 
    Living Alone 105 28 
    Age (mean) 105 105 69.738 8.894 48 89 
ICECAP-O (base) 105 105 0.772 0.168 0.159 1 
ICECAP-O (1 year) 107 56 0.861 0.134 0.514 1 
ICECAP-O (3 year) 107 54 0.836 0.135 0.481 1 
WOMAC (base) 105 105 50.628 17.052 18 91 
Pain 
 
105 10.857 3.817 2 20 
Stiffness 
 
105 4.714 1.517 1 8 
Physical Function 
 
105 35.057 12.711 7 64 
WOMAC (1 year) 107 56 16.018 14.633 0 68 
Pain 
 
56 2.589 3.561 0 13 
Stiffness 
 
56 1.768 1.513 0 8 
Physical Function 
 
56 11.661 10.786 0 47 
WOMAC (3 year) 107 54 20.667 19.443 0 72 
Pain 
 
54 3.111 3.78 0 14 
Stiffness 
 
54 1.741 1.604 0 6 
Physical Function 
 
54 15.815 15.471 0 52 
N,total population; n,sub population from N; min, minimum; max, maximum; ICECAP-O range 0-1; 
WOMAC range 0-96. 
 
 
6.4.3.2 WOMAC Imputation 
For the 105 patients included at baseline, WOMAC was completed in full by 81 of the 
patients prior to their operation. Four patients did not complete the pain category fully, with 3 
patients not responding to one question and one patient not responding to two questions. 
Twenty-six patients did not complete all seventeen physical function questions. Fifteen only 
failed to complete one question, with question 20 (difficulty getting in or out of the bathtub), 
the most problematic question for this sample, with 17 patients failing to give a response. No 




For the patients who completed sufficient questions on both the ICECAP-O and WOMAC at 
1 year follow up (n=56), nine patients did not complete all the pain questions. Seven patients 
failed to complete only one of the pain questions, with question 5 (pain while standing) 
causing the most non-completions (six) for this category. Fifteen patients failed to complete 
all of the physical function questions, with eight patients failing to complete only one 
question. Question 20 again had the lowest response rate with ten patients not answering. 
Once more, all stiffness questions were completed in full. 
 
At three years follow up, fifty four patients completed the ICECAP-O and WOMAC to a 
standard where overall scores could be calculated. Two patients did not complete one of the 
pain questions (question 1 pain when walking on a flat surface). All other patients completed 
all five pain category questions. Eight patients did not complete all seventeen physical 
function questions, with five patients failing to complete only one question. None of these 
eight patients answered question 20, once again highlighting the low levels of response to 
problems getting in and out of the bath question. Both stiffness questions were completed by 
all patients once again. 
 
6.4.3.3 Relationship between ICECAP-O and WOMAC score 
Figure 10 shows the relationship between ICECAP-O and WOMAC in the prediction dataset. 
Figure 10 indicates a trend towards higher ICECAP-O scores. Table 8 presents the 
relationship between ICECAP-O responses and WOMAC scores from the prediction dataset. 
For all but two capability attributes (attachment and security), there is an increase in 
WOMAC score as capability responses decrease. For the security attribute, there is little 




WOMAC scores for the lower levels of capability follow similar patterns to the ICECAP-O’s 
role, enjoyment and control attributes. There is no clear pattern for WOMAC scores with the 
attachment capability attribute. These results are intuitive with the symptoms of OA, as it 
would not be expected to have an impact on psychological well-being (i.e. attachment) as 
much as physical well-being. 
 
 
















Attachment (Love and Friendship) 
  (4) I can have all of the love and friendship that I want 58 52.3(17.9) 
(3) I can have a lot of the love and friendship that I want 36 47.3(15.4) 
(2) I can have a little of the love and friendship that I want 9 49.6(17.7) 
(1) I cannot have any of the love and friendship that I want 2 66.5(04.9) 
Security (Thinking about the future) 
  (4) I can think about the future without any concern 15 45.9(17.3) 
(3) I can think about the future with only a little concern 49 45.1(15.7) 
(2) I can only think about the future with some concern 29 56.1(15.3) 
(1) I can only think about the future with a lot of concern 12 65.7(14.4) 
Role (Doing things that make me feel valued) 
  (4) I am able to do all of the things that make me feel valued 14 39.4(14.2) 
(3) I am able to do many of the things that make me feel valued 46 46.0(15.8) 
(2) I am able to do a few of the things that make me feel valued 38 57.1(15.8) 
(1) I am unable to do any of the things that make me feel valued 7 68.7(08.1) 
Enjoyment (Enjoyment and Pleasure) 
  (4) I can have all of the enjoyment and pleasure that I want 12 39.5(15.3) 
(3) I can have a lot of the enjoyment and pleasure that I want 46 45.3(14.3) 
(2) I can have a little of the enjoyment and pleasure that I want 37 56.5(16.7) 
(1)I cannot have any of the enjoyment and pleasure that I want 10 66.7(13.8) 
Control (Independence) 
  (4) I am able to be completely independent 26 38.6(14.8) 
(3) I am able to be independent in many things 46 47.3(12.9) 
(2) I am able to be independent in a few things 27 64.4(14.0) 
(1) I am unable to be at all independent 6 66.5(15.9) 
freq.; frequency; n, population; SD, standard deviation 
   
 
6.4.3.4 Model Specification  
Stepwise regression was applied for both ICECAP-O score and ICECAP-O attributes 
Mapping Models (see Table 6). Age and sex were not explored beyond Model 1 as they were 
omitted as non-significant variables for predicting ICECAP-O from the backwards 
elimination stepwise regression process. Variable transformation was applied in Model 3 to 




Figure 9. The assumption of proportional odds between categorical levels did not hold for 
ICECAP-O dimensions using the Wald test, so ML regression was used for Models 8-10.  
 
6.4.3.5 Internal Validation Results 
1 year and 3 year post operation data were combined to validate the Mapping Models 
described in Table 6. Table 9 presents the results of the validation. The majority of models 
relied on all individuals where ICECAP-O and WOMAC scores could be calculated 
(responses at two follow-up periods =110 individual responses in total). However, for models 
6 and 7, all items on WOMAC had to be completed, which reduced the sample size for both 
of these model validations. The Monte Carlo Simulation model (Model 10) produced the 
lowest absolute difference from predicted to observed ICECAP-O mean score at 0.0233. 
Model 10 also produced the highest variety in ICECAP-O responses, although this is in part 
due to the Monte Carlo simulation process employed in this model. All OLS models which 
were not transformed to address the non-normally distributed ICECAP-O data resulted in 
higher ICECAP-O scores than are feasible in reality, as full capability is equal to 1. This may 
explain why all predicted ICECAP-O scores are above the observed ICECAP-O scores. In 
terms of prediction error statistics, Model 4, which predicted ICECAP-O from the three 
WOMAC category scores, produced the lowest mean absolute error (MAE = 0.0832) and root 
mean squared error (RMSE = 0.1193). Model 4 also produced the highest R² at 0.3976. It is 
therefore recommended that out of the ten models tested here, predicting capability by 
category scores of pain, stiffness and physical function produces the most accurate results for 





















Difference* MAE(SD) RMSE 
Overall 
R²  
1 110 0.8486 0.9344 0.6695 1.0372 0.0858 0.1000(0.099) 0.1406 0.3198 
2 110 0.8486 0.9410 0.6608 1.0365 0.0924 0.1046(0.102) 0.1454 0.3125 
3 110 0.8486 0.8871 0.6516 0.9196 0.0385 0.0865(0.089) 0.1240 0.2394 
4 110 0.8486 0.9041 0.5709 1.0516 0.0556 0.0832(0.086) 0.1193 0.3976 
5 110 0.8486 0.9283 0.6498 1.0279 0.0797 0.0970(0.094) 0.1344 0.3637 
6 83 0.8562 0.8841 0.4232 1.0603 0.0279 0.0966(0.084) 0.1276 0.2326 
7 103 0.8520 0.9362 0.6362 1.0108 0.0842 0.1026(0.100) 0.1429 0.2495 
8 110 0.8486 0.8737 0.6432 0.9010 0.0251 0.0874(0.087) 0.1229 0.2131 
9 110 0.8486 0.8897 0.6753 0.9136 0.0411 0.0965(0.099) 0.1379 0.0429 
10 110×1000 0.8486 0.8719 0.1588 1.0000 0.0233 0.0874(0.093) 0.1226 0.2108  
n, validation sample size; min, minimum; max, maximum; MAE, mean absolute error; RMSE, root mean squared error; SD, standard deviation; R², square of the Pearson product-moment  




6.4.3.6 Recommended Mapping Model 
In Table 10, the preferred Mapping Model (Model 4) which can be used to predict ICECAP-O 
from WOMAC category scores is presented. 95% confidence intervals are given around the 
explanatory variables, which can be used in sensitivity analysis to account for uncertainty 
around the model algorithm. 
 
Table 10 Best Performing Mapping Algorithm:  
Predicting ICECAP-O scores from WOMAC category scores (Model 4) 
Variable Coefficient(SE) t P>|t| 95% Confidence Interval 
Pain  0.0019(0.007)  0.28 0.780 [-0.0114,0.0152] 
Stiffness  0.0141(0.013)  1.13 0.263 [-0.0108,0.0391] 
Physical Function -0.0088(0.002) -4.51 0.000 [-0.0127,-0.0049] 
Constant  0.9950(0.048) 20.89 0.000 [0.9005,1.0896] 
SE; standard error. 
6.4.3.7 What aspects of ICECAP-O are WOMAC categories predicting? 
Given the validation results of the previous section, it was also possible to examine exactly 
which attributes of capability were being captured by changes in the WOMAC category 
scores for pain, stiffness and physical function score respectively. This was carried out by 
analysing the predictive ability of each capability dimension on ICECAP-O, by individually 
examining the relationship with each WOMAC category score from the prediction dataset 
through ML regression. Table 11 presents the findings from this research. 
 
The prediction of the ICECAP-O dimension ‘control’ from the physical function category on 
WOMAC produced the highest significance in terms of R² at 0.2143, with significant p-values 
for all control response levels at the 1 percent level. The WOMAC physical function category 




ICECAP-O dimensions (security, role and enjoyment). Stiffness is best able to predict the 
security dimension, in particular the two lower levels of security responses. Pain is able to 
predict the two lower levels from full capability on three dimensions (role, enjoyment and 
control). There is no apparent relationship between any of pain, stiffness and physical 
function on the one hand, and the attachment ICECAP-O attribute on the other. 
 
Table 11 Prediction of ICECAP-O dimensions from WOMAC categories: 
multinomial logistic (ML) regression p-values 
Category 




   a lot of capability (level 3) 0.041 0.023 0.359 
a little capability (level 2) 0.335 0.884 0.757 
No capability (level 1) 0.448 0.613 0.218 
Pseudo R² 0.0275 0.0304 0.0143 
Security 
   a lot of capability (level 3) 0.532 0.146 0.840 
a little capability (level 2) 0.152 0.014 0.051 
no  capability (level 1) 0.026 0.001 0.003 
Pseudo R² 0.0562 0.0617 0.0800 
Role 
   a lot of capability (level 3) 0.143 0.951 0.156 
a little capability (level 2) 0.004 0.203 0.001 
no capability (level 1) 0.001 0.217 0.000 
Pseudo R² 0.0739 0.0184 0.1139 
Enjoyment 
   a lot of capability (level 3) 0.181 0.209 0.332 
a little capability (level 2) 0.004 0.062 0.003 
No capability (level 1) 0.003 0.084 0.001 
Pseudo R² 0.0649 0.0179 0.0985 
Control 
   a lot of capability (level 3) 0.219 0.564 0.006 
a little capability (level 2) 0.000 0.054 0.000 
No capability (level 1) 0.002 0.091 0.000 





This chapter explored the predictive ability of an instrument capturing capability well-being 
(ICECAP-O) from a condition-specific health status questionnaire (WOMAC) for arthritis 
patients requiring surgery on their affected knee or hip. The mapping results produced in 
Table 9 shows that WOMAC categories (pain, stiffness and physical function) are the best 
predictors of overall ICECAP-O score (Model 4), with the lowest prediction error statistics 
(MAE = 0.0832 and RMSE = 0.1193) as well as the highest goodness-of-fit statistic (R² = 
0.3976). The secondary analysis investigated the prediction of ICECAP-O dimension 
responses from the WOMAC categories and found that the control dimension and the 
physical function score produced the highest goodness-of-fit (R²=0.2143). Physical function 
was able to predict the lower two levels of four of the five capability attributes (p-
value<0.05), when using full capability as the base case in ML regressions. The stiffness 
category was most closely related to the security dimension on ICECAP-O, while pain was 
able to predict lower levels of role, enjoyment and control (p-value<0.05). The attachment 
dimension on ICECAP-O had no significant relationship with any WOMAC category. 
 
This is the first time the prediction of capability well-being from a condition-specific health 
questionnaire has been explored. For OA patients, it shows that all categories on the 
WOMAC index are related to ICECAP-O dimensions as shown in the secondary analysis (see 
Table 11). The preferred mapping model (Model 4, Table 10) allows ICECAP-O scores to be 





There are limitations associated with this research. First, the dataset employed here is 
relatively small for mapping studies, although smaller datasets have been applied previously 
(Brazier et al., 2010). The mapping model validations were limited to internal validation using 
follow-up data. This has been the approach for similar mapping work between WOMAC and 
health utility in the past (Barton et al., 2008). However, individual responses over time were 
not nested like more advanced mapping methods (Rivero-Arias et al., 2010), so error 
predictions are likely to be slightly underestimated. Additionally, the internal validation 
dataset applied was not large enough to capture differences between item scores for both 
instruments. When a larger sample size is available, it would be of interest to explore the 
“probabilistic mapping” approach which has been shown to produce lower prediction errors 
for both OLS and ML regressions in a recent mapping study between the SF-12 and EQ-5D 
(Le & Doctor, 2011). Finally, the importance of external validation models has recently been 
highlighted again in the mapping literature (Dakin et al., 2013b). No external validation 
dataset was available here. However, the importance of assessing external validity when such 
information is available is recognised.  
 
No other study has attempted to predict a statistical relationship between capability and a 
condition-specific health status questionnaire. Other mapping studies between WOMAC and 
health utility instruments have been undertaken, which were detailed in Section 6.3.2. While 
these studies are not directly comparable to the results obtained here, the R² of 0.3976 from 
the preferred model (Model 4) has similar explanatory power as those other studies that 
predicted from condition-specific to health utility previously. ICECAP-O research has 
primarily focused on the validation of the questionnaire in different countries and population 




study has assessed the relationship between EQ-5D and ICECAP-O for quality of care 
transition patients and found a positive correlation between the health utility instrument and 
the measure of capability well-being (Couzner et al., 2012). Another study aimed to address 
whether ICECAP-O could be used as a substitute or complement for health utility measures, 
specifically the EQ-5D, for elderly individuals attending a falls prevention clinic (Davis et al., 
2013). Whilst the research presented here contradicts their overall finding that ICECAP-O 
only provides complementary information to health utility, as it has been shown that there is a 
relationship between change in health and capability (see Table 11), a better test, as Davis and 
colleagues (2013) have suggested, would be to track longitudinal changes in both capability 
and health utility instruments simultaneously. 
 
For clinicians and policymakers interested in measuring broader individual well-being rather 
than disease-specific or generic health questionnaires, based on this research the ICECAP-O 
can capture the WOMAC categories of pain, stiffness and physical function. A mapping 
algorithm is provided to generate ICECAP-O scores from WOMAC category scores for OA 
patients requiring joint replacement. However, given the relatively small sample size 
employed here, caution is recommended in interpreting capability outcomes solely from this 
algorithm. Whilst mapping is useful when direct data are unavailable, it remains a second-best 
option for capability questionnaires. Given the multi-faceted influences on individual well-
being and the fact that some elements of the ICECAP-O, the attachment attribute in particular, 





CHAPTER 7. SUFFICIENT CAPABILITY 
7.1 INTRODUCTION 
Previously this thesis has dealt with the role of the capability approach (Chapter 3) in 
comparison to standard practice within health economics (Chapter 2), as well as exploring the 
relationship between condition-specific health status and capability for osteoarthritis (OA) 
patients by mapping from the WOMAC Osteoarthritis index to the ICECAP-O Capability 
index (Chapter 6). Much of the work within the capability approach in health has focused on 
theoretical justification (Anand & Dolan, 2005; Coast et al., 2008c; Ruger, 2010a; Smith et 
al., 2012) and development of capability instruments (Grewal et al., 2006; Anand et al., 2009; 
Al-Janabi et al., 2012a). Less attention has been paid to date to the application of such 
instruments. The literature review of empirical capability applications was presented in 
Chapter 4 to explore the use of decision making rules when using capability outcomes. In this 
chapter, aspects of the capability empirical literature review are drawn upon to develop a 
specific methodology for assessing capability outcomes in health economic evaluations. 
 
Two aspects of the capability approach may influence the theoretical framework for economic 
evaluations. The first is to use a broader definition of individual well-being focusing on 
capability such that benefits of interventions that go beyond health alone are included in the 
evaluation. This question was, in part, addressed in Chapter 6 where it was found that 
condition-specific categories of pain, stiffness and physical function were able to predict the 
majority of the ICECAP-O attributes (excluding the attachment attribute). As already 
discussed in Chapter 3 and 4, a number of areas have been identified where adopting the 




Lorgelly et al., 2010a; McAllister et al., 2012; Netten et al., 2012; Payne et al., 2013; Simon 
et al., 2013). The aim of adopting a broader measurement of individual well-being to assist in 
resource allocation in healthcare decision-making should focus on a fair assessment across the 
health and related services, so that adopting the capability perspective should not 
disadvantage interventions which significantly improve individual well-being through 
improved health.  
 
The second aspect of the practical applications of the capability approach that may influence 
the theoretical framework for economic evaluations is to consider alternative decision rules 
that give greater weight to distributional concerns in relation to the relief of (capability) 
deprivation. In terms of resource allocation, the question most associated with the capability 
approach and Amartya Sen’s “Equality of what?” is not the only consideration for health 
economics. Of equal importance in an evaluation setting is the further question, also 
recognised by Sen: 
“Corresponding to ‘equality of what?’, there is, in fact, also the question: ‘efficiency 
of what?’” (Sen, 1993, p. 50) 
 
In this chapter the focus is on the second aspect of the practical applications of the capability 
approach, exploring the use of alternative decision rules derived from work within the 
capability approach on multidimensional poverty. More specifically, the aim is to develop a 
method which answers the question “Efficiency of What?” that is in line with the theoretical 
underpinnings of the capability approach. It was discovered in the capability literature review 
in Chapter 4 that capability maximisation was rarely the rationale for studies. Alternatively, a 




being to live a valuable life, was more commonly implemented. Therefore, this chapter 
focuses on incorporating a capability instrument that is developed for health and social 
evaluations and sits within a threshold approach to reducing capability deprivation. This 
chapter draws on both health economics (Chapter 2) and capability (Chapter 3 and 4) 
methodology to develop a new method for aiding resource allocation decisions, which will 
from here onwards be referred to as the “sufficient capability approach”.  
 
The remainder of the chapter is structured as follows. The capability questionnaire and the 
dataset used in this chapter are first detailed. Then, the method for aggregating capability data 
utilised by a number of the capability applications in Chapter 4, known as the Alkire-Foster 
(AF) methods of multidimensional poverty, is further emphasised. The AF methods are the 
main source for applying the sufficient capability approach. How sufficient capability can be 
calculated, as well as combining a sufficient capability score with time are then elaborated. 
Section 7.3 reports the AF methods and sufficient capability results from the dataset used to 




7.2.1 Measure of Capability: ICECAP-O 
The ICECAP-O is a five part questionnaire, aimed to capture capability well-being for the 
older (65 and over) population. The measure has been already described in detail in Chapter 3 





A small dataset from the clinical orthopaedic area of joint replacement is used to illustrate the 
potential of the sufficient capability approach to be used within a clinical context. The dataset 
is a subset of the Tayside Joint Replacement cohort (Pollard et al., 2009). Between September 
2006 and June 2007, 107 patients about to undergo primary joint replacement surgery at 
Ninewells Hospital, Dundee, UK, were asked to complete the ICECAP-O questionnaire. 
Follow-up post-operative data were collected at both one and three years after baseline. 
Although a relatively small dataset, it is the first context in which pre-intervention and post-
intervention data are available for any of the ICECAP questionnaires and will provide 
adequate information to illustrate the sufficient capability approach. This was the same dataset 
used for the mapping conducted in Chapter 6. 
 
7.2.3 Alkire-Foster method of multidimensional poverty measures 
A recent development within the capability literature is the use of multidimensional poverty 
indices (MPIs) within the fields of human development and international poverty assessment. 
The MPIs are taken from a methodology called the Alkire-Foster (AF) measures (Alkire & 
Foster, 2011a). The AF methodology was explained in detail in Chapter 4. 
 
Since 2010, MPIs have been collected for cross country comparisons of multidimensional 
poverty by the United Nations (UN) and are reported in their human development reports, by 
measuring three dimensions (health, education and living standards) across ten indicators of 
states of poverty (Klugman, 2010). This notion of broadening the assessment of poverty, 




(GDP)), follows from the approach used in constructing the Human Development Index 
(HDI). This multidimensional approach is not unique to the UN, as the Organisation for 
Economic Co-operation and Development (OECD) Better Life Initiative also draws on 
multiple (eleven) indicators, including health, to develop a better life index as another 
alternative to GDP (Stiglitz et al., 2009). 
 
Although the AF methods are proving popular within the human development literature, they 
have, to date, only been analysed using cross-sectional data for cross-country comparisons 
(Klugman, 2010). Additionally, new areas were identified in the empirical capability review 
in Chapter 4 where the AF methods are used such as freedom poverty (Callander et al., 
2012b), child poverty (Roelen et al., 2010), and energy poverty indices (Nussbaumer et al., 
2012). Once more, these new applications of the AF methods rely on cross-sectional data. In 
Figure 11, a simple example of how the AF measures are used in practice is presented. To be 
able to utilise this approach within health to help guide resource allocation decisions, an 
additional refinement is required. 
 
7.2.4 Threshold of Sufficient Capability 
One possible approach to measuring capability poverty using the ICECAP-O instrument is to 
follow the AF methodology (Alkire & Foster, 2011a) and capability objectives as set out in 
the previous section. This sets a minimum threshold level of capability that a person must 
achieve to be considered to have a “sufficient” level of capability wellbeing. This minimum 
level here is called the threshold of sufficient capability (TSC) and is defined as the level of 





Figure 11 Example of Alkire-Foster measures of multidimensional poverty 
 
Take 3 individuals (X,Y & Z) assessed across 4 dimensions (D1,D2,D3,D4) which indicate 
poverty. 
All 4 dimensions are categorical with 5 (1-5) responses possible for each dimension. 
 
 Dimension 1 Dimension 2 Dimension 3 Dimension 4 
Individual X 2 3 4 5 
Individual Y 3 3 3 3 
Individual Z 5 1 4 2 
 
Let poverty line across 4 dimensions fall at response level 3. 
Let cutoff for an individual to be classified as poor fall below poverty line on any one 
dimension. 
Let values for levels below poverty line for level 1 = 1; level 2 = 0.3. 
 
(1) Headcount Ratio (H) = p/P 
p = individual X (poor on dimension 1) & individual Z (poor on dimension 2 & 4) =2 
P = total sample size = 3 
H = 2/3 = 0.667 
 
(2) Adjusted Headcount Ratio (M0) = H×(dp/D) 
Individual X dp = 1 out of 4 dimensions 
Individual Z dp = 2 out of 4 dimensions 
dp = 3 out of 8 dimensions 
M0 = 0.667×(3/8) = 0.250 
 
(3) Adjusted Poverty Gap (M1) = M0×(lp/L) 
Individual X lp = 1 out of 8 levels below poverty line 
Individual Z lp = 3 out of 8 levels below poverty line 
lp = 4 out of 16 levels below poverty line 
M1 = 0.250×(4/16) = 0.063 
 
(4) Adjusted FGT (M2) = M0×vp/V 
Individual X vp = 0.3 out of 4 for lowest value attached across all dimensions 
Individual Z vp = 1.3 (1+0.3) out of 4 for lowest value attached across all dimensions 
vp = 1.6 out of 8 values attached to lowest dimensions for poor, p 







The threshold for sufficient capability (TSC) is defined as: 
TSC = td1+td2+...tdₓ=>k, where k = [td1...tdn]                                                                       (7.1) 
Here td is the threshold level for each dimension that is “sufficient” which depends on k, the 
cutoff number of dimensions to be considered poor, must fall within the range of the total 
number of dimensions measured [td1...tdn].  
 
A person who has reached a level of capability across all attributes which is deemed 
‘sufficient’ will have reached an adequate level of wellbeing, indicating that further allocation 
of resources to this individual is no longer a priority. A person who does not reach the 
sufficient level on the attributes examined falls below the overall threshold depending on the 
cutoff in dimensions (k) to be considered in poverty. To improve the level of sufficient 
capability within a population, the aim of using the threshold of sufficient capability is to 
move as many people to sufficient levels of capability or as close to the TSC as possible. 
 
To apply this approach in practice, the first fundamental step in defining the TSC using the 
AF measures is the “identification method” (see Section 4.5.4.1). This requires determining 
the threshold level on each dimension below at which there is considered to be a shortfall in 
sufficient capability. For the capability measure employed here, the ICECAP-O (see Table 
12) has four levels of capability for each of its five attributes, conceptually ranging through 
full capability (level 4) , a lot of capability (level 3), a little capability (level 2) and no 




implemented in theory, given that there is no need for the level in which a person is 
considered to be in capability poverty to be consistent across attributes. 
 
 Here, two possibilities are considered for ease of interpretation:  
 Option 1: assuming that if a person has at least ‘a lot’ of capability (i.e. level 3) on 
each attribute they have sufficient capability (“33333”).  
 Option 2: assuming that if a person has at least ‘a little’ capability (i.e. level 2) on each 
attribute they have sufficient capability (“22222”). 
 








Attachment (Love and Friendship) 
   (4) I can have all of the love and friendship that I want 0.2535 0.2679 0.2412 
(3) I can have a lot of the love and friendship that I want 0.2325 0.2679 0.2412 
(2) I can have a little of the love and friendship that I want 0.1340 0.1545 0.2412 
(1) I cannot have any of the love and friendship that I want -0.0128 -0.0147 -0.0230 
Security (Thinking about the future) 
   (4) I can think about the future without any concern 0.1788 0.1234 0.1189 
(3) I can think about the future with only a little concern 0.1071 0.1234 0.1189 
(2) I can only think about the future with some concern 0.0661 0.0761 0.1189 
(1) I can only think about the future with a lot of concern 0.0321 0.0370 0.0578 
Role (Doing things that make me feel valued) 
  (4) I am able to do all of the things that make me feel valued 0.1923 0.2066 0.2332 
(3) I am able to do many of the things that make me feel valued 0.1793 0.2066 0.2332 
(2) I am able to do a few of the things that make me feel valued 0.1296 0.1494 0.2332 
(1) I am unable to do any of the things that make me feel valued 0.0151 0.0174 0.0272 
Enjoyment (Enjoyment and Pleasure) 
   (4) I can have all of the enjoyment and pleasure that I want 0.1660 0.1893 0.2132 
(3) I can have a lot of the enjoyment and pleasure that I want 0.1643 0.1893 0.2132 
(2) I can have a little of the enjoyment and pleasure that I want 0.1185 0.1365 0.2132 
(1) I cannot have any of the enjoyment and pleasure that I want 0.0168 0.0193 0.0302 
Control (Independence) 
   (4) I am able to be completely independent 0.2094 0.2129 0.1936 
(3) I am able to be independent in many things 0.1848 0.2129 0.1936 
(2) I am able to be independent in a few things 0.1076 0.1240 0.1936 
(1) I am unable to be at all independent -0.0512 -0.0590 -0.0922 





The original values of ICECAP-O are then re-scaled so that 1 is equal to the threshold of 
sufficient capability, so that the new objective only gives priority to those below sufficient 
capability. The formula for calculating values for each threshold dimension is presented 
below: 
Vtx=   vtx 
         Σn(vt1...vtn)                                                                                                        (7.2) 
 
Here Vtx = new value on threshold dimension level x, vtx= original value of the threshold 
dimension level x, Σn(vt1...vtn) = sum of threshold value levels across all dimensions before 
transformation (i.e., original ICECAP-O values).  
(e.g. from Table 12, level 3 on the attachment attribute for threshold Option 1 “33333”,       
vtx ≈ 0.2325; Σ[vt1+vt2+...vtn] when TSC “33333” ≈ 0.868; thus Vtx≈ 0.2679) 
 
Therefore, any scores higher than the sufficient capability threshold for each option will have 
the equivalent value of the sufficient capability threshold value. Any shortfalls in capability 
below this threshold are then allocated a shortfall value according to both:  
 the extent of that shortfall  (whether at the level of ‘no capability’ or ‘a little 
capability’ for option 1; not applicable for option 2 as only one level of ‘no capability’ 
below threshold) and;  
 the rescaled ICECAP-O population values. The ICECAP-O general population based 
value set is additive and on a linear scale, such that the numerical value is meaningful 
and the values across all attributes can be summed to give an overall index between 0 - 
representing no capability and 1 - representing full capability. For options 1 and 2, the 
index score of 1 will now represent TSC in each scenario depending on each threshold 




7.2.5 Sufficient Capability Score 
Once the threshold has been determined, values for levels below the threshold need to be 
calculated to reflect societal values of these states of capability well-being. This is required to 
apply the most complex of the AF measures of multidimensional poverty methods (the 
adjusted-FGT or M2, see Figure 11). For values below the threshold for a dimension, the 
following method is used to calculate the capability value compared with the threshold level: 
 
Vₓ =   vₓ 
      Σvt1+vt2+...vtn  ; unless vₓ>vtx, then Vₓ≡ Vtx for TSC =1                               (7.3) 
 
This calculation generates a new 0-1 value scale for ICECAP-O, with 0 still reflecting the “no 
capability” response levels on all ICECAP-O attributes. However, 1 no longer reflects “full 
capability” across all attributes, instead this reflects the threshold of sufficient capability 
(TSC). To calculate an overall reflection of sufficient capability, individual responses are 
summed across this new scale to calculate an individual’s Sufficient Capability Score (SCS). 
To calculate SCS for an individual, the values attached for each threshold option proposed in 
the previous section are presented in Table 12. For example, using threshold option 1 “33333” 
as the level where sufficient capability is reached, an ICECAP-O profile of “43233” has the 
same SCS score as an ICECAP-O profile of “44244”.  In Table 13 and Figure 12, an 
individual example of how the sufficient capability score (SCS) is calculated for a given 






Table 13 Shortfall in Sufficient Capability on ICECAP-O for individual A; 
(threshold Option 1 “33333”) 




only in  
each  
section  
I can have all of the love and friendship that I want    4   
I can have a lot of the love and friendship that I want    3   
I can have a little of the love and friendship that I want    2   
I cannot have any of the love and friendship that I want    1   
     
2. Thinking about the future      
I can think about the future without any concern    4   
I can think about the future with only a little concern    3   
I can only think about the future with some concern    2   
I can only think about the future with a lot of concern    1   
     
3. Doing things that make you feel valued      
I am able to do all of the things that make me feel valued    4   
I am able to do many of the things that make me feel valued    3   
I am able to do a few of the things that make me feel valued    2   
I am unable to do any of the things that make me feel 
valued  
  1   
     
4. Enjoyment and pleasure      
I can have all of the enjoyment and pleasure that I want    4   
I can have a lot of the enjoyment and pleasure that I want    3   
I can have a little of the enjoyment and pleasure that I want    2   
I cannot have any of the enjoyment and pleasure that I want    1   
     
5. Independence      
I am able to be completely independent    4   
I am able to be independent in many things    3   
I am able to be independent in a few things    2   
I am unable to be at all independent    1   
     Individual A ICECAP-O profile (42132); Highlight Green = sufficient capability for given attribute and given 





Figure 12 Shortfalls in Sufficient Capability for Threshold Option 1 (“33333”) 
 
Sufficient Capability Score (SCS) = Sufficient Capability (1) –  Total Shortfall (0-1). Shortfall for individual A (42132) for 
threshold option 1 (“33333”) = 0.325; SCS for individual A = 0.675. Capability instrument, ICECAP-O . 
 
7.2.6 Sufficient Capability Over Time  
Whilst improvement in individual wellbeing is important, another key calculation in health 
evaluations is to consider both wellbeing (however defined) and changes in wellbeing over 
time. This is something which has not been tackled in detail within the capability literature (as 
emphasised in Chapter 4) and has been identified as an issue for practical evaluations (Alkire 
et al., 2008). This aspect of the sufficient capability approach can, however, draw on the 
current methods applied to generate health economics outcomes, like QALYs.  
 
At this stage it is important to note the different anchors used on HRQoL measures such as 
EQ-5D and the ICECAP-O capability instrument. In general terms, extra-welfarist HRQoL 
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states worse than dead depending on the valuation method used (this was discussed in greater 
depth in Chapter 2). Similarly, the ICECAP-O is anchored on a 0-1 scale, although the 
anchors for ICECAP-O are no capability to full capability (Coast et al., 2008a). The ICECAP-
O is anchored differently to HRQoL measures used to produce QALYs. For that reason, to 
incorporate the ICECAP-O within a QALY would be inconsistent with the current anchoring 
system used to generate a health QALY. The zero value on the ICECAP-O index can be 
interpreted as: 
“A number of states may produce such a zero value: assessment of capabilities as being non-
existent in relation to all attributes; unconsciousness; and death” (Coast et al., 2008a, p.878) 
 
SCS is a flexible measure which can be applied to maximise capability levels for a given 
threshold, or inversely minimise shortfalls from the sufficient capability threshold. Therefore, 
similar approaches to those used for the QALY as a health maximising outcome or the 
Disability Adjusted Life Years (DALYs) as a disease burden minimising outcome (Murray & 
Lopez, 1996), could be applied in practice. Three examples of outcomes maximising to 
sufficient capability and one example of a minimising capability deprivation outcome are 
explored further next. 
 
7.2.6.1 Poverty Free Years (capability) 
The first outcome that is considered here combines the first Alkire-Foster method, the 
headcount ratio, over time, to calculate a measure of prevalence of poverty within a given 
population over time. The headcount ratio (H) treats an individual who is below the threshold 




attributes for a given measure. Alkire and Foster (2011a) argue that their other methods of 
multidimensional poverty are more appropriate to capture the broader influences of 
deprivation. Thus, the poverty free years (capability) (PFY(c)) outcome will act as a simple 
method of separating those below a given threshold, with those who have reached sufficient 
capability. Equation 7.4 is the appropriate calculation for PFY(c)  
PFY(c) = (1-H)×T                                                                                                                 (7.4) 
where H = headcount ratio and T=time in that state 
 
7.2.6.2 Years of Sufficient Capability (equivalent) 
To combine SCS over time for threshold options in Section 7.2.4, Years of Sufficient 
Capability (YSC) are generated to give a longitudinal measure representing gains in sufficient 
capability over time. The calculation is represented in Equation 7.5 below: 
YSC = SCS×T                                                                                                                       (7.5) 
where SCS = Sufficient Capability Score and T = Time 
 
7.2.6.3 Years of Insufficient Capability (equivalent) 
To measure shortfalls in sufficient capability over time, Years of Insufficient Capability (YIC) 
are measured by the combining the inverse of the Sufficient Capability Score (SCS) with 
time. The calculation of YIC is represented in Equation 7.6  
YIC = (1-SCS) ×T                                                                                                               (7.6) 





7.2.6.4 Years of Full Capability (equivalent) 
Whilst thresholds of sufficient capability have been suggested to be below the highest 
possible levels, it may very well be the case that sufficient capability is represented at the top 
level across all capability dimensions for a given questionnaire. If this is the scenario, then the 
approach required is comparable to the current health maximisation outcome objective. 
However, since the values associated with the QALY are generally calculated with a trade-off 
between quality and quantity of life, it would be misleading to call a similar capability 
outcome using the ICECAP-O capability valuation dataset a QALY. Therefore, the term 
Years of Full Capability (YFC) here is used to calculate the maximisation of capability across 
the population with no time preference. Equation 7.7 below presents the YFC calculation 
YFC = ICECAP-O×T, where ICECAP-O = original ICECAP-O values and T = Time      (7.7) 
 
7.3 RESULTS 
In this section, the methods of applying the sufficient capability approach are tested on a 
sample of patients who completed the ICECAP-O at three points. The demographics of the 
population are presented in Section 7.3.1. In Section 7.3.2, the four Alkire Foster (AF) 
methods are tested for this dataset. The AF methods were explained in Chapter 4 and an 
example of how to calculate the methods was previously presented in Figure 11 in this 
Chapter. The threshold options for calculating a sufficient capability score are then tested in 
Section 7.3.3. Finally, the four sufficient capability outcomes are tested to see if the different 






Table 14 summarises the demographics for the Tayside replacement cohort. At baseline, the 
average age of this population was 69.27 years. The ICECAP-O scores at baseline for the 106 
patients who completed the ICECAP-O was 0.773, less than the ICECAP-O average from the 
general population valuation dataset (0.815) (Coast et al., 2008a) and from a more recent, 
larger general population sample (0.832) (Flynn et al., 2011). 
 
Table 14 Baseline Descriptive Statistics for Tayside replacement dataset 
 
N n Mean SD Min Max 
Sample size  107 
     Missing data 106 1 
    Males  106 55 
    Employed 106 13 
    Living Alone 106 28 
    Age (mean) 106 106 69.720  8.854  48.000  89.000  
ICECAP-O (base) 106 106 0.773  0.167   0.159  1.000  
ICECAP-O (1 year) 106 58 0.862  0.132   0.516  1.000  
ICECAP-O (3 year) 106 55 0.832  0.138  0.481  1.000  
ICECAP-O complete (base) 42 42 0.789  0.132  0.368  0.998  
ICECAP-O complete (1 year) 42 42 0.851  0.134  0.516  1.000  
ICECAP-O complete (3 year) 42 42 0.824  0.146  0.481  1.000  
N,total population; n,sub population from N; SD, standard deviation; min, minimum; max, maximum 
 
7.3.2 Alkire-Foster measures 
In the first analysis, the results for patients who completed the ICECAP-O at all three time-
points (n=42) are presented for both threshold options at “a lot of capability 33333” and “a 
little capability 22222”. The Alkire-Foster methods are calculated at all possible cutoffs (k) 
for the three time periods for both threshold options. Table 15 presents the AF measures for 





Table 15 AF poverty methods applied to ICECAP-O levels using “33333” as the poverty threshold (n=42) 
33333 BASELINE   1-YEAR POST-OP   3-YEAR POST-OP 
CUTOFF(K) K=1 K=2 K=3 K=4 K=5   K=1 K=2 K=3 K=4 K=5   K=1 K=2 K=3 K=4 K=5 
AF           AF           AF           
H 0.7381 0.5000 0.3333 0.1667 0 H 0.3571 0.3095 0.1905 0.1190 0.0238 H 0.4762 0.3333 0.2619 0.1905 0 
M0 0.3476 0.3000 0.2333 0.1333 0 M0 0.2000 0.1905 0.1429 0.1000 0.0238 M0 0.2524 0.2238 0.1952 0.1524 0 
M1 0.0931 0.1029 0.0950 0.0647 0 M1 0.0627 0.0659 0.0607 0.0480 0.0143 M1 0.0782 0.0879 0.0870 0.0686 0 
M2 0.0610 0.0698 0.0655 0.0433 0 M2 0.0431 0.0449 0.0417 0.0338 0.0095 M2 0.0519 0.0603 0.0595 0.0445 0 
AF, Alkire and Foster multidimensional poverty methods; k, cutoff in number of dimensions for individuals to be poor; H, headcount ratio; M0, adjusted headcount ratio;  
M1, adjusted poverty gap; M2, adjusted-Foster-Greer-Thorbecke measure. More details on AF methods in Figure 11 
 
 
Table 16 AF poverty methods applied to ICECAP-O levels using “22222” as the threshold (n=42) 
22222 BASELINE   1-YEAR POST-OP   3-YEAR POST-OP 
CUTOFF(K) K=1 K=2 K=3 K=4 K=5   K=1 K=2 K=3 K=4 K=5   K=1 K=2 K=3 K=4 K=5 
AF            AF            AF            
H 0.1667 0.0476 0.0238 0 0 H 0.1190 0 0 0 0 H 0.1667 0.0238 0.0238 0 0 
M0 0.0476 0.0238 0.0143 0 0 M0 0.0238 0 0 0 0 M0 0.0429 0.0143 0.0143 0 0 
M1 0.0476 0.0238 0.0143 0 0 M1 0.0238 0 0 0 0 M1 0.0429 0.0143 0.0143 0 0 
M2 0.0100 0.0095 0.0079 0 0 M2 0.0025 0 0 0 0 M2 0.0073 0.0064 0.0064 0 0 
AF, Alkire and Foster multidimensional poverty methods; k, cutoff in number of dimensions for individuals to be poor; H, headcount ratio; M0, adjusted  






From both Tables 15 and 16, it is clear that the choice of threshold and cutoff is crucial in 
measuring the level of poverty in terms of sufficient capability for a given population. Using 
the simplest AF measures, the Headcount Ratio (H), and the cutoff (k) = 1, comparing Table 
15 and 16 shows that while almost three quarters (73.8%) of the population have shortfalls in 
sufficient capability at the TSC of “33333”, less than one fifth (16.7%) of the population have 
shortfalls at the lower threshold of “22222”.  
 
7.3.3 Sufficient Capability for Threshold Option 1 (33333) 
Overall, the SCS for the baseline population (n=106) threshold option 1 (33333) is 0.857. 
This is lower than the average of the sample from the ICECAP-O valuation dataset, which has 
an average SCS score of 0.894 with the same TSC (see Table 17 for ICECAP-O valuation 
dataset responses below threshold. Data from Coast et al. 2008a). Table 18 shows the 
attributes in which shortfalls in sufficient capability occurred pre-intervention, with the 
“enjoyment” attribute reporting the highest number of shortfall responses below the “33333” 
threshold (46.23%). 
Table 17 ICECAP-O valuation dataset responses below Threshold of Sufficient 
Capability (n=313) 
ICECAP-O  ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
level 2 8.95% 30.03% 23.00% 21.09% 17.89% 
level 1 3.83% 12.46% 3.51% 4.15% 2.24% 
ICECAP-O original value average, 0.815; SCS (33333), 0.894; SCS (22222), 0.961; level 1, ‘no’ 
capability on ICECAP-O; level 2, ‘a little’ capability on ICECAP-O 
 
Table 18 Responses below Threshold of Sufficient Capability “33333”(baseline) 
ICECAP-O responses (baseline) 
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
TOTAL 
RESPONSES 
level 2 9 29 38 38 27 26.60% 
level 1 2 12 7 11 6 7.17% 
Below TSC 
per attribute 10.38% 38.68% 42.45% 46.23% 31.13%   




In Table 19, SCS is calculated for patients who completed the ICECAP-O at one year post-
operation (n=58). This resulted in an increased SCS score of 0.05 (0.88→0.93) from baseline 
for these individuals. Patients who completed ICECAP-O at three year post intervention 
(n=55) also reported an improved SCS from baseline by 0.031 (0.881→0.912), which can be 
seen in Table 20. In Tables 19 and 20, the improvements in the lower levels of capability 
come predominantly from the “role” and “enjoyment” ICECAP-O attributes. 
 
Table 19 Responses below Threshold of Sufficient Capability “33333” (baseline 
and 1 year post operation; n=58) 
ICECAP-O responses (baseline)       
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
TOTAL 
RESPONSES 
level 2 3 15 21 22 14 25.86% 
level 1 1 6 2 5 1 5.17% 
Responses 
below TSC 
per attribute 6.90% 36.21% 39.66% 46.55% 25.86%   
       
ICECAP-O responses (1 year)       
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
TOTAL 
RESPONSES 
level 2 10 8 11 15 4 16.55% 
level 1 0 6 0 0 1 2.41% 
Responses 
below TSC 
per attribute 17.24% 24.14% 18.97% 25.86% 8.62%   
SCS, Sufficient Capability Score; TSC = Threshold of Sufficient Capability; SCS (baseline “33333”) = 0.88; SCS (1 year 









Table 20 Responses below Threshold of Sufficient Capability “33333” (baseline 
and three year post-operation; n=55) 
ICECAP-O responses (baseline)       
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
Total 
Responses 
level 2 3 17 22 22 13 28.00% 
level 1 0 5 1 4 2 4.36% 
Responses 
below TSC 
per attribute 5.45% 40.00% 41.82% 47.27% 27.27%   
       ICECAP-O responses (3 year)         
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
Total 
Responses 
level 2 4 16 13 11 10 19.64% 
level 1 0 5 3 1 1 3.64% 
Responses 
below TSC 
per attribute 7.27% 38.18% 29.09% 21.82% 20.00%   
SCS, Sufficient Capability Score; TSC, Threshold of Sufficient Capability; SCS (baseline “33333”) = 0.881;  
SCS (3 year “33333”) = 0.912. 
 
 
7.3.4 Sufficient Capability for Threshold Option 2 (22222) 
The proportion of responses below SCS threshold option 2 (22222) at baseline, one year and 
three year post-intervention can be seen in the level 1 ICECAP-O responses on Tables 21,22 
and 23 respectively. Overall, the SCS at baseline population (n=106) is 0.940, which is lower 
than the average of the sample from the valuation dataset with an average SCS score of 0.961 
with the same threshold (see Table 18). The “security” and “enjoyment” attributes have the 
highest proportion of responses below the “22222” threshold (see Table 21). In Table 22, SCS 
is calculated for patients who completed the ICECAP-O at one year post-operation (n=58). 
This resulted in an increased SCS score of 0.028 (0.961→0.989). Patients who completed 
ICECAP-O at three years post intervention (n=55) also reported an improved SCS from 
baseline of 0.008 (0.967→0.978), which can be seen in Table 23. The “enjoyment” attribute 




Table 21 Responses below Threshold of Sufficient Capability “22222”(baseline) 
ICECAP-O responses (baseline) 
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
TOTAL 
RESPONSES 
level 1 2 12 7 11 6 7.17% 
Below TSC 
per attribute 1.89% 11.32% 6.60% 10.38% 2.83%   
n = 106; SCS, Sufficient Capability Score; TSC, Threshold of Sufficient Capability; SCS = 0.940; TSC "22222" 
 
Table 22 Responses below Threshold of Sufficient Capability “22222” (baseline 
and 1 year post operation; n=58) 
ICECAP-O responses (baseline)       
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
TOTAL 
RESPONSES 
level 1 1 6 2 5 1 5.17% 
Responses 
below TSC 
per attribute 1.72% 10.34% 3.45% 8.62% 1.72%   
       
ICECAP-O responses (1 year)       
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
TOTAL 
RESPONSES 
level 1 0 6 0 0 1 2.41% 
Responses 
below TSC 
per attribute 0.00% 10.34% 0.00% 0.00% 1.72%   
SCS, Sufficient Capability Score; TSC = Threshold of Sufficient Capability;  SCS (baseline “22222”) = 0.961; SCS (1 
year) = 0.989. 
 
Table 23 Responses below Threshold of Sufficient Capability “22222” (baseline 
and three year post-operation; n=55) 
ICECAP-O responses (baseline)       
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
Total 
Responses 
level 1 0 5 1 4 2 4.36% 
Responses 
below TSC 
per attribute 0.00% 9.10% 1.82% 7.27% 3.64%   
       ICECAP-O responses (3 year)         
Below TSC ATTACHMENT SECURITY ROLE ENJOYMENT CONTROL 
Total 
Responses 
level 1 0 5 3 1 1 3.64% 
Responses 
below TSC 
per attribute 0.00% 9.10% 5.45% 1.82% 1.82%   
SCS, Sufficient Capability Score; TSC, Threshold of Sufficient Capability; SCS (baseline “22222”) = 0.967; SCS (3 year 





7.3.5. Sufficient Capability Outcomes over time 
The four outcomes of sufficient capability [(1) poverty free years (capability), (2) years of 
sufficient capability, (3) years of insufficient capability, (4) years of full capability are tested 
over time with this sample population who completed the ICECAP-O at all three time points 
(n=42). This was used to get an indication of the changes in capability over time for each of 
the four outcomes proposed here.  
 
7.3.5.1 Poverty Free Years (capability) – (PFY(c)) 
Poverty Free Years (capability) are calculated both for option 1 (33333) and option 2 (22222). 
Firstly, option 1 reported a headcount ratio of 0.738 at baseline, which significantly decreased 
at year 1 (0.358) and year 3 (0.476). Using the area under the curve approach, where the 
benefits of the intervention are deducted from the benefits of the control group (Drummond et 
al., 2005), poverty free years (capability) are increased by 0.832 during this time period (i.e. 
[3-[0.5(0.738+0.358)+(0.358+0.476)]]-[3-(0.738×3)] = 0.832). 
 
As for option 2, the headcount ratio for the arthritis population in capability poverty was 
considerably less (0.167). At year 1, this reduced to 0.119 but returned to baseline level at 
year 3. Therefore, the PFY(c) gained from this intervention is less than option 1, with a gain 





7.3.5.2 Years of Sufficient Capability – (YSC) 
This analysis involves calculating the change in SCS over time to generate Years of Sufficient 
Capability (YSC). YSC is calculated using the area under the curve approach.  
 
For Option 1 (33333) the SCS for the 42 patients at baseline is 0.871, which is assumed to 
stay constant if the intervention was not provided to the patients. SCS at one year (0.923) and 
SCS at three year post-intervention (0.902) are used to calculate the intervention group, with 
each SCS is assumed to be connected linearly. Figure 13 shows this calculation graphically. 
The darker area on Figure 13 displays the YSC gain from treatment, which is equal to 0.109 
YSC gained compared with no intervention provided (i.e. [0.5(0.871+0.923)+(0.923+0.902)]-
[3×0.871] = 0.109). 
 
For Option 2 (22222) SCS for the 42 patients at baseline is 0.965, which is assumed to stay 
constant if the intervention was not provided to the patients. SCS at follow up at one year 
(0.987) and SCS at three year post-intervention (0.972). Combining these three time-points 
and comparing results to a constant SCS over the three years results in 0.04 YSC gained 








Figure 13 Example of Years of Sufficient Capability (YSC) for Osteoarthritis 
Patients (n=42) for threshold option 1 “33333” 
 
 
7.3.5.3 Years of Insufficient Capability – (YIC) 
The calculation of Years of Insufficient Capability (YIC) is intended to minimise shortfalls in 
sufficient capability. This is the inverse calculation of YSC. Therefore, for Option 1 (33333) 
YIC at baseline is 0.129, at the one year follow-up is at 0.077 and at the three year follow-up 
of 0.098. With the baseline YIC held constant over three years, the YIC saved from the joint 
replacement is 0.109.  
 
Similarly for Option 2 (22222), YIC for the arthritis patients in this dataset pre-operation is 
0.035. YIC at one year (0.013) and three years (0.028) post-operation, results in a YIC saved 
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7.3.5.4 Years of Full Capability – (YFC) 
Years of Full Capability (YFC) are calculated in the same area under the curve approach as 
for Years of Sufficient Capability (YSC). At baseline, YFC for the arthritis patients are equal 
to 0.789 (i.e. when the threshold of sufficient capability is equal to 44444 on the ICECAP-O). 
YFC at year one (0.851) at year three (0.824) follow up result in YFC gained of 0.128 when 
compared with the baseline score over a three year period (i.e. 
[0.5(0.789+0.851)+(0.851+0.824)]-[3×0.789] = 0.128).  
 
Table 24 summarises all the different outcomes across both threshold options in this study. 
While three of the four outcomes produce similar results, the poverty free years (capability) 
outcome results in a greater improvement. This represented an increase in the population 
whose capability levels improved to the extent that they met the threshold of sufficient 
capability following treatment and who were below the threshold at baseline. However, the 
PFY(c) was calculated using the simplest of the AF methods, the headcount ratio (H). All 
three other outcomes apply the most complex of the AF methods, the adjusted Foster Greer 
Thorbecke or M2, which takes account of number of attributes and values of shortfalls below 








Table 24 Capability Outcomes for Tayside Replacement Dataset (n=42) 






Poverty Free Years (capability) PFY(c) 33333 0.738 0.358 0.476 0.832 
  
22222 0.167 0.119 0.167 0.072 
Years of Sufficient Capability YSC 33333 0.871 0.923 0.902 0.109 
  
22222 0.965 0.987 0.972 0.040 
Years of Insufficient Capability YIC 33333 0.129 0.077 0.098 0.109 
  
22222 0.035 0.013 0.028 0.040 
Years of Full Capability YFC 44444 0.789 0.851 0.824 0.128 
TSC, Threshold of Sufficient Capability on ICECAP-O 
 
7.4. DISCUSSION 
This is the first study to formulate a new decision rule based on achieving sufficient capability 
using a capability questionnaire. This new approach is flexible in how it can be applied in 
practice, i.e. either maximising in a method similar, although not identical to QALYs, or 
minimising in a method similar to DALYs, as shown by the development of four new 
outcomes. However, the objective of “capability efficiency” (Cookson, 2005b) or efficiency 
in achieving capability needs to be rationalised in association with the theoretical 
underpinnings of the capability perspective. Maximising total population levels of capability 
or minimising total levels of capability poverty is not in line with how the capability approach 
was designed to be implemented in practice, as emphasised in Chapters 3 and 4. This study 
has therefore adopted methods from the multidimensional poverty literature, closely linked to 
the capability approach, to develop a practical methodology for generating capability 
outcomes through what is called here the “sufficient capability approach”. The example above 




as results in terms of the assessment of benefit gained inevitably vary considerably depending 
on the threshold chosen (as shown in Table 24). 
 
Cookson (2005b) discussed the possibility of aligning the QALY with the capability approach 
(or what Cookson calls the ‘capability QALY’), accounting for both health and non-health 
functionings that influence capability. Whilst appreciating his meticulous framework, the 
primary concern with Cookson’s approach to incorporating capability (or “capability 
efficiency”) within health economics using the “capability QALY” (Cookson, 2005b).  
 
This Chapter deviates from Cookson’s approach by firstly capturing capability directly, 
although the ICECAP questionnaires were not available at the time of Cookson’s proposal. 
More importantly, his definition of the “efficiency of what?” is not in line with the capability 
approach, as the sufficient capability approach allows distributional considerations to be 
handled within the efficiency measure, by improving those with shortfalls in sufficient 
capability as a priority. Simply re-interpreting the QALY as a ‘capability QALY’ seems 
unsatisfactory from a capability perspective, as emphasised in Chapter 4 and the proposal of 
the sufficient capability approach is offered as an alternative. Four sufficient capability 
outcomes were developed and calculated for a sample of OA patients to provide an 
illustration of the approaches. 
 
There are limitations associated with the application of the sufficient capability approach in 




First, the dataset of 107 patients at baseline, and the smaller sample sizes available at 
follow-up was relatively small. Nevertheless, it was large enough to show significant change 
in the overall sufficient capability score (SCS) between follow-up periods, in particular for 
threshold option 1 “33333”, and was useful in illustrating the methods and outcomes of the 
sufficient capability approach in practice. 
 
Second, and possibly more significant than the small sample size limitation, is the comparison 
to show how sufficient capability changed and improved over time. There was no control 
group available whereby an intervention versus no intervention could be compared, which 
would have given more meaningful results as to whether the sufficient capability outcomes 
were capturing tangible differences between outcomes and due to the intervention provided to 
these patients. While there is some evidence which suggests that older age (over 75 years) 
leads to reduced capability (Flynn et al., 2011), this was based on cross-sectional data. 
Therefore, a conservative assumption was made to keep capability the same as baseline over 
the three years as a proxy longitudinal control group. 
 
Third, the selection of the threshold of sufficient capability (TSC) was undoubtedly somewhat 
arbitrary. The selection of the ‘a little capability or 22222’ threshold was guided partly by 
capability theorists assertion that all basic capabilities are of equal importance (Nussbaum, 
2000; Venkatapuram, 2011); therefore, no capability for any attribute is of chief priority to 
avoid. The selection of the ‘a lot of capability or 33333’ was guided by previous research with 
the ICECAP-O questionnaire, which showed that average ICECAP-O UK population values 




vs. UK over 65 years old ICECAP-O average values = 0.832 (Flynn et al., 2011)). The 
“33333” threshold may also provide a more reasonable identification of sufficient capability 
within a developed nation such as the UK where higher levels of capability would be 
expected, rather than the lower threshold of “22222”. Additionally, the cutoff (k) for the 
number of capability attributes required to reach TSC was also a subjective choice, made for 
ease of interpreting the methodology (where, k = 1 meaning that a person was below 
sufficient capability if they were below the attribute threshold level on any one attribute). 
Such uncertainty in defining a suitable TSC and cutoff of TSC is open to scrutiny, and 
requires further exploration and justification for the methods to be taken forward. 
 
Fourth, the ICECAP-O has been used here as the measure of sufficient capability. Whilst this 
may be appropriate for the arthritis population (mean age approximately 70) in this dataset, to 
allocate resources across the entire health service, the more recently developed ICECAP-A 
(Al-Janabi et al., 2012a) is likely to be a more suitable measurement of capability. The design 
of the ICECAP-A is for the general adult (18+) population, compared to the ICECAP-O, 
which is designed for older people specifically. Nevertheless, the same methodology can be 
applied with the ICECAP-A.  
 
Fifth, assumptions are made to combine sufficient capability with time to generate sufficient 
capability outcomes over time. The assumption of sufficient capability outcomes to be 
constant over time was made for simplicity, and no discount rate was applied. The second 
assumption is that the “no capability” score on the 0-1 scale remains at zero as no capability 




develop a better understanding on the capability depreciation (if any) over time, as well as 
whether there are worse states than the “pits” state of no capability on all the ICECAP-O 
attributes. 
 
There is no particular need for the sufficient capability methodology to be exclusive to the 
ICECAP questionnaires. It could be used with other capability instruments, such as the other 
capability questionnaires described in Chapter 3, and could potentially be applied to generic 
measures of health like the EQ-5D, with the emphasis being on minimum thresholds for 
health. 
 
This chapter proposes a method to incorporate the capability approach within health economic 
evaluations. It draws from capability applications and combines a capability instrument with 
time for a number of outcomes. The key finding from this chapter is that the choice of 
threshold of sufficient capability is likely to be crucial to the resource allocation process if this 
methodology was implemented across a national health service, as shown in Table 24 where 




CHAPTER 8. METHODOLOGY FOR OBTAINING CAPABILITY 
OUTCOMES FROM AN ECONOMIC MODEL: A CASE STUDY 
8.1 INTRODUCTION 
It has already been established in this thesis that capability can be predicted from measures of 
physical function (see Chapter 6). Additionally, Chapter 7 has outlined a methodology to 
generate meaningful outcomes which can be of value in allocating scarce resources from a 
capability perspective. In Chapter 5, the case study for incorporating a capability instrument 
into an economic model was identified as the Birmingham Rheumatoid Arthritis Model 
(BRAM). Using the methodology from Chapter 6 and 7, it is now possible to incorporate a 
capability instrument into an economic model through mapping (Chapter 6) to generate 
outcomes from the capability approach (Chapter 7). In this chapter, the methods for 
generating capability outcomes from the BRAM model are explained. 
 
The remainder of the chapter is structured as follows. In Section 8.2, an outline of the main 
characteristics of the case study is presented. The case study chosen has been implemented on 
a number of occasions in the past to aid decision-making in the UK (Barton et al., 2004a; 
Clark et al., 2004; Chen et al., 2006; Malottki et al., 2011). A focus on how previous 
economic outcomes were generated in the selected case study is of primary interest to the 
generation of capability outcomes in this chapter. Then the methods (Section 8.3) for 
generating four capability outcomes from the chosen case study are outlined, with a results 




the outcomes for further analysis in an evaluation. The results of the evaluation are presented 
in Chapter 9. 
 
8.2 BACKGROUND TO THE BIRMINGHAM RHEUMATOID ARTHRITIS MODEL 
(BRAM) 
Following the justification of the selected case study (Chapter 5), this section details the main 
features of the case study. The focus, in particular, is on the type of outcomes which have 
been produced from this case study previously, which act as a comparator to the methodology 
of generating capability outcomes from the case study in the following section. Information 
within Section 8.2 is not original work by the author of this thesis and is presented here for 
illustration of the BRAM model process. 
 
8.2.1 A review of previous BRAM versions 
BRAM is an individual sampling model, a type of model that accounts for individual patient 
pathways at a patient-level basis (Barton et al., 2004a). The model is designed to represent 
clinical treatment for patients with rheumatoid arthritis, a chronic ailment that is caused by 
inflamed synovial tissue between joints. Rheumatoid arthritis is a progressive disease that 
causes functional disability, significant pain and destruction of the joints, which can in turn 
lead to premature mortality (Kvien, 2004). 
 
Each individual pathway in an individual sampling model produces a virtual patient history, 




It is then from these patient histories that mean population values in terms of costs and 
benefits can be generated (Barton et al., 2004a). 
 
Over the period between 2000 and 2013, four different BRAM models have been developed 
for aiding decision-making in terms of the cost-effectiveness of different drug treatment 
strategies for rheumatoid arthritis within the UK. The first model developed by the West 
Midlands Health Technology Assessment Collaboration was known as the Birmingham 
Preliminary Model (or BPM02 from now on, with 02 indicating year of model publication) 
(Jobanputra et al., 2002). The BPM02 was used to assess the introduction of new biologic 
treatments, clinically called anti-bodies against tumour necrosis factor (anti-TNFs) drugs 
which include etanercept (ETN) and infliximab (IFX) to the National Health Service (NHS). 
The introduction of either of these two drugs, as a third-line therapy or last active treatment, 
was compared with a sequence of non-biologic disease modifying anti-rheumatic drugs 
(DMARDs) beginning with sulphasalazine (SSZ) then methotrexate (MTX) then gold 
(sodium aurothiomalate - GST) which are a likely starting treatment strategy if biologic 
treatments were not available (Jobanputra et al., 2002). The DMARD sequence employed in 
BPM02 can be seen in Figure 14 (originally Figure 14 featured in the BPM02 report 
(Jobanputra et al., 2002)). 
 
In BPM02 and all subsequent BRAM models, the choice of model was an individual 
sampling model, due to the rigidness associated with Markov modelling in terms of the 
independence of transition probabilities from timeframe (Markov assumption) and previous 




with such a model (Barton et al., 2004b). In an individual sampling model, each patient 
pathway produces a number of virtual patient histories, which aims to give a true reflection of 
the population characteristics under consideration (Barton et al., 2004b). 
Figure 14 Treatment strategy options and patient pathway represented in 
BPM02 
 
In Figure 14, a circle represents a different stage in BPM02, with the majority of circles representing a drug treatment, as well as dead and 
palliation treatment (Pall). Other abbreviations are SSZ, sulphasalazine; MTX, methotrexate; GST, gold; AZA, azathioprine; D-Pen, 
penicillamine; HCQ, hydroxychloroquine; LEF, leflunomide; CyA cyclosporin; Comb, combination of MTX plus CyA. 
Source: Originally appeared as Figure 9, p. 54 in Jobanputra et al. (2002) 
 
BPM02 classified toxicity or loss of effectiveness as the reasons that individuals quit a 
treatment within the model. The sole patient characteristic required in BPM02 was a patient’s 
remaining lifetime, which was calculated from relevant life expectancy tables for rheumatoid 
arthritis patients. The BPM02 model also assumed that improved health related quality of life 
associated with DMARDs and anti-TNFs was fixed, with the health improvement lost when 
quitting that treatment. Mortality effects from DMARDs were not included in BPM02. Other 
limits to changes in individual status over time for the first BRAM version included the 




within BPM02. However, many of the assumptions in BPM02 were made due to the time 
constraints associated with developing the model, hence the use of the word ‘Preliminary’ in 
the title of the first model version (Jobanputra et al., 2002). 
 
More time was required for the further enhancement of the model to better capture changes in 
patient pathways during drug treatment strategies for rheumatoid arthritis patients. The main 
recommendations for improving BPM02 were elaborated in a report in 2004 (Barton et al., 
2004a). The main change from BPM02 to the subsequent BRAM models is the introduction 
of the Health Assessment Questionnaire-Disability Index (HAQ-DI), as the primary predictor 
of changes in health related quality of life as an individual moves through the model. HAQ-
DI, a measure of functional disability used commonly in rheumatoid arthritis trials, is 
calculated on a discrete scale 0-3 at 0.125 increments (Bruce & Fries, 2003). HAQ-DI is also 
used to predict the likelihood of mortality in subsequent models from BPM02, as higher 
HAQ-DI scores indicate higher physical function limitations which is negatively linked to life 
expectancy. Average HAQ-DI scores are also allowed to vary for different treatments and the 
effect of joint replacement, measured again by HAQ-DI score, is also allowed for in the 
enhanced model versions. The process of an individual going through the next three versions 
of BRAM is outlined in Figure 15, which originally appeared in Barton et al. (2004a). 
 
The changes to BPM02 outlined in Barton et al (2004a) were first implemented in a new 
model in the same year of recommendation (BRAM04 from now on). BRAM04 looked at the 
introduction of anakinra, a new drug treatment, into a DMARD sequence representing current 




term improvement captured in BPM02 when starting a new treatment is now measured using 
a fixed improvement (decrease) in HAQ-DI score in BRAM04. This allowed patients’ HAQ-
DI scores to deteriorate whilst on treatment, but HAQ-DI could never go above the worst 
possible score of 3. This deterioration could now be captured in BRAM04 because of the 
number of increased initial input characteristics of individuals in the revised model, which not 
only included HAQ-DI score, but also the age and sex of the individual at the start of 
treatment.  
 
Figure 15 Individual patient pathway in BRAM04, BRAM06 and BRAM11 
models(Barton et al., 2004a) 
 
 
Source: Figure 15 above originally appeared in Barton et al. (2004), Fig. 3, p. 14. DMARD, Disease Modifying anti-Rheumatic Drug: HAQ, 






The next BRAM version, BRAM06, evaluated the cost-effectiveness of etanercept and 
infliximab once more, as well as a new anti-TNF, adalimumab (Chen et al., 2006). Further 
changes were instigated in BRAM06, including HAQ-DI improvement being allowed to vary 
for individuals when starting a new treatment. The model also allowed for greater benefits to 
be apportioned to those who had higher HAQ-DI scores, as they had greater potential to 
benefit from treatment. Two early withdrawal steps for patients were introduced into the 
model, for reasons of toxicity at six weeks and either toxicity or loss of effectiveness at 
twenty four weeks. BRAM06 was also used for a subsequent NICE report which was 
concerned with the sequential use of biologic treatments, which included rituximab, a 
monoclonal antibody targeting B lymphocytes, as an alternative strategy (Barton, 2008). 
 
The final and most recent version of the BRAM is BRAM11 and was developed to evaluate 
adalimumab, etanercept, infliximab, rituximab and abatacept after the failure of one anti-TNF 
previously (Malottki et al., 2011). The primary change in this model was the introduction of 
probabilistic sensitivity analysis (PSA), which reflects the uncertainty entering the model by 
placing relevant distributions on the input parameters when feasible (Briggs et al., 2006). An 
example of the change in HAQ-DI for a patient over time from BRAM04, BRAM06 and 








Figure 16 Representation of HAQ-DI change over time for patients in BRAM 
Models (BRAM04, BRAM06 and BRAM11) (Malottki et al., 2011) 
 
AB shows initial improvement on biologic; this improvement is lost when treatment changes to leflunomide (LEF) represented by CD; DE 
shows the initial improvement from LEF; higher HAQ-DI scores between EF represents gradual deterioration of the patient over time; 
similar process for final treatment, until point J where the patient dies from other causes. 
Source: Malottki et al. (2011), Fig. 94, p 147 
 
8.2.2 Economic outcomes in previous BRAM versions 
The focus of interest in this case study is the costs and benefits used to generate economic 
outcomes from BRAM models. Costs and QALYs for different strategies are compared using 
the incremental cost-effectiveness ratio (ICER) approach for all four versions of BRAM, 
which is the decision-rule favoured by NICE (NICE, 2013). 
 
Costs have been handled in a comparable manner in all versions of the BRAM, accounting for 
patient start off costs with a new treatment, along with monitoring costs throughout time on 
each treatment which varied for each drug respectively. Later versions (BRAM06 and 




case analysis or through sensitivity analysis. However, all evaluations were conducted from 
the NHS or NHS and personal and social services perspective, as recommended by NICE at 
the time of the development of the previous BRAM models (NICE, 2008). Therefore, patient 
indirect costs and carer costs have not been considered in any of the BRAM versions. Patient 
and carer costs for rheumatoid arthritis patients are recognised as having a considerable 
impact on those affected by the disease, particularly in terms of lost hours and lost 
productivity at work (Kvien, 2004). 
 
The economic outcomes from the BRAM models have been consistent throughout all 
versions, with the BRAM team following NICE guidance in generating QALYs for different 
treatment strategies. In all four versions of the BRAM, the economic outcome generated is 
QALYs, although methods for their generation varied for each version of BRAM. In all four 
models, the HAQ-DI is the primary predictor of quality of life for the respective models in the 
QALY calculation. This is also true for the majority of other economic models involving 
rheumatoid arthritis patients when applying a measure of condition-specific or generic health 
status instrument to predict health utility (Marra et al., 2011). 
 
In the first model version (BPM02), limited time meant that an opinion of the likely 
relationship between an improvement (i.e. decrease) in HAQ-DI score and EQ-5D score 
informed the calculation of quality of life, which allowed for the calculation of QALYs. Any 
HAQ-DI improvement/deterioration was multiplied by 0.2 to generate the change in quality of 
life. However, such ‘quick and dirty’ techniques have questionable validity issues (Coast, 




questionnaires which is not easily comparable with QALYs generated from related studies 
(Coast, 1992; Fryback et al., 1997). The use of statistical associations such as mapping are 
now more commonly used and recommended (Brazier et al., 2010), rather than the 
‘reprocessing’(Coast, 1992) approach applied in BPM02. In BRAM04, BRAM 06 and 
BRAM11 a statistical approach to identify a relationship was employed (i.e. mapping). 
 
Generating a regression analysis between HAQ-DI and EQ-5D is used in the later three 
BRAM versions (Barton et al., 2004a). A linear relationship between HAQ-DI and EQ-5D is 
applied in BRAM04 and BRAM06, whilst BRAM11 employed a quadratic relationship 
between HAQ-DI and EQ-5D, with Quality of Life predicted by both HAQ-DI and the square 
function of HAQ-DI. From a frequentist statistical point of view, the use of the quadratic 
regression would seem to be unwarranted given the earlier regression analysis which 
suggested that HAQ-DI alone was the best predictor of EQ-5D scores (Barton et al., 2004a). 
However, the incorporation of PSA into BRAM11 required a Bayesian approach that takes 
account of the uncertainty between the relationship of predicting EQ-5D from HAQ-DI more 
systematically. A summary of the algorithms used to generate health related quality of life in 
each of the models can be seen in Table 25. 
 
The BRAM model has developed from a preliminary model with many constraints into a 
model which now accounts for different types of uncertainty and economic outcome 
measures. The question for this research is whether and how it can be further extended to 





Table 25 BRAM models and Quality of Life Calculation for QALYs 
BRAM 
version 





HAQ-DI improvement from treatment 
multiplied by 0.2 
HAQ-DI reduction of 1 = 0.2 
improvement in quality of life 
BRAM04 
 
Linear regression HAQ-DI score used to 
predict EQ-5D as QoL measure QoL = 0.862-0.327×HAQ-DI 
 
BRAM06 Same as BRAM04 Same as BRAM04 
 
BRAM11 
Quadratic equation with HAQ-DI and 




QoL, Quality of Life; HAQ-DI, Health Assessment Questionnaire-Disability Index 
 
8.3 METHODS 
In this section, the methods for incorporating a capability instrument, the ICECAP-O, to 
produce capability outcomes from BRAM are outlined.  
 
8.3.1 BRAM version 
The choice of BRAM model to carry out this analysis in reality could be any of the four 
versions previously described in Section 8.2.2. However, an important aspect of this research 
is to compare what is done presently in health economics with what could be done with 
capability outcomes. Therefore, while other comparisons with earlier BRAM versions might 
provide insightful findings, the choice of BRAM model for this study is BRAM11 (Malottki 
et al., 2011), given that it relates most closely to current health economic evaluations and 
models for the rheumatoid arthritis population. Table 26 and Table 27 present the main 
components of the starting population dataset in BRAM11, specifically age and sex (Table 
26) and HAQ-DI as the measure of physical function (Table 27), which make up the main 




Table 26 Age and sex distribution when starting treatment in BRAM11 
  Age(years)             
Sex 15-24 25-34 35-44 45-54 55-64 65-74 75-84 Total 
Male 0.0 0.4 1.9 5.2 6.5 3.8 1.2 19 
Female 0.1 1.5 8.2 22.1 27.7 16.3 5.1 81 
Source: Malottki et al. (2011), Table 66, p. 149 
Table 27 Distribution of HAQ-DI scores among population when starting 
treatment in BRAM11 
HAQ-DI 0.125 0.25 0.375 0.5 0.625 0.75 0.875 1 
% 0.0 0.1 0.2 0.5 0.7 1.2 1.7 2.2 
HAQ-DI 1.125 1.25 1.375 1.5 1.625 1.75 1.875 2 
% 2.9 3.6 4.3 5.1 5.8 6.6 7.2 7.7 
HAQ-DI 2.125 2.25 2.375 2.5 2.625 2.75 2.875 3 
% 8.1 8.4 8.3 8.0 7.1 5.9 3.7 0.7 
Source: Malottki et al. (2011), Table 67, p. 149; %, proportion of population recording a given HAQ-DI score 
8.3.2 Dataset 
The dataset employed to predict the relationship between a starting measure of physical 
function (HAQ-DI) and a target measure of capability (ICECAP-O) is the baseline 
information from the Tayside Joint Replacement dataset. This dataset was also applied in 
Chapter 6 to investigate the feasibility to map from a measure of physical function 
(WOMAC) to a measure of capability (ICECAP-O).  
 
8.3.3 Instruments 
This section explains the two instruments of interest for this case study, the Health 





8.3.3.1 Starting Measure: Amended version of the Health Assessment 
Questionnaire – Disability Index (HAQ-DI) 
The health assessment questionnaire (HAQ) is primarily used as a measurement of functional 
disability in patients with rheumatoid arthritis. The HAQ has been frequently used, refined 
and modified since its inception over thirty years ago (Fries et al., 1980). While the “full 
HAQ” incorporates five dimensions of outcome (known as the five Ds: “disability”, 
“discomfort”, “drug side effects”, “dollar costs” and “death”), the most widely used aspect of 
the HAQ is the disability index, the HAQ-DI (Bruce & Fries, 2003), which is the primary 
interest in this study, as this was the measure applied previously in BRAM11.  
 
In the traditional HAQ-DI format, there are 20 questions covering 8 areas of physical function 
(dressing and grooming, rising, eating, walking, hygiene, reach, grip, activities), with 2 to 3 
questions for each functioning (see Appendix 6). The highest (worst) score for each area of 
functioning is used to calculate the HAQ-DI score, with each of the eight categories valued 
equally. Additionally, polar questions regarding the extra support patients require from 
individuals, aids and devices are sometimes taken into consideration. When extra assistance is 
required in a HAQ-DI category, a score of 2 (much difficulty) is recorded for that category, 
unless 3 (unable to do) has already been reported. The final HAQ-DI score for each person 
ranges from 0 (no problems functioning) to 3 (not able to function). A simpler measure of the 
HAQ-DI called the modified HAQ or MHAQ, which only asks one question per functioning 
(8 in total) has been developed more recently and is now used interchangeably with the 





HAQ-DI scores were processed through responses given in the physical function questions 
section collected alongside ICECAP-O in the Tayside Joint Replacement cohort. Physical 
function items from this dataset were taken from the initial pool development of the new 
Aberdeen measures of impairment, activity limitations and participation restriction (Pollard et 
al., 2009). The items used in this study were from the development of the activity limitation 
part of the measure, which came primarily from the WOMAC questionnaire (Bellamy et al., 
1988) but also HAQ-DI and SF-36 (Ware, Jr. & Sherbourne, 1992). Previous research has 
shown a strong relationship between the HAQ-DI and the WOMAC (Bruce & Fries, 2004). 
Questions were restructured in the WOMAC questionnaire format to ask patients about the 
degree of their difficulty on a 0-4 scale (no-severe difficulty). 
 
Out of the twenty questions from the eight areas of physical function captured on HAQ-DI, 
eleven questions were worded in a directly comparable manner, two questions required four 
physical function questions to capture the HAQ-DI questions fully, while the remaining seven 
questions had no comparable questions in this dataset. Two of the eight categories on 
HAQ-DI (eating and grip) had no comparable questions in this dataset. However, since only 
six out of the eight categories are required to be completed to record a HAQ-DI score (Bruce 
& Fries, 2003), the study proceeded with fifteen questions across six categories to calculate an 
amended HAQ-DI score here (see Appendix 7 for amended version of HAQ-DI). Table 28 
and 29 represent the 101 individuals who completed both the amended HAQ-DI questionnaire 
and the ICECAP-O questionnaire to record an overall HAQ-DI score and ICECAP-O 
responses. Table 28 and 29 represent the prediction dataset characteristics which act as a 




Table 28 Age and sex population for prediction dataset 
  Age(years)               
Sex 15-24 25-34 35-44 45-54 55-64 65-74 75-84 85-94 Total 
Male 0 0 0 1 12 25 13 1 54 
Female 0 0 0 2 13 13 13 2 47 
 
Table 29 Distribution of amended HAQ-DI scores in prediction dataset 
HAQ-DI 0.125 0.25 0.375 0.5 0.625 0.75 0.875 1 
% 0.00 0.00 0.99 0.00 1.98 0.99 3.96 3.96 
HAQ-DI 1.125 1.25 1.375 1.5 1.625 1.75 1.875 2 
% 5.94 6.93 4.95 5.94 7.92 10.89 9.90 5.94 
HAQ-DI 2.125 2.25 2.375 2.5 2.625 2.75 2.875 3 
% 5.94 5.94 0.99 3.96 3.96 2.97 3.96 1.98 
 
 
8.3.3.2 Target Measure: ICECAP-O capability questionnaire 
The ICECAP-O capability questionnaire has been explained in detail in Chapter 3 of this 
thesis. In summary, ICECAP-O consists of five attributes of capability well-being: 
attachment, security, role, enjoyment and control (see Appendix 1 for full questionnaire). 
These five attributes responses are valued on the ICECAP-O index, where 1 is equal to full 
capability and zero equal to no capability (Coast et al., 2008a). An important distinction 
between ICECAP-O and the starting measure (HAQ-DI) is that the best score for ICECAP-O 
is at the top of the index (one on a 1-0 scale), whilst the best score for HAQ-DI it is at the 
bottom of the index (zero on a 0-3 scale).  
 
8.3.4 Capability Outcomes 
In Chapter 7, the methodology and types of capability outcomes which could be applied in 




the methods required to generate the capability outcomes from the BRAM model are outlined, 
with a section devoted to each capability outcome. 
 
8.3.4.1 Capability Outcome 1 (CO1): Years of Full Capability (YFC) 
Years of Full Capability (YFC) look to sum capability over time in a similar but not identical 
method as to how QALYs calculate health related quality of life over time. One YFC is equal 
to full capability for a year while a zero YFC score represents no capability for a given year.  
 
The methods of statistical analysis are explained below. This follows a similar approach to 
Chapter 6, which looked at predicting a relationship between WOMAC and ICECAP-O. 
 
The first step in the statistical analysis involved the generation of descriptive statistics for all 
possible dependent and independent variables. Three independent variables (overall HAQ-DI 
score, age, sex) were explored for predictive significance, as all three variables were present 
in the prediction and study (i.e. BRAM11) datasets. Overall ICECAP-O score (continuous 
variable) and ICECAP-O dimensions (categorical variables) were the dependent variables 
considered. Scatter-graphs were used initially to explore the association between ICECAP-O 
scores and each of the potential explanatory variables. Box-plots for each of the five attributes 
of capability well-being were employed to ascertain the relationship between each attribute 





Since this study is the first mapping attempt from HAQ-DI to capability, there was no a priori 
position on which mapping model was the most appropriate. While a number of potential 
model specifications are available (Brazier et al., 2010), due to the summary nature of the 
primary explanatory variable (HAQ-DI), only two regression model specifications were 
considered for further analysis. 
 
8.3.4.1.1 ICECAP-O as a continuous dependent variable  
Ordinary least squares (OLS) regression was the first regression chosen due to the prevalent 
use of this approach in mapping studies (Brazier et al., 2010), particularly for arthritis 
mapping studies (Marra et al., 2011). There have been notable limitations using OLS when 
predicting EQ-5D scores in previous studies, particularly due to ceiling effects (Gray et al., 
2006). However, there were no ceiling effects with the ICECAP-O dataset, as only one person 
recorded the highest capability score achievable. The three explanatory variables consisted of 
two continuous variables (HAQ-DI score, age) and one discrete variable (sex). Stepwise 
regression (as explained in Chapter 6) was used to test the significance of the three 
explanatory variables. Backward elimination stepwise regression was employed here (Draper 
& Smith, 1998).  
 
8.3.4.1.2 ICECAP-O attributes (5) as categorical dependent variables  
There were two regression model options available for use with categorical dependent 
variables: ordinal logistic (OL) or multinomial logistic (ML) regression (detailed explanation 




proportionality between categories, ML regression is employed. Three ML methods 
(expected-utility method; most-likely probability and Monte Carlo simulation, see Chapter 6 
for explanations) were considered if the assumptions necessary for OL regression were 
violated. 
 
8.3.4.1.3 Prediction Measures  
While common measures of goodness of fit of regression models such as R² play an important 
role in showing the explanatory power of a model for the dependent variable, the main 
interest for mapping is in the ability to predict the dependent variable from the explanatory 
variables in the model. Two common measures have been prominently used in mapping 
studies (Brazier et al., 2010): mean absolute error (MAE) and root mean squared error 
(RMSE). All models are tested for these two measures of prediction error, with lower 
prediction error scores indicating a better model for prediction. All models were also tested 
for normality and heteroscedasticity. Analysis was carried out using STATA Version 10.1 and 










8.3.4.1.4 Prediction Specification 
The prediction specifications of YFC in terms of ICECAP-O from BRAM11 are outlined 
below: 
 
(1) Overall ICECAP-O score = f(HAQ-DI score, age, sex) 
The overall HAQ-DI score, age and sex are the independent variables in specification 
1. The ICECAP-O, HAQ-DI and age are entered as continuous variables, while sex is 




(2) Overall ICECAP-O score = f(HAQ-DI score) 
A reduced version of specification 1, with overall HAQ-DI score as the only predictor 
variable. It is noted that (2) is regression 2 in the results section for YFC 
 
(3) Overall ICECAP-O score = f(HAQ-DI score²) 
An alternative to specification two, which is implemented when the residuals of a 
regression are skewed and heteroscedastic. The square number of overall HAQ-DI 
score was chosen after using the “ladder” command in STATA, which produced the 
lowest p-value and highest chi-square for the HAQ-DI variable. It is noted that (3) is 






(4) ICECAP-O dimensions = f(HAQ-DI score, age, sex) 
The five ICECAP-O dimensions are entered as categorical variables. The overall 
HAQ-DI score and age are continuous independent variables. Sex is entered as a 
dummy variable. 
 
(5) ICECAP-O dimensions = f(HAQ-DI score) 
A reduced version of specification 4. The five ICECAP-O dimensions are inserted as 
five categorical dependent variables. Overall HAQ-DI score is the sole predictor 
variable, which is entered as a continuous variable. It is noted that (5) are regressions 
4-6 in the YFC results section with 4 (Expected-Utility), 5 (Most Likely Probability) 
and 6 (Monte Carlo simulation). 
 
Regressions 1-3 prediction errors are estimated through Ordinary Least Squares (OLS), the 
most commonly used regression method for mapping from one instrument to another in health 
economics (Brazier et al., 2010). Regression 4-6 can be estimated using OL or ML regression.  
 
8.3.4.2 Capability Outcome 2 (CO2): Poverty Free Years (capability) (PFY(c)) 
Poverty Free Years (capability), or PFY(c), measures the amount of time an individual is poor 
or not poor in terms of capability well-being. Whether a person is poor or not depends on the 
threshold of sufficient capability (TSC), which was discussed in detail in Chapter 7 and is set 
to a lot of capability on all the ICECAP-O attributes (i.e. 33333) for the remainder of this 




sufficient capability for a given HAQ-DI score, a logit regression is employed. The equation 
for calculating PFY(c) is presented below: 
 
PFY(c) = Pr(TSC=1)                                                                                                             (8.1) 
where Pr(TSC=1) equals the probability of reaching the threshold of sufficient capability 
(TSC) for a given HAQ-DI score. 
 
Other tests on the prediction dataset for PFY(c) included whether different age or sex 
characteristics resulted in differing probabilities of poverty in terms of capability for sub-
groups. 
 
8.3.4.3 Capability Outcome 3 (CO3): Insufficient Capability Score (ICS)  
Insufficient Capability Score (ICS) is determined by the shortfalls of sufficient capability (if 
any) for an individual at a given time point. Years of Insufficient Capability (YIC) is the 
method of summing the opposite of sufficient capability score (SCS) over time so that 
shortfalls in sufficient capability are accounted for. The SCS, ICS and YIC have been 
explained in detail in Chapter 7. 
 
The calculation of the inverse of the sufficient capability score is explored using a number of 
regression options. The first regression option tested is simple OLS, calculating ICS for a 




approach, commonly used in cost-based regression models (Manning et al., 1981; Liu et al., 
2010; Winkelmann, 2012) which has also been gaining popularity in mapping studies recently 
(Chuang & Kind, 2009; Dakin et al., 2010; Dakin et al., 2013b). There are likely to be a high 
proportion of individuals who reach the threshold of sufficient capability (TSC), so in a 
similar way that a high proportion of patients record zero costs, the two-part model approach 
appears appropriate for generating those who record shortfalls in sufficient capability.  
 
The first part of the two part model assesses the probability of sufficient capability for a given 
HAQ-DI score, using a logit regression. This is equivalent to the probability regression 
employed for capability outcome PFY(c), which was described in Section 8.3.4.2. The second 
part of the model assesses the shortfall of sufficient capability for a given HAQ-DI score if 
the threshold of sufficient capability (TSC) has not been achieved. The values attached to the 
shortfalls in sufficient capability for ICECAP-O at the TSC of 33333 are presented in the 
previous chapter (see Chapter 7, Table 12). The algorithm used to calculate ICS for any of the 
25 potential HAQ-DI scores, is presented below: 
 
ICS = 1-[Pr(TSC = 1) + (1 – Pr(TSC =1))IC ]                                                                      (8.2) 
where IC is the predicted ICS, conditional on falling below the threshold of sufficient 





8.3.4.4 Capability Outcome 4 (CO4): Sufficient Capability Score (SCS)  
The sufficient capability score (SCS) is the conceptual opposite of the ICS, so that the index 
of 0-1 for SCS means that a score of 1 is equal to sufficient capability. A score of one for a 
full year is equal to 1 year of sufficient capability (YSC). Further elaboration of both methods 
can be found in Chapter 7. 
 
Like ICS, two types of regression models are tested for SCS. Firstly by calculating the 
relationship between SCS and HAQ-DI, and secondly through a two-part model. In the 
second approach, SCS is calculated by adding the probability of those who reached sufficient 
capability for a given HAQ-DI score, to those who are not capability sufficient multiplied by 
their SCS, which is less than 1. For those who have not reached the threshold of sufficient 
capability (TSC), their SCS is the opposite of ICS (i.e.1 minus their ICS score). The algorithm 
for calculating SCS is presented below, and is presented graphically in Figure 17: 
SCS = Pr(TSC=1)×1 + Pr(TSC=0)×(1-ICS)                                                                       (8.3) 












Part I + 






8.4.1 Descriptive Statistics 
Table 30 presents the demographics of the patient population. Six patients did not fully 
complete either the ICECAP-O or the amended HAQ-DI, so were excluded from further 
analysis. The mean ICECAP-O score for the remaining 101 patients was 0.779. The mean 
amended HAQ-DI score was 1.773. The 101 respondents had a mean age of 69.94 years.  
 
Table 30 Descriptive Statistics for Prediction Dataset 
  N Mean 
Standard 
Deviation Min Max 
Sample size  107   
  Missing data 6(excluded below)   
  Males  54   
  Employed 13   
  Living Alone 27   
  Age (mean) 101 69.941 8.812 
48.819 89.164 
HAQ-DI  101  1.774 0.598 0.375 3 
ICECAP-O 101 0.779 0.162 0.159 1 
↓ Capability Level 1 2 3 4 




2 9 36 54 
Security 
 
10 28 48 15 
Role  
 
5 37 46 13 
Enjoyment 
 
10 34 46 11 
Control   4 27 44 26 
N, population numbers; Min, Minimum; Max, Maximum 
 
Figure 18 shows the relationship between ICECAP-O and HAQ-DI and indicates a clear 
skewness towards higher ICECAP-O scores. This was an early indication that variable 




reported a level of capability above 0.5 on ICECAP-O, irrespective of HAQ-DI score. 
Notwithstanding this, those who reported better physical function on HAQ-DI (i.e. less than 
1), they also reported high capability (greater than 0.6 in all instances).  
 
Figure 18 Relationship between ICECAP-O and HAQ-DI 
 
 
8.4.2 Capability Outcome (1): Years of Full Capability 
In total, six models predicted ICECAP-O scores or dimensions. Three models (Models 1-3) 
predicted overall ICECAP-O scores as a continuous variable through OLS regression. 
Regression 1 considered HAQ-DI score, age and sex as explanatory variables of overall 
ICECAP-O scores. Stepwise regression eliminated both age and sex as non-significant 
predictors of capability in this sample. The reduced equation of HAQ-DI as the sole predictor 
of ICECAP-O is illustrated in Regression 2. Model specification tests showed that Regression 
2 has residuals which produced non-normally distributed and heteroscedastic data. Data 
transformation was required to address these issues, which were corrected for in Regression 3, 



















Regressions 4-6 explored ICECAP-O attributes as dependent variables. The assumption of 
proportional odds between categorical levels did not hold for ICECAP-O dimensions using 
the Wald test, so OL regression was not used here. Instead, the three methods of ML 
regression (Expected Utility Method – Regression model 4, Most-Likely Probability – 
Regression model 5, Monte Carlo Simulation – Regression model 6) were analysed for their 
ability to predict ICECAP-O categories with HAQ-DI as the sole explanatory variable. 
 
Table 31 presents the predictive statistics for the six regression models. All regressions 
recorded predicted ICECAP-O scores equal to or above the observed ICECAP-O scores, 
which is likely to be due to the negatively skewed ICECAP-O data. Regression 6 (Monte 
Carlo simulation) predicted the highest observed capability score (i.e. 44444 or ICECAP-O 
score = 1) at the individual level, while Regression 4 is most distant from this value with its 
high score at 0.889. Regression 6 also produced the lowest ICECAP-O score achievable at the 
individual level (i.e. 11111 or 0.000), while the remaining models’ minimums were all greater 
than 0.55. Regressions 1, 2 and 3 have predicted ICECAP-O scores closest to the observed 
mean. 
 





ICECAP-O Min  Max 
Abs. 
Diff. MAE (SE) RMSE R² 
1 101 0.779 0.779 0.594 0.963 0.000 0.102(0.093) 0.138 0.262 
2 101 0.779 0.779 0.614 0.968 0.000 0.101(0.096) 0.139 0.248 
3 101 0.779 0.779 0.572 0.906 0.000 0.099(0.097) 0.138 0.262 
4 101 0.779 0.786 0.586 0.889 0.007 0.097(0.099) 0.138 0.266 
5 101 0.779 0.829 0.574 0.914 0.030 0.101(0.115) 0.153 0.218 
6 101*1000 0.779 0.788 0 1 0.009 0.097(0.099) 0.138 0.262 
S.D., standard deviation; RMSE, root mean squared error; MAE, mean absolute error; Abs Diff, absolute difference between 




In this study, the primary interest is in the predictive ability of ICECAP-O from HAQ-DI. All 
three of the OLS regressions (Regressions 1-3) produce similar predicted average ICECAP-O 
scores to the observed sample, with the ML regressions (Regressions 4-6) reporting averages 
higher than the mean (0.007-0.030). Regression 3 (HAQ-DI² predicting overall ICECAP-O 
score) produced the lowest MAE statistics for the OLS regressions (Regression 1-3) with 
MAE = 0.099. Two of the multinomial models (Regression 4, Expected Utility; Regression 6, 
Monte Carlo simulation) produced slightly lower MAE of 0.097 each, but this lower error is 
negated in the RMSE statistics with Regressions 3, 4 and 6 recording 0.138. Given that the 
main concern is generating overall ICECAP-O scores for YFC, the simplest method with 
lowest computational difficulty is Model 3, which is the prediction of ICECAP-O from 
HAQ-DI². Although Model 4 and Model 6 produce lower MAE, the difference from average 
observed to predicted ICECAP-O score is greater than the averages from the OLS regressions. 
Table 32 gives the regression required to predict the ICECAP-O from the amended HAQ-DI 
used in this study. 
Table 32 Predicting the ICECAP-O from the amended HAQ-DI: Mapping Model 
Variable Coefficient 
Standard 
error t P>|t| 
95% Confidence 
Interval 
HAQ-DI² -0.0376 0.006 -5.94 0.000 [-0.0502,-0.0250] 
Constant 0.9108 0.026 34.83 0.000 [0.8589,0.9627] 
 
The prediction of Years of Full Capability (YFC) from Regression 3 is outlined in Table 330. 
Table 33 Predicted Years of Full Capability for given HAQ-DI score 
HAQ-DI 0 0.125 0.25 0.375 0.5 0.625 0.75 0.875   
YFC 0.9108 0.9102 0.9084 0.9055 0.9014 0.8961 0.8896 0.8820 
 HAQ-DI 1 1.125 1.25 1.375 1.5 1.625 1.75 1.875 
 YFC 0.8732 0.8632 0.8520 0.8397 0.8262 0.8115 0.7957 0.7786 
 HAQ-DI 2 2.125 2.25 2.375 2.5 2.625 2.75 2.875 3 
YFC 0.7604 0.7410 0.7205 0.6987 0.6758 0.6518 0.6265 0.6001 0.5725 




8.4.3 Capability Outcome (2): Poverty Free Years (capability) (PFY(c)) 
Whilst the mapping work in Chapter 6 and the mapping for YFC showed that there was little 
predictive relationship between sex and overall ICECAP-O score, a different finding occurred 
when predicting PFY(c). Table 34 below shows that males appear more likely to reach 
sufficient capability than females in this dataset, when the threshold of sufficient capability 
(TSC) is set to a lot of capability on all attributes (i.e. 33333). The difference between the 
sexes is statistically different using the chi-square test (p = 0.01927).  
 
Table 34 Capability poverty statistics in Tayside joint replacement cohort 
  Female Male Total 
  Capability Poor 35 28 63 
  Sufficient Capability 12 26 38 
  Total 47 54 101 
   
The finding presented in Table 34 led to two potential methods for predicting PFY(c). One 
option, applying the two part model, is to express the probability of having sufficient 
capability for the whole population, while the second possibility is to separate the probability 
of sufficient capability for males and females, which may take account of the differences 
observed in Table 34 more accurately. The probabilities for each scenario are presented in 
Table 35. All three predictions are carried out by applying logistic regression to predict a 
binary outcome (poor or not poor in terms of sufficient capability). 
 
Table 35 records an unintuitive result for a HAQ-DI score of 2.25 when broken down by sex. 
For every other HAQ-DI score, either male or female categories are above or below the 




to have reached TSC at the best HAQ-DI score (0) than males, they are more likely to have 
reached TSC at the worst HAQ-DI score. Given these ambiguities with the sex statistics, the 
decision was made to only employ overall probabilities of reaching the threshold of sufficient 
capability (TSC). The prediction of PFY(c) from HAQ-DI scores can thus be seen in Column 
2 of Table 35.  
 
Table 35 Probability that individual has reached threshold of sufficient 
capability (TSC) given their HAQ-DI score for all, males and females 
HAQ-DI Pr(TSC)-ALL Pr(TSC)-Male Pr(TSC)-Female 
0 0.9470 0.9828 0.8073 
0.125 0.9330 0.9765 0.7791 
0.25 0.9155 0.9681 0.7480 
0.375 0.8941 0.9567 0.7141 
0.5 0.8680 0.9415 0.6776 
0.625 0.8367 0.9213 0.6389 
0.75 0.7996 0.8951 0.5982 
0.875 0.7565 0.8639 0.5562 
1 0.7076 0.8190 0.5133 
1.125 0.6533 0.7673 0.4702 
1.25 0.5948 0.7060 0.4276 
1.375 0.5334 0.6362 0.3860 
1.5 0.4710 0.5602 0.3461 
1.625 0.4095 0.4813 0.3081 
1.75 0.3507 0.4033 0.2726 
1.875 0.2961 0.3298 0.2398 
2 0.2467 0.2639 0.2098 
2.125 0.2033 0.2070 0.1826 
2.25 0.1658 0.1598 0.1583 
2.375 0.1340 0.1217 0.1366 
2.5 0.1076 0.0916 0.1176 
2.625 0.0858 0.0685 0.1008 
2.75 0.0681 0.0508 0.0862 
2.875 0.0539 0.0375 0.0736 
3 0.0425 0.0276 0.0626 
Pr(TSC), probability for reaching threshold of sufficient capability for whole sample; ALL, all population; Male, for men 





8.4.3 Capability Outcome (3): Years of Insufficient Capability (YIC)  
To calculate Years of Insufficient Capability (YIC), the inverse of the sufficient capability 
score is required. The insufficient capability score (ICS) is composed of the individuals who 
are classified as poor in the Tayside cohort from Table 34 (i.e. individuals who have not 
reached sufficient capability). As can be seen from Table 34, 63 of the 101 individuals do not 
reach the threshold of sufficient capability (TSC). The sixty three people who exhibit 
shortfalls in sufficient capability are the focus of analysis when generating the insufficient 
capability score (ICS). 
 
An OLS regression with ICS predicted from HAQ-DI, resulted in ICS scores below zero for 
some HAQ-DI scores. Therefore, two-part models are a more appropriate way of calculating 
ICS from a measure of physical function, such as HAQ-DI. Part 1 of the model is the same 
calculation used to generate PFY(c) in section 8.4.2. However, even when the zeros were 
excluded from the second part of the two part model, HAQ-DI scores still predicted ICS 
scores lower than zero. Given the limitations of HAQ-DI on its own, the prediction of ICS 
based on HAQ-DI², similar to the YFC calculation in the previous section, is tested and 
produced algorithm 8.4 below, which is used to predict ICS in the BRAM model. The formula 
for calculating ICS from this dataset is presented in equation 8.4. 
 
ICS = 0.0964+0.0289(HAQ-DI²)                                                                            (8.4) 
 
Algorithm 8.4 resulted in acceptable distribution of ICS scores based on HAQ-DI (0.0964-




conditional on the probability that an individual did not reach TSC for each given HAQ-DI 
score (i.e. the opposite probability exhibited in column 2, Table 35). The HAQ-DI scores 
predictions of ICS for this population are outlined in Table 36: 
 
Table 36 Predicted Insufficient Capability Score for given HAQ-DI score 
 HAQ-DI 0 0.125 0.25 0.375 0.5 0.625 0.75 0.875   
ICS 0.0051 0.0065 0.0083 0.0106 0.0137 0.0176 0.0226 0.0289 
 HAQ-DI 1 1.125 1.25 1.375 1.5 1.625 1.75 1.875 
 ICS 0.0366 0.0461 0.0574 0.0705 0.0854 0.1020 0.1201 0.1394 
 HAQ-DI 2 2.125 2.25 2.375 2.5 2.625 2.75 2.875 3 
ICS 0.1597 0.1808 0.2025 0.2246 0.2472 0.2701 0.2935 0.3172 0.3413 
ICS, Insufficient Capability Score 
 
8.4.4 Capability Outcome (4): Years of Sufficient Capability (YSC) 
It has already been explained in the last section, that the two-part model is appropriate for 
capability outcomes with a high proportion of individuals reaching the optimum point, in this 
scenario, the threshold of sufficient capability (TSC). The sufficient capability score (SCS) is 
used to calculate Years of Sufficient Capability (YSC) for the opposite calculation of ICS 
from Table 36. SCS for a given HAQ-DI can be calculated from Table 37 below. While Table 
37 is the direct opposite of Table 36, it is presented here for clarity to show how the SCS is 
calculated in comparison. 
 
Table 37 Predicted Sufficient Capability Score for given HAQ-DI score 
HAQ-DI 0 0.125 0.25 0.375 0.5 0.625 0.75 0.875   
SCS 0.9949 0.9935 0.9917 0.9894 0.9863 0.9824 0.9774 0.9711 
 HAQ-DI 1 1.125 1.25 1.375 1.5 1.625 1.75 1.875 
 SCS 0.9634 0.9539 0.9426 0.9295 0.9146 0.8980 0.8799 0.8606 
 HAQ-DI 2 2.125 2.25 2.375 2.5 2.625 2.75 2.875 3 
SCS 0.8403 0.8192 0.7975 0.7754 0.7528 0.7299 0.7065 0.6828 0.6587 





The primary aim of this chapter was to detail the methods for generating capability outcomes 
from an existing economic model which has been used to aid health decision-making, the 
BRAM. The methods for generating four capability outcomes from the relationship between a 
questionnaire of physical function (the amended HAQ-DI) and a questionnaire of capability 
well-being (ICECAP-O) has been outlined. The production of each of the four capability 
outcomes is discussed individually below.  
 
8.5.1 Capability Outcome (1): Years of Full Capability (YFC) 
In this study, the ability of econometric regression models to predict capability well-being in 
terms of ICECAP-O to generate Years of Full Capability (YFC) from a physical function 
questionnaire (HAQ-DI) for arthritis patients has been investigated. This is the second attempt 
to use a mapping approach with the capability wellbeing measure. Results from Chapter 6 
suggest that the majority of the ICECAP-O attributes can be captured by a measure of 
physical function. Six models are tested for predictive ability. The regression chosen was the 
transformed version of HAQ-DI² as the predictor of ICECAP-O scores (i.e. Regression 3 in 
Table 31). Regression 3 produced minimal difference from observed to predicted ICECAP-O 
average scores, as well as the equally lowest RMSE. 
 
This is the first attempt to generate capability outcomes in terms of YFC, which can be 
subsequently applied to economic models to test the change in overall capability well-being 




error prediction statistics. In a similar manner to health economics mapping work (Brazier et 
al., 2010), the method with the lowest complexity in application is chosen. 
 
There are a number of limitations associated with this research. The HAQ-DI scores were 
inferred from physical function questions in the form of the WOMAC (0-4), so a rescaling 
exercise was required to fit questions to the HAQ-DI 0-3 scale (see Appendix 7). The sample 
size of 101 individuals is small compared to previous mapping studies using the response 
mapping approach (Gray et al., 2006; Rivero-Arias et al., 2010), so 1000 Monte Carlo 
simulations were required in order to reach equivalent sample sizes. However, there are 
mapping studies with smaller sample sizes (Brazier et al., 2010) and for an exploratory study 
such as this in a novel area of research, the data are sufficient to provide interesting results.  
 
There was also a limitation with the type of sample, which was comprised of patients awaiting 
joint replacement and this meant that individuals were not evenly distributed across HAQ-DI 
scores, unlike in previous mapping studies using the HAQ-DI (Barton et al., 2004a). 
However, the distribution of HAQ-DI in this prediction dataset is comparable with the patient 
input into BRAM11 (see Table 27 and 29). Finally, validation of mapping models usually 
takes place in an external dataset as well as the prediction dataset, but lack of data restricted 
analysis to internal validation here. 
 
This research looked at all potential mapping algorithms which have been used in previous 




approach has produced lower predictive errors than the response mapping approach and OLS 
predictions (Le & Doctor, 2011). Due to the way in which HAQ-DI was calculated here, it 
could not be fully broken down for dimension-specific analysis. Therefore this new approach 
to mapping could not be tested here. Future studies with such detailed variables should look at 
applying this Bayesian approach in statistical analysis.  
 
8.5.2 Capability Outcome (2): Poverty Free Years (capability) (PFY(c)) 
To predict PFY(c) in this study from HAQ-DI, logistic regressions are applied to test the 
probability of poverty, given a threshold of sufficient capability (TSC). A calculation of sex 
and HAQ-DI, and HAQ-DI solely are used to predict the probability of reaching TSC. There 
was a significant difference in the ability of different sexes to reach the TSC, with men more 
likely to reach TSC than women. However, the HAQ-DI variable was the only variable used 
to predict PFY(c) due to the unreliability of splitting an already small sample size in two. 
 
The generation of PFY(c) from a measure of physical function allows for a new type of 
capability outcome to be generated from economic decision models that have never been used 
before. The major strength of this research is that it allows the further exploration of 
capability outcomes such as PFY(c) in decision models which can then be used as a simplistic 
capability outcome to aid decision-makers. 
 
There are a number of limitations associated with the methodology employed to generate 




version of HAQ-DI. Therefore, the transferability of this mapping algorithm to other studies 
is questionable. However, given the time constraints and the data available for this study, this 
was the best option available for this research. 
 
This study shows how the capability outcome PFY(c) can be generated from a measure of 
physical function using a two-part model. For policy makers interested in exploring broader 
benefits of interventions, PFY(c) offers the most straightforward methodology drawn from 
multidimensional poverty methodology, explored in Chapter 7, to generate capability 
outcomes. However, it should be noted that such a simplistic method can also be a misleading 
tool in evaluating improvements in social welfare. The problems around the PFY(c) 
methodology have already been discussed in detail in Chapter 7.  
 
While this study found that differences exist between the sexes for reaching the threshold of 
sufficient capability (TSC), the dataset applied here was not large enough to include such a 
factor in the generation of PFY(c). Previous research on representative samples of the elderly 
population in the UK have shown little difference in capability well-being overall for sex 
(Coast et al., 2008a; Flynn et al., 2011). However, when attention switches towards a TSC, 
there are indications that sex may play an important role in defining whether an individual has 
sufficient capability, when the TSC is set to a lot of capability on all the ICECAP-O 
attributes. Comparing TSC achieved with the valuation dataset used for ICECAP-O (Coast et 
al., 2008a), it does not appear to be limited to a specific condition, as can be seen in Table 38. 




Table 38 Sufficient Capability among ICECAP-O valuation sample of UK elderly 
population (Coast et al., 2008a) 
  Females Males  Total 
Capability Poor 111 76 187 
Sufficient Capability 66 60 126 
Total 177 136 313 
 
8.5.3 Capability Outcome (3): Years of Insufficient Capability (YIC) 
To predict ICS from HAQ-DI scores to generate Years of Insufficient Capability (YIC), two 
econometric regression models were considered – OLS and a two-part model. When using 
HAQ-DI alone to predict ICS led to answers outside the 0-1 index of the measure. 
Conversely, introducing a two part model by itself was not adequate to produce ICS scores 
within the 0-1 index. Similarly to the generation of YFC as discussed in Section 8.5.1, 
HAQ-DI required transformation so that only values of ICS between 0 and 1 are recorded.  
 
This is the first attempt to incorporate the most complex multidimensional poverty 
methodology into an outcome which can be used by decision-makers for resource allocation. 
This research will permit the exploration of this capability outcome in particular, to help 
evaluate between interventions, with the aim of minimising shortfalls of sufficient capability. 
 
As with all of the capability outcomes examined here, there are a number of limitations 
associated with the ICS calculation. Overall HAQ-DI scores are from an amended version, so 
that outcomes can be generated from BRAM11. It is not recommended to use the mapping 
algorithm applied here if actual HAQ-DI and ICECAP-O data can be generated in the same 




The ICS capability aggregation method allows for the assessment of population shortfalls in 
sufficient capability over time with Years of Insufficient Capability (YIC). Chapter 6 showed 
that such outcomes which account for broader definitions of well-being can be generated from 
measures of physical function. However, it is still recommended that primary collection of 
ICECAP and other capability questionnaires are likely to give a more accurate indication of 
capability well-being within different population groups. 
 
An unexpected finding from this analysis was the requirement for retransformation of 
HAQ-DI in the two-part model to generate ICS scores for those individuals whose ICS was 
greater than zero. Future research should focus on whether this is due to the severity (or lack 
thereof) of the shortfalls in sufficient capability for this arthritis dataset. If more severe losses 
of sufficient capability are encountered, the need for re-transformation may not be necessary 
 
8.5.4 Capability Outcome (4): Years of Sufficient Capability (YSC) 
Finally, in this chapter it is shown how to generate the sufficient capability score (SCS) 
through mapping. SCS is the opposite of ICS, such that the aim is to maximise levels of 
sufficient capability. Reversing the ICS into SCS allows for a closer comparison with 
traditional economic outcomes from health economic evaluations such as the QALY, as well 
as implementing the most complex methods of multidimensional poverty measures into a 
capability outcome that can be used to measure changes in sufficient capability over time (i.e., 




8.6 CONCLUDING THOUGHTS 
This chapter has documented methods of generating capability outcomes from a measure of 
physical function. This will allow the generation of capability outcomes which can be used in 
an evaluation framework. It also enables the exploration of the feasibility of considering each 
of these outcomes in an economic evaluation (or decision-making context). This is explored 




CHAPTER 9. GENERATING CAPABILITY OUTCOMES FROM THE 
BIRMINGHAM RHEUMATOID ARTHRITIS MODEL: RESULTS 
 
9.1 INTRODUCTION 
In Chapter 8, the methodology for generating capability outcomes from the Birmingham 
Rheumatoid Arthritis Model 2011 version (BRAM11) (Malottki et al., 2011) is outlined. This 
chapter presents the results of the case study, investigating the feasibility of generating 
capability outcomes from an existing evaluation framework. 
 
As explained in the previous chapter, the BRAM model was chosen after a case study 
selection process. While four versions of the BRAM have been produced over the last decade 
(Jobanputra et al., 2002; Clark et al., 2004; Chen et al., 2006; Malottki et al., 2011), the most 
recent BRAM version (i.e. BRAM11) has been chosen to compare capability outcomes to 
previous cost-effectiveness results. The results from BRAM11 used for aiding cost-
effectiveness for rheumatoid arthritis patients by NICE are summarised in Section 9.2. 
 
To distinguish the work undertaken previously in BRAM11 to that produced using capability 
outcomes here, BRAM12 will refer to the modifications made to BRAM11 in order to 
generate new capability outcomes. The 12 in BRAM12 stands for 2012, when the majority of 
this part of research was carried out. While the methodology for generating capability 
outcomes is accounted for in the previous chapter, particular changes from BRAM11 to 




results of the four capability outcomes from BRAM12. The four capability outcomes are: 
Years of Full Capability (YFC), Poverty Free Years (capability) – PFY(c), Years of 
Insufficient Capability (YIC), and Years of Sufficient Capability (YSC). Each of the 
capability outcome results are discussed in turn in section 9.5 before comparing the results in 
a case study discussion in section 9.6.  
 
9.2 MODEL SPECIFICATION 
The work in BRAM11 was carried out independently by researchers prior to this. It is 
presented as work that was previously completed but its inclusion in the thesis is required to 
give a fuller understanding of the case study specification presented in section 9.3.  
 
9.2.1 BRAM11 – Modelling Benefits 
The most recent Birmingham Rheumatoid Arthritis Model (BRAM11) evaluated the cost-
effectiveness of adalimumab (ADA), etanercept (ETN), infliximab (IFX), rituximab (RTX) 
and abatacept (ABT) following the failure of a first tumour necrosis factor (TNF) inhibitor for 
rheumatoid arthritis patients. Differences in cost-effectiveness in the individual sampling 
model are compared by measuring the differences in costs and QALYs for the interventions 
(Malottki et al., 2011). 
 
Quality of life (QoL) scores in BRAM11 are calculated by obtaining an Ordinary Least 
Squares (OLS) quadratic equation between the Health Assessment Questionnaire – Disability 




questionnaires was predicted from a dataset where both questionnaires were collected 
simultaneously (Hurst et al., 1997). The algorithm applied to predict Quality of Life (QoL) in 
BRAM11 is presented in algorithm 9.1 below: 
 
QoL = 0.804 – 0.203 x HAQ-DI – 0.045 x HAQ-DI²                                                      (9.1) 
 
From the above algorithm, QoL represents the dependent variable, which in this scenario is 
the EQ-5D global index score, where individual preferences are scaled to a 0-1 death to full 
health index (Dolan, 1997). The parameters represent the ability of HAQ-DI and HAQ-DI² to 
predict EQ-5D. The constants are mean numbers around this relationship, which are allowed 
to vary around the 95% confidence interval for each parameter respectively in BRAM11. 
BRAM11 was the first BRAM version to use a quadratic equation. This was appropriate as 
Probabilistic Sensitivity Analysis (PSA) was carried out in BRAM11 for the first time, and so 
the outcomes required a Bayesian approach to handling uncertainty. Previous BRAM models 
have relied on a linear relationship between EQ-5D and HAQ-DI only (Barton, 2011). 
 
The BRAM models are known as individual sampling models. For each individual (virtual) 
drug treatment pathway, there is an underlying pattern that the patient is assumed to follow 
based on clinical guidance. Each individual starts and spends time on a treatment, before 
quitting treatment for reasons of loss of effectiveness or toxicity. When a treatment is stopped, 
the following treatment begins and this cycle continues until no remaining treatments are 




in the model. A fixed improvement on starting a treatment is assumed, which is lost when that 
treatment ceases. HAQ-DI declines over time to reflect the likelihood of frailty with age. This 
is modelled as an increase in HAQ-DI of 0.125 every 2.7 years for all treatments except for 
palliation, where HAQ-DI increases occur every 2 years (Barton, 2011). 
 
The starting population for BRAM11 are those who have already failed their first TNF 
inhibitor. Six treatment sequences are compared in BRAM11. Five interventions - ADA, 
ETN, IFX, RTX and ABT – as alternative treatment commencing a sequence following the 
failure of the first TNF inhibitor, and a sixth sequence starting with a conventional disease 
modifying anti-rheumatic drug (DMARD), leflunomide (LEF). In the first five sequences, 
LEF is the second therapy after the first drug has failed for each respective sequence.  
 
For each new treatment, a random number is drawn for each individual, which measures the 
improvement in terms of HAQ-DI, using an appropriate distribution. Another random number 
is drawn simultaneously to measure the length of time on treatment for each drug (Malottki et 
al., 2011). Qol is combined with time on treatment to generate Quality Adjusted Life Years 







9.2.2 BRAM11 – Modelling Costs 
Costs for each treatment include the cost of the drugs themselves, as well as additional costs 
relating to the administration and other costs involved with the consumption of each 
treatment. Costs were calculated for the year 2008. Costs are discounted at 3.5% per annum as 
recommended by NICE (NICE, 2008).  
 
9.2.3 BRAM11 Results 
BRAM11 is run using a fixed random number seed for at least 10,000 virtual patients. The 
Incremental Cost Effectiveness Ratio (ICER) is the method used to compare the costs and 
effects of the different sequences. The threshold of willingness to pay for an additional QALY 
is £20,000-£30,000, where interventions are expected to be below for approval within the UK, 
as recommended by NICE (NICE, 2013).  
 
Quasi-confidence intervals are employed for ICERs, representing sampling uncertainty for 
each model run and not parameter uncertainty. Fixed stopping rules for Quasi-confidence 
intervals are used to ascertain acceptable levels of uncertainty around the ICERs for 
individuals sampled for each sequence (as practiced in BRAM04 and BRAM06). The first 
rule entailed that when one treatment dominated another, quasi-confidence intervals for cost 
and QALYs were required to avoid zero. Decision stopping rule two was employed in 
scenarios where no strict dominance occurred and a quasi-confidence interval [lower (L), 
upper (U)] ratio for the ICER had to fall below the following ratios before sampling was 





U < 5,000  or L > 200,000:  U/L < 2.5 
U < 10,000  or L > 100,000:  U/L < 2.0 
U < 20,000  or L > 50,000:  U/L < 1.5 
U < 30,000  or L > 30,000:  U/L < 1.2 
L < 30,000  or U > 30,000:  U/L < 1.1  
For example, a cost per QALY gain of £25,000 would require confidence intervals 
(£22,750,£27,250) or narrower to meet the 1.2 lower to upper ratio for ICERs less than 
£30,000 (i.e. £27250/£22,750 = 1.2). 
 
Table 39 presents the baseline cost and QALYs for the six treatment sequences from 
BRAM11 if a deterministic analysis, rather than a PSA had been run. RTX has the lowest 
ICER compared with standard treatment (LEF) and dominates three of the other four 
sequences (ETN, IFX and ADA). The cost per additional QALY of ABT over RTX is over 
£100,000, considerably higher than the current guidance.  
 
Table 39 BRAM11 deterministic results  










ABT vs. RTX 
Option 1 ETN etanercept 75,100 2.80 38,900 Yes- RTX 
 Option 2 IFX infliximab 73,000 2.80 36,100 Yes- RTX 
 Option 3 ADA adalimumab 74,800 2.89 34,300 Yes- RTX 
 Option 4 RTX rituximab 69,400 3.10 21,100 No 
 Option 5 ABT abatacept 93,000 3.28 38,400 No >100,000 
Option 6 LEF leflunomide 49,000 2.13       
ETN, etanercept; IFX, infliximab; ADA, adalimumab; RTX, rituximab; ABT, abatacept; LEF, leflunomide; QALYs, Quality Adjusted Life 





In BRAM12 the majority of the features from BRAM11 are preserved. Costs and discount 
rates remained unchanged. The only change for BRAM12 is the measurement of benefit for 
each model run. The methods for generating the benefit in BRAM12 (i.e. capability 
outcomes) were explained in detail in the previous chapter. 
 
The method of combining costs and effects is also the same in BRAM12 as BRAM11 as they 
are compared between different drug treatment sequences using ICERs. Since this is the first 
attempt to combine capability with costs over time, there is no accepted willingness to pay per 
unit of capability improvement a priori as there is for QALYs. Therefore the model run 
stopping rules for number of patients to run through BRAM12 need to be very precise in 
terms of the confidence interval ratio between upper and lower levels of ICERs. All capability 
outcomes are required to reach the upper to lower ratio of 1.2 before enough patients are 
deemed to have run through the model for additional confidence, given that there is no 
established decision rule for capability outcomes (e.g. WTP per QALY gain threshold of 
£20,000-£30,000 in UK). Costs and capability outcomes are discounted at a rate of 3.5% per 
annum. 
 
The results for four capability outcomes are presented in the next section. They are Years of 
Full Capability (YFC); Poverty Free Years (capability) – PFY(c); Years of Insufficient 
Capability (YIC); Years of Sufficient Capability (YSC). Methods for generating each 
outcome were detailed in the previous chapter. This chapter is not reported as an economic 
evaluation, as the motivation of this research was the feasibility of generating capability 




evaluation meets standard economic evaluation guidance (Husereau et al., 2013) is reported in 
Appendix 8. 
 
The final sub-section of the results in this chapter present the differences in outcome between 
BRAM11 and BRAM12, which looks at the range between most effective and least effective 
intervention, as well as the ordering of sequences in terms of most to least effective. From the 
BRAM11 deterministic results in Table 39, the difference is 1.15 QALYs gained by ABT 
compared to LEF. Additionally the lowest cost per additional unit of outcome gained 
compared with standard treatment is also analysed. In BRAM11 the cost per QALY gained of 
RTX over LEF was £21,100. 
 
9.4 RESULTS 
9.4.1 Capability Outcome (1): Years of Full Capability (YFC) 
YFC is the measurement of capability over time based on the original ICECAP-O valuation 
index of 0-1 no capability to full capability (Coast et al., 2008a). Table 40 below presents the 
findings from the first run of BRAM12. The stopping rule criteria of the 1.2 ratio from upper 
to lower confidence intervals resulted in 100,000 patients through this model run and 250,000 
patients for the ICER for rituximab (RTX) compared with abatacept (ABT). 
 
The treatment with highest YFC gained is abatacept (ABT) with 9.91 YFC compared with 




gains is 0.56 YFC. RTX compared with LEF produced the lowest cost per additional YFC of 
approximately £40,200. 
 
Table 40 Years of Full Capability (YFC) & ICER (100,000 patients) 
Option Cost (£) QSE   YFC QSE   
1. ETN 75293 126 
 
9.70 0.0139 
 2. IFX 73266 118 
 
9.70 0.0139 
 3. ADA 74825 125 
 
9.73 0.0139 
 4. RTX 69472 116 
 
9.86 0.0143 
 5. ABT 92932 161 
 
9.91 0.0141 




       Option ICERvsLEF (£) Quasi-CI [L-U] ICERvsRTX (£) Quasi-CI [L-U] 
1. ETN 76700 70000 82400 
   2. IFX 69500 64300 75600 
   3. ADA 68100 63300 73600 
   4. RTX 40200 38000 42700 
   5. ABT 78500 74600 82700 471000* 343000 752000 
ETN, etanercept; IFX, infliximab; ADA, adalimumab; RTX, rituximab; ABT, abatacept; LEF, leflunomide; YFC, Years of Full 
Capability; ICER, Incremental Cost-Effectiveness Ratio; QSE. Quasi Standard Error. 
*250,000 patient simulations were required to get the confidence level ratio below 2.5 
 
 
9.4.2 Capability Outcome (2): Poverty Free Years (capability) (PFY(c)) 
PFY(c) is the measurement of the probability of freedom from sufficient capability poverty 
over time. Whether an individual is classified as free from capability poverty or capability 
poor is dependent on the threshold of sufficient capability (TSC) – the capability poverty line, 
which is set to a lot of capability on the ICECAP-O attributes (i.e., 33333).  
 
Table 41 presents the PFY(c) for the second running of BRAM12. 40,000 patients were 




it can be seen that ABT produces the highest number of PFY(c) at 4.75 years. Leflunomide 
has the lowest number of poverty free years at 3.72. The distance between most and least 
effective is 1.03 years. RTX compared with LEF produced the lowest cost per additional 
poverty free year of approximately £24,400. 
Table 41 Poverty Free Years (capability) - PFY(c) & ICER (40,000 patients) 
Option Cost (£) QSE PFY(c) QSE   
1. ETN 75271 199 4.29 0.0167 
 2. IFX 73126 186 4.30 0.0167 
 3. ADA 75074 197 4.42 0.0168 
 4. RTX 69336 183 4.55 0.0184 
 5. ABT 92892 255 4.75 0.0179 
 6. LEF 49106 124 3.72 0.0153 
 
       Option ICERvsLEF (£) Quasi-CI [L-U] ICERvsRTX (£) Quasi-CI [L-U] 
1. ETN 45900 43200 49000 
   2. IFX 41500 39100 44300 
   3. ADA 37200 35400 39300 
   4. RTX 24400 23300 25700 
   5. ABT 42400 40900 44000 115000 95800 143000 
ETN, etanercept; IFX, infliximab; ADA, adalimumab; RTX, rituximab; ABT, abatacept; LEF, leflunomide; PFY(c), Poverty  
Free Years (capability); ICER, Incremental Cost-Effectiveness Ratio; QSE, Quasi Standard Error 
 
9.4.3 Capability Outcome (3): Years of Insufficient Capability (YIC) 
YIC is the combination of the insufficient capability score (ICS) as calculated in the previous 
chapter with time. Unlike the three other capability outcomes, the aim is to minimise YIC 
rather than maximise. 
 
Table 42 presents the results of the third run of BRAM12. 100,000 virtual patients were 
required to reach the 1.2 confidence interval stopping rule for the ICER, except for one ICER 
calculation which required 250,000 to get to an acceptable ratio level. The strategy with the 




YIC is leflunomide (LEF) with 2.49. The difference between the highest and lowest YIC is 
0.38. The strategy with the lowest cost per year reduction in YIC compared with leflunomide 
(LEF) is rituximab (RTX) at approximately £62,600.  
 
Table 42 Years in Insufficient Capability (YIC) & ICER (100,000 patients) 
Option Cost (£) QSE   YIC QSE   
1. ETN 75293 126 
 
2.26 0.0054 
 2. IFX 73266 118 
 
2.26 0.0054 
 3. ADA 74825 125 
 
2.23 0.0054 
 4. RTX 69472 116 
 
2.16 0.0053 
 5. ABT 92932 161 
 
2.10 0.0052 




       Option ICERvsLEF (£) Quasi-CI [L-U] ICERvsRTX (£) Quasi-CI [L-U] 
1. ETN 114700 108500 121500 
   2. IFX 105800 99800 112300 
   3. ADA 100100 95200 104500 
   4. RTX 62600 59900 65500 
   5. ABT 114500 110600 118700 402800* 358100  459100 
ETN, etanercept; IFX, infliximab; ADA, adalimumab; RTX, rituximab; ABT, abatacept; LEF, leflunomide; YIC, Years of Insufficient 
Capability; ICER, Incremental Cost-Effectiveness Ratio; QSE, Quasi Standard Error. 
*250,000 patient simulations were required to get the confidence level ratio below 1.5 
 
9.4.4 Capability Outcome (4): Years of Sufficient Capability (YSC) 
YSC is the combination of the Sufficient Capability Score (SCS) as calculated in the previous 
chapter with time. It is the opposite of YIC, such that the aim is to maximise capability levels 
below sufficient capability, rather than minimise shortfalls in sufficient capability. This was 
explained in detail in the Chapter 7. YSC allows a direct comparison of the sufficient 
capability methodology with the previous maximising capability outcomes to be drawn. 
 
Table 43 presents the final BRAM12 run. 100,000 patients were required to meet the 1.2 




250,000 virtual patient runs. From Table 43, the highest YSC is for ABT at 11.01. The lowest 
YSC is for LEF at 10.431. The difference between lowest and highest is 0.58 YSC. The 
lowest cost per additional year of sufficient capability is for RTX compared with LEF, which 
costs approximately £38,800 for an additional year of sufficient capability. 
Table 43 Years of Sufficient Capability (YSC) & ICER (100,000 patients) 
Option Cost (£) QSE   YSC QSE   
1. ETN 75293 126 
 
10.79 0.0165 
 2. IFX 73266 118 
 
10.79 0.0154 
 3. ADA 74825 125 
 
10.82 0.0154 
 4. RTX 69472 116 
 
10.96 0.0159 
 5. ABT 92932 161 
 
11.01 0.0157 




       Option ICERvsLEF (£) Quasi-CI [L-U] ICERvsRTX (£) Quasi-CI [L-U] 
1. ETN 73100 67300 80200 
   2. IFX 67100 61800 73500 
   3. ADA 65700 60800 71400 
   4. RTX 38800 36600 41400 
   5. ABT 75600 71700 80000 449000* 322000 742000 
ETN, etanercept; IFX, infliximab; ADA, adalimumab; RTX, rituximab; ABT, abatacept; LEF, leflunomide; YSC, Years of 
Sufficient Capability; ICER, Incremental Cost-Effectiveness Ratio; QSE, Quasi Standard Error 
*250,000 patient simulations were required to get the confidence level ratio below 2.5 
 
9.4.5 Comparison of Model results 
Table 44 presents a summary of the differences in BRAM model runs for each outcome 
respectively. In comparing the capability outcomes from BRAM12 with the QALY outcomes 
from BRAM11, there appears to be very few differences between the orderings of drug 
treatment strategies. The sensitivity of change between highest and lowest outcome in terms 
of effectiveness in capability outcomes ranges from 1.03 for PFY(c) to 0.38 for YIC. The 



















BRAM11 QALYS 5,4,3,2,1,6 1.15 QALYs  [3.10-2.13] £21100 per QALY gain <30,000 
BRAM12 YFC 5,4,3,2,1,6 0.56 YFC [9.91-9.35] £42700 per YFC gain ??? 
BRAM12 PFY(c) 5,4,3,2,1,6 1.03 PFY(c) [4.75-3.72] £24400 per PFY(c) ??? 
BRAM12 YIC 5,4,3,2,1,6 0.38 YIC [2.10-2.49] £62600 per YIC avoided ??? 
BRAM12 YSC 5,4,3,2,1,6 0.58 YSC [11.01-10.43] £38800 per YSC gained ??? 
QALYs, Quality Adjusted Life Years; YFC, Years of Full Capability; PFY(c) Poverty Free Years (capability); YIC, Years of Insufficient 
Capability; YSC, Years of Sufficient Capability; RTX, rituximab; LEF, leflunomide; ICER, Incremental Cost Effectiveness Ration; WTP, 
willingness to pay of decision-makers for a positive unit change in outcome; ???, value unknown. 
 
9.5 DISCUSSION OF EACH MODEL RUN IN BRAM12 
9.5.1 Capability Outcome (1): Years of Full Capability (YFC) 
In the first model run of BRAM12, Years of Full Capability (YFC) are produced to measure 
the overall benefit of treatment, using the ICECAP-O valuation dataset to anchor capability 
scores on a 0-1 no capability-full capability index. The treatment strategy commencing with 
ABT produced the highest YFC (9.91), whilst LEF produced the lowest YFC (9.35). 
Applying the incremental cost-effectiveness ratio (ICER) for costs and YFC for different 
treatment strategies, the most cost-effective treatment strategy compared with standard 
treatment (LEF) is RTX at £40,200. 
 
This is the first attempt of modelling a capability outcome from an economic model used 
previously to aid decision-making in the UK. YFC allows for the full incorporation of the 
ICECAP-O index to be implemented in a capability outcome, where the objective is to 
maximise total levels of YFC within the population. It shows that YFC can be generated for 
an economic model by mapping from physical function (HAQ-DI) to capability (ICECAP-O), 




outcomes in a wider variety of clinical areas in health where capability data such as 
ICECAP-O is not widely available or collected over a long time period. 
 
Nevertheless, there are some limitations to this research. As with the generation of QALYs in 
BRAM11, the generation of YFC relies on the change in physical function (HAQ-DI) within 
BRAM12. Therefore, the primary driver of change in YFC is the change in physical function. 
If capability outcomes such as YFC are aiming to capture broader benefits than health alone, 
such a reliance on a measure of physical function could prove misleading in terms of the true 
capability benefits for the population under consideration.  
 
Given that the interest in this research is in the change of benefits from the outcome measure 
used in BRAM11 (QALYs) with those used in BRAM12, no other changes to BRAM12 were 
made. A full evaluation using a decision model applying the capability approach would also 
aim to capture a broader range of costs associated with the societal perspective, rather than 
just the NHS and personal and social service costs as currently recommended (NICE, 2013). 
Additionally, the same method of discounting QALYs at 3.5% per annum is also in place for 
capability outcomes here. The issue of whether discounting outcomes in health economics is 
applicable for capability outcomes is not explored here, but it is likely to raise similar 
questions as those raised with discounting of QALYs (Gravelle & Smith, 2001; Brouwer et 





No other study has tried to generate capability outcomes from an economic model. One study 
has compared ICECAP-O with health utility measures such as EQ-5D and SF-6D, in order to 
generate QALYs using the capability instrument (Rowen et al., 2012). However, there is no 
particular rationale for implementing the ICECAP-O in a QALY framework. The QALY is 
the benchmark outcome in health economic evaluations and there appears to be a certain 
amount of support to input any new measure within health into the current dead-full health 
QALY index criterion (Rowen et al., 2012). For this to be implemented in practice, a close 
crossover of scales is required between measures (Brazier et al., 2004a). So far, there is 
conflicting evidence as to whether the ICECAP-O and the EQ-5D-3L are complements (Davis 
et al., 2013) or substitutes (Makai et al., 2013) for each other. So far, this research has been 
limited to small sample sizes and particular patient groups. Further research is required to 
verify these results and whether or not the instruments could, or should, be used 
interchangeably. 
 
For policymakers interested in maximising levels of capability across a population, YFC 
offers a method for implementing such an objective. In order for capability questionnaires to 
be comparable with YFC from the ICECAP-O, such as Adult Social Care Outcome Toolkit 
(ASCOT) (Netten et al., 2012) and OxCAP (Lorgelly et al., 2008; Anand et al., 2009) 
questionnaires, they would need to be re-scaled in a similar approach to the ICECAP-O 
valuation index (Coast et al., 2008a). This would allow for meaningful comparisons to be 





9.5.2 Capability Outcome (2) Poverty Free Years (capability) (PFY(c)) 
The second run of BRAM12 produced Poverty Free Years (capability) (PFY(c)), an outcome 
predicting the likelihood of a population free from capability poverty throughout their time 
during treatment. For BRAM12, PFY(c) is calculated over the remaining lifetime of 
rheumatoid arthritis patients. The treatment commencing with ABT produced the highest 
PFY(c) at 4.7547 poverty free years, while LEF yielded the lowest PFY(c) of 3.7215. The 
most cost effective treatment compared with LEF is RTX at £24,400 per additional PFY(c).  
 
This is the first attempt to incorporate poverty methodology within a health economics 
framework. Poverty, in this scenario, refers to capability poverty – a level of capability which 
is insufficient to have a decent level of individual well-being. By implementing the headcount 
ratio methodology (Sen, 1976; Foster et al., 1984) within an outcome, the overall likelihood 
of falling below a decent level of capability well-being within a population can be judged. 
 
Additionally, poverty and capability have rarely been measured over time (Alkire et al., 2008) 
to the same degree as health economic outcomes are extrapolated over time in decision 
models. Therefore the calculation of PFY(c) represents another first as it is a combination of a 
measure of freedom from capability poverty over the lifetime of patients within the model. 
 
The limitations concerning predicting capability from physical function are relevant here as 
for all capability outcomes in BRAM12. Furthermore, there are weaknesses apparent for the 
PFY(c) outcome specifically. Measuring capability poverty using a binary outcome of poverty 




explored in detail in Chapters 4 and 7. In summary, for an outcome like PFY(c), the depth or 
severity of poverty within the population cannot be ascertained. Thus, it can be misleading 
when many people just below the poverty line improve enough to cross the poverty threshold, 
while those worse off neglibly improve their wellbeing. This has been shown previously when 
relying on a single indicator of poverty (income) which can lead to misleading poverty of 
population sub-groups in the United States. The African-American population sub-group was 
evaluated as poorest when using income only, but when other factors were accounted for such 
as educational attainment, health status and health insurance, the Hispanic group was the 
worst off in that jurisdiction (Alkire & Foster, 2011a). A headcount ratio such as PFY(c) can 
therefore overestimate the improvements within a population and should be handled with 
caution. 
 
The measurement of poverty presented here in terms of PFY(c) has not been attempted before 
in a health economic evaluation framework and is recognised as an area which has been 
neglected within the discipline (Mooney, 2009). In this scenario, poverty is put forward in 
terms of shortfalls in sufficient capability, with the aim of minimising the levels of capability 
poverty, falling short of the threshold of sufficient capability required for a decent standard of 
living. Therefore, poverty in this scenario is just as applicable to developed nations as it is to 
human development in developing countries.  
 
The issue of addressing equity within health economic outcomes is a key aim for many health 
economists looking for an alternative way of assessing improvements in individual well-being 




to account for equity in terms of fair-innings (Williams, 1997), proportional shortfall (Stolk et 
al., 2004) and severity of illness (Nord et al., 1999), with varying degrees of success. More 
recently, equity weights have been attached to QALY outcomes by the social value of a 
QALY team (Baker et al., 2010). However, for all of these attempts, there appears an inability 
to consistently apply such methods in generating economic outcomes or in defining what 
equity issues are of primary importance in evaluations, although there has been some success 
in the Netherlands, primarily the proportional shortfall method (van de Wetering et al., 2013).  
 
The capability approach allows researchers to apply a consistent theoretical basis to 
evaluations and focus on helping those with the lowest levels of capability as a priority (Sen, 
1985; Sen, 2009). Having such a theoretical basis can allow for a clear and coherent 
framework for evaluation, where generating meaningful outcomes is just one of a number of 
key changes required to evaluations from the current health economic paradigm. PFY(c) 
offers one of a number of potential capability outcomes which can be used in this mode.  
 
The production of PFY(c) allows for a measure of prevalence of capability poverty within 
health economic evaluations and how this changes over time with different interventions. 
Whilst not tested here, an outcome of prevalence of poverty in terms of health could be 
applied in a similar manner. However, there is a theoretical basis for poverty measurement 
within the capability context. Such use of a poverty measure of health would have to be 
rationalised as to why it would be useful to decision-makers. For those policymakers 
interested in overall levels of capability poverty, PFY(c) provides a practical outcome which 




9.5.3 Capability Outcome (3): Years of Insufficient Capability (YIC) 
YIC is the first attempt to incorporate the multidimensional poverty methodology, specifically 
the adjusted-Foster Greer Thorbecke (FGT) or M2 poverty measure (Alkire & Foster, 2011a) 
into an outcome which can be tracked over time. The calculation of insufficient capability 
score (ICS) is combined with time to give the prevalence of poverty within a population, as 
well as accounting for severity of poverty to get YIC, with the aim of minimising levels of 
YIC. In the third run of BRAM12, the treatment strategy commencing with ABT produced 
the lowest YIC at 2.1049, while LEF produced the highest YIC at 2.4876. The cost of 
reducing YIC by a year is lowest for RTX compared with LEF at £62,600 per year of 
insufficient capability averted. 
 
YIC represents a direct application of the adjusted-FGT measure (Alkire & Foster, 2011a) 
over time and accounts for the severity of capability poverty within a population. The measure 
of YIC overcomes the particular weaknesses outlined for PFY(c) in terms of addressing the 
sensitivity of capability poverty, giving additional weight to lower capability levels. 
 
The calculation of YIC in BRAM12 is limited by the fact that it is predicted from a measure 
of physical function (HAQ-DI), a limitation for all capability outcomes analysed here. 
Furthermore, YIC aims to minimise shortfalls in sufficient capability and is therefore not 
directly comparable with the other capability outcomes in BRAM12 or QALYs from 
BRAM11, which look to maximise their specific objectives respectively. YIC appears more 
suitable to draw comparisons with DALY calculations, which look to reduce morbidity and 




given  that the objective is to reach zero levels on YIC, a complication with the current 
BRAM12 model is that zero levels are comparable to state of being dead, which represents 
QALY zero levels in the original BRAM11. This is not ideal for YIC as its optimum is 
comparable with a state which would not be the objective of decision-makers (i.e. being 
dead). While the YIC does not produce any surprising results in relation to this complication 
here, it is an issue that would need to be addressed in further modelling using this unique 
capability outcome considered here. 
 
This is the first attempt to apply multidimensional poverty methodology in an outcome that 
accounts for changes in capability over time. Previously, the multidimensional poverty 
methodology has been applied in global studies, within a multidimensional poverty index 
(MPI) now routinely collected by the United Nations (UN) to compare levels of poverty 
across a number of dimensions internationally (Klugman, 2010; Klugman, 2011). However, 
there have been relatively few attempts to quantify levels of capability over time, as well as 
combining such outcomes with population values attached to different capability states 
(Chiappero-Martinetti & Roche, 2009). This is where work carried out in health economics 
can aid the development of the methodology further, by combining the methodology outlined 
by Alkire and Foster (Alkire & Foster, 2011a; Alkire & Foster, 2011b) with common health 
economic techniques applied to assess changes in states of well-being over time for 
individuals. 
 
The YIC offers a method for policymakers to assess the shortfalls of sufficient capability 




shortfalls in sufficient capability, something which is unaccounted for in the PFY(c) 
calculation. It could also potentially offer an alternative mechanism to DALYs (Murray & 
Lopez, 1996; Fox-Rushby & Hanson, 2001). DALYs are used frequently within assessing 
health in developing countries. However, assumptions in relation to age weights inherent in 
DALY calculation have caused considerable controversy (Anand & Hanson, 1997; Arnesen & 
Nord, 1999). Therefore the YIC outcome could provide a viable alternative to those who have 
objections to the underlying basis of the DALY.  
 
9.5.4 Capability Outcome (4): Years of Sufficient Capability (YSC) 
YSC allows for the combination of the Sufficient Capability Score (SCS) with time, so that 
the outcome can assess sufficient levels of capability over time. It offers a reversal of the YIC 
calculation, in that the aim is to maximise capability levels to sufficient capability, rather than 
minimise shortfalls of sufficient capability levels. This allows for a direct comparison with the 
other two capability outcomes from BRAM12 as well as the original QALY results from 
BRAM11. In the final run of BRAM12, the strategy commencing with ABT produced the 
highest YSC of 11.0105, while LEF generated the lowest YSC of 10.431 years of sufficient 
capability. The most cost-effective treatment in comparison to LEF is rituximab (RTX) which 
costs £38,800 per additional YSC. 
 
This study shows how to implement the most complex multidimensional poverty 
methodology using an outcome measure that specifies the relevant attributes and thus is more 
akin to outcomes found in economic evaluations. However, unlike the usual use of common 




to reach a sufficient level rather than the highest point achievable as the optimum. It offers a 
method for comparing a capability outcome incorporating the most complex multidimensional 
poverty methodology, which can be compared with QALYs and the other maximising 
capability outcomes generated here. 
 
The YSC outcome generated here suffers from the same limitations as the previous three 
capability outcomes in BRAM12, relying on the relationship between capability and physical 
function to predict YSC. However, this is not an issue of conceptual validity; rather it is one 
of data availability. Along with the assumptions made in the original BRAM11, this limitation 
is not unique to this research nor to the use of capability measures, but is a broader issue in 
health economics when relevant measures have not been collected alongside a trial. However, 
the relationship between physical function and capability is not well established, with the only 
primary research to date that has explored this relationship being limited to the exploration in 
Chapter 6 of this thesis. 
 
There is no clear method as to how equity should be incorporated into the current health 
economic paradigm, with numerous equity considerations of potential importance to decision-
makers (Dolan et al., 2005b; Culyer & Bombard, 2012). Methods range from adjusting 
QALYs with equity weights (Baker et al., 2010) to having a list of all equity considerations to 
be reviewed in order of importance on a case-by-case basis (Culyer & Bombard, 2012). There 
is no consensus to as to which method is most appropriate in the UK. A capability framework 
which addresses concerns about shortfalls in sufficient capability in an outcome over time 




and the other capability outcomes considered in this chapter address equity considerations in 
terms of shortfalls of sufficient capability explicitly within an evaluation between different 
interventions.  
 
Some developed nations have come to consensus as to how equity should be incorporated into 
economic evaluations such as the Netherlands who have adopted the method of proportional 
shortfall (van de Wetering et al., 2013) and Norway which adopted a scale of severity of 
illness to include alongside traditional QALY outcomes in evaluations (Nord, 2012). 
However, no such consensus is applicable to all nations, with diverse values on equity likely 
in different jurisdictions. Addressing equity explicitly in the primary economic outcome has 
the advantage of knowing that certain values are built in to the outcome and therefore not 
troubled by how to combine measures of equity and efficiency simultaneously. By shifting the 
objective of the capability outcomes such as YSC here to maximising levels of sufficient 
capability, the optimum criterion shifts focus further to those individuals who are deemed to 
be of primary concern in terms of their shortfalls of sufficient capability.  
 
YSC allows decision-makers to maximise the achievement of capability gains in those 
individuals deemed not to have a level of sufficient capability within the population under 
evaluation. The aim is to increase levels up to the threshold of sufficient capability, with 
changes above this threshold excluded from analysis. The YSC offers the blending of 
multidimensional poverty methodology with an outcome that can track changes in time, a 
common feature in health economic evaluations. However, the rationale for the TSC needs to 




Further research would be required for a TSC which reflected a societal valuation of sufficient 
capability. Finally, the maximisation objective for YSC may be a more familiar and therefore 
convenient tool over the minimisation objective also considered with YIC in helping to aid 
the decision-making process. 
 
9.6 DISCUSSION COMPARING BRAM12 MODEL RESULTS 
In this case study, BRAM12 generated four capability outcomes, the first such undertaking 
for both economic modelling and measuring capability over time. This chapter gives a menu 
of capability outcomes to decision-makers looking to apply broader benefit measures in 
evaluations between competing interventions. It shows that it is feasible to generate capability 
outcomes from a decision analytic model, relying on a relationship between physical function 
and capability to generate meaningful outcomes. 
 
The results in BRAM12 suggest that there is no variation in the ordering of strategy outcome 
benefits from the QALY BRAM11 results, which is more than likely due to the HAQ-DI 
having a prominent role in providing the basis of change in well-being for all model outputs. 
The difference between the highest and lowest benefit strategy varies for the four capability 
outcomes, as can be seen in Table 44. PFY(c) produce the highest difference between most 
and least effective. YIC proved the smallest difference to change from lowest to highest. 
Similar sensitivity is observed between YFC and YSC. However, considering all outcomes 
have different index ranges compared to QALY calculations from BRAM11, such differences 





This is the first attempt to explore the feasibility of developing and using potentially 
appropriate capability outcome for aiding decision-making in health. It compares four 
capability outcomes, outcomes which have been theoretically and methodologically explained 
in detail in the previous two chapters. The methods used in BRAM12 offers guidance and 
practical advice on how to generate capability outcomes, which can produce meaningful 
comparisons between interventions. 
 
There are limitations associated with relying on this information solely to judge the most 
appropriate capability outcome to recommend for common application. The primary 
limitation here is the inability to compare outcomes here with another intervention to assess 
the change in outcomes in a resource allocation decision, when only one intervention can be 
funded. However, the work that has been carried out here will allow others to compare the 
outcomes generated here with their research as a comparator, which will help to assess the 
validity of the capability outcomes further.  
 
There is no accepted willingness to pay for an additional unit change in capability outcomes 
which decision-makers have become accustomed to with QALYs. However, considering the 
stage of development of the capability outcomes, it is not surprising that willingness to pay 
thresholds for capability outcomes are not available. Again, once the capability outcomes are 
tested for different interventions, a greater understanding of the likely willingness to pay for 





That all capability outcomes here relied on the HAQ-DI measure of physical function is a 
clear drawback. However, this weakness is not only limited to this study but also traditional 
economic outcomes generated from models such as BRAM11, where health utility is 
predicted from other routine data collected in clinical trials. 
 
Health interventions for older people (Grewal et al., 2006), public health (Lorgelly et al., 
2010a), complex interventions (Payne et al., 2013) and social care (Netten et al., 2012) have 
already been identified as areas where adopting a broad capability approach theory to 
evaluation could prove worthwhile. Until now, there has been no formulation of how an 
evaluation framework adopting capability theory would take place. Rather it has been 
suggested in open terms as an alternative to current practice (Anand & Dolan, 2005; Coast et 
al., 2008c; Ruger, 2010b; Smith et al., 2012), with little formulation as to how an evaluation 
framework based on capability could be implemented. This chapter shows that capability 
outcomes can be generated from an economic model and implemented to evaluate changes in 
capability between different interventions. 
 
While this research is the closest attempt to implementing a full capability evaluation, a 
number of significant questions remain. This chapter has presented a menu of capability 
outcomes that could be useful in a decision-making context. If the decision of most 
appropriate capability outcome is judged in a traditional health economics way of the most 
sensitive to change of all potential measures (Grieve et al., 2009; Turner et al., 2013), then the 
PFY(c) outcome would be the most appropriate tool (see Table 44 for sensitivity between 




use is not transferable to deciding which capability outcome is most appropriate. If this were 
the case recent evidence of the sensitivity to change is greater on the EQ-5D-3L than the 
ICECAP-O (Couzner et al., 2013b), but both questionnaires are on different scales so are not 
directly comparable. From a theoretical perspective, the PFY(c) has a number of limitations 
that can give misleading results. Using both sensitivity and theoretical rationale, the YSC is 
likely to be most appropriate, which allows for a wider application of capability instruments 
to generate capability outcomes more so than some of the other outcomes explored in this 
chapter. Further research is necessary to assess the ability to compare capability 
questionnaires which value shortfalls in sufficient capability differently.  
 
While this chapter has presented a number of capability outcomes for decision-makers to 
apply, it cannot be determined from this research how much a decision-maker is willing to 
pay for a unit change per capability outcome. In Table 44, the comparison of the most cost-
effective treatment for QALYs from BRAM11, along with the willingness-to-pay of NICE to 
recommend a treatment as cost-effective over another strategy is presented. While it is 
possible to compare the ICER for each intervention as an estimation for a likely lower 
threshold of willingness to pay for a unit of capability improvement (given the ICER in 
BRAM11 is £21,200/QALY – lower than the £30,000 cost per additional QALY 
recommended currently), such inference of a likely threshold for capability change for 
decision-makers from this single study is tenuous. Further studies would be required to get a 





Finally, this chapter, in particular, has focused on generating capability outcomes from an 
economic model. In order to apply a full capability based evaluation, a broader perspective of 
costs as well as benefits should be adopted. Inclusion of additional costs such as lost 
productivity and costs to family may have a significant impact on findings. Future research 
could explore a full capability based evaluation, measuring broader benefits and costs, as well 





CHAPTER 10. THESIS DISCUSSION AND CONCLUSION 
 
10.1 INTRODUCTION 
In this thesis, a case has been argued for the adoption of an alternative theoretical basis for 
evaluating health interventions in economic evaluations, namely the capability approach. 
Many of the early criticisms of capability theory were concerned with the practical difficulty 
of capturing, within applied analysis, the richness of data on people’s choices to live lives that 
were of value to them (Sugden, 1993). Developing outcomes for assessing individual well-
being has been a challenging process for researchers interested in the adoption of the 
capability theory, but still, a number of contributions have been made within the health 
economics field to measure capabilities directly (Grewal et al., 2006; Coast et al., 2008a; Al-
Janabi et al., 2012a; Lorgelly et al., 2008; Anand et al., 2009; Kinghorn, 2010). Until now, 
less attention has been placed on how such measures could be used within an evaluation 
framework. 
 
The research presented here has been primarily concerned with how a capability evaluation 
space and objective for capability instruments could be practically applied within a health 
economic evaluation and still have close ties with the theoretical basis of the capability 
approach. The ICECAP-O questionnaire was the choice of measuring capability, due to the 
questionnaire’s development through qualitative interviews to reflect the most important 
capabilities for the population under examination (Grewal et al., 2006) and also the fact that 
population values have been developed for different capability levels on the questionnaire’s 




In the remainder of this chapter, the key findings from this thesis are outlined in Section 10.2. 
In Section 10.3 the strengths of the research undertaken are outlined, with a focus on the 
primary advances made within the thesis. In Section 10.4, a counter-balance to the strengths 
of the research is presented by discussing the limitations involved with the work undertaken. 
 
In Section 10.5, attention is turned towards the research implications of the findings presented 
throughout the thesis. Emphasis is placed on the implications for health economists and 
decision-makers who are interested in a broader assessment of well-being within an 
evaluation framework compared with the current prevailing applications that focus on health 
alone. Section 10.6 presents further research questions which have been raised through the 
findings from this research. Guidance is offered on future research topics which would be of 
most benefit for moving the operationalisation of the capability approach, as presented here, 
towards a similar level of the current economic applications within healthcare. In Section 
10.7, a conclusion is drawn from this discussion and the thesis overall.  
 
10.2 KEY FINDINGS 
There are a number of distinct findings from the work conducted in this thesis to the health 
economics and capability disciplines. They are (i) the development of a methodology, i.e. 
sufficient capability, that allows the assessment of capability levels through a practical 
framework within an appropriate evaluative space for the practical application of the 
capability approach; (ii) the development of capability outcomes, for which capability 




the relationship between capability and health related functioning as captured by two 
questionnaires. 
 
10.2.1 The illustration and development of the sufficient capability 
methodology 
This thesis represents the first attempt to operationalise the capability approach within a 
practical evaluation framework that can be used by decision-makers. The current “reference 
case” for health economic evaluations by the National Institute for Health and Care 
Excellence (NICE) within the UK consists of the implementation of the cost-utility analysis 
framework, with Quality Adjusted Life Years (QALYs) as the primary outcome of health 
benefit from treatment (NICE, 2013). The reference case that is currently employed by NICE 
to allocate resources across a healthcare system was challenged throughout the thesis and an 
alternative theory relying on Sen’s capability approach was argued. 
 
In Chapter 2, it was shown that alternative outcomes to the QALY are also focused on 
producing health outcomes, rather than a broader measure of well-being. While willingness to 
pay offers an alternative to health outcomes as a measure of utility, it falls short of a 
multidimensional evaluation space, which the extra-welfarism framework was developed to 
incorporate (Hurley, 1998; Brouwer et al., 2008). Therefore, a truly extra-welfarist approach 
measures more than one aspect of individual’s well-being, rather than health or utility only. 
Therefore, for decision-makers who want to account for the effects of health interventions 
beyond the health of the patient alone, current empirical applications offer no method of 




In Chapter 3, it was found that the justification of developing the extra-welfarist approach 
came from Amartya Sen’s critique of welfare economic theory. Sen developed an alternative 
theory to welfare economics based on individuals capabilities, that is, the ability of 
individuals to do and ways of being in their life that are valuable to them (Sen, 1992; Sen, 
1993; Sen, 2009). The capability approach was explained as an alternative to welfarism and 
the differences between extra-welfarism employed in health economics and the capability 
approach were discussed. A full application of the capability approach within health 
economics, as Sen intended, would require broader aspects of well-being to be captured than 
are currently within health related quality of life instruments used to produce QALY 
outcomes (Verkerk et al., 2001; Coast et al., 2008c; Smith et al., 2012).  
 
Two conceptualisations of the capability approach within the health field have cautioned 
against the use of a monist outcome like QALYs (Ruger, 2010a; Venkatapuram, 2011). This 
is in spite of both conceptualisations focusing on the two areas that the QALY measure 
typically captures well, i.e. reduced morbidity and increased life expectancy. Some health 
economists have attempted to align capability theory with the QALY outcome (Cookson, 
2005b; Bleichrodt & Quiggin, 2013). It was argued in this thesis that such QALY 
formulations are a dilution of the capability theory to fit within a traditional health economics 
approach, rather than shaping an outcome based on capability theory. 
 
Other attempts have been made to capture capability directly within health economics. The 
OxCAP (Oxford Capability Questionnaires) group compiled questions from household and 




Nussbaum’s ten central human capabilities (Anand et al., 2009; Lorgelly et al., 2008; Simon 
et al., 2013). The Adult Social Care Outcomes Toolkit (ASCOT) outcome was developed to 
capture social care related quality of life to generate a social care QALY comparable with a 
health QALY (Netten et al., 2012). The ICECAP questionnaires directly attempt to measure 
capabilities, as opposed to the OxCAP indicators of capability (Anand et al., 2009). The 
ICECAP measure emphasise capabilities which are important to the UK population, 
developed through qualitative research (Grewal et al., 2006; Al-Janabi et al., 2012a). Given 
that the ICECAP questionnaires have population valuations attached to each attribute level on 
the respective questionnaire, it was decided that for the incorporation of the capability 
approach within health economic evaluations, the ICECAP measures are the most developed 
at this stage. 
 
In light of the findings from Chapter 2 of the criticisms that have been levelled at the QALY, 
namely the narrow evaluation space and the health maximand decision rule, Chapter 4 
attempted to identify alternative decision rules within the capability literature. From the 
studies that were identified as relevant within the comprehensive pearl growing review, the 
potential scope of capability assessed was vast with large numbers of dimensions of capability 
and health playing a major role in how many studies assessed capability well-being. Of 
particular interest was for the studies identified which focused on health, health itself was 
rarely the primary objective for measuring people’s capabilities. Rather, the focus was on 
where poor health would have a negative impact on capabilities and therefore the person’s 





In terms of a decision rule for capability, while there were some examples of maximisation 
(Netten et al., 2012; Renouard, 2011; Tikly & Barrett, 2011), they were in the minority. Much 
of the capability research was focused on poverty analysis, in particular, the multidimensional 
influences on poverty. Much of this multidimensional poverty research focused on the 
avoidance of multidimensional states of poverty, rather than reaching an optimum capability 
state available. This was primarily led by the seminal work of Alkire and Foster on the 
formalisation of multidimensional poverty within the capability approach as a measurement of 
“unfreedom” (Alkire & Foster, 2011a). 
 
Following on from the capability empirical literature review in Chapter 4, Chapter 7 
attempted to develop a decision rule based on the concept of sufficient capability. The 
methods for sufficient capability drew primarily on the multidimensional poverty methods of 
Alkire and Foster. Chapter 7 developed a methodology as to how instruments which capture 
capability could be used within health economics by applying the sufficient capability 
approach. Unlike previous attempts to align the QALY with the capability approach, this 
work attempted to align the theoretical underpinnings of capability theory with a direct 
measure of capability well-being, the ICECAP-O questionnaire (Grewal et al., 2006; Coast et 
al., 2008a). 
 
In Chapter 8, the methodology for choosing a case study to operationalise the sufficient 
capability methodology within an economic model was detailed. The chosen case study was 
the Birmingham Rheumatoid Arthritis Model (BRAM). Methods were implemented to 




capability outcomes. Capability outcomes were estimated through mapping between a proxy 
of the Health Assessment Questionnaire Disability Index (HAQ-DI) onto the ICECAP-O. 
 
10.2.2 Development of capability outcomes 
Before this thesis, little research had been carried out on how applications of the capability 
approach are used in practice. In Chapter 4, a review of capability applications suggests that 
the health maximisation objective of health economics does not necessarily transpire when 
applying the capability approach in practice. Therefore, previous attempts of re-interpreting 
the QALY as an outcome of “capability efficiency” (Cookson, 2005b) or “capability as 
menus” (Bleichrodt & Quiggin, 2013), without a consideration of whether the maximisation 
principle is applicable in a capability based evaluation. 
 
In Chapter 7, an alternative proposal to the maximisation principle of health economic 
outcomes was presented. By employing the Alkire-Foster methods of multidimensional 
poverty, the most frequent method of aggregating capability attributes to form an indicator as 
discovered in Chapter 4, four potential capability outcomes were developed and illustrated in 
Chapter 7, based on a principle called “sufficient capability”. 
 
Finally, in Chapter 9, the results of the BRAM model case study were presented. A number of 
potential outcomes of sufficient capability were estimated. These outcomes were compared to 
the orderings produced with previous cost per QALY and incremental cost effectiveness ratio 




vary with the original QALY orderings, when ICERs were introduced, the cost per unit of 
capability changed significantly depending on the threshold of sufficient capability and 
outcome implemented. Therefore, the choice of capability outcome and sufficient capability 
threshold is of crucial importance for the application of this approach in practice. 
 
10.2.3 Understanding the relationship between health and capability wellbeing 
The influence of health upon capability is essential for the adoption of the capability approach 
within health economics and related health disciplines. This thesis has shown the ability to 
predict capability levels on a questionnaire of capability well-being from a condition-specific 
health status questionnaire for OA patients. 
 
Chapter 6 set out an agenda for exploring the relationship between capability and measures of 
health through the process of mapping between two instruments. Mapping was used to 
explore the relationship between a measure of condition-specific health status, the WOMAC 
Osteoarthritis Index, with a measure of capability, the ICECAP-O for a group of OA patients 
who required a hip or knee replacement. The aim in Chapter 6 was to show whether capability 
levels could be inferred from changes in health status. Given that much of the data available 
within clinical trials are often measures of health related well-being, it would be a big barrier 






In Chapter 6, it was shown that the categories of pain, stiffness and physical function on the 
WOMAC, were able to predict the majority of levels on the ICECAP-O attributes (security, 
role, enjoyment and control). The strongest relationship was between the physical function 
category and the control attribute on the ICECAP-O (R²=0.2143). The attachment attribute 
levels on the ICECAP-O could, unsurprisingly, not be predicted from the WOMAC. While 
the WOMAC was not able to capture all changes on the ICECAP-O, all categories on the 
WOMAC showed some relationship with ICECAP-O attributes, adding strength to the 
argument that the capability questionnaire could be used in health economics as a broader 
outcome measure than health alone. 
  
10.3 STRENGTHS OF RESEARCH 
The main strengths of this thesis is that it is the first to (i) align the capability 
conceptualisations to health with those developing capability questionnaires; (ii) conduct a 
systematic literature search strategy for review of capability applications; (iii) explore the 
feasibility of mapping from condition-specific health status to capability questionnaires; (iv) 
develop a capability objective for economic evaluations; and (v) incorporate capability 
outcomes within an economic model. 
 
10.3.1 Aligning capability conceptual theory with questionnaire development 
In Chapter 3, a literature review of research which could be classified within the fields of the 
capability approach and health economics was presented. While this is not the first attempt to 
look at the types of capability outcomes available for use within health economics (Lorgelly 




developing capability questionnaires within health economics. It is also the first attempt to 
align the two main conceptualisations of the capability approach in health with health 
economics (Ruger, 2010a; Venkatapuram, 2011). While both conceptualisations appear to 
resist health economic outcomes currently implemented, Chapter 3 attempts to align 
differences noted by the conceptual philosophers of the capability approach with the practical 
developers of capability questionnaires for healthcare assessment. This alignment was further 
guided by the development of an alternative objective of sufficient capability in Chapter 7, to 
the currently used objective of QALY maximisation. 
 
10.3.2 Implementing an explicit literature search strategy for capability reviews  
Chapter 4 completed an empirical literature review of the most up to date methods of 
measuring capabilities and using objectives and decision rules used for such outcomes. A 
multidisciplinary search was conducted so that a broad consensus of how the capability 
approach is currently being applied could be assessed. No other review of the application of 
the capability approach has targeted which attributes are captured by instruments, how such 
instruments are aggregated, as well as how such instruments could be used to aid decision-
making within their respective fields.  
 
Previous reviews of empirical capability literature were not explicit in how studies were 
chosen for their review or what kind of search strategy took place (Kuklys & Robeyns, 2005; 
Robeyns, 2006; Chiappero-Martinetti & Roche, 2009). The search strategy employed in 
Chapter 4 was the Comprehensive Pearl Growing strategy. Keyword search terms were 




health economic systematic reviews (Roberts et al., 2002). The comprehensive pearl growing 
strategy is most appropriate when a keyword search would return tens of thousands of studies, 
which happens when words have multiple meanings and uses within the academic literature 
(e.g. costs, equity and capability). Given that the aim of the search was to assess the 
application across as many disciplines as possible, the pearl growing methodology was 
particularly suitable to the review as reported here (Dolan et al., 2005b). 
 
10.3.3 The feasibility of mapping from health status to capability 
This was the first study to map from a condition-specific measure of health to a measure of 
capability. This has led to a greater understanding of the relationship between the WOMAC 
categories of pain, stiffness and physical function with the capability well-being attributes on 
the ICECAP-O questionnaire. Previous research has suggested that the ICECAP-O may only 
be a complement to health status questionnaires such as the EQ-5D-3L (Davis et al., 2013). 
However, the ability of the WOMAC categories to predict ICECAP-O attribute levels would 
suggest that the ICECAP-O is capturing something completely separate to changes in health 
status somewhat of a contradiction to the findings of Davis and colleagues (2013). 
 
10.3.4 The development of a capability objective for economic evaluations 
Previous attempts to operationalise the capability approach within health economics have 
relied purely on economic methodology to conceptualise the way a capability evaluation 
could be carried out using the QALY outcome (Cookson 2005; Bleichrodt & Quiggin 2013). 
In Chapter 7, both methods from health economics and the findings from Chapter 4 on 




objective is referred to as “sufficient capability”, which incorporates the practicability of 
economic outcomes, as well as guidance from the capability approach as to what the objective 
of a capability evaluation should entail. All outcomes tested within the objective in Chapter 7 
were also illustrated with patient data, unlike prior attempts to align the QALY measure with 
the capability approach, which relied purely on mathematical formulations and was not 
illustrated in practice using data (Cookson, 2005b; Bleichrodt & Quiggin, 2013). 
 
10.3.5 The incorporation of capability outcomes within an economic model 
The sufficient capability outcomes developed in Chapter 7 were also tested within a case 
study. The Birmingham Rheumatoid Arthritis Model (BRAM) model was used previously to 
aid decision-making in the UK. A number of potential capability outcomes that were 
developed in Chapter 7 were subsequently tested in the BRAM case study model. This was 
the first study to apply capability outcomes within an economic evaluation which analysed the 
different drug treatment strategies for rheumatoid arthritis patients. The modelling of 
capability outcomes over time within the BRAM represents the first measure of capability 
longitudinally, over a patient’s life cycle as captured through the BRAM. This case study, 
detailed through Chapters 8 and 9, offers a substantial contribution to the operationalisation of 
the capability approach compared to previous attempts in the literature. 
 
10.4 LIMITATIONS OF RESEARCH 
Whilst this was the first time that research in this area has undertaken the focus of translating 
capability questionnaires (specifically the ICECAP-O) into model outputs, it must be noted 




occur are (i) the framing of the capability application review; (ii) generalising the relationship 
between health status and capability; (iii) defining sufficient capability; (iv) methods for 
incorporating the ICECAP-O into an economic model; and (v) the BRAM model case study 
itself.   
 
10.4.1 Capability empirical review search strategy 
A limited timeframe was selected for study inclusion within the capability empirical review. 
This was done to focus on the current approaches of applying the capability approach in 
assessing well-being. Additionally, the search strategy was chosen to ease the burden of 
sifting through an insurmountable number of unrelated studies. Therefore, a search based over 
a longer time period and wider search strategy scope may have captured additional studies 
involved in this area. However, the search strategy choice and timeframe were judged to be 
suitable as the low likelihood of obtaining many additional studies, which would have had 
little benefit to the chapter objective of getting a consensus on the evaluative space and 
decision rule that applied the capability approach across disciplines. 
 
10.4.2 The relationship between health status and capability 
A relatively small sample size of 107 patients requiring joint replacement was used for the 
mapping study, although smaller mapping sample sizes have been used in practice (Brazier et 
al., 2010). Therefore, any inferences from the results of Chapter 6 must account for this 
limitation. The validity of the mapping was limited to internal validation of the dataset for 
osteoarthritis patients, with follow-up responses used to check the predictions from baseline. 




WOMAC (Barton et al., 2008), the clear recommendation is that mapping functions should be 
externally validated when an external dataset is available (Dakin et al., 2013b). 
 
One study with the ICECAP-O indicated that the capability measure may be a complement 
rather than a substitute to the EQ-5D for patients of a falls prevention clinic (Davis et al. 
2012). A contrasting study has suggested that the ICECAP-O is able to capture health and 
wellbeing more generally for older hospital patients (Makai et al., 2013). No direct 
comparison with a measure used to generate QALYs was carried out in this thesis. This would 
have given a stronger justification for the use of a measure of capability well-being instead of 
a health related quality of life instrument in economic evaluations. 
 
Other mapping studies have attempted to include additional data beyond the two measures in 
the mapping process, e.g. clinical or socio-demographic data. The prediction of capability 
may have been improved slightly for the patients from WOMAC to ICECAP-O if a measure 
of psychological well-being had been included. However, this broader approach also has the 
limitation which makes such mapping algorithms less useful when only WOMAC data has 
been collected, so this was deemed an acceptable sacrifice for the research undertaken in 
chapter 6. 
 
10.4.3 Defining Sufficient Capability  
The testing of the sufficient capability methodology relied on one patient group, so a 




decision rule could not be tested between two population groups to show cases where 
different interventions would be prioritised over others. 
 
The thresholds of sufficient capability tested were set at levels between the highest and lowest 
capability levels to show how the sufficient capability methodology would work in practice. 
Developing “sufficiency” in terms of capability is likely to vary between different 
populations. However, no determination of what sufficient capability should or should not be 
was made within the thesis. 
 
Compared with previous methods of applying the capability approach, while a number of 
alternatives were tested, no specific outcome is recommended beyond the further exploration 
of the sufficient capability approach. This is in comparison with the clear objective of the 
maximisation of a specific outcome (QALYs) by other researchers (Cookson, 2005b; 
Bleichrodt & Quiggin, 2013). 
 
10.4.4 Methods for incorporating ICECAP-O into an economic model case 
study 
To incorporate the ICECAP-O into the BRAM, a mapping function between the HAQ-DI and 
the ICECAP-O was required. Previously a mapping between the HAQ-DI and the EQ-5D was 
used to calculate QALY gains from the different drug treatment strategies for rheumatoid 





While the majority of questions from the HAQ-DI were collected in the Tayside dataset, the 
questionnaire was not completed in its entirety within the mapping sample. The primary 
objective of the dataset was to develop a new Aberdeen measure of impairment, activity 
limitation and participation restriction using item response theory across a number of related 
questionnaires, resulting in HAQ-DI questions being excluded from collection (Pollard et al., 
2009).  
 
To calculate the necessary six category scores to complete a HAQ-DI overall score, some 
questions from the WOMAC and SF-36 were used as proxies. While this is far from the ideal 
scenario, these were the best data available to explore a capability measure in an economic 
model. A further limitation was that the mapping functions were validated within the baseline 
dataset. This was as a consequence of the data used to calculate the adjusted HAQ-DI was not 
collected at follow-up. Only the WOMAC questionnaire and the ICECAP-O were completed 
at 1 year and 3 year follow up. 
 
10.4.5 The BRAM case study 
Due to time and budget constraints of the Ph.D. studentship, an original case study which was 
developed from inception was outside the remit of this research project. This was primarily 
due to the lack of capability data collected over a period of time long enough to develop a 
case study and the fact that the capability measures are emerging. Therefore, a body of data 
does not already exist. Case studies with direct data collected over a reasonable time period 
are likely to have more certainty with their findings. However, this was not possible here. For 




decision-making in health, the methods adopted within the BRAM case study were deemed 
acceptable for the purposes of this thesis. The potential for a number of case studies was 
explored. However, due to the extent of the research required to carry out one case study and 
the lack of relevant ICECAP data, the BRAM12 model was the only case study carried out in 
this thesis. Ideally, an area where the capability approach is believed to be beneficial, such as 
public health interventions (Lorgelly et al., 2010a; Saith, 2011), would have been chosen for a 
case study and compared with the findings from BRAM12. 
 
Within the selected case study, only the outcomes from the BRAM model case study were 
changed. This was so that the focus was on changes from the outcome side due to the 
incorporation of the ICECAP-O into the model and not as a result of other changes which 
could have been made. Therefore, aspects within the model on the costs side, which focus on 
costs to the NHS and personal and social services only, may be broadened within a full 
capability evaluation to societal costs. This was beyond the objectives of this thesis, as its 
primary focus is on the benefit aspect of economic evaluation. 
 
The method of comparing costs with capability outcomes was the incremental cost-
effectiveness ratio (ICER). This method was used because there was no alternative metric for 
combining the changes of costs and effects from the studies explored from the capability 
literature in Chapter 4. The ICER did have the advantage of being a direct comparison with 
the previous QALY output from the original BRAM results. While alternatives to ICERs may 





10.5 IMPLICATIONS OF FINDINGS FOR HEALTH ECONOMICS AND DECISION-
MAKERS IN HEALTHCARE 
There are a number of important implications from this research. They are (i) a new method 
for allocating resources using the capability approach as the theoretical basis; and (ii) the 
development of sufficient capability as a method of incorporating distributional concerns 
within the outcome of interest.  
 
10.5.1. A new method for allocating resources across healthcare   
This thesis offers an alternative framework for aiding decision-making in health, which 
attempts to incorporate more than health improvement into the outcome measure. For 
decision-makers interested in allocating resources across a health service, this research will be 
of particular interest to those who believe economic outcomes should capture a broader 
impact on individual well-being, rather than health only. 
 
Currently, health economic evaluations are primarily employed within the health service for 
measuring technical efficiency (i.e. choosing one of a number of potential interventions for a 
given population group). This would seem an appropriate use of the current QALY, given the 
different methods of calculating health status within QALYs (e.g. EQ-5D, SF-6D, HUI3), 
making comparisons between QALYs across a health service nonsensical. While this may be 
an adequate approach for an ever expanding health service with infinite resources, the recent 
years of curbed spending within the NHS would suggest that such an approach may not be 
helpful in allocating resources efficiently, which includes the withdrawl of non-effective 




achievement of a sufficient level of capability for the maximum number of the population, 
given the finite resources available for a given period. When people have sufficient capability, 
resources are aimed at those with the lowest levels below the threshold of sufficient 
capability, with the aim of improving levels to a society’s given threshold point of sufficient 
capability. This methodology is focused on allocating resources in healthcare, but if sufficient 
capability was a main criterion across public services, this could allow for comparisons of 
impact of capability wellbeing between resources from different public sectors attempting to 
achieve similar goals (e.g. education versus sports funding versus health interventions for 
reducing obesity). 
 
10.5.2 Sufficient Capability and Extra-Welfarism 
The sufficient capability approach also gives an alternative method for applying the capability 
approach within health economics outside of the QALY measurement. Two notable 
conceptualisations of the capability approach within health rejected the use of the QALY 
(Ruger, 2010a; Venkatapuram, 2011), so the approach offered here may be more in line with 
the objectives of capability theorists too. Health economists who are interested in measuring 
broader benefits than health alone may also favour this approach.  
 
A number of ways of handling distributional concerns with QALYs in the current extra-
welfarist framework have been made. The Dutch approach is the inclusion of such equity 
weights within the QALY, namely the fair innings approach combined with health 
maximisation to calculate proportional shortfall (Stolk et al., 2004). Other studies have done 




the social value of a QALY project (Baker et al., 2010). The Norwegian approach outlines 
equity considerations alongside the QALY outcome, keeping concerns from equity separate 
from the QALY score (Nord, 2012). A similar approach has attempted to develop an equity 
checklist which a decision-maker should account for as well as the QALY calculation (Culyer 
& Bombard, 2012). While there does not appear to be a general consensus about the method 
of incorporating equity information given to decision-makers in QALY outcomes, research 
like the studies just referred to would indicate that the QALY will continue to play an 
important role in aiding decision-making in health, in the short-term at least. However, it is 
argued in this thesis that the problems with the health maximising objective used for QALYs 
is down to a combination of the limited evaluative space on health alone and an inappropriate 
objective of QALY maximisation from a capability perspective. 
 
The sufficient capability approach may also allow a mechanism for the comparison across 
well-being from different areas of public policy. While questionnaires such as ICECAP were 
specifically developed for use within the health and social care setting (Grewal et al., 2006), 
the questionnaires give no direct consideration of health within the questionnaire. While some 
may see this as a disadvantage within the health setting, the flexibility of the non-specific 
measures of capability well-being may offer a truer guide as to what areas of public funding 
are contributing most to a general population’s overall well-being. The lack of a direct 
measure of health does not appear to be a problem as changes in functional health are 





Given that the capability approach is a direct critique of welfare economics, it is not so clear 
whether welfare economists will be sympathetic to the approach outlined here. However, this 
thesis has attempted to outline where the true “extra” in “extra-welfarism” can be found 
(Birch & Donaldson, 2003), within a more direct representation of Sen’s capability theory in 
an evaluation framework. 
 
10.6 FUTURE RESEARCH RECOMMENDATIONS 
While this thesis has addressed a number of issues with the applications of a capability 
approach within economic evaluation, a number of lingering questions remain following this 
research. 
 
10.6.1 The relationship between capability and health measures 
As noted in Section 10.4.3, research with the ICECAP-O questionnaire and the EQ-5D-3L 
have reported conflicting arguments about the role of the ICECAP-O as a complement (Davis 
et al., 2013) or a substitute (Makai et al., 2013) to the EQ-5D measure of health related quality 
of life. Research undertaken in Chapter 6 would lead to agreement with the latter argument of 
a substitution effect between health and capability questionnaires, considering that aspects of 
capability can be predicted from categories of pain, stiffness and physical function on the 
WOMAC Osteoarthritis Index (Mitchell et al., 2013). Given the limited sample sizes of both 
the study in this thesis and the previous studies mentioned above, future research should 
explore whether or not the ICECAP questionnaires can accurately assess changes in a health 





One method of exploring this relationship further would be the “probabilistic mapping” 
approach (Le & Doctor, 2011). A relatively large dataset would be required to test the 
substitution ability of a measure of capability with a measure of health related utility. This 
framework will also be useful to validate the WOMAC to ICECAP-O predictions for joint 
replacement patients when a larger dataset is available. The probabilistic framework produced 
lower error statistics than OLS or the response mapping approach from SF-12 to EQ-5D (Le 
& Doctor, 2011). 
 
It is also important to note that the ICECAP-O and other capability questionnaires applied in 
health research have so far looked at measuring capability or measuring functioning. As was 
shown in the review of capability applications in Chapter 4, no attempt has been made to 
directly incorporate the third tenet of the capability approach within questionnaires, i.e. 
individual agency (see Section 3.2.4). While research has been undertaken to measure agency 
goals from pre-existing datasets (Alkire, 2005; Ibrahim & Alkire, 2007; Burchardt, 2009), 
little research has been undertaken on the combination and trade-offs of agency enhancement 
with capability and functioning to assess the overall well-being of an individual. How this 
concept of agency relates to health related quality of life could also provide an interesting 
avenue for future research. 
 
10.6.2 Defining Sufficient Capability for a society 
The sufficient capability approach offers a new rationale for the implementation of capability 
instruments within economic evaluations. An illustrative example of the sufficient capability 




Chapter 9. However, a number of questions about the application of the newly developed 
methodology for health economic evaluations remain. 
 
The sufficient capability approach applied here used the ICECAP-O (for 65 years), as this was 
the most developed questionnaire of the ICECAP family at the time of this research. The 
ICECAP-O questionnaire values also relied on the population age group the questionnaire is 
aimed at, i.e., the over 65s (Coast et al., 2008a). Attempts to apply the approach across a 
health service would necessitate a questionnaire more applicable to the general population, 
such as the ICECAP-A (for adults aged 18 and over) (Al-Janabi et al., 2012a). However, there 
is concern about how older people would answer the broader questionnaire, as the over 65 
year olds struggled to interpret the achievement and progress category on the ICECAP-A (Al-
Janabi et al., 2013). A mapping between the ICECAP-O and the ICECAP-A may allow for 
older people to complete the questionnaire developed specifically for them, yet be able to 
compute meaningful comparison with the rest of the general adult population’s important 
capabilities.  
 
While the case study showed how capability outcomes could be implemented within 
economic models, it was beyond the scope of the case study to ascertain the usefulness of a 
charge in capability outcomes for decision-makers. While it did take some time for 
willingness to pay thresholds of a QALY to emerge (McCabe et al., 2008), attempts are 
currently being made to systematically develop thresholds that decision-makers use to justify 
policy decisions on the basis of cost-effectiveness (Claxton et al., 2013). However, a similar 




which focused on developing a capability methodology for evaluation, as well as how 
capability instruments could be applied within economic models with limited data through 
mapping. Future research could qualitatively explore decision-makers views on the 
meaningfulness in changes of outcome measures such as Years of Sufficient Capability 
(YSC) for patients in the health service. 
 
Another area for further research which would take the findings from this thesis forward 
would be an example of outcome results between interventions. While the cost per additional 
QALY is the favoured method by NICE to compare outcomes, alternative methods for 
prioritising resources such as league tables may also shed light on how a sufficient capability 
approach may lead to different priority orderings across a health service. Ideally, this would 
present a scenario where capability outcomes show different results from QALY outcomes, to 
show that the capability approach offers an alternative that does not result in the same 
orderings as the QALY outcome. This is a method which has been used by advocates of the 
contingent valuation methodology, which have attempted to show differences in orderings 









The research presented in this thesis has attempted to implement the capability approach 
within an evaluation framework, something which was deemed impossible twenty years ago 
(Sugden, 1993). A sufficient capability methodology was developed from multidimensional 
poverty methodology to generate capability outcomes from the ICECAP-O capability 
questionnaire. This thesis sheds light on the relationship between health and capability 
questionnaires, showing that some questions of a broader measure of well-being than health 
can be estimated from condition-specific health questionnaires. While this thesis has done 
much to implement the capability approach within an evaluation framework, further research 
is required to show if the sufficient capability methodology offers a practical alternative to the 
current methodology applied in health economic evaluations currently. 
 
From this research it can be said that condition-specific health status categories of pain, 
stiffness and physical function on the WOMAC questionnaire are able to predict the majority 
of capability attributes captured on the ICECAP-O for arthritis patients requiring joint 
replacement. The existence of this relationship allowed the prediction of relevant outcomes 
for a capability evaluation to be predicted from a BRAM model. However, further research is 
required on defining sufficient capability for a given society before this approach to allocating 
resources could be implemented across a health service. More research is also required to 
show whether a shift to the sufficient capability approach would lead to any change in priority 
given to certain interventions over others, compared with the current health maximisation 





Appendix 1: The ICECAP-O Questionnaire(Coast et al., 2008a) 
 ABOUT YOUR QUALITY OF LIFE 
   
    By placing a tick (ü) in ONE box in EACH group below, please indicate which statement best describes your 
quality of life at the moment. 
1. Love and Friendship       
I can have all of the love and friendship that I want      4 
I can have a lot of the love and friendship that I want     3 
I can have a little of the love and friendship that I want      2 
I cannot have any of the love and friendship that I want     1 
        
        
2. Thinking about the future      
I can think about the future without any concern     4 
I can think about the future with only a little concern     3 
I can only think about the future with some concern     2 
I can only think about the future with a lot of concern     1 
        
        
3. Doing things that make you feel valued      
I am able to do all of the things that make me feel valued     4 
I am able to do many of the things that make me feel valued     3 
I am able to do a few of the things that make me feel valued      2 
I am unable to do any of the things that make me feel valued      1 
        
        
4. Enjoyment and pleasure      
I can have all of the enjoyment and pleasure that I want     4 
I can have a lot of the enjoyment and pleasure that I want     3 
I can have a little of the enjoyment and pleasure that I want     2 
I cannot have any of the enjoyment and pleasure that I want      1 
        
        
5. Independence      
I am able to be completely independent     4 
I am able to be independent in many things     3 
I am able to be independent in a few things     2 
I am unable to be at all independent      1 




Appendix 2: Data Extraction Sheet for Capability Application Review 
Criteria Justification 
Name of author(s), title of study, year of 
publication 
Summary information necessary for descriptive 
statistics 
Are details available on the type of the attributes 
within the capability related measure? 
Understanding the components of capability 
related measures across discipline 
Type of application of the capability approach? 
For example poverty and well-being assessment 
in advanced economies. 
The Robeyns’ (2006) groups of studies where the 
capability approach has been applied should help 
to analyse similar studies together. 
Was the capability related measure developed for 
a specific context? If so, which context? 
It has been argued by those who have applied of 
the capability approach that measures can be 
developed to address a specific policy question 
Country study conducted Can the study findings be applied in a UK 
setting? 
Was the study country/area specific or cross-
national/disciplinary? Which country and what 
area of focus?  
It is important to ascertain the potential for 
interdisciplinary research, as areas which are 
applied within a number of fields/countries, may 
be more adaptable to a health analysis setting 
Are comparisons made between different 
population groups? 
An important role in allocating resources is the 
commensurate nature of population comparisons 
Objective of study? Health maximisation, poverty reduction etc... 
Are decision criteria/rules discussed? 
What methods were used? 
If a measure has been promoted within a study, 
do the authors suggest how decision-makers 





Appendix 3: Studies included in review of capability applications 
Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Grewal et al., 
2006) 





ICECAP-O Index of capability versus preference-based measure of 
health related utility 
(Walker, 2006) 2006 1 A1 viii. 4 C Autonomy 
Knowledge 
Social Relations 
Respect and recognition 
Aspiration 
Voice 
Bodily Integrity and bodily health 
Emotional integrity and emotions 
Education 
capabilities  
gender equity in capability & equality of capabilities in 
education 
(Anand & Santos, 
2007) 
2007 1 A2 vi. 1 F Sexual Assault 
Domestic Violence 
Violence Assault 





(Distaso, 2007) 2007 1 A1 i. 2 F Consumption 
Income Distribution 
Life Expectancy (boys) 





Aesthetic and cultural values 
Multidimensional 
sustainability 
wellbeing index  
Index of sustainability (-1-+1) 
(Clark & Qizilbash, 
2008) 
2008 1 B1 iii. 4 F Clean water 
Health 







Self-worth and respect 
Survival  
Religion 
"core" poverty Identifying the core poor as a priority 
(Coast et al., 2008a) 2008 1 A1 x. 1 C (same as Grewal et al. 2006) ICECAP-O Attributes are valued on a 1(full capability) to 0 (no 




Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Krishnakumar & 
Ballon, 2008) 
2008 1 A1 i. 6 F Knowledge 
Living conditions 




Structural equation modelling approach to measuring the 
influences on capabilities 
(Murphy & 
Gardoni, 2008) 
2008 1 B3 iv. 8 C N/A N/A Capability assessed by two separate thresholds. Minimum 
levels of capability attainment acceptable after a hazard. It 
can be tolerable for some individuals to fall below 
acceptable threshold, so long as lower capability attainment 
is temporary, reversible, and probability of falling below 
tolerable threshold is sufficiently small 
(Wagle, 2008) 2008 1 A1 iv. 5 F Education 
Condition of Health 





Across measures of economic well-being, social inclusion 
and capability: poverty is rated as follows: abject poor, very 
poor, poor and non-poor 
(Walker, 2008) 2008 1 A1 viii. 1 C Knowledge 
Social Relations 
Critical Thinking 
Imagination and empathy 
Recognition and respect 





Having economic opportunities 
Functional 
capabilities  
Equality in capabilities for all students 
(Anand et al., 2009) 2009 1 A2 iv. 1 F Nussbaum’s 10 central human 
capabilities (see Table X) 




(Burchardt, 2009) 2009 1 B3 iv. 1 A N/A N/A A definition called "capability as autonomy", to include the 
conditions in which goals, aspirations and preferences are 
formed 
(Di Tommaso et al., 
2009) 
2009 1 A2 vi. 2 F Bodily health 
Bodily integrity 





(Hobson & Fahlén, 
2009) 
2009 1 A1 vii. 2 F Working times 
Flexibility 
Employment situation 






Measures of Work 
Family Balance in the 
European Social 
Survey 
Shifting focus of WFB from activation and increased 
productivity to measures of agency freedom and the 




Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Kerstenetzky & 
Santos, 2009) 
2009 1 A1 iii. 6 F Be well-sheltered 
Be healthy 
Do gratifying work 
Enjoy good schooling level 
Have protected children 
Be free from hunger and 
undernourishment 
Dress adequately 
Enjoy access to public services 
Not suffer discrimination 
Live without fear 
Participate in community life 
Participate in the associative life of the 
city 
Be happy and proud oneself 
Index of Freedom 
(IF) 
Poverty as insufficiency of basic capabilities 
(Rosano et al., 
2009) 





(ISEE) -  
Equivalence scales to give the true extent of poverty versus 
traditional poverty lines 




Capability Indicators  Arbitrary thresholds of poverty. Poor in one dimension = 
capability deprivation 
(Young, 2009) 2009 1 A1 viii. 8 C Functional life skills learning 
Cognitive life skills learning 
Interpersonal like skills learning 
Personal life skills learning as agency 
freedom 
Cross-cutting basic capabilities 
Basic capability from 
learning  
A threshold of basic learning 
(Addabbo et al., 
2010) 




Integration and affiliation 
Expression 
Participation 
Gender Budgets gender budgets could become a tool for assessing the gender 
division of labour, the distribution of resources and the share 
of individual and public responsibilities 







Basic threshold of 
social protection 
Chie Solidario aims to equalise capability by ensuring the 
poorest can achieve a minimum set of basic functionings 
(Clark & Hulme, 
2010) 
2010 1 B3 iv. 8 C N/A N/A Making a case for the incorporation of time into the 




Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Ferrer & Carrasco, 
2010) 
2010 1 A1 x. 8 C 18 Questions related to capability for 
changes in diet or physical activity 
Assessing Patients' 
Capability in Diet 
and Physical Activity 
Clinical success depends on events outside the control of the 
health care system: patient's ability to manage their health 
behaviours should be of focus 
(Floro & 
Pichetpongsa, 2010) 




index  (WBI) 
Poverty line measures of income do not show the effect and 
work effort of these home-based workers. Improvement 
through WBI (0-1) more N.B. 
(Gardoni & 
Murphy, 2010) 
2010 2 A1 i. 3,5 F Longevity 
Physical and mental health 
Affiliation and mobility 
Command over resources 
(measured across 8 indicators) 
Disaster Impact Index 
(DII)  
0-1 (no consequences-maximum consequences) 










Cape York Institute 
for Policy and 
Leadership 'capability 
indicators' 
Statistical equality between indigenous and non-indigenous 
and cultural differences cannot be assumed away 











Choice Framework Empowering consumers and producers in decision-making 
through the Choice Framework 
(Murphy & 
Gardoni, 2010) 
2010 1 A3 iv. 8 C N/A N/A A just society maximises the variability within groups and 
minimizes the variability among groups 
(Roelen et al., 
2010) 
2010 1 B1 iii. 3 F Education poverty 
Health poverty 
Shelter poverty 
Water and sanitation poverty 
Child work 
Leisure poverty 




Child poverty index 
for Vietnam: 
Poverty cutoff in two dimensions, normalised child poverty 




Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Alkire & Foster, 
2011a) 







Health measured as Body Mass Index 
Years of schooling 
Multidimensional 
Poverty Index (MPI) 
Reducing unfreedoms 
(Anand et al., 2011) 2011 1 A1 i. 6 C Health 
Freedom of Political Expression 
Freedom of Political Participation 
Freedom of Religion 
Freedom of Thought 
Emotional Capabilities 
Security 
Environment and Social Relations 
Discrimination Outside of Work 
Discrimination at Work 
Nehring-Puppe type 
index  
count of dimensions where above a threshold level 
(Arndt & Volkert, 
2011) 
2011 1 B2 iv. 2 F Social opportunities 
Economic Facilities 
Political Freedoms 
(measured across 13 indicators) 






2011 1 A1 vi. 8 F Health 
Education 
Participation 
(across six indicators) 
The Relative Women 
Disadvantage Index 
combined with 
Womens Quality of 
Life Index  -  
a high disparity that disadvantages women) to 1 (no 
disparity) 
(Beyazit, 2010) 2011 1 B3 iv. 8 C N/A N/A Moving away from sole focus of monetary gain 
(Binder & Broekel, 
2011) 





Having satisfying social relations 




2011 1 A1 iv. 8 F Life 
Physical security 
Health 
Education and learning 
Standard of living 
Productive and valued activities 
Participation, influence, voice 
Individual, family and social life 
Identity, expression, self-respect 
The Equality and 
Human Rights 
Commission 
Human Rights in terms of the achievement of substantive 





Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Grunfeld et al., 
2011) 








virtuous spiral model 
(CESVS).  
The CES virtuous spiral model assumes a minimum set of 
capabilities to make effective use of ICTS 
(Hobson et al., 
2011) 
2011 2 A1 vii. 2 A Employment and working time 
Parental leave 
Work environment and work culture 
Agency and 
capabilities to 
achieve a work-life 
balance 
Agency freedom through work-life balance (WLB) through 
flexibility, rights to reduce hours and parental leave 
(Kivunike et al., 
2011) 






(Kleine, 2011) 2011 1 A1 ix. 1,6 C (same as Klein 2010) Choice Framework Empowering consumers and producers in decision-making 
through the Choice Framework 
(Mabsout, 2011) 2011 1 A1 x. 4 C Education 
Earnings share 




Shortfalls in health functioning, in relation to the decision-
making role of women 
(Maddox & 
Esposito, 2011) 
2011 2 B3 viii. 8 F N/A N/A Minimum threshold of functioning (sufficiency) versus a 
dichotomy split literate/illiterate 
(Matsuyama & 
Mori, 2011) 
2011 1 A3 iv. 8 C N/A N/A Distribution of goods equalizing well-being freedom 
(achievement), the total amount of goods being fixed. 
(Nguefack-Tsague 
et al., 2011) 




(Reitinger et al., 
2011) 
2011 1 A2 vii. 8 C Life 
Knowledge and aesthetic experience 






Area of Protection 
(AoP) 
N/A 
(Renouard, 2011) 2011 1 B1 vii. 8 C To be integrated into networks 
To commit oneself to a project within a 
group 
To have specific attachments to others 
To try and value others’ objectives 
considering them as ends 
 
 





Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Smith & Barrett, 
2011) 
2011 2 B2 viii. 4 F Freedom from hunger during a school 
day 
Ability to meet financial costs of 
primary education 
Freedom from need to be self-reliant, 
economically, emotionally or 
practically 
Opportunities to pursue primary 
education whilst living close to family 
Opportunity to use language of 
instruction outside of school or 
opportunity to be schooled in language 
used in pupil’s community 
Opportunity to study or read at home 
Basic Capabilities in 
education quality 
N/A 
(Tikly & Barrett, 
2011) 
2011 1 B2 viii. 4 C Inclusion 
Relevance 
Democratic 
Measure of good 
quality education 
N/A 
(Al-Janabi et al., 
2012a) 





ICECAP-A Health status an influence on capability well-being, not 
over-riding priority 
(Ansari et al., 2012) 2012 1 A3 iii. 8 C N/A N/A Bonding and Bridging social capital to enhance capabilities 
(Arndt et al., 2012) 2012 2 B1 iii. 3,4 F Severe water deprivation 
Severe sanitation facilities deprivation 
Severe shelter deprivation 
Severe education deprivation 
Severe information deprivation 
Welfare indicators  First order dominance 
(Callander et al., 
2012b) 





Not in Poverty, At risk of Freedom Poverty, Financial 
Poverty, Freedom Poverty, Extreme Poverty.  
(Callander et al., 
2012c) 
2012 1 B1 iv. 7 F (same as Callander et al. 2012b)  Freedom Poverty 
Measure  
(Not in Poverty, At risk of Freedom Poverty, Financial 
Poverty, Freedom Poverty, Extreme Poverty.)  
(Callander et al., 
2012a) 
2012 2 A1 iv. 7 F (same as Callander et al. 2012b) Freedom Poverty 
Measure   




2012 2 A2 ix. 2 F Educational 
Personal 
Professional 
(measured across 8 indicators) 
Capability set from 
internet use  
N/A 




Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Kleine et al., 2012) 2012 1 B2 ix. 1,3,6 A (same as Kleine 2010) Choice Framework N/A 





(REAT) 2. Design for 
Health (DFH) 3. 
System for Observing 
Play and Leisure 
Activity (SOPLAY) 
Equality of Capabilities 
(Lewis, 2012a) 2012 1 A1 x. 5 C N/A System for Observing 
Play & Leisure 
Activity in Youth 
(SOPLAY) and 
System for Observing 
Play & Recreation in 
Communities 
(SOPRAC) 
Built Environment Capability 
(Maguire et al., 
2012) 
2012 1 B2 viii. 5 C Practical reasoning 
Educational resilience 




Respect, dignity and recognition 
Arts Education 
Pathway Model  
None as such (1 to 5 strongly disagree: 5 strongly agree on 
questions) 
(McAllister et al., 
2012) 
2012 2 B3 x. 1 A N/A N/A Trade-offs between empowerment and health status 
(McLean & Walker, 
2012) 
2012 1 A2 viii. 4 F Informed vision 
Affiliation 
Resilience 
Social and collective struggle 
Emotional awareness 
Integrity 
Assurance and confidence 




Education of professionals orientated to poverty reduction 
and the public good 
(Netten et al., 2012) 2012 2 B1 x. 1 F Personal cleanliness and comfort 
Accommodation cleanliness and 
comfort 
Food and drink 
Safety 
Social participation and involvement 
Occupation 
Control over daily life  





Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 
(Nikiema et al., 
2012) 
2012 1 A1 x. 4 C Knowing where to go to seek care 
Getting permission to go 
Getting money for treatment 
Distance to health facility 
Having to take transportation 
Not wanting to go alone 
Concern that there may not be a female 
health provider 
The index of 
perceived ability to 
overcome healthcare 
seeking   
Having no problems on the women's perceived ability to 
access health care 
(Norcia et al., 2012) 2012 1 B2 iii. 2 F A place for shelter and protection Functioning well-
being 
N/A 
(Notten & Roelen, 
2012) 




(measured across 13 indicators) 
Deprivation 
indicators  
Absolute adjusted headcount with a cumulative threshold of 
one deprivation. 
(Nussbaumer et al., 
2012) 
2012 2 B1 i. 4 F Cooking 
Lighting 




(measured across six indicators) 
Multidimensional 
Energy Poverty Index 
(MEPI) 
Energy poverty minimisation 




Housing and living environment 
Family and community life 
Transport and communication 
Participation 




(Peris et al., 2012) 2012 1 A2 ii. 6 A Who are we? 
What problems does our community 
have? 
Which of these problems are about our 
natural resources? 
What is the most important problem we 
want to act on? 
What work do we have to do to 
improve our problem? 
What do we hope the future will be like 
after the project? 








Costs of the projects to do the jobs we 
have planned and the months in which 
each job will be done. 
Authors Year Wave Search 
cat. 
Group Region Focus Attributes Aggregation Objective/Decision Rule 






Comparable to the HDI 
(Van Ootegem & 
Verhofstadt, 2012) 
2012 1 A2 iv. 2 C Happy life 
Achievement of dreams and goals 
Healthy life 
Education 




Life Domains  N/A 
(Walker, 2012) 2012 2 A3 viii. 8 C N/A N/A Capability approach advanced opposed to human capital 
approach in reducing education inequality 
(Wust & Volkert, 
2012) 







Accounting for more than financial poverty 
Author: First Author; Year: Year of Publication; Group: Thematic Grouping of studies within similar subject area; Focus: Aspect of the Capability Approach study focused on; 
Thematic Groups: i. General assessment of Human Development, ii. Assessing small scale development projects, iii. Identifying the poor in developing countries, iv. Poverty and well-being assessment in advanced 
economies, v. Deprivation of disabled people, vi. Assessing gender inequalities, vii. Debating policies, viii. Education, ix. Technology, x. Health 
Focus: C, Capabilities; F, Functioning; A, Agency 





Appendix 4: Studies excluded at the second stage of categorisation 




Region Primary Focus of Study Reason for exclusion 
(James, 
2006) 
2006 1 A4 ix. F 8 This paper shows how measuring the 
benefits of the internet in developing 
nations can be captured through Sen's 
functionings approach. 
This study was an ethnographic study and no 




2007 1 A4 x. C 5 This paper looks at the capability 
framework to understand recovery from 
schizophrenia. 
This study offers no measure or decision rule so 
is excluded from the review. 
(Alkire, 
2008) 
2008 1 B4 iv. F 8 This book chapter look at methods as to 
how dimensions of multidimensional 
poverty measures should be chosen. 
The focus of this review is on already developed 
measures and methods of aggregation. It is 
assumed that choosing attributes has already 





2008 1 B4 iv. F 2 This study looks at methods of 
measuring monetary and non-monetary 
benefits of poverty using fuzzy set 
theory. 
While the paper talks about methods for 
measuring well-being, it is not directly linked to 
applying the capability approach and is not 




2008 1 B4 viii. C 7 This study aims to demonstrate that the 
capability approach provides a useful 
framework for interpreting the 
brokering of learning 
No measurement of capability is offered in this 
paper. Whilst the capability approach is 
recommended, it is not clear from this study 





2008 1 B4 iii. F 8 This book chapter looks at methods of 
identifying and measuring chronic 
poverty measures 
This chapter reviews previous applications, but 
does not offer a unique measure, nor decision 
rules which such a measure should be based on. 






2008 1 B4 iv. F 8 This study looks at the latent variable 
models used to weight and aggregate 
unobservable variables 
Whilst related to measures proposing capability 
indices, this paper does not provide a measure or 




2009 1 B4 iv. C 8 This paper compares the theory of the 
capability approach with the conditions 
of life approach 
No measurement of capability or decision rule is 
suggested. A critique of the CA is offered where 












2010 2 A4 iv. C 1 This paper offers an attempt of 
conceptualising the capability approach 
for assessing cross-sector urban 
regeneration projects, with the impact 
on those of greatest disadvantage as a 
priority 
No measure of capability or decision rule is 
discussed in this paper, as it offers an early 
formulation of how the capability approach 





2010 1 A4 x. C 8 This paper provides a review of public 
health outcomes and the approach to 
capability in health economics 
No unique measure or decision rule is put 




2011 1 A4 iv. F 1 This study investigates the circulatory 
problem of Sen's capability approach: 
individual resources, conversion factors 
and valuable functionings endogeniety. 
This is tackled econometrically using 
reduced-form vector autoregressions. 
They find that income and being happy 
can be considered both as a functioning 
and resource for other functionings. 
Being well-sheltered and having 
satisfying social relations are 
independent of other influences here 
This paper looks at the relationship between 
different functionings, rather than a particular 




2011 1 B4 vii. C 8 This paper developed an 
entrepreneurship model based on the 
capabilities approach 
While this study looked at the role of 
entrepreneurship in developing capability, it did 
not develop an index as such, nor how such an 




2011 2 A4 vii. C 2 This study looks at Slovenian parents 
work-life balance effect on their 
capabilities. The qualitative study is 
primarily interested in the gender 
inequality of roles for the parents 
No measure of capabilities to focus on or 
decision rule is given within this study, so it is 
excluded from the review 
(Vaughan, 
2011) 
2011 1 A4 ix. C 7 This study looks at the role of ICT4D 
within indigenous communities in 
Australia 
The paper does not develop attributes to use or 
discuss how such a measure could be use to aid 
decision-making, so it was excluded 
(Wang, 
2011) 
2011 1 A4 viii. C 3 This paper set out to measure social 
exclusion through the capability 
approach and Sen's definitions of 
deprivation (constitutive deprivation, 
instrumental deprivation, active  
Paper has no measure of capability embedded 





deprivation, passive deprivation).  








2012 1 A4 i. F 8 Eight types of weighting structure were 
explored: frequency; statistical; most-
favourable; equal or arbitrary; expert 
opinion; price based; self-stated; 
hedonic 
While Decancq provides an illuminating review 
of methods to weight indices, this is not the 




2012 2 A4 viii. C 4 This paper explores the role of 
increased capability and agency in 
converting children's functioning 
achievement 
The paper does not offer a measure of capability 
or a decision rule as to what should be the 
objective of such an evaluation. 
(Foster et 
al., 2012) 
2012 2 A4 iv. F 8 This paper examines the robustness of 
rankings from multidimensional indices 
such as the Human Development Index 
(HDI), Index of Economic Freedom and 
the Environmental Performance Index. 
While previous research showed 
redundancy when high correlation 
existed between indicators, this paper 
suggests that higher correlations are 
associated with more robust rankings 
The paper is not directly linked to the capability 
approach, but looks at the method of aggregation 
of the HDI as well as a number of indices. 




2012 3 B4 viii. C 3 This paper argues against viewing 
education as a basic commodity, which 
is not appropriate within Conflict-
Affected Fragile States (CAFS) such as 
Afghanistan and that an assessment in 
line with the capability approach would 
encourage children with disabilities to 
participate more in education 
This paper offers no methods for measuring 
capabilities or a decision rule of priority, so is 
excluded from the remainder of the review 
(Walby, 
2012) 
2012 1 B4 iv. F 1 This presents a critique of Sen's 
capability approach. It believes that the 
focus of equality could be overturned 
by using Sen's choice theory 
This study is a critique of the capability 
approach, which does not inform outcome 
measurement or decision rules, so has been 
excluded 
 
Author: First Author; Year: Year of Publication; Group: Thematic grouping of studies within similar subject area; Focus: Aspect of the Capability Approach study focused on; 
Thematic Groups: i. General assessment of Human Development, ii. Assessing small scale development projects, iii. Identifying the poor in developing countries, iv. Poverty and well-being assessment in advanced 
economies, v. Deprivation of disabled people, vi. Assessing gender inequalities, vii. Debating policies, viii. Education, ix. Technology, x. Health 
Focus: C, Capabilities; F, Functioning; A, Agency 




Appendix 5: Western McMasters and Ontario (WOMAC) Osteoarthritis Index  











PAIN: How much pain have you had... 
1. When walking on a flat surface?      
2. when going up or down stairs?      
3. at night while in bed?      
4. while sitting or lying down?      
5. while standing?      
STIFFNESS : How severe has your stiffness been... 
6. after you first wake up in the morning?      
7. after sitting or lying down or while resting 
later in the day? 
     
PHYSICAL FUNCTION: How much difficulty have you had... 
8. when going down the stairs?      
9. when going up the stairs?      
10. when getting up from a sitting position?      
11. while standing?      
12. when bending to the floor?      
13. when walking on a flat surface      
14. getting in or out of a car, or getting on or 
off a bus? 
     
15. while going shopping?      
16. when putting on your socks or panty hose 
or stockings? 
     
17. when getting out of bed?      
18. when taking off your socks or panty hose 
or stockings? 
     
19. while lying in bed?      
20. when getting in or out of the bathtub?      
21. while sitting?      
22. when getting on or off the toilet?      
23. while doing heavy household chores?      
24. while doing light household chores?      
Note: not actual WOMAC Questionnaire layout. Above is truncation of actual questionnaire structure 
 






Appendix 6: The HAQ-DI (adjusted from Barton et. al., 2004a) 
We are interested in learning how your illness affects your ability to function in daily life.   
Please feel free to add any comments at the end of this 
form      
PLEASE TICK THE ONE RESPONSE WHICH BEST DESCRIBES YOUR USUAL ABILITIES OVER THE 
PAST WEEK 
  Without With With Unable 
  ANY SOME MUCH to 
  difficulty difficulty difficulty do 
  Score = 0 Score = 1 Score = 2 Score = 3 
1. DRESSING & GROOMING - Are you able to:         
Dress yourself including tying shoelaces and doing buttons?         
Shampoo your hair?         
2. RISING - Are you able to:         
Stand up from an armless straight chair?         
Get in and out of bed?         
3. EATING - Are you able to:         
Cut your meat?         
Lift a cup or glass to your mouth?         
Open a new carton of milk (or soap powder)?         
4. WALKING - Are you able to:         
Walk outdoors on flat ground?         
Climb up five steps?         
5. HYGIENE - Are you able to:         
Wash and dry your entire body?         
Take a bath?         
Get on and off the toilet?         
6.REACH - Are you able to:         
Reach and get a 5 lb object (e.g. a bag of potatoes) from above your 
head?         
Bend down to pick up clothing from the floor?         
7. GRIP - Are you able to:         
Open car doors?         
Open jars which have been previously opened?         
Turn taps on and off?         
8. ACTIVITIES - Are you able to:         
Run errands and shop?         
Get in and out of a car?         
Do chores such as vacuuming, housework or light gardening?         
     
How the HAQ-DI is calculated:     
Add the highest score for each of the eight categories together, before dividing by eight to get a score between 0-3. 
22 polar questions relating to aids, devices & help required are also asked (not presented here).  








Appendix 7: Amended HAQ-DI (worked example) 
Degree of Difficulty Questionnaire None Mild Moderate Severe Extreme Score 
HAQ Score   0 1 2 3 4 0-4 
1. Dressing & 
Grooming: 
       
Dressing yourself HAQ-DI   X    
Putting on/off shoes WOMAC   X   2 
Washing your hair HAQ-DI   X    
2. Rising:        
Rising from sitting WOMAC    X  3 
Rising from bed WOMAC   X    
Getting into bed HAQ-DI   X    
3. Eating:        
n/a       - 
4. Walking:        
Short distances SF-36    X  3 
Climbing stairs SF-36   X    
5. Hygiene        
Washing and drying HAQ-DI   X    
Getting in/out of bath WOMAC    X  3 
Getting on/off toilet WOMAC   X    
6. Reach        
Bending to floor WOMAC    X  3 
7. Grip        
n/a       - 
8. Activities        
Going shopping WOMAC   X    
Getting in/out of car WOMAC   X   2 
Light domestic duties WOMAC   X    
Total Score (0-24)             16 
Average (Total/6)       2.67 
HAQ_DI (Average*0.75, as HAQ-DI on a 0-3 scale)        2 
n/a , not available 




Appendix 8: Consolidated Health Economic Evaluation Reporting Statement for 
BRAM12 
Items to include when 
reporting economic 
evaluations of health 
interventions 
Section/item  




Title and abstract  
Title  1  Identify the study as an economic 
evaluation or use more specific terms 
such as “cost-effectiveness analysis”, 
and describe the interventions 
compared.  
N/A 
Abstract  2  Provide a structured summary of 
objectives, perspective, setting, 
methods (including study design and 
inputs), results (including base case 






3  Provide an explicit statement of the 
broader context for the study. 
Present the study question and its 




Target population and 
subgroups  
4  Describe characteristics of the base 
case population and subgroups 
analysed, including why they were 
chosen.  
p. 222 
Setting and location  5  State relevant aspects of the system(s) 
in which the decision(s) need(s) to be 
made.  
p. 223 
Study perspective  6  Describe the perspective of the study 
and relate this to the costs being 
evaluated.  
p. 228 
Comparators  7  Describe the interventions or strategies 
being compared and state why they 
were chosen.  
p. 227 
Time horizon  8  State the time horizon(s) over which 
costs and consequences are being 
evaluated and say why appropriate.  
p. 227 
Discount rate  9  Report the choice of discount rate(s) 
used for costs and  






Choice of health 
outcomes  
10  Describe what outcomes were used as 
the measure(s) of benefit in the 
evaluation and their relevance for the 




11a  Single study-based estimates: Describe 
fully the design features of the single 
effectiveness study and why the single 
study was a sufficient source of 
clinical effectiveness data.  
N/A 
11b  Synthesis-based estimates: Describe 
fully the methods used for 
identification of included studies and 
synthesis of clinical effectiveness data.  
N/A 
Measurement and 
valuation of preference 
based outcomes  
12  If applicable, describe the population 
and methods used to elicit preferences 
for outcomes.  
p. 235-242 
Estimating resources and 
costs  
13a  Single study-based economic 
evaluation: Describe approaches used 
to estimate resource use associated 
with the alternative interventions. 
Describe primary or secondary 
research methods for valuing each 
resource item in terms of its unit cost. 
Describe any adjustments made to 
approximate to opportunity costs.  
N/A 
13b  Model-based economic evaluation: 
Describe approaches and data sources 
used to estimate resource use 
associated with model health states. 
Describe primary or secondary 
research methods for valuing each 
resource item in terms of its unit cost. 
Describe any adjustments made to 






Currency, price date, and 
conversion  
14  Report the dates of the estimated 
resource quantities and unit costs. 
Describe methods for adjusting 
estimated unit costs to the year of 
reported costs if necessary. Describe 
methods for converting costs into a 
common currency base and the 
exchange rate.  
p. 262 
Choice of model  15  Describe and give reasons for the 
specific type of decision-analytical 
model used. Providing a figure to 
show model structure is strongly 
recommended.  
p. 223 
Assumptions  16  Describe all structural or other 
assumptions underpinning the 





Analytical methods  17  Describe all analytical methods 
supporting the evaluation. This could 
include methods for dealing with 
skewed, missing, or censored data; 
extrapolation methods; methods for 
pooling data; approaches to validate or 
make adjustments (such as half cycle 
corrections) to a model; and methods 
for handling population heterogeneity 
and uncertainty.  
p. 232-234 
Results  
Study parameters  18  Report the values, ranges, references, 
and, if used, probability distributions 
for all parameters. Report reasons or 
sources for distributions used to 
represent uncertainty where 
appropriate. Providing a table to show 




Incremental costs and 
outcomes  
19  For each intervention, report mean 
values for the main categories of 
estimated costs and outcomes of 
interest, as well as mean differences 
between the comparator groups. If 
applicable, report incremental cost-
effectiveness ratios.  
p. 265-269 
Characterising uncertainty  20a  Single study-based economic 
evaluation: Describe the effects of 
sampling uncertainty for the estimated 
incremental cost and incremental 
effectiveness parameters, together with 
the impact of methodological 
assumptions (such as discount rate, 
study perspective).  
N/A 
20b  Model-based economic evaluation: 
Describe the effects on the results of 
uncertainty for all input parameters, 
and uncertainty related to the structure 




Characterising heterogeneity  21  If applicable, report differences in 
costs, outcomes, or cost-effectiveness 
that can be explained by variations 
between subgroups of patients with 
different baseline characteristics or 
other observed variability in effects 










Study findings, limitations, 
generalisability, and current 
knowledge  
22  Summarise key study 
findings and describe 
how they support the 
conclusions reached. 
Discuss limitations and 
the generalisability of the 
findings and how the 




Source of funding  23  Describe how the study 
was funded and the role 
of the funder in the 
identification, design, 
conduct, and reporting of 
the analysis. Describe 
other non-monetary 
sources of support.  
N/A 
Conflicts of interest  24  Describe any potential for 
conflict of interest of 
study contributors in 
accordance with journal 
policy. In the absence of 
a journal policy, we 
recommend authors 
comply with International 












Addabbo, T., Lanzi, D., & Picchio, A. (2010). Gender Budgets: A Capability Approach. 
Journal of Human Development and Capabilities, 11, 479-501. 
Al-Janabi, H., Flynn, T., & Coast, J. (2011). QALYs and Carers. Pharmacoeconomics, 29, 
1015-1023. 
Al-Janabi, H., Flynn, T., & Coast, J. (2012a). Development of a self-report measure of 
capability wellbeing for adults: the ICECAP-A. Quality of Life Research, 21, 167-176. 
Al-Janabi, H., Keeley, T., Mitchell, P., & Coast, J. (2013). Can capabilities be self-reported? 
A think aloud study. Social Science & Medicine, 87, 116-122. 
Al-Janabi, H., Peters, T., Brazier, J., Bryan, S., Flynn, T., Clemens, S. et al. (2012b). An 
investigation of the construct validity of the ICECAP-A capability measure. Qual Life Res. 
Alkire, S. (2008). Choosing Dimensions: The Capability Approach and Multidimensional 
Poverty. In N.Kakwani & J. Silber (Eds.), The Many Dimensions of Poverty (pp. 89-119). 
Basingstoke: Palgrave Macmillan. 
Alkire, S. (2009). Concepts and Measures of Agency. In K.Basu & R. Kanbur (Eds.), 
Arguments for a Better World: Essays in Honor of Amartya Sen (pp. 455-474). Oxford, UK: 
Oxford University Press. 
Alkire, S., Qizilbash, M., & Comim, F. (2008). Introduction. In F.Comim, M. Qizilbash, & S. 
Alkire (Eds.), The Capability Approach: Concepts, Measures and Applications (pp. 1-25). 
Cambridge, UK: Cambridge University Press. 
Alkire, S. & Deneulin, S. (2009). A Normative Framework for Development. In S.Deneulin & 
L. Shahani (Eds.), An Introduction to the Human Development and Capability Approach (pp. 
3-31). London: Earthscan. 
Alkire, S. (2002). Valuing freedoms: Sen's capability approach and poverty reduction. 
Oxford: Oxford University Press. 
Alkire, S. (2005). Subjective Quantitative Studies of Human Agency. Social Indicators 
Research, 74, 217-260. 
Alkire, S. & Foster, J. (2011a). Counting and multidimensional poverty measurement. 
Journal of Public Economics, 95, 476-487. 
Alkire, S. & Foster, J. (2011b). Understandings and misunderstandings of multidimensional 
poverty measurement. Journal of Economic Inequality, 9, 289-314. 





Anand, P., Hunter, G., Carter, I., Dowding, K., Guala, F., & van Hees, M. (2009). The 
Development of Capability Indicators. Journal of Human Development and Capabilities, 10, 
125-152. 
Anand, P., Hunter, G., & Smith, R. (2005). Capabilities and Well-Being: Evidence Based on 
the SenNussbaum Approach to Welfare. Social Indicators Research, 74, 9-55. 
Anand, P., Krishnakumar, J., & Tran, N. B. (2011). Measuring welfare: Latent variable 
models for happiness and capabilities in the presence of unobservable heterogeneity. Journal 
of Public Economics, 95, 205-215. 
Anand, P. & Santos, C. (2007). Violent crime, gender inequalities and well-being: models 
based on a survey of individual capabilities and crime rates for England and Wales. Revue 
d'économie politique, 117, 135-160. 
Anand, P. & van Hees, M. (2006). Capabilities and achievements: An empirical study. 
Journal of Socio-Economics, 35, 268-284. 
Anand, S. & Hanson, K. (1997). Disability-adjusted life years: a critical review. Journal of 
Health Economics, 16, 685-702. 
Anderson, E. (2010). Justifying the Capabilities Approach to Justice. In H.Brighouse & I. 
Robeyns (Eds.), Measuring Justice. Primary Goods and Capabilities ( Cambridge: 
Cambridge University Press. 
Andronis, L., Malottki, K., Moore, D., & Barton, P. (2009). Providing Public Health 
information to prevent skin cancer: Modelling strategies for primary prevention of skin 
cancer London: National Institute for Health and Clinical Excellence. 
Ansari, S., Munir, K., & Gregg, T. (2012). Impact at the "Bottom of the Pyramid": The Role 
of Social Capital in Capability Development and Community Empowerment. Journal of 
Management Studies, 49, 813-842. 
Arends-Kuenning, M. & Amin, S. (2001). Women's Capabilities and the Right to Education 
in Bangladesh. International Journal of Politics, Culture, and Society, 15, 125-142. 
Arndt, C., Distante, R., Hussain, M. A., Østerdal, L. P., Huong, P. L., & Ibraimo, M. (2012). 
Ordinal Welfare Comparisons with Multiple Discrete Indicators: A First Order Dominance 
Approach and Application to Child Poverty. World Development, 40, 2290-2301. 
Arndt, C. & Volkert, J. (2011). The Capability Approach: A Framework for Official German 
Poverty and Wealth Reports. Journal of Human Development and Capabilities, 12, 311-337. 
Arnesen, T. & Nord, E. (1999). The value of DALY life: problems with ethics and validity of 
disability adjusted life years. British Medical Journal, 319, 1423-1425. 
Arrow, K. J. (1963). Uncertainty and the Welfare Economics of Medical Care. The American 




Asali, M., Reddy, S., & Visaria, S. (2005). Intercountry comparisons of poverty based on a 
capability approach: a pilot study. New York: Columbia University [On-line]. 
Atkinson, A. B. (2003). Multidimensional Deprivation: Contrasting Social Welfare and 
Counting Approaches. Journal of Economic Inequality, 1, 51-65. 
Auguste, P., Barton, P., Hyde, C., & Roberts, T. E. (2011). An economic evaluation of 
positron emission tomography (PET) and positron emission tomography/computed 
tomography (PET/CT) for the diagnosis of breast cancer recurrance. Health Technology 
Assessment, 15, 1-54. 
Backhouse, R. E. & Medema, S. G. (2009). Retrospectives: On the Definition of Economics. 
The Journal of Economic Perspectives, 23, 221-234. 
Baker, R., Bateman, I., Donaldson, C., Jones-Lee, M., Lanscar, E., Loomes, G. et al. (2010). 
Weighting and valuing quality-adjusted life-years using stated preference methods: 
preliminary results from the Social Value of a QALY Project. Health Technology Assessment, 
14, 1-161. 
Balestrino, A. (1996). A note on functioning-poverty in affluent societies. Notizie di Politeia, 
12, 97-106. 
Baltussen, R. & Niessen, L. (2006). Priority setting of health interventions: the need for multi-
criteria decision analysis. Cost Effectiveness and Resource Allocation, 4. 
Barrientos, A. (2010). Protecting Capability, Eradicating Extreme Poverty: Chile Solidario 
and the Future of Social Protection. Journal of Human Development and Capabilities, 11, 
579-597. 
Barton, G., Sach, T., Jenkinson, C., Avery, A., Doherty, M., & Muir, K. (2008). Do estimates 
of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores? 
Health and Quality of Life Outcomes, 6. 
Barton, P. (2008). Further cost-effectiveness analysis of sequential analysis of sequential TNF 
inhibitors for rheumatoid arthritis patients. 
Barton, P., Jobanputra, P., Wilson, J., Bryan, S., & Burls, A. (2004a). The use of modelling to 
evaluate new drugs for patients with a chronic condition: the case of antibodies against 
tumour necrosis factor in rheumatoid arthritis. Health Technology Assessment, 8, 1-91. 
Barton, P. (2011). Development of the Birmingham Rheumatoid Arthritis Model: past, 
present and future plans. Rheumatology, 50, iv32-iv38. 
Barton, P. & Andronis, L. (2009). Prevention of cardiovascular disease at population level: 
Modelling strategies for primary prevention of cardiovascular disease London: National 
Institute for Health and Clinical Excellence. 
Barton, P., Andronis, L., Briggs, A., McPherson, K., & Capewell, S. (2011). Effectiveness 
and cost effectiveness of cardiovascular disease prevention in whole populations: modelling 




Barton, P., Bryan, S., & Robinson, S. (2004b). Modelling in the economic evaluation of 
health care: selecting the appropriate approach. Journal of Health Services Research & 
Policy, 9, 110-118. 
Bellamy, N., Buchanan, W., Goldsmith, C. H., Campbell, J., & Stitt, L. (1988). Valdiation 
study of WOMAC: a health status instrument for measuring clinically important patient 
relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis in the knee or 
the hip. J Rheumatol, 30, 167-178. 
Bellamy, N. (2004). WOMAC Osteoarthritis Index User Guide (Rep. No. Verson VII). 
Brisbane, Australia. 
Bérenger, V. & VerdierChouchane, A. (2011). From the Relative Women Disadvantage 
Index to Women's QualityofLife. Journal of Human Development and Capabilities, 12, 
203-233. 
Betti, G. & Verma, V. (2008). Fuzzy measures of the incidence of relative poverty and 
deprivation: a multi-dimensional perspective. Statistical Methods and Applications, 17, 225-
250. 
Beyazit, E. (2010). Evaluating Social Justice in Transport: Lessons to be Learned from the 
Capability Approach. Transport Reviews, 31, 117-134. 
Binder, M. & Broekel, T. (2011). Applying a Nonparametric Efficiency Analysis to Measure 
Conversion Efficiency in Great Britain. Journal of Human Development and Capabilities, 12, 
257-281. 
Binder, M. & Coad, A. (2011). Disentangling the Circularity in Sen's Capability Approach: 
An Analysis of the Co-Evolution of Functioning Achievement and Resources. Soc Indic Res, 
103, 327-355. 
Birch, S. & Donaldson, C. (1987). Applications of cost-benefit analysis to health care: 
Departures from welfare economic theory. Journal of Health Economics, 6, 211-225. 
Birch, S. & Donaldson, C. (2003). Valuing the benefits and costs of health care programmes: 
where's the 'extra' in extra-welfarism? Soc Sci Med, 56, 1121-1133. 
Birch, S. & Gafni, A. (2003). Economics and the evaluation of health care programmes: 
generalisability of methods and implications for generalisability of results. Health Policy, 64, 
207-219. 
Birch, S. & Gafni, A. (2006). Decision rules in economic evaluation. In A.M.Jones (Ed.), The 
Elgar Companion to Health Economics (pp. 492-502). Cheltenham, UK: Edward Elgar. 
Bleichrodt, H. & Quiggin, J. (2013). Capabilities as menus: A non-welfarist basis for QALY 
evaluation. Journal of Health Economics, 32, 128-137. 





Boardman, A. E. (2006). Cost-benefit analysis: concepts and practice. (3rd ed.) Upper Saddle 
River, New Jersey: Pearson/Prentice Hall. 
Boorse, C. (1975). On the Distinction between Disease and Illness. Philosophy & Public 
Affairs, 5, 49-68. 
Boorse, C. (1977). Health as a Theoretical Concept. Philosophy of Science, 44, 542-573. 
Bosch, J. L. & Hunink, M. G. M. (1996). The Relationship between Descriptive and 
Valuational Quality-of-life Measures in Patients with Intermittent Claudication. Medical 
Decision Making, 16, 217-225. 
Brandolini, A. & D'Alessio, G. (1998). Measuring well-being in the functioning space. Rome: 
Banca d'Italia [On-line]. 
Brazier, J., Ratcliffe, J., Salomon, J. A., & Tsuchiya, A. (2007). Measuring and Valuing 
Health Benefits for Economic Evaluation. Oxford: Oxford Uiversity Press. 
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure 
of health from the SF-36. J Health Econ, 21, 271-292. 
Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004a). A comparison of the EQ-5D 
and SF-6D across seven patient groups. Health Economics, 13, 873-884. 
Brazier, J. & Tsuchiya, A. (2010). Preference-based condition-specific measures of health: 
what happens to cross programme comparability? Health Economics, 19, 125-129. 
Brazier, J., Yang, Y., Tsuchiya, A., & Rowen, D. (2010). A review of studies mapping (or 
cross walking) non-preference based measures of health to generic preference-based 
measures. Eur J Health Econ, 11, 215-225. 
Brazier, J. E., Kolotkin, R. L., Crosby, R. D., & Williams, G. R. (2004b). Estimating a 
Preference-Based Single Index for the Impact of Weight on Quality of Life-Lite (IWQOL-
Lite) Instrument from the SF-6D. Value in Health, 7, 490-498. 
Brennan, A., Chick, S. E., & Davies, R. (2006). A taxonomy of model structures for 
economic evaluation of health technologies. Health Economics, 15, 1295-1310. 
Brennan, V. K. & Dixon, S. (2013). Incorporating Process Utility into Quality Adjusted Life 
Years: A Systematic Review of Empirical Studies. Pharmacoeconomics, 31, 677-691. 
Briggs, A., Claxton, K., & Sculpher, M. (2006). Decision Modelling for Health Economic 
Evaluation. Oxford, UK: Oxford University Press. 
Briggs, A., Sculpher, M., & Buxton, M. (1994). Uncertainty in the economic evaluation of 
health care technologies: The role of sensitivity analysis. Health Economics, 3, 95-104. 
Briggs, A. H. & O'Brien, B. J. (2001). The death of cost-minimization analysis? Health 




Brooks, R. (1996). EuroQol: the current state of play. Health Policy, 37, 53-72. 
Broome, J. (2006). Weighing Lives. Oxford: Oxford University Press. 
Broome, J. (2009). Why Economics Needs Ethical Theory. In K.Basu & R. Kanbur (Eds.), 
Arguments for a better world: essays in honor of Amartya Sen (pp. 7-14). Oxford, UK: 
Oxford University Press. 
Brouwer, W. B. F., Culyer, A. J., van Exel, N. J., & Rutten, F. F. H. (2008). Welfarism vs. 
extra-welfarism. Journal of Health Economics, 27, 325-338. 
Brouwer, W. B. F., Niessen, L. W., Postma, M. J., & Rutten, F. F. H. (2005). Need for 
differential discounting of costs and health effects in cost effectiveness analyses. British 
Medical Journal, 331, 446-448. 
Bruce, B. & Fries, J. (2004). Longitudinal comparison of the Health Assessment 
Questionnaire (HAQ) and the Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC). Arthritis Care & Research, 51, 730-737. 
Bruce, B. & Fries, J. F. (2003). The Stanford Health Assessment Questionnaire: a review of 
its history, issues, progress, and documentation. The Journal of Rheumatology, 30, 167-178. 
Burchardt, T. (2009). Agency Goals, Adaptation and Capability Sets. Journal of Human 
Development and Capabilities, 10, 3-19. 
Burchardt, T. & Vizard, P. (2011). 'Operationalizing' the Capability Approach as a Basis for 
Equality and Human Rights Monitoring in Twentyfirstcentury Britain. Journal of Human 
Development and Capabilities, 12, 91-119. 
Button, K. J. (2003). Recent developments in transport economics. Cheltenham: Edward 
Elgar. 
Buxton, M. J., Drummond, M. F., Van Hout, B. A., Prince, R. L., Sheldon, T. A., Szucs, T. et 
al. (1997). Modelling in Economic Evaluation: An Unavoidable Fact of Life. Health 
Economics, 6, 217-227. 
CADTH (2006). Guidelines for the Economic Evaluation of Health Technologies: Canada. 
(3rd ed.) Ottawa: Canadian Agency for Drugs and Technologies in Health. 
Caiels, J., Forder, J., Malley, J., Netten, A., & Windle, K. (2010). Measuring the outcomes of 
low-level services: Final report (Rep. No. Discussion Paper 2699). University of Kent: 
Canterbury: PSSRU. 
Callander, E. J., Schofield, D., & Shrestha, R. (2012a). Capacity for Freedom  Using a New 
Poverty Measure to Look at Regional Differences in Living Standards within Australia. 
Geographical Research, 50, 411-420. 
Callander, E. J., Schofield, D., & Shrestha, R. (2012b). Towards a holistic understanding of 





Callander, E., Schofield, D., & Shrestha, R. (2012c). Capacity for Freedom New Way of 
Measuring Poverty Amongst Australian Children. Child Indicators Research, 5, 179-198. 
Caro, J. J., Nord, E., Siebert, U., McGuire, A., McGregor, M., Henry, D. et al. (2010). The 
efficiency frontier approach to economic evaluation of health-care interventions. Health 
Economics, 19, 1117-1127. 
Carr-Hill, R. A. (1989). Assumptions of the QALY procedure. Social Science & Medicine, 
29, 469-477. 
Chen, Y.-F., Jobanputra, P., Barton, P., Jowett, S., Bryan, S., Clark, W. et al. (2006). A 
systematic review of the effectiveness of adalimumab, etanercept and infliximab for the 
treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-
effectiveness. Health Technology Assessment, 10. 
Chen, Y.-F., Jowett, S., Barton, P., Malottki, K., Hyde, C., Gibbs, J. et al. (2009). Clinical and 
cost-effectiveness of epoprostenol, iloprost, bosentan, silaxentan and sildenafil for pulmonary 
arterial hypertension within their licensed indications: a systematic review and economic 
evaluation. Health Technology Assessment, 13. 
Chiappero-Martinetti, E. (2000). A multidimensional assessment of well-being based on Sen's 
functioning approach. Rivista Internazionale di Scienze Sociali, 108, 207-239. 
Chiappero-Martinetti, E. (2003). Unpaid work and household well-being. In A.Picchio (Ed.), 
Unpaid Work and the Economy: A Gender Analysis of the Standards of Living ( London: 
Routledge. 
Chiappero-Martinetti, E. & Roche, J. (2009). Operationalization of the capability approach, 
from theory to practive: a review of techniques and empirical applications. In E.Chiappero-
Martinetti (Ed.), Debating Global Society: Reach and Limits of the Capability Approach ( 
Milan: Fondazione Giangiacomo Feltinelli. 
Chokshi, D. A. & Farley, T. A. (2012). The Cost-Effectiveness of Environmental Approaches 
to Disease Prevention. New England Journal of Medicine, 367, 295-297. 
Chuang, L.-H. & Kind, P. (2009). Converting the SF-12 into the EQ-5D: An Empirical 
Comparison of Methodologies. Pharmacoeconomics, 27, 491-505. 
Clark, D. & Hulme, D. (2010). Poverty, time and vagueness: integrating the core poverty and 
chronic poverty frameworks. Cambridge Journal of Economics, 34, 347-366. 
Clark, D. A. & Qizilbash, M. (2008). Core Poverty, Vagueness and Adaptation: A New 
Methodology and Some Results for South Africa. The Journal of Development Studies, 44, 
519-544. 
Clark, W., Jobanputra, P., Barton, P., & Burls, A. (2004). The clinical and cost-effectiveness 
of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and 




Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S. et al. (2013). Methods 
for the Estimation of the NICE Cost Effectiveness Threshold (Rep. No. CHE Research Paper 
81). York: Centre for Health Economics. 
Claxton, K., Paulden, M., Gravelle, H., Brouwer, W., & Culyer, A. J. (2011). Discounting and 
decision making in the economic evaluation of health-care technologies. Health Economics, 
20, 2-15. 
Claxton, K., Sculpher, M., McCabe, C., Briggs, A., Akehurst, R., Buxton, M. et al. (2005). 
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. 
Health Economics, 14, 339-347. 
Coast, J. (1992). Reprocessing data to form QALYs. British Medical Journal, 305, 87-90. 
Coast, J. (2004). Is economic evaluation in touch with society's health values? British Medical 
Journal, 329, 1233-1236. 
Coast, J. (2009). Maximisation in extra-welfarism: A critique of the current position in health 
economics. Social Science & Medicine, 69, 786-792. 
Coast, J., Flynn, T. N., Natarajan, L., Sproston, K., Lewis, J., Louviere, J. J. et al. (2008a). 
Valuing the ICECAP capability index for older people. Social Science & Medicine, 67, 874-
882. 
Coast, J., Peters, T., Natarajan, L., Sproston, K., & Flynn, T. (2008b). An assessment of the 
construct validity of the descriptive system for the ICECAP capability measure for older 
people. Quality of Life Research, 17, 967-976. 
Coast, J., Smith, R., & Lorgelly, P. (2008c). Should the capability approach be applied in 
Health Economics? Health Economics, 17, 667-670. 
Coast, J., Smith, R. D., & Lorgelly, P. (2008d). Welfarism, extra-welfarism and capability: 
The spread of ideas in health economics. Social Science & Medicine, 67, 1190-1198. 
Cohen, G. A. (1993). Equaity of What? On Welfare, Goods, and Capabilities. In 
M.C.Nussbaum & A. Sen (Eds.), The Quality of Life (pp. 9-29). Oxford: Oxford University 
Press. 
Comim, F., Qizilbash, M., & Alkire, S. (2008). The Capability Approach: Concepts, 
Measures and Applications. Cambridge, UK: Cambridge University Press. 
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R. et al. (2007a). 
Methadone and buprenorphine for the management of opioid dependence: a systematic review 
and economic evaluation. Health Technology Assessment, 11. 
Connock, M., Stevens, C., Fry-Smith, A., Jowett, S., Fitzmaurice, D., Moore, D. et al. 
(2007b). Clinical effectiveness and cost-effectiveness of different models of managing long-
term oral anticoagulation therapy: a systematic review and economic modelling. Health 




Cookson, R., Drummond, M., & Weatherly, H. (2009). Explicit incorporation of equity 
considerations into economic evaluation of public health interventions. Health Economics, 
Policy and Law, 4, 231-245. 
Cookson, R. (2003). Willingness to pay methods in health care: a sceptical view. Health 
Economics, 12, 891-894. 
Cookson, R. (2005a). QALYs and capabilities: a response to Anand. Health Economics, 14, 
1287-1289. 
Cookson, R. (2005b). QALYs and the capability approach. Health Economics, 14, 817-829. 
Cornelius, N. & Wallace, J. (2010). Cross-Sector Partnerships: City Regeneration and Social 
Justice. Journal of Business Ethics, 94, 71-84. 
Couzner, L., Ratcliffe, J., Lester, L., Flynn, T., & Crotty, M. (2013a). Measuring and valuing 
quality of life for public health research: application of the ICECAP-O capability index in the 
Australian general population. International Journal of Public Health, 58, 367-376. 
Couzner, L., Crotty, M., Norman, R., & Ratcliffe, J. (2013b). A Comparison of the EQ-5D-3L 
and ICECAP-O in an Older Post-Acute Patient Population Relative to the General Population. 
Applied Health Economics and Health Policy, 11, 415-425. 
Couzner, L., Ratcliffe, J., & Crotty, M. (2012). The relationship between quality of life, health 
and care transition: an empirical comparison in an older post-acute population. Health and 
Quality of Life Outcomes, 10, 69. 
CRD (2009). Systematic Reviews: CRD's guidance for undertaking reviews in health care 
University of York: Centre for Reviews and Dissemination. 
Culyer, A. J. (1989). The Normative Economics of Health Care Finance and Provision. 
Oxford Review of Economic Policy, 5, 34-58. 
Culyer, A. J. & Bombard, Y. (2012). An Equity Framework for Health Technology 
Assessments. Medical Decision Making, 32, 428-441. 
Dakin, H., Devlin, N., Feng, Y., Rice, N., O'Neill, P., & Parkin, D. (2013a). The influence of 
cost-effectiveness and other factors on NICE decisions. http://news.ohe.org/2013/04/30/nice-
decisions-exploring-the-influence-of-cost-effectiveness-and-other-factors/ [On-line]. 
Dakin, H., Gray, A., & Murray, D. (2013b). Mapping analyses to estimate EQ-5D utilities and 
responses based on Oxford Knee Score. Quality of Life Research, 22, 683-694. 
Dakin, H., Petrou, S., Haggard, M., Benge, S., & Williamson, I. (2010). Mapping analyses to 
estimate health utilities based on responses to the OM8-30 otitis media questionnaire. Quality 
of Life Research, 19, 65-80. 
Dakin, H. & Wordsworth, S. (2013). Cost-minimisation analysis versus cost-effectiveness 




Daniels, N., Kennedy, B., Kawachi, I., Cohen, J., & Rogers, J. (2000). Is Inequality Bad for 
Our Health? Boston: Beacon Press. 
Daniels, N. (2008). Just health: meeting health needs fairly. Cambridge: Cambridge 
University Press. 
Davis, J., Liu-Ambrose, T., Richardson, C., & Bryan, S. (2013). A comparison of the 
ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or 
substitutes? Quality of Life Research, 22, 969-977. 
de Bekker-Grob, E. W., Ryan, M., & Gerard, K. (2012). Discrete choice experiments in health 
economics: a review of the literature. Health Economics, 21, 145-172. 
Dean, H., Bonvin, J. M., Vielle, P., & Farvaque, N. (2005). Developing capabilities and rights 
in welfare-to-work policies. European Societies, 7, 3-26. 
Decancq, K. & Lugo, M. a. A. (2012). Weights in Multidimensional Indices of Wellbeing: An 
Overview. Econometric Reviews, 32, 7-34. 
Devlin, N. J. & Sussex, J. (2011). Incorporating multiple criteria in HTA: methods and 
processes London: Office of Health Economics. 
Di Tommaso, M. L., Shima, I., Strøm, S., & Bettio, F. (2009). As bad as it gets: Well-being 
deprivation of sexually exploited trafficked women. European Journal of Political Economy, 
25, 143-162. 
Distaso, A. (2007). Well-being and/or quality of life in EU countries through a 
multidimensional index of sustainability. Ecological Economics, 64, 163-180. 
Dolan, P. (1997). Modeling Valuations for EuroQol Health States. Medical Care, 35, 1095-
1108. 
Dolan, P., Gudex, C., Kind, P., & Williams, A. (1995). A Social Tariff for EuroQol: Results 
from a UK General Population Survey (Rep. No. 138). York: Centre for Health Economics. 
Dolan, P. & Kahneman, D. (2008). Interpretations Of Utility And Their Implications For The 
Valuation Of Health. The Economic Journal, 118, 215-234. 
Dolan, P., Lee, H., King, D., & Metcalfe, R. (2009). Valuing health directly. British Medical 
Journal, 339. 
Dolan, P., Loomes, G., Peasgood, T., & Tsuchiya, A. (2005a). Estimating the Intangible 
Victim Costs of Violent Crime. British Journal of Criminology, 45, 958-976. 
Dolan, P., Shaw, R., Tsuchiya, A., & Williams, A. (2005b). QALY maximisation and people's 
preferences: a methodological review of the literature. Health Economics, 14, 197-208. 
Dolan, P. & Tsuchiya, A. (2009). The social welfare function and individual responsibility: 




Donaldson, C., Mason, H., & Shackley, P. (2012). Contingent valuation in health care. In 
A.M.Jones (Ed.), The Elgar Companion to Health Economics (2nd ed., pp. 425-437). 
Cheltenham, UK: Edward Elgar Publishing Limited. 
Dowswell, G., Ryan, A., Taylor, A., Daley, A., Freemantle, N., Brookes, M. et al. (2012). 
Designing an intervention to help people with colorectal adenomas reduce their intake of red 
and processed meat and increase their levels of physical activity: a qualitative study. BMC 
Cancer, 12, 255. 
Draper, N. & Smith, H. (1998). Applied Regression Analysis. (3rd ed.) New York: Wiley. 
Drèze, J. & Sen, A. K. (1989). Hunger and public action. Oxford: Clarendon Press. 
Drummond, M., Brixner, D., Gold, M., Kind, P., McGuire, A., & Nord, E. (2009). Towards a 
Consensus on the QALY. Value in Health, 12, S31-S35. 
Drummond, M., Sculpher, M. J., Torrance, G. W., O'Brien, B. J., & Stoddart, G. L. (2005). 
Methods for the Economic Evaluation of Health Care Programmes. (3rd ed.) Oxford: Oxford 
University Press. 
Drummond, M., Torrance, G., & Mason, J. (1993). Cost-effectiveness league tables: More 
harm than good? Social Science & Medicine, 37, 33-40. 
Edlin, R., McCabe, C., Round, J., Wright, J., Claxton, K., Sculpher, M. et al. (2013). 
Understanding Harris' understanding of CEA: is cost effective resource allocation undone? 
Journal of Health Services Research & Policy, 18, 34-39. 
Evans, D. B., Chisholm, D., & Tan-Torres Edejer, T. (2006). Generalized cost-effectiveness 
analysis: principles and practice. In A.M.Jones (Ed.), The Elgar comapnion to health 
economics (pp. 479-491). Cheltenham, UK: Edward Elgar. 
Feeny, D., Furlong, W., Boyle, M., & Torrance, G. W. (1995). Multi-attribute health status 
classification systems. Health Utilities Index. Pharmacoeconomics, 7, 490-502. 
Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., Depauw, S. et al. (2002). 
Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 
System. Med Care, 40, 113-128. 
Ferrer, R. L. & Carrasco, A. V. (2010). Capability and Clinical Success. The Annals of Family 
Medicine, 8, 454-460. 
Fertig, M. (2012). Educational leadership and the Capabilities Approach: evidence from 
Ghana. Cambridge Journal of Education, 42, 391-408. 
Fischer, K. E. (2012). A systematic review of coverage decision-making on health 
technologiesEvidence from the real world. Health Policy, 107, 218-230. 
Fletcher, K., Mant, J., McManus, R., Campbell, S., Betts, J., Taylor, C. et al. (2010). Protocol 




history of stroke of transient ischaemic attack (TIA) in primary care. BMC Cardiovascular 
Disorders, 10, 37. 
Floro, M. S. & Pichetpongsa, A. (2010). Gender, Work Intensity, and Well-Being of Thai 
Home-Based Workers. Feminist Economics, 16, 5-44. 
Flynn, T. N., Chan, P., Coast, J., & Peters, T. J. (2011). Assessing Quality of Life among 
British Older People Using the ICEPOP CAPability (ICECAP-O) Measure. Applied Health 
Economics and Health Policy, 9, 317-329. 
Flynn, T. N., Louviere, J. J., Peters, T. J., & Coast, J. (2007). Bestworst scaling: What it can 
do for health care research and how to do it. Journal of Health Economics, 26, 171-189. 
Forder, J., Towers, A. M., Caiels, J., Beadle-Brown, J., & Netten, A. (2008). Measuring 
Outcomes in Social Care: Second Interim Report (Rep. No. 2542). University of Kent: 
Canterbury: PSSRU. 
Foster, J., Greer, J., & Thorbecke, E. (1984). A Class of Decomposable Poverty Measures. 
Econometrica, 52, 761-766. 
Foster, J. E., McGillivray, M., & Seth, S. (2012). Composite Indices: Rank Robustness, 
Statistical Association, and Redundancy. Econometric Reviews, 32, 35-56. 
Foster, N., Tooth, S., & Hill, J. (2010). The BEEP study: a trial aiming to improve the 
effectiveness of physiotherapy-led exercise for knee pain in older adults in primary care. 
http://www.controlled-trials.com/ISRCTN93634563 [On-line]. 
Fox-Rushby, J. & Hanson, K. (2001). Calculating and presenting disability adjusted life years 
(DALYs) in cost-effectiveness analysis. Health Policy and Planning, 16, 326-331. 
Fox-Rushby, J. A. (2002). Disability Adjusted Life Years (DALYs) for decision-making? An 
overview of the literature London: Office of Health Economics. 
Frew, E. J. (2010). Benefit assessment for cost-benefit analysis studies in health care using 
contingent valuation methods. In E.McIntosh, P. M. Clarke, E. J. Frew, & J. J. Louviere 
(Eds.), Applied Methods of Cost-Benefit Analysis in Health Care (pp. 97-118). Oxford, UK: 
Oxford University Press. 
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980). Measurement of patient 
outcome in arthritis. Arthritis & Rheumatism, 23, 137-145. 
Fryback, D., Lawrence, W., Martin, P., Klein, R., & Klein, B. (1997). Predicting Quality of 
Well-being Scores from the SF-36: Results from the Beaver Dam Health Outcomes Study. 
Medical Decision Making, 17, 1-9. 
Fukuda-Parr, S. (2003). The human development paradigm: operationalizing Sen's ideas on 




Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001). The Health Utilities 
Index (HUI) system for assessing health-related quality of life in clinical studies. Annals of 
Medicine, 33, 375-384. 
Gafni, A. (1994). The standard gamble method: what is being measured and how it is 
inerpreted. Health Services Research, 29, 207-224. 
Gafni, A. (2006). Economic Evaluation of Health-care Programmes: Is CEA Better than 
CBA? Environmental & Resource Economics, 34, 407-418. 
Gafni, A., Walter, S., & Birch, S. (2013). Uncertainty and the decision maker: assessing and 
managing the risk of undesirable outcomes. Health Economics, 22, 1287-1294. 
Gandjour, A. (2010). Theoretical Foundation of Patient v. Population Preferences in 
Calculating QALYs. Medical Decision Making, 30, E57-E63. 
Garber, A. M., Weinstein, M. C., Torrance, G. W., & Kamlet, M. S. (1996). Theoretical 
Foundations of Cost-Effectiveness Analysis. In M.R.Gold, J. E. Siegel, L. B. Russell, & M. C. 
Weinstein (Eds.), Cost-Effectiveness in Health and Medicine (pp. 25-53). Oxford, UK: 
Oxford University Press. 
Gardoni, P. & Murphy, C. (2010). Gauging the societal impacts of natural disasters using a 
capability approach. Disasters, 34, 619-636. 
Gasper, D. (2007). What is the capability approach?: Its core, rationale, partners and dangers. 
The Journal of Socio-Economics, 36, 335-359. 
Gerard, K. (1993). Setting priorities in the new NHS: can purchasers use cost-utility 
information? Health Policy, 25, 109-125. 
Gerard, K. & Mooney, G. (1993). Qaly league tables: Handle with care. Health Economics, 2, 
59-64. 
Ghomrawi, H., Mandl, L., Rutledge, J., Alexiades, M., & Mazumdar, M. (2011). Is there a 
role for expectation maximization imputation in addressing missing data in research using 
WOMAC questionnaire? Comparison to the standard mean approach and a tutorial. BMC 
Musculoskeletal Disorders, 12, 109. 
Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-Effectiveness in 
Health and Medicine. Oxford: Oxford University Press. 
Gravelle, H., Brouwer, W., Niessen, L., Postma, M., & Rutten, F. (2007). Discounting in 
economic evaluations: stepping forward towards optimal decision rules. Health Economics, 
16, 307-317. 
Gravelle, H. & Smith, D. (2001). Discounting for health effects in costbenefit and cost-




Gray, A. M., Rivero-Arias, O., & Clarke, P. M. (2006). Estimating the association between 
SF-12 responses and EQ-5D utility values by response mapping. Medical Decision Making, 
26, 18-29. 
Greco, G., Skordis, J., & Mills, A. (2009). Methodological challenges for developing an 
outcome measure based on Sen's Capability approach for assessing women's wellbeing in 
rural Malawi Sheffield, UK: Health Economists' Study Group. 
Grewal, I., Lewis, J., Flynn, T., Brown, J., Bond, J., & Coast, J. (2006). Developing attributes 
for a generic quality of life measure for older people: Preferences or capabilities? Social 
Science & Medicine, 62, 1891-1901. 
Gries, T. & Naudé, W. (2011). Entrepreneurship and human development: A capability 
approach. Journal of Public Economics, 95, 216-224. 
Grieve, R., Grishchenko, M., & Cairns, J. (2009). SF-6D versus EQ-5D: reasons for 
differences in utility scores and impact on reported cost-utility. European Journal of Health 
Economics, 10, 15-23. 
Grootendorst, P., Marshall, D., Pericak, D., Bellamy, N., Feeny, D., & Torrance, G. W. 
(2007). A model to estimate health utilities index mark 3 utility scores from WOMAC index 
scores in patients with osteoarthritis of the knee. The Journal of Rheumatology, 34, 534-542. 
Grunfeld, H., Hak, S., & Pin, T. (2011). Understanding benefits realisation of iREACH from 
a capability approach perspective. Ethics and Information Technology, 13, 151-172. 
Gudex, C. & Kind, P. (1988). The QALY toolkit (Rep. No. 38). York: Centre for Health 
Economics (CHE). 
Hadorn, D. C. (1991a). Setting health care priorities in Oregon: Cost-effectiveness meets the 
rule of rescue. JAMA: The Journal of the American Medical Association, 265, 2218-2225. 
Hadorn, D. C. (1991b). The role of public values in setting health care priorities. Social 
Science & Medicine, 32, 773-781. 
Haefeli, M., Elfering, A., McIntosh, E., Gray, A., Sukthankar, A., & Boos, N. (2008). A Cost-
Benefit Analysis Using Contingent Valuation Techniques: A Feasibility Study in Spinal 
Surgery. Value in Health, 11, 575-588. 
Hammitt, J. K. (2002). QALYs Versus WTP. Risk Analysis, 22, 985-1001. 
Hanley, N. & Barbier, E. B. (2009). Pricing nature: cost-benefit analysis and environmental 
policy. Cheltenham, UK: Edward Elgar. 
Harreveld, R. & Singh, M. (2008). Amartya Sen's Capability Approach and the Brokering of 
Learning Provision for Young Adults. Vocations and Learning, 1, 211-226. 




Hartley, R. J., Keen, E. M., Large, J. A., & Tedd, L. A. (1990). Search Strategies. In Online 
Searching: Principles and Practice (pp. 153-173). London: Bowker-Saur. 
Hatakka, M. & Lagsten, J. (2011). The capability approach as a tool for development 
evaluation  analyzing students' use of internet resources. Information Technology for 
Development, 18, 23-41. 
Hauber, A. B. (2009). Healthy-years equivalent: wounded but not yet dead. Expert Review of 
Pharmacoeconomics & Outcomes Research, 9, 265-269. 
Hawthorne, G., Richardson, J., & Osborne, R. (1999). The Assessment of Quality of Life 
(AQoL) instrument: a psychometric measure of Health-Related Quality of Life. Quality of 
Life Research, 8, 209-224. 
Henderson, C., Knapp, M., Fernández, J.-L., Beecham, J., Hirani, S. P., Cartwright, M. et al. 
(2013). Cost effectiveness of telehealth for patients with long term conditions (Whole 
Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a 
pragmatic, cluster randomised controlled trial. British Medical Journal, 346. 
Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D. et al. (2011). 
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). 
Quality of Life Research, 20, 1727-1736. 
Hicks, J. R. (1939). The Foundations of Welfare Economics. The Economic Journal, 49, 696-
712. 
HM Treasury (2003). The Green Book: Appraisal and Evaluation in Central Government 
London: TSO: HM Treasury. 
Hobson, B. & Fahlén, S. (2009). Competing Scenarios for European Fathers: Applying Sen's 
Capabilities and Agency Framework to WorkFamily Balance. The ANNALS of the American 
Academy of Political and Social Science, 624, 214-233. 
Hobson, B., Fahlén, S., & Takács, J. (2011). Agency and Capabilities to Achieve a Work-Life 
Balance: A Comparison of Sweden and Hungary. Social Politics: International Studies in 
Gender, State & Society, 18, 168-198. 
Holland, R., Matheson, C., Anthony, G., Roberts, K., Priyardarshi, S., MacRae, A. et al. 
(2012). A pilot randomised controlled trial of brief versus twice weekly versus standard 
supervised consumption in patients on opiate maintenance treatment. Drug and Alcohol 
Review, 31, 483-491. 
Holmes, D. (2013). Report triggers quibbles over QALYs, a staple for health metrics. Nature 
Medicine, 19. 
Hopper, K. (2007). Rethinking social recovery in schizophrenia: What a capabilities approach 




Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The Health Utilities Index 
(HUI): concepts, measurement properties and applications. Health and Quality of Life 
Outcomes, 1, 54. 
Hulme, D. & McKay, A. (2008). Identifying and Measuring Chronic Poverty: Beyond 
Monetary Measures? In N.Kakwani & J. Silber (Eds.), The Many Dimensions of Poverty ( 
Basingstoke: Palgrave Macmillan. 
Human Development Report (2013). The Rise of the South: Human Progress in a Diverse 
World United Nations Development Programme. 
Hunt, E. K. (2002). History of economic thought: a critical perspective. (2nd ed.) New York: 
M. E. Sharpe. 
Hurley, J. (1998). Welfarism, Extra-Welfarism and Evaluative Economic Analysis. In 
M.L.Barer, T. E. Getzen, & G. L. Stoddart (Eds.), Health, health care and health economics: 
perspectives on distribution (pp. 373-395). Chicester, England: John Wiley & Sons Ltd. 
Hurley, J. (2000). An overview of the normative economics of the health sector. In (1 ed., pp. 
55-118). Elsevier. 
Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997). Measuring health-related 
quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-
5D). Rheumatology, 36, 551-559. 
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D. et al. 
(2013). Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. 
BMC Medicine, 11, 80. 
Hutubessy, R., Chisholm, D., & Tan-Torres Edejer, T. (2003). Generalized cost-effectiveness 
analysis for national-level priority-setting in the health sector. Cost Effectiveness and 
Resource Allocation, 1, 8. 
Ibrahim, S. & Alkire, S. (2007). Agency and Empowerment: A Proposal for Internationally 
Comparable Indicators. Oxford Development Studies, 35, 379-403. 
James, J. (2006). The Internet and poverty in developing countries: Welfare economics versus 
a functionings-based approach. Futures, 38, 337-349. 
Jit, M., Barton, P., Chen, Y.-F., Uthman, O., Aveyard, P., & Meads, C. (2009). School-based 
interventions to prevent the uptake of smoking among children and young people: cost-
effectiveness model London: National Institute for Health and Clinical Excellence. 
Jobanputra, P., Barton, P., Bryan, S., & Burls, A. (2002). The effectiveness of infliximab and 
etanercept for the treatment of rheumatoid arthritis: a systematic review and economic 
evaluation. Health Technology Assessment, 6. 
Johnson, F. R. (2009). Editorial: Moving the QALY Forward or Just Stuck in Traffic? Value 




Jordan, K., Bulloch, H., & Buchanan, G. (2010). Statistical equality and cultural difference in 
Indigenous wellbeing frameworks: A new expression of an enduring debate. Australian 
Journal of Social Issues, 45, 333-362. 
Kaambwa, B., Bryan, S., Barton, P., Parker, H., & Martin, G. (2006). Relationship between 
the EuroQol-5d and Barthel Index - examining the use of proxy outcome measures for older 
people. In Health Economists' Study Group (HESG) York, UK. 
Kaambwa, B., Billingham, L., & Bryan, S. (2013). Mapping utility scores from the Barthel 
index. European Journal of Health Economics, 14, 231-241. 
Kaldor, N. (1939). Welfare Propositions of Economics and Interpersonal Comparisons of 
Utility. The Economic Journal, 49, 549-552. 
Kelly, A. (2012). Sen and the art of educational maintenance: evidencing a capability, as 
opposed to an effectiveness, approach to schooling. Cambridge Journal of Education, 42, 
283-296. 
Kelly, M., Morgan, A., Ellis, S., Younger, T., Huntley, J., & Swann, C. (2010). Evidence 
based public health: A review of the experience of the National Institute of Health and 
Clinical Excellence (NICE) of developing public health guidance in England. Social Science 
& Medicine, 71, 1056-1062. 
Kerstenetzky, C. L. & Santos, L. (2009). Poverty as Deprivation of Freedom: The Case of 
Vidigal Shantytown in Rio de Janeiro. Journal of Human Development and Capabilities, 10, 
189-211. 
Kinghorn, P. B. (2010). Developing a Capability Approach to Measure and Value Quality of 
Life: An application to chronic pain. PhD Thesis University of East Anglia. 
Kivunike, F. N., Ekenberg, L., Danielson, M., & Tusubira, F. F. (2011). Perceptions of the 
role of ICT on quality of life in rural communities in Uganda. Information Technology for 
Development, 17, 61-80. 
Klarman, H. E., Francis, J. O., & Rosenthal, G. D. (1968). Cost Effectiveness Analysis 
Applied to the Treatment of Chronic Renal Disease. Medical Care, 6, 48-54. 
Klasen, S. (2000). Measuring poverty and deprivation in South Africa. Review of Income and 
Wealth, 46, 33-58. 
Kleine, D. (2010). ICT4WHAT?Using the choice framework to operationalise the capability 
approach to development. Journal of International Development, 22, 674-692. 
Kleine, D. (2011). The capability approach and the 'medium of choice': steps towards 
conceptualising information and communication technologies for development. Ethics and 
Information Technology, 13, 119-130. 
Kleine, D., Light, A., & Montero, M. J. (2012). Signifiers of the life we value?  considering 
human development, technologies and Fair Trade from the perspective of the capabilities 




Klugman, J. (2010). Human Development Report 2010. The Real Wealth of Nations: 
Pathways to Human Development New York, NY 10017: United Nations Development 
Programme. 
Klugman, J. (2011). Human Development Report 2011. Sustainability and Equity: A Better 
Future for All New York, NY10017: United Nations Development Programme. 
Kreps, D. M. (1979). A Representation Theorem for "Preference for Flexibility". 
Econometrica, 47, 565-577. 
Krishnakumar, J. & Ballon, P. (2008). Estimating Basic Capabilities: A Structural Equation 
Model Applied to Bolivia. World Development, 36, 992-1010. 
Krishnakumar, J. & Nagar, A. L. (2008). On Exact Statistical Properties of Multidimensional 
Indices Based on Principal Components, Factor Analysis, MIMIC and Structural Equation 
Models. Social Indicators Research, 86, 481-496. 
Kuklys, W. (2005). Amartya Sen's Capability Approach: Theoretical Insights and Empirical 
Applications. Berlin: Springer-Verlag. 
Kuklys, W. & Robeyns, I. (2005). Sen's Capability Approach to Welfare Economics. In 
Amartya Sen's Capability Approach (pp. 9-30). Springer-Verlag, Berlin. 
Kvien, T. K. (2004). Epidemiology and Burden of Illness of Rheumatoid Arthritis. 
Pharmacoeconomics, 22, S1-S12. 
Lavaque-Manty, M. (2001). Food, Functioning and Justice: From Famines to Eating 
Disorders. Journal of Political Philosophy, 9, 150-167. 
Le, Q. A. & Doctor, J. N. (2011). Probabilistic Mapping of Descriptive Health Status 
Responses Onto Health State Utilities Using Bayesian Networks: An Empirical Analysis 
Converting SF-12 Into EQ-5D Utility Index in a National US Sample. Medical Care, 49, 451-
460. 
Lessmann, O. (2009). Conditions of Life, Functionings and Capability: Similarities, 
Differences and Complementary Features. Journal of Human Development and Capabilities, 
10, 279-298. 
Lewis, F. (2012a). Auditing Capability and Active Living in the Built Environment. Journal 
of Human Development and Capabilities, 13, 295-315. 
Lewis, F. (2012b). Toward a general model of built environment audits. Planning Theory, 11, 
44-65. 
Lewis, J. & Giullari, S. (2005). The adult worker model family, gender equality and care: the 
search for new policy principles and the possibilities and problems of a capabilities approach. 
Economy and Society, 34, 76-104. 
Lin, F. J., Longworth, L., & Pickard, A. (2013). Evaluation of content on EQ-5D as compared 




Lipscomb, J., Drummond, M., Fryback, D., Gold, M., & Revicki, D. (2009). Retaining, and 
Enhancing, the QALY. Value in Health, 12, S18-S26. 
Liu, L., Strawderman, R. L., Cowen, M. E., & Shih, Y. C. (2010). A flexible two-part random 
effects model for correlated medical costs. Journal of Health Economics, 29, 110-123. 
Longworth, L. & Rowen, D. (2013). Mapping to Obtain EQ-5D Utility Values for Use in 
NICE Health Technology Assessments. Value in Health, 16, 202-210. 
Longworth, L. & Rowen, D. (2011). NICE DSU Technical Support Document 10: The use of 
mapping methods to estimate health state utility values. 
Loomes, G. & McKenzie, L. (1989). The use of QALYs in health care decision making. 
Social Science & Medicine, 28, 299-308. 
Lord, J., Laking, G., & Fischer, A. (2004). Health care resource allocation: is the threshold 
rule good enough? Journal of Health Services Research & Policy, 9, 237-245. 
Lorgelly, P. K., Lawson, K. D., Fenwick, E. A., & Briggs, A. H. (2010a). Outcome 
measurement in economic evaluations of public health interventions: a role for the capability 
approach? International journal of environmental research and public health, 7, 2274-2289. 
Lorgelly, P. K., Lorimer, K., Fenwick, E. A., & Briggs, A. H. (2008). The Capability 
Approach: Developing an Instrument for Evaluating Public Health Interventions: Final 
Report Glasgow, UK: Glasgow Centre for Population Health. 
Lorgelly, P. K., Coast, J., & Smith, R. D. (2010b). Concepts of capability and overlooked 
applications. American Journal of Public Health, 100, 1823-1824. 
Lovibond, K., Jowett, S., Barton, P., Caulfield, M., Heneghan, C., Hobbs, F. R. et al. (2011). 
Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a 
modelling study. The Lancet, 378, 1219-1230. 
Mabsout, R. (2011). Capability and Health Functioning in Ethiopian Households. Social 
Indicators Research, 101, 359-389. 
Maddox, B. & Esposito, L. (2011). Sufficiency Re-examined: A Capabilities Perspective on 
the Assessment of Functional Adult Literacy. The Journal of Development Studies, 47, 1315-
1331. 
Maguire, C., Donovan, C., Mishook, J., Gaillande, G. d., & Garcia, I. (2012). Choosing a life 
one has reason to value: the role of the arts in fostering capability development in four small 
urban high schools. Cambridge Journal of Education, 42, 367-390. 
Makai, P., Brouwer, W., Koopmanschap, M., & Nieboer, A. (2012). Capabilities and quality 
of life in Dutch psycho-geriatric nursing homes: an exploratory study using a proxy version of 




Makai, P., Koopmanschap, M., Brouwer, W., & Nieboer, A. (2013). A validation of the 
ICECAP-O in a population of post-hospitalized older people in the Netherlands. Health and 
Quality of Life Outcomes, 11. 
Malottki, K., Barton, P., Tsourapas, A., Uthman, O., Liu, Z., Routh, K. et al. (2011). 
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid 
arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and 
economic evaluation. Health Technology Assessment, 15. 
Mann, J. M., Gostin, L., Gruskin, S., Brennan, T., Lazzarini, Z., & Fineberg, H. V. (1994). 
Health and Human Rights. Health and Human Rights, 1, 6-23. 
Mann, R., Brazier, J., & Tsuchiya, A. (2009). A comparison of patient and general population 
weightings of EQ-5D dimensions. Health Economics, 18, 363-372. 
Manning, W. G., Morris, C. N., Newhouse, J. P., Orr, L. L., Duan, N., Keeler, E. B. et al. 
(1981). A Two-Part Model of the Demand for Medical Care: Preliminary Results from the 
Health Insurance Study. In J.van der Gaag & M. Perlman (Eds.), Health, Economics, and 
Health Economics (pp. 103-123). Amsterdam: North-Holland. 
Marra, C., Bansback, N., Anis, A., & Shojania, K. (2011). Introduction to economic modeling 
for clinical rheumatologists: application to biologic agents in rheumatoid arthritis. Clinical 
Rheumatology, 30, S9-S18. 
Matsuyama, J. & Mori, K. (2011). Freedom And Achievement Of Well-Being And Adaptive 
Dynamics Of Capabilities. Metroeconomica, 62, 494-511. 
Mauskopf, J., Paul, J., Grant, D., & Stergachis, A. (1998). The Role of CostConsequence 
Analysis in Healthcare DecisionMaking. Pharmacoeconomics, 13, 277-288. 
Maynard, A. (1991). Developing the Health Care Market. The Economic Journal, 101, 1277-
1286. 
McAllister, M., Dunn, G., Payne, K., Davies, L., & Todd, C. (2012). Patient empowerment: 
The need to consider it as a measurable patient-reported outcome for chronic conditions. BMC 
Health Services Research, 12, 157. 
McCabe, C., Claxton, K., & Culyer, A. J. (2008). The NICE Cost-Effectiveness Threshold: 
What it is and What that Means. Pharmacoeconomics, 26, 733-744. 
McCabe, C., Claxton, K., & Tsuchiya, A. (2005a). Orphan drugs and the NHS: should we 
value rarity? British Medical Journal, 331. 
McCabe, C., Stevens, K., Roberts, J., & Brazier, J. (2005b). Health state values for the HUI 2 
descriptive system: results from a UK survey. Health Economics, 14, 231-244. 
McIntosh, E., Clarke, P. M., Frew, E. J., & Louviere, J. J. (2010). Applied Methods of Cost-




McKie, J. & Richardson, J. (2003). The Rule of Rescue. Social Science & Medicine, 56, 
2407-2419. 
McLean, M. & Walker, M. (2012). The possibilities for university-based public-good 
professional education: a case-study from South Africa based on the 'capability approach'. 
Studies in Higher Education, 37, 585-601. 
Mehrez, A. & Gafni, A. (1989). Quality-adjusted Life Years, Utility Theory, and Healthy-
years Equivalents. Medical Decision Making, 9, 142-149. 
Menzel, P., Dolan, P., Richardson, J., & Olsen, J. A. (2002). The role of adaptation to 
disability and disease in health state valuation: a preliminary normative analysis. Social 
Science & Medicine, 55, 2149-2158. 
Mishan, E. J. (1988). Cost-benefit analysis: an informal introduction. (4th ed.) Unwin 
Hyman, London. 
Mitchell, P. M., Roberts, T. E., Barton, P. M., Pollard, B. S., & Coast, J. (2013). Predicting 
the ICECAP-O Capability Index from the WOMAC Osteoarthritis Index: Is Mapping onto 
Capability from Condition-Specific Health Status Questionnaires Feasible? Medical Decision 
Making, 33, 547-557. 
Mooney, G. (2009). Challenging Health Economics. Oxford, UK: Oxford University Press. 
Mooney, G. & Ryan, M. (1993). Agency in health care: Getting beyond first principles. 
Journal of Health Economics, 12, 125-135. 
Morris, S., Devlin, N., & Parkin, D. (2007). Economic Analysis in Health Care. John Wiley & 
Sons, Ltd. 
Morris, S., Devlin, N., Parkin, D., & Spencer, A. (2012). Economic Analysis in Health Care. 
(2nd ed.) Cichester: John Wiley and Sons, Ltd. 
Mortimer, D. & Segal, L. (2008). Comparing the Incomparable? A Systematic Review of 
Competing Techniques for Converting Descriptive Measures of Health Status into QALY-
Weights. Medical Decision Making, 28, 66-89. 
Mrcela, A. K. & Sadar, N. C. (2011). Social Policies Related to Parenthood and Capabilities 
of Slovenain Parents. Social Politics, 18, 199-231. 
Murphy, C. & Gardoni, P. (2008). The Acceptability and the Tolerability of Societal Risks: A 
Capabilities-based Approach. Science and Engineering Ethics, 14, 77-92. 
Murphy, C. & Gardoni, P. (2010). Assessing capability instead of achieved functionings in 
risk analysis. Journal of Risk Research, 13, 137-147. 
Murray, C. & Lopez, A. (1996). The Global Burden of Disease: a comprehensive assessment 
of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 




Netten, A., Burge, P., Malley, J., Potoglou, D., Towers, A.-M., Brazier, J. et al. (2012). 
Outcomes of social care for adults: developing a preference-weighted measure. Health 
Technology Assessment, 16, 1-184. 
Netten, A., McDaid, D., Fernàndez, Forder, J., Knapp, M., Matosevic, T. et al. (2005). 
Measuring and understanding social services outputs (Rep. No. 2132/3). University of Kent: 
Canterbury: PSSRU. 
Netten, A., Ryan, M., Smith, P., Skatun, D., Healey, A., Knapp, M. et al. (2002). The 
Development of a Measure of Social Care Outcome for Older People (Rep. No. 1690/2). 
University of Kent: Canterbury: PSSRU. 
Neumann, P. J., Chi-Hui, F., & Cohen, J. T. (2009). 30 Years of Pharmaceutical Cost-Utility 
Analyses: Growth, Diversity and Methodological Improvement. Pharmacoeconomics, 27, 
861-572. 
Neumann, P. J. & Greenberg, D. (2009). Is The United States Ready For QALYs? Health 
Affairs, 28, 1366-1371. 
Nguefack-Tsague, G., Klasen, S., & Zucchini, W. (2011). On Weighting the Components of 
the Human Development Index: A Statistical Justification. Journal of Human Development 
and Capabilities, 12, 183-202. 
NICE (2001). Guidance for Manufacturers and Sponsors (Rep. No. 5). London: National 
Institute for Clinical Excellence. 
NICE (2004). Guide to the methods of technology appraisal London: National Institute for 
Clinical Excellence (NICE). 
NICE (2008). Guide to the methods of technology appraisal (2nd ed.) London: National 
Institute for Health and Clinical Excellence. 
NICE (2009a). Assessing cost effectiveness. In The guidelines manual (3rd ed., pp. 81-91). 
London: National Institute for Health and Clinical Excellence (NICE). 
NICE (2009b). Methods for the development of NICE public health guidance. (2nd ed.) 
London, UK: National Institute for Health and Clinical Excellence (NICE). 
NICE (2011). Supporting investment in public health: Reivew of methods for assessing cost 
effectiveness, cost impact and return on investment London: National Institute for Health and 
Clinical Excellence (NICE). 
NICE (2013). Guide to the methods of technology appraisal 2013 London: National Institute 
for Health and Care Excellence (NICE). 
Nikiema, B., Haddad, S., & Potvin, L. (2012). Measuring women's perceived ability to 




Norcia, M., Rissotto, A., & Noci, E. (2012). Measuring Poverty Through Capabilities: 
Prelminiary Results of a Resarch in Italy. OIDA International Journal of Sustainable 
Development, 4, 39-46. 
Nord, E. (1992). An Alternative To QALYs: The Saved Young Life Equivalent (SAVE). 
British Medical Journal, 305, 875-877. 
Nord, E. (1995). The Person-trade-off Approach to Valuing Health Care Programs. Medical 
Decision Making, 15, 201-208. 
Nord, E. (1999). Cost-Value Analysis in Health Care: Making Sense out of QALYs. 
Cambridge, UK: Cambridge University Press. 
Nord, E. (2012). Measuring concerns for severity: Re-examination of a health scale with 
purported equal interval properties. Health Policy, 105, 312-316. 
Nord, E., Enge, A. U., & Gundersen, V. (2010). QALYs: is the value of treatment 
proportional to the size of the health gain? Health Economics, 19, 596-607. 
Nord, E., Pinto, J. L., Richardson, J., Menzel, P., & Ubel, P. (1999). Incorporating societal 
concerns for fairness in numerical valuations of health programmes. Health Economics, 8, 25-
39. 
Nordenfelt, L. (1995). On the Nature of Health: An Action-Theoretic Approach. (2nd ed.) 
Dordrecht, The Netherlands: Kluwer Academic Publishers. 
Nordenfelt, L. (2007). The concepts of health and illness revisited. Medicine, Health Care 
and Philosophy, 10, 5-10. 
Notten, G. & Roelen, K. (2012). A New Tool for Monitoring (Child) Poverty: Measures of 
Cumulative Deprivation. Child Indicators Research, 5, 335-355. 
Nussbaum, M. C. (2000). Women and human development: The capabilities approach. 
Cambridge: Cambridge University Press. 
Nussbaum, M. C. (2011). Creating Capabilities: The Human Development Approach. 
Harvard University Press. 
Nussbaumer, P., Bazilian, M., & Modi, V. (2012). Measuring energy poverty: Focusing on 
what matters. Renewable and Sustainable Energy Reviews, 16, 231-243. 
O'Shea, E., Gannon, B., & Kennelly, B. (2008). Eliciting preferences for resource allocation 
in mental health care in Ireland. Health Policy, 88, 359-370. 
Olsen, J. A. & Donaldson, C. (1998). Helicopters, hearts and hips: Using willingness to pay to 
set priorities for public sector health care programmes. Social Science & Medicine, 46, 1-12. 
Olson, K. (2002). Recognizing Gender, Redistributing Labor. Social Politics: International 




Palmer, S. & Torgerson, D. J. (1999). Definitions of efficiency. British Medical Journal, 318, 
1136. 
Parks, S. (2012). Divergent pathways of development: a comparative case study of human 
well-being in two Thai provinces. Environment and Planning C: Government and Policy, 30, 
891-909. 
Payne, K., McAllister, M., & Davies, L. M. (2013). Valuing the economic benefits of 
complex interventions: when maximising health is not sufficient. Health Economics, 22, 258-
271. 
Peris, J., Farinas, S., Lopez, E., & Boni, A. (2012). Expanding collective agency in rural 
indigenious communities in Guatemala: a case for El Almanario approach. International 
Development Planning Review, 34, 83-102. 
Perrons, D. (2012). Regional performance and inequality: linking economic and social 
development through a capabilities approach. Cambridge Journal of Regions, Economy and 
Society, 5, 15-29. 
Petrou, S. & Gray, A. (2011). Economic evaluation using decision analytical modelling: 
design, conduct, analysis, and reporting. British Medical Journal, 342. 
Pharmaceutical Benefits Advisory Committee (2008). Guidelines for preparing submissions 
to the Pharmaceutical Benefits Advisory Committee. (4.3 ed.) Canberra: Australian 
Government: Department of Health and Ageing. 
Phipps, S. (2002). The WellBeing of Young Canadian Children in International Perspective: 
A Functionings Approach. Review of Income and Wealth, 48, 493-515. 
Pollard, B., Dixon, D., Dieppe, P., & Johnston, M. (2009). Measuring the ICF components of 
impairment, activity limitation and participation restriction: an item analysis using classical 
test theory and item response theory. Health and Quality of Life Outcomes, 7, 1-20. 
Qizilbash, M. (2002). A note on the measurement of poverty and vulnerability in the South 
African context. Journal of International Development, 14, 757-772. 
Qizilbash, M. (2003). Vague language and precise measurement: the case of poverty. Journal 
of Economic Methodology, 10, 41-58. 
Rawles, J. (1989). Castigating QALYs. Journal of Medical Ethics, 15, 147. 
Reinhardt, U. E. (2011). Is There a Market for Ruger's 'Right to Health'? Journal of Human 
Development and Capabilities, 12, 557-563. 
Reitinger, C., Dumke, M., Barosevcic, M., & Hillerbrand, R. (2011). A conceptual framework 
for impact assessment within SLCA. The International Journal of Life Cycle Assessment, 16, 
380-388. 
Renouard, C. (2011). Corporate Social Responsibility, Utilitarianism, and the Capabilities 




Richardson, J., McKie, J., & Bariola, E. (2011). Review and Critique of Health Related Mulit 
Attribute Utility Instruments (Rep. No. 64). Melbourne, Australia: Monash University. 
Rivero-Arias, O., Ouellet, M., Gray, A., Wolstenholme, J., Rothwell, P. M., & Luengo-
Fernandez, R. (2010). Mapping the Modified Rankin Scale (mRS) Measurement into the 
Generic EuroQol (EQ-5D) Health Outcome. Medical Decision Making, 30, 341-354. 
Roberts, J., Brazier, J., & Tsuchiya, A. (2005). Mapping the Overactive Bladder 
Questionnaire to SF6D indices stage 2: final results.   
Ref Type: Unpublished Work 
Roberts, T. E., Robinson, S., Barton, P. M., Bryan, S., McCarthy, A., Macleod, J. et al. 
(2007). Cost effectiveness of home based population screening for Chlamydia trachomatis in 
the UK: economic evaluation of chlamydia screening studies (ClaSS) project. British Medical 
Journal, 335. 
Roberts, T. E., Tsourapas, A., Middleton, L. J., Champaneria, R., Daniels, J. P., Cooper, K. G. 
et al. (2011). Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine 
system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. 
British Medical Journal, 342. 
Roberts, T., Henderson, J., Mugford, M., Bricker, L., Neilson, J., & Garcia, J. (2002). 
Antenatal ultrasound screening for fetal abnormalities: a systematic review of studies of cost 
and cost effectiveness. British Journal of Obstetrics and Gynaecology, 109, 44-56. 
Robeyns, I. (2003). Sen's capability approach and gender inequality: selecting relevant 
capabilities. Feminist Economics, 9, 61-92. 
Robeyns, I. (2005a). Assessing global poverty and inequality: income, resources, and 
capabilities. Metaphilosophy, 36, 30-49. 
Robeyns, I. (2005b). The Capability Approach: a theoretical survey. Journal of Human 
Development, 6, 93-117. 
Robeyns, I. (2006). The Capability Approach in Practice. Journal of Political Philosophy, 14, 
351-376. 
Robinson, J. C. (1986). Philosophical Origins of the Economic Valuation of Life. The 
Milbank Quarterly, 64, 133-155. 
Roelen, K., Gassmann, F., & Neubourg, C. (2010). Child Poverty in Vietnam: Providing 
Insights Using a Country-Specific and Multidimensional Model. Social Indicators Research, 
98, 129-145. 
Rosano, A., Mancini, F., & Solipaca, A. (2009). Poverty in People with Disabilities: 
Indicators from the Capability Approach. Social Indicators Research, 94, 75-82. 





Rouse, P. C., Ntoumanis, N., Duda, J. L., Jolly, K., & Williams, G. C. (2011). In the 
beginning: Role of autonomy support on the motivation, mental health and intentions of 
participants entering an exercise referral scheme. Psychology & Health, 26, 729-749. 
Rowen, D., Brazier, J., Tsuchiya, A., & Alava, M. n. H. (2012). Valuing states from multiple 
measures on the same visual analogue sale: a feasibility study. Health Economics, 21, 715-
729. 
Ruger, J. P. (1998). Aristotelian Justice and Health Policy: Capability and Incompletely 
Theorized Agreements. Ph.D. dissertation Harvard University. 
Ruger, J. P. (2004). Health and social justice. The Lancet, 364, 1075-1080. 
Ruger, J. P. (2006). Ethics and governance of global health inequalities. Journal of 
Epidemiology and Community Health, 60, 998-1002. 
Ruger, J. P. (2010a). Health and Social Justice. Oxford: Oxford University Press. 
Ruger, J. P. (2010b). Health Capability: Conceptualization and Operationalization. American 
Journal of Public Health, 100, 41-49. 
Ruger, J. P. (2011). Shared Health Governance. The American Journal of Bioethics, 11, 32-
45. 
Ruger, J. P. (2012). Fair Enough? Inviting Inequities in State Health Benefits. New England 
Journal of Medicine, 366, 681-683. 
Ruggeri Laderchi, C. (1999). The many dimensions of poverty in Peru: theoretical debates 
and empirical evidence. Queen Elizabeth House Working Paper Series 29.  
Ref Type: Unpublished Work 
Ruggeri Laderchi, C. (1997). Poverty and its many dimensions: The role of income as an 
indicator. Oxford Agrarian Studies, 25, 345-360. 
Ruggeri Laderchi, C., Saith, R., & Stewart, F. (2003). Does it Matter that we do not Agree on 
the Definition of Poverty? A Comparison of Four Approaches. Oxford Development Studies, 
31, 243-274. 
Sach, T., Smith, R. D., & Whynes, D. K. (2007). A 'League Table' of Contingent Valuation 
Results for Pharmaceutical Internveions: A Hard Pill to Swallow? Pharmacoeconomics, 25, 
107-127. 
Saith, R. (2011). A Public Health Perspective on the Capability Approach. Journal of Human 
Development and Capabilities, 12, 587-594. 
Salomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A. et al. (2012). 
Common values in assessing health outcomes from disease and injury: disability weights 





Schlosser, R. W., Wendt, O., Bhavnani, S., & Nail-Chiwetalu, B. (2006). Use of information
seeking strategies for developing systematic reviews and engaging in evidencebased 
practice: the application of traditional and comprehensive Pearl Growing. A review. 
International Journal of Language & Communication Disorders, 41, 567-582. 
Schokkaert, E. & Van Ootegem, L. (1990). Sen's concept of the living standard applied to the 
Belgian unemployed. Recherches Economiques de Louvain, 56, 429-450. 
Sculpher, M. J., Claxton, K., Drummond, M., & McCabe, C. (2006). Whither trial-based 
economic evaluation for health care decision making? Health Economics, 15, 677-687. 
Segall, S. (2010). Health, luck and justice. Woodstock, Oxfordshire: Princeton University 
Press. 
Sen, A. (1977). Social choice theory: A re-examination. Econometrica, 45, 53-89. 
Sen, A. (1970). The Impossibility of a Paretian Liberal. The Journal of Political Economy, 78, 
152-157. 
Sen, A. (1976). Poverty: An Ordinal Approach to Measurement. Econometrica, 44, 219-231. 
Sen, A. (1979). Personal Utilities and Public Judgements: Or What's Wrong With Welfare 
Economics. The Economic Journal, 89, 537-558. 
Sen, A. (1980). Equality of What? In The Tanner Lectures. 
Sen, A. (1985). Commodities and Capabilities. Amsterdam, North-Holland. 
Sen, A. (1992). Inequality Reexamined. (1st ed.) Oxford University Press. 
Sen, A. (1993). Capability and Well-Being. In M.Nussbaum & A. Sen (Eds.), The Quality of 
Life (1st ed., pp. 30-53). Oxford University Press. 
Sen, A. (1999). Development as Freedom. Oxford University Press, Oxford. 
Sen, A. (2002). Health: Perception versus observation. British Medical Journal, 324, 860-861. 
Sen, A. (2004). Capabilities, Lists, and Public Reason: Continuing the Conversation. Feminist 
Economics, 10, 77-80. 
Sen, A. (2009). The Idea of Justice. Harvard University Press. 
Sendi, P., Gafni, A., & Birch, S. (2002). Opportunity costs and uncertainty in the economic 
evaluation of health care interventions. Health Economics, 11, 23-31. 
Simon, J., Anand, P., Gray, A., Rugkåsa, J., Yeeles, K., & Burns, T. (2013). Operationalising 
the capability approach for outcome measurement in mental health research. Social Science & 




Smith, A. (1776). An Inquiry into the Nature and Causes of the Wealth of Nations. Oxford: 
Clarendon Press. 
Smith, M. & Barrett, A. M. (2011). Capabilities for learning to read: An investigation of 
social and economic effects for Grade 6 learners in Southern and East Africa. International 
Journal of Educational Development, 31, 23-36. 
Smith, R., Lorgelly, P., Al-Janabi, H., Venkatapuram, S., & Coast, J. (2012). The capability 
approach: an alternative evaluation paradigm for health economics? In A.Jones (Ed.), The 
Elgar Companion to Health Economics (2nd ed., pp. 415-424). Cheltenham, UK: Edward 
Elgar Publishing, Inc. 
Sprangers, M. A. G. & Schwartz, C. E. (1999). Integrating response shift into health-related 
quality of life research: a theoretical model. Social Science & Medicine, 48, 1507-1515. 
Stafinski, T., McCabe, C. J., & Menon, D. (2010). Funding the Unfundable: Mechanisms for 
Managing Uncertainty in Decisions on the Introduction of New and Innovative Technologies 
into Healthcare Systems. Pharmacoeconomics, 28, 113-142. 
Stafinski, T., Menon, D., & McCabe, C. J. (2011). Health Technology Funding Decision-
Making Processes Around the World: The Same, Yet Different. Pharmacoeconomics, 29, 
475-495. 
Stahl, J. (2008). Modelling Methods for Pharmacoeconomics and Health Technology 
Assessment. Pharmacoeconomics, 26, 131-148. 
Stiglitz, J. E., Sen, A., & Fitoussi, J.-P. (2009). Report by the Commission on the 
Measurement of Economic Performance and Social Progress Paris: Commission of the 
Government of France. 
Stinnett, A. A. & Paltiel, A. D. (1996). Mathematical programming for the efficient allocation 
of health care resources. Journal of Health Economics, 15, 641-653. 
Stolk, E., van Donselaar, G., Brouwer, B., & Busschbach, J. (2004). Reconciliation of 
Economic Concerns and Health Policy: Illustration of an Equity Adjustment Procedure Using 
Proportional Shortfall. Pharmacoeconomics, 22, 1097-1107. 
Sugden, R. (1993). Review: Welfare, Resources, and Capabilities: A Review of Inequality 
Reexamined by Amartya Sen. Journal of Economic Literature, 31, 1947-1962. 
Sugden, R. & Williams, A. (1978). The Principles of Practical Cost-Benefit Analysis. Oxford 
University Press. 
Sullivan, P. W. (2011). Are Utilities Bounded at 1.0? Implications for Statistical Analysis and 
Scale Development. Medical Decision Making, 31, 787-789. 
Sullivan, P. W. & Ghushchyan, V. (2006). Mapping the EQ-5D Index from the SF-12: US 
General Population Preferences in a Nationally Representative Sample. Medical Decision 




Sunstein, C. R. (1995). Incompletely Theorized Agreements. Harvard Law Review, 108, 
1733-1772. 
Sutton, E. J. & Coast, J. (2013). Development of a supportive care measure for economic 
evaluation of end-of-life care using qualitative methods. Palliative Medicine. 
Tan-Torres Edejer, T., Baltussen, E. R., Adam, T., Hutubessy, R., Acharya, A., Evans, D. B. 
et al. (2003). Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: 
World Health Organisation. 
The World Bank (2010). Extreme Poverty Continues to Fall. 
http://data.worldbank.org/news/extreme-poverty-rates-continue-to-fall [On-line]. 
Thokala, P. & Duenas, A. (2012). Multiple Criteria Decision Analysis for Health Technology 
Assessment. Value in Health, 15, 1172-1181. 
Tikly, L. & Barrett, A. M. (2011). Social justice, capabilities and the quality of education in 
low income countries. International Journal of Educational Development, 31, 3-14. 
Torrance, G. W., Thomas, W. H., & Sackett, D. L. (1972). A Utility Maximisation Model for 
Evaluation of Health Care Programs. Health Services Research, 7, 118-133. 
Tosh, J. C., Longworth, L. J., & George, E. (2011). Utility values in National Institute for 
Health and Clinical Excellence (NICE) Technology Appraisals. Value in health : the journal 
of the International Society for Pharmacoeconomics and Outcomes Research, 14, 102-109. 
Trani, J. F., Bakhshi, P., & Nandipati, A. (2012). 'Delivering' education; maintaining 
inequality. The case of children with disabilities in Afghanistan. Cambridge Journal of 
Education, 42, 345-365. 
Tsuchiya, A., Brazier, J., McColl, E., & Parkin, D. (2002). Deriving preference-based single 
indices from non-preference based condition specific instruments: converting AQLQ into EQ-
5D indices. HEDS Discussion Paper. 
Tsuchiya, A. & Dolan, P. (2005). The QALY Model and Individual Preferences for Health 
States and Health Profiles over Time: A Systematic Review of the Literature. Medical 
Decision Making, 25, 460-467. 
Turner, N., Campbell, J., Peters, T., Wiles, N., & Hollinghurst, S. (2013). A comparison of 
four different approaches to measuring health utility in depressed patients. Health and Quality 
of Life Outcomes, 11, 81. 
Ubel, P., Loewenstein, G., & Jepson, C. (2003). Whose quality of life? A commentary 
exploring discrepancies between health state evaluations of patients and the general public. 
Quality of Life Research, 12, 599-607. 
ul Haq, M. (1990). Concept and measurement of human development: Human Development 




van de Wetering, E., Stolk, E., van Exel, N., & Brouwer, W. (2013). Balancing equity and 
efficiency in the Dutch basic benefits package using the principle of proportional shortfall. 
The European Journal of Health Economics, 14, 107-115. 
Van Ootegem, L. & Verhofstadt, E. (2012). Using Capabilities as an Alternative Indicator for 
Well-being. Social Indicators Research, 106, 133-152. 
Vaughan, D. (2011). The importance of capabilities in the sustainability of information and 
communications technology programs: the case of remote Indigenous Australian 
communities. Ethics and Information Technology, 13, 131-150. 
Venkatapuram, S. (2011). Health Justice: An Argument from the Capabilities Approach. 
Cambridge, UK: Polity Press. 
Verkerk, M. A., Busschbach, J. J. V., & Karssing, E. D. (2001). Health-related quality of life 
research and the capability approach of Amartya Sen. Quality of Life Research, 10, 49-55. 
von Neumann, J. & Morgenstern, O. (1953). Theory of games and economic behaviour. (3rd 
ed.) Princeton, New Jersey: Princeton University Press. 
Wagle, U. R. (2008). Multidimensional poverty: An alternative measurement approach for the 
United States? Social Science Research, 37, 559-580. 
Wagle, U. (2009). Capability Deprivation and Income Poverty in the United States, 1994 and 
2004: Measurement Outcomes and Demographic Profiles. Social Indicators Research, 94, 
509-533. 
Walby, S. (2012). Sen and the Measurement of Justice and Capabilities: A Problem in Theory 
and Practice. Theory, Culture & Society, 29, 99-118. 
Walker, M. (2006). Towards a capability-based theory of social justice for education policy-
making. Journal of Education Policy, 21, 163-185. 
Walker, M. (2008). A human capabilities framework for evaluating student learning. 
Teaching in Higher Education, 13, 477-487. 
Walker, M. (2012). A capital or capabilities education narrative in a world of staggering 
inequalities? International Journal of Educational Development, 32, 384-393. 
Wang, L. (2011). Social exclusion and inequality in higher education in China: A capability 
perspective. International Journal of Educational Development, 31, 277-286. 
Ware, J. E., Kolinski, M., & Keller, S. (1995). How to Score the SF-12 Physical and Mental 
Health Summaries: A User's Manual. New England Medical Centre, Boston, MA: Boston: 
The Health Institute. 
Ware, J. E., Jr. & Sherbourne, C. D. (1992). The MOS 36-Item Short-Form Health Survey 




Weinstein, M. C. & Stason, W. B. (1977). Foundations of cost-effectiveness analysis for 
health and medical practices. The New England journal of medicine, 296, 716-721. 
Weinstein, M. C. (1990). Principles of Cost-Effective Resource Allocation in Health Care 
organizations. International Journal of Technology Assessment in Health Care, 6, 93-103. 
Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The Basics. Value in Health, 
12, S5-S9. 
Whitehead, M. (1990). The concepts and principles of equity and health Copenhagen: World 
Health Organization. 
Whitehurst, D. G. T. & Bryan, S. (2011). Another Study Showing that Two Preference-Based 
Measures of Health-Related Quality of Life (EQ-5D and SF-6D) are Not Interchangeable. But 
Why Should We Expect Them to be? Value in Health, 14, 531-538. 
Williams, A. (1985). Economics of Coronary Artery Bypass Grafting. British Medical 
Journal, 291, 326-329. 
Williams, A. (1997). Intergenerational Equity: An Exploration of the 'Fair Innings' Argument. 
Health Economics, 6, 117-132. 
Winkelmann, R. (2012). Copula bivariate probit models: with an application to medical 
expenditures. Health Economics, 21, 1444-1455. 
Wolfe, F. (2001). Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a 
difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 
rheumatoid arthritis patients following leflunomide initiation. The Journal of Rheumatology, 
28, 982-989. 
Wust, K. & Volkert, J. (2012). Childhood and Capability Deprivation in Germany: A 
Quantitative Analysis Using German Socio-Economic Panel Data. Social Indicators 
Research, 106, 439-469. 
Xie, F., Pullenayegum, E. M., Li, S. C., Hopkins, R., Thumboo, J., & Lo, N. N. (2010). Use 
of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-
5D Utility Index. Value in Health, 13, 873-878. 
Young, M. (2009). Basic Capabilities, Basic Learning Outcomes and Thresholds of Learning. 
Journal of Human Development and Capabilities, 10, 259-277. 
Zaidi, A. & Burchardt, T. (2005). Comparing incomes when needs differ: equivalization for 
the extra costs of disability in the U.K. Review of Income and Wealth, 51, 89-114. 
 
 
